apps.who.intapps.who.int/medicinedocs/documents/s21677en/s21677… · xls file · web...

IRAN DRUG LIST

دارو نام دارويي شکل مصرف راه دارو دسته توضيحات تاریخ

Drug Name Dosage Form Route of Admin ATC Code Description List Name Date

CAPSULE ORAL V09FX02 For Diagnostic Use 1389/10/25

CAPSULE ORAL V09FX02 For Diagnostic Use 1389/10/25

SOLUTION ORAL V09FX02 For Diagnostic Use 1389/10/25

SOLUTION ORAL V09FX02 For Therapeutic Use 1389/10/25

PARENTERAL V09IX04 For Diagnostic Use 1389/10/25


PARENTERAL V09 For Diagnostic Use 1389/10/25

ايران داروهاي الفبايي فهرست

فهرستدارويي -سطح

دسترسی

(123I) Sodium Iodide 0.1 mCi

(123I) Sodium Iodide 0.2 mCi

(123I) Sodium Iodide 2 mCi/ml

(131I) Sodium Iodide (3.5-150) mCi

(18F) Fludeoxyglucose (10-30) mCi

INJECTION, SOLUTION

(18F) Sodium Fluoride 10 mCi

INJECTION, SOLUTION

(62Cu) Pyruvaldehyde bis (N4-methylthiosemicarbazone) (PTSM) (50-100) mCi

INJECTION, SOLUTION

IRAN DRUG LIST




دسترسی

PARENTERAL V10 For Therapeutic Use 1389/10/25

INJECTION PARENTERAL B01AC13 -

Absorption Base BULK V03 -

A.C.A* TABLET ORAL NO2BE51

A.C.A* TABLET ORAL N02BE51

Acarbose 100 mg TABLET ORAL A10BF01 -

Acarbose 50 mg TABLET ORAL A10BF01 -

Acetaminophen 325 mg CAPSULE, GELATIN COATED ORAL N02BE01 -

(64Cu) Diacetyl-bis(N4-methylthiosemicarbazone) (ATSM) (5-10) mCi

INJECTION, SOLUTION

Abciximab 2 mg/ml, 5ml

داروهاي فهرستدسترسي با

در. فقط خاصداروخانه

توزيع بيمارستانيداروهاي ميشود فهرست

بالکAcetaminophen 250mg+caffeine 65mg+ASA 250mg

Acetaminophen 162.5mg+caffeine 32.5mg+ASA 325mg

داروهاي فهرستOTC

IRAN DRUG LIST




دسترسی

INJECTION INTRAVENOUS N02BE01 -

INJECTION, SOLUTION INTRAVENOUS N02BE01 -

Acetaminophen 100 mg/ml SUSPENSION ORAL N02BE01 -

Acetaminophen 100 mg/ml SOLUTION ORAL N02BE01 -

SUSPENSION ORAL N02BE01 -

SOLUTION ORAL N02BE01 -

Acetaminophen 10 mg/ml, 100ml


به. فقط خاصتزريق صورت

در ، وريديپس و بيمارستان

پروتکل تهيه ازمصرف موردگيرد .قرار








Acetaminophen 120 mg/5ml


Acetaminophen 120 mg/5ml


IRAN DRUG LIST




دسترسیAcetaminophen 125 mg SUPPOSITORY RECTAL N02BE01 -

Acetaminophen 125 mg TABLET, DISINTEGRATING ORAL N02BE01 کشور داخل در تولید شرط به 1389/7/17

INTRAVENOUS DRIP N02BE01 -

INTRAVENOUS DRIP N02BE01 -




INJECTION, SOLUTION, CONCENTRATE











IRAN DRUG LIST




دسترسی

PARENTERAL N02BE01 -

Acetaminophen 160 mg TABLET, DISPERSIBLE ORAL N02BE01 - 1389/6/29


Acetaminophen 325 mg SUPPOSITORY RECTAL N02BE01 -

Acetaminophen 325 mg TABLET ORAL N02BE01 -

Acetaminophen 500 mg TABLET ORAL N02BE01 -

Acetaminophen 500 mg CAPSULE, GELATIN COATED ORAL N02BE01 -

Acetaminophen 500 mg TABLET, EFFERVESCENT ORAL N02BE01 Soluble


Acetaminophen 80 mg TABLET, DISPERSIBLE ORAL N02BE01 -

Acetaminophen 150 mg/ml, 6.7ml





پروتکل تهيه ازمصرف موردگيرد داروهاي .قرار فهرست

OTCداروهاي فهرست








OTC

IRAN DRUG LIST




دسترسیTABLET ORAL N02BE71

CAPSULE, GELATIN COATED ORAL N02BE71 1389/11/4

TABLET ORAL N02BE51

CAPSULE ORAL N02BE71

CAPSULE, SOFT GEL ORAL N02BE71 1390/07/04

SYRUP ORAL R05X 1392/09/25

Acetaminophen Codeine 300/10 mg

Acetaminophen 300mg + Codeine Phosphate 10mg

Acetaminophen/ Codeine Phosphate 300/10 mg

Acetaminophen 300mg + Codeine Phosphate 10mg داخل در تولید شرط بهکشور

Acetaminophen/Caffeine 500/65 mg

Acetaminophen 500mg + Caffeine 65mg


Acetaminophen/ Caffeine/ Ibuprofen 325/(30-40)/ 200 mg

Acetaminophen 325mg + Caffeine (30-40) mg + Ibuprofen 200mg


Acetaminophen/Caffeine / Ibuprofen 325/ 40/200 mg

Acetaminophen 325mg + Caffeine 40 mg+ Ibuprofen 200mg


Acetaminophen/Chlorpheniramine Maleate/Dextrometorphan HBr/Phenylephrine HCl 160/1/5/2.5 mg/5ml

Acetaminophen160 mg/Chlorpheniramine Maleate 1 mg/DextrometorphanHBr 5 mg/Phenylephrine HCl 2.5mg/5ml


IRAN DRUG LIST




دسترسیSYRUP ORAL R05X 1391/06/13

SYRUP ORAL R05X 1392/05/01

Acetazolamide 250 mg TABLET ORAL S01EC01 -

Acetazolamide 500 mg INJECTION, POWDER, PARENTERAL S01EC01 **(As Sodium)**

Acetic Acid BULK V03 -

Acetone BULK V03 -

Acetylcholine Chloride 1% INJECTION OPHTHALMIC S01EB09 -

Acetylcysteine 200 mg TABLET ORAL R05CB01 -

Acetylcysteine 200 mg TABLET, EFFERVESCENT ORAL R05CB01 -

Acetylcysteine 200 mg/ml INJECTION PARENTERAL V03AB23 -

Acetylcysteine 600 mg TABLET, EFFERVESCENT ORAL R05CB01 -

Acetaminophen/DiphenhydramineHCL/phenylephrine HCL

(Acetaminophen160 mg/DiphenhydramineHCL12.5mg/phenylephrine HCL2.5 mg)/5ml


Acetaminophen/Guaifensine/phenylephrine

Acetaminophen125/Guaifenesine 50mg/phenylephrine2.5/5ml


داروهاي فهرستبالک




توزيع بيمارستانيميشود

IRAN DRUG LIST




Acetylcysteine 600 mgدسترسی Sachet ORAL R05CB01

POWDER ORAL R05CB

Aciclovir 250 mg PARENTERAL J05AB01

Aciclovir 500 mg INJECTION, POWDER PARENTERAL J05AB01

Aciclovir 200 mg TABLET ORAL J05AB01 -

Aciclovir 3% OINTMENT OPHTHALMIC S01AD03 -


Aciclovir 5% CREAM TOPICAL D06BB03 -


Acitretin 10 mg CAPSULE ORAL D05BV02 -

Acitretin 25 mg CAPSULE ORAL D05BV02 -

Acetylcysteine/Ascorbic Acid 600/75 mg

(Acetylcysteine 600mg + Vitamin C 75mg)/SACHET

INJECTION, POWDER, LYOPHILIZED




دسترسي بادر. فقط خاص

داروخانهتوزيع بيمارستاني

ميشود

IRAN DRUG LIST




دسترسیPARENTERAL B02BD03 -

PARENTERAL B02BD03 -

Adalimumab 40mg/0.8ml INJECTION,SOLUTION PARENTERAL L04AB04 1391/12/23

Adapalene 0.1% CREAM TOPICAL D10AD03 -

Adapalene 0.1% GEL TOPICAL D10AD03 -

Adapalene 0.1% LOTION TOPICAL D10AD03 -

Adapalene 0.1% SOLUTION TOPICAL D10AD03 -

Adefovir Dipivoxil 10 mg TABLET ORAL J05AF08 -

INJECTION PARENTERAL C01EB10

Activated Prothrombin Complex (concentrated) 1000 U


Activated Prothrombin Complex (concentrated) 500 U


Adenosine 3 mg/ml, 2ml




IRAN DRUG LIST




دسترسی

TABLET ORAL R05X

Capsule, Liquid filled ORAL R05X

Adult Cold Preparations_1: (Decongestant+ Analgesic)

As Decongestant: Phenylephrine HCl (5mg) or Pseudoephedrine HCl (30mg ,120mg) ,As Analgesic: Acetaminophen ( 250,325, 500 mg) or Ibuprofen(200mg) or Naproxen sodium( 220mg), The combinations to be exist in international Pharmacopoeia, if 120 mg Pseudoephedrine is in formulation it would be extended release



As Decongestant: Phenylephrine HCl (5mg) or Pseudoephedrine HCl (30mg ,120mg) ,As Analgesic: Acetaminophen ( 250,325, 500 mg) or Ibuprofen(200mg) or Naproxen sodium( 200mg), The combinations to be exist in international Pharmacopoeia , if 120 mg Pseudoephedrine is in formulation it would be extended release


IRAN DRUG LIST




دسترسی

TABLET ORAL R05X


TABLET ORAL R05X

Adult Cold Preparations_2: (Decongestant + Expectorant+ Analgesic)

As Decongestant: Pseudoephedrine HCl (30 mg),As Expectorant : Guaifenesin ( 200 mg), As Analgesic: Acetaminophen ( 325 mg), The combinations to be exist in international Pharmacopoeia





Adult Cold Preparations_3: (Antihistamine + Analgesic )

As Antihistamine: Chlorpheniramine maleate(2mg) or Diphenhydramine HCl (12.5 ,25mg), As Analgesic : Acetaminophen ( 325, 500 mg), The combinations to be exist in international Pharmacopoeia


IRAN DRUG LIST




دسترسی


TABLET ORAL R05X

Adult Cold Preparations_3: (Antihistamine + Analgesic )



Adult Cold Preparations_4: (Decongestant +Antihistamine+ Analgesic)

As Analgesic: Acetaminophen ( 162.5 , 300,325, 500, 650 mg) ,As Decongestant: Phenylephrine HCl (5,10 mg) or Pseudoephedrine (30,60mg) , As Antihistamine: Diphenhydramine HCl (12.5, 25 mg) or Chlorpheniramine maleate (2 , 4 mg) or Clemastine fumarate (0.335mg), The combinations to be exist in international Pharmacopoeia


IRAN DRUG LIST




دسترسی


TABLET ORAL R05X


As Analgesic: Acetaminophen ( 162.5 ,250, 300,325, 500, 650 mg) ,As Decongestant: Phenylephrine HCl (5,10 mg) or Pseudoephedrine (30,60mg) , As Antihistamine: Diphenhydramine HCl (12.5, 25 mg) or Chlorpheniramine maleate (2 , 4 mg) or Clemastine fumarate (0.335mg), The combinations to be exist in international Pharmacopoeia


Adult Cold Preparations_5: (Antitussive + Decongestant + Analgesic )

As Antitussive: Dextromethorphan HBr (10,15mg) , As Decongestant : Pseudoephedrine HCl (30 mg) or Phenylephrine HCl (5 mg), As Analgesic: Acetaminophen (325-500 ), The combinations to be exist in international Pharmacopoeia


IRAN DRUG LIST




دسترسی


TABLET ORAL R05X




Adult Cold Preparations_6: (Antitussive+ Antihistamine+ Analgesic )

As Analgesic : Acetaminophen(300 mg), As antihistamine: Chlorpheniramine maleate (2 mg ) , As Antitussive: Dextromethorphan(15 mg ), The combinations to be exist in international Pharmacopoeia


IRAN DRUG LIST




دسترسی


TABLET ORAL R05X




Adult Cold Preparations_7 :(Antitussive+ Antihistamine+ Decongestant+ Analgesic)

As Antitussive : Dextromethorphan(10,15 mg), As Antihistamine: Chlorpheniramine maleate (2 mg) , As Decongestant : Pseudoephedrine (30 mg) or Phenylephrine HCl (5 mg), As Analgesic: Acetaminophen (250, 325,500 mg), The combinations to be exist in international Pharmacopoeia


IRAN DRUG LIST




دسترسی



TABLET ORAL R05X




Adult Cold Preparations_8: (Antitussive+ Expectorant+ Decongestant+ Analgesic)

As Antitussive : Dextromethorphan (10, 15 mg), As Expectorant : Guaifenesin (100, 200 mg), As Decongestant : Pseudoephedrine HCl (30mg) or Phenylephrine HCl (5mg), As Analgesic: Acetaminophen(250, 325 mg), The combinations to be exist in international Pharmacopoeia





IRAN DRUG LIST




دسترسی

Albendazole 200 mg TABLET, CHEWABLE ORAL P02CA03

Albendazole 200 mg/5ml SUSPENSION ORAL P02CA03

Albendazole 400 mg TABLET, CHEWABLE ORAL P02CA03

INJECTION, SOLUTION PARENTERAL B05AA01

Treatment of hydatid disease (cystic echinococcosis due to E. granulosus larvae or alveolar echinococcosis due to E. multilocularis larvae).



Albumin (Human) 20%, 100ml




IRAN DRUG LIST




دسترسی


















Albumin (Human) 20%, 50ML




Albumin (Human) 5%, 100ML




IRAN DRUG LIST




دسترسی



Alemtuzumab 30 mg/ ml INTRAVENOUS DRIP L01XC04

Alendronate 10 mg TABLET ORAL M05BA04

Alendronate 35 mg TABLET ORAL M05BA04 **(As Sodium)**

Alendronate 70 mg TABLET ORAL M05BA04 **(As Sodium)**

TABLET ORAL M05BB03 1390/1/29

TABLET ORAL M05BB03 1390/3/9









Concentrate for Intravenous Infusion Treatment of osteogenesis

imperfecta in pediatric patients 4 years of age and older Treatment of the bone manifestations of Gaucher disease

Alendronic acid/Colecalciferol 70 mg/140mcg

**(As Sodium Alendronate, 3H2O)** Colecalciferol 5600 IU


**(As Sodium Alendronate, 3H2O)** Colecalciferol 2800 IU در تولید شرط به

کشور داخل

IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL N01AH02


INJECTION PARENTERAL N01Ah02

Alglucosidase Alfa 50 mg INJECTION, POWDER PARENTERAL A16AB07 1390/07/05

Allergenic Extracts INJECTION PARENTERAL V01AA20 -

Allopurinol 100 mg TABLET ORAL M04AA01 -

Allopurinol 300 mg TABLET ORAL M04AA01 -

Alprazolam 0.5 mg TABLET ORAL N05BA12 -

Alprazolam 1 mg TABLET ORAL N05BA12 -

Alfentanil (as HCl) 0.5 mg/ml, 2ml




Alfentanil (as HCl) 0.5 mg/ml, 10ml




Alfentanil (as HCl) 0.5 mg/ ml, 5ml




جهت - - متابولیک داروهای خاص داروهای گردد 14فهرست می ثبت بیمار .

IRAN DRUG LIST




دسترسیAlteplase 10 mg INJECTION, POWDER PARENTERAL B01AD02

Alteplase 20 mg INJECTION, POWDER PARENTERAL B01AD02

Alteplase 50 mg INJECTION, POWDER PARENTERAL B01AD02

Aluminium Chloride BULK V03 -

TABLET, CHEWABLE ORAL A02AB01 **(as Dried Gel)**

SUSPENSION ORAL A02AB01 **(as Gel)**

TABLET, CHEWABLE ORAL A02AX

SUSPENSION ORAL A02AX

SUSPENSION ORAL A02AX

POWDER, FOR SUSPENSION ORAL A02AX

intraventricular hemorrhage associated with intracerebral hemorrhage

داروهاي فهرست(orphan) خاص






Aluminium Hydroxide 300 mg


Aluminium Hydroxide 320 mg/5ml


Aluminium/Magnesium 200/200 mg

Aluminium hydroxide 200mg + magnesium hydroxide 200mg


Aluminium/Magnesium 225/200 mg/5ml

(Aluminium hydroxide 225mg+magnesium hydroxide 200)/5ml


Aluminium/Magnesium 225/200 mg/5ml, 10ml

(Aluminium hydroxide 225mg+magnesium hydroxide 200mg)/5ml **Sachet**


Aluminium/Magnesium 564/174 mg

(Aluminium hydroxide 564mg + Magnesium hydroxide 174mg)/sachet


IRAN DRUG LIST




دسترسی

SUSPENSION ORAL A02AF02Aluminium/Magnesium/Simethicone

(Aluminium hydroxide 225mg+magnesium hydroxide 200mg+simethicone 25mg)/5ml


IRAN DRUG LIST




دسترسی

TABLET, CHEWABLE ORAL A02AF02

SUSPENSION ORAL A02AF02

CAPSULE ORAL N04BB01 -

Aluminium/Magnesium/Simethicone

Aluminium hydroxide 200mg+magnesium hydroxide 200mg+simethicone 25mg


Aluminium/Magnesium/Simethicone 10 ml

(Aluminium hydroxide 225mg+magnesium hydroxide 200mg+simethicone 25mg)/5ml**SACHET**


Amantadine Hydrochloride 100 mg

IRAN DRUG LIST




دسترسی

TABLET ORAL N07AA30 -

Amikacin 250 mg/ml, 2ml INJECTION PARENTERAL J01GB06

Ambenonium Chloride 10 mg

Treatment of bronchopulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients

IRAN DRUG LIST




دسترسی

Amikacin 50 mg/ml, 2ml INJECTION PARENTERAL J01GB06 **(As Sulfate)**

IRAN DRUG LIST




دسترسی

TABLET ORAL C03EA01

INJECTION PARENTERAL B02AA01 -

Amiloride/Hyrochlorothiazide 5/50 mg

**(As dihydrate) 5mg + hyrochlorothiazide 50mg

Amino Caproic Acid 250 mg/ml

IRAN DRUG LIST




دسترسی


INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01 1390/1/29

Amino Caproic Acid 400 mg/ml,10ml

Aminoacid 5 % / Electrolyte

Isoleucine 2.50g+Leucine 4.45g+lysine HCl 4.28g+Methionine 2.20g+Phenylalanine 2.35g+Threonine 2.10g+Tryptophane 0.80g+Valine 3.10g+Arginine 5.75g+Histidine 1.50g+Alanine 5.25g+Glycine 6.00g+ Asparatic acid 2.80g+ Glutamic acid 3.60g +Proline 2.75g+Serine 1.15g+Tyrosine 0.40g+ Sodium acetate 3H2O 1.361g+ Sodium chloride 0.964g + Sodium hydroxide 0.140g+potassium acetate 2.453g+ Magnesium chloride 6H2O 0.508g+Disodium phosphate dodecahydrate 3.581g+ Water for inj. Q.S. to 1000 ml




IRAN DRUG LIST




دسترسی

INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01 1390/1/29Aminoacid 10 % / Electrolyte

{Isoleucine (0.77-13.80)mg+leucine (1.10-15.76)mg+Lysine HCL(1.08-15.75)mg+Methionine (0.40-8.80)mg+Phenylalanine (0.75-8.80)mg+Threonine (0.50-9.00)mg+Tryptophane (0.23-3.00)mg+ Valine (0.75-12.40)mg+ Arginine (0.93-20.00)mg+ Histidine (0.65-9.80)mg+ Alanine (0.846-82.00)mg+ Glycine (0.31-19.20)mg + Asparatic acid (0.65-10.50)mg + Glutamic acid (1.14-11.07)mg+Proline (1.15-17.00)mg + Serine (0.60-14.10)mg+ Tyrosine (0.05-10.16)mg+Sodium Acetate 3H2O 2.858mg+Sodium Hydroxide 0.360mg+Pottassium Acetate 2.453mg + Magnesium Chloride 6H2O 0.508mg+Disodium Phosphate dodecahydrate 3.581mg}/ml




IRAN DRUG LIST




دسترسی

Aminoacid 10 % INTRAVENOUS DRIP B05BA01 1389/8/24INJECTION, SOLUTION, CONCENTRATE

{Isoleucine (0.77-13.80)mg+leucine (1.10-15.76)mg+methionine (0.40-8.80)mg+phenylalanine (0.75-8.80)mg+threonine (0.50-9.00)mg+tryptophane (0.23-3.00)mg+ valine (0.75-12.40)mg+ arginine (0.93-20.00)mg+ histidine (0.65-9.80)mg+ alanine (0.846-82.00)mg+ taurine (0.12-2.00)mg+proline (1.15-17.00)mg+ serine (0.60-14.10)mg+ tyrosine (0.05-10.16)mg+ cysteine (0.074-2.00)mg+ asparagine (0.32-4.09)mg+ asparatic acid (0.65-10.50)mg+ glycine (0.31-19.20)mg+ glutamic acid (1.14-11.07)mg+ Lysine hydrochloride (1.08-15.75)mg+ Lysine acetate (3.34-9.31)mg+ornithine (0.63-3.75)mg +glutamine (1.20-22.08)mg +N-acetylcycteine 1.40 mg}/ml




IRAN DRUG LIST




دسترسی

Aminoacid 10 % INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01 1391/5/4

Isoleucine 8g +leucine 13g+lysine8.51g+methionine3.12g+phenylalalnine3.75g+threonine4.4g+Tryptophane2.01g+valine9g+Arginine7.50g+histidine4.76g+alanine9.3g+Glycine4.15g+N-Acetylcysteine0.7g+proline9.71g+serine7.67g+N-Acetyl tyrosine5.176g+Malic acid2.62g+Taurine0.4g water for inj Q.S. to1000 ml




IRAN DRUG LIST




دسترسی

Aminoacid 10 % INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01 1390/09/21

INTRAVENOUS DRIP B05BA01 1389/11/4

Isoleucine 5g + leucine 8.9g+ Lysine acetate 5.74 g + Lysine monohydrate 3.12 g+ methionine 4.4 g+ phenylalanine 4.7 g+ threonine 4.2 g+ tryptophane 1.6g+ valine6.2 g+ arginine 11.5 g+ histidine3 g+ alanine10.5 g+ glycine12g+ asparatic acid5.6 g+ glutamic acid 7.2 g+ proline 5.5 g+ serine 2.3 g+ tyrosine 0.4 g




Aminoacid 10 % /Electrolyte


{Isoleucine (0.77-13.80)mg+leucine (1.10-15.76)mg+Methionine (0.40-8.80)mg+Phenylalanine (0.75-8.80)mg+Threonine (0.50-9.00)mg+Tryptophane (0.23-3.00)mg+ Valine (0.75-12.40)mg+ Arginine (0.93-20.00)mg+ Histidine (0.65-9.80)mg+ Alanine (0.846-82.00)mg+ Taurine (0.12-2.00)mg+Proline (1.15-17.00)mg+ Serine (0.60-14.10)mg+ Tyrosine (0.05-10.16)mg+ Cysteine (0.074-2.00)mg+ Asparagine (0.32-4.09)mg+ Asparatic acid (0.65-10.50)mg+ Glycine (0.31-19.20)mg+ Glutamic acid (1.14-11.07)mg+ Lysine hydrochloride (1.08-15.75)mg+ Lysine acetate (3.34-9.31)mg+Ornithine (0.63-3.75)mg +Glutamine (1.20-22.08)mg +Acetylcysteine 0.68 mg+N-Acetyltyrosine 1.23 mg+Sodium Acetate 3H2O 3.95mg+Pottassium Acetate 2.454mg+Magnesium Acetate 4H2O 0.56mg+Sodium Dihydrogen Phosphate dihydrate 1.404mg+Malic Acid 1.01mg+Sodium Hydroxide 0.2mg}/ml




IRAN DRUG LIST




دسترسی

Aminoacid 5% INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01


Isoleucine 2.55g+Leucine 4.45g+Lysine HCl 3.5g +Methionine 1.9g+Phenylalanine2.55g+Threonine 2.05g+Tryptophane 0.90g+Valine 2.40g+Arginine 4.60g+Histidine 2.6g+Alanine 6.85g+Aminoacetic acid 3.95g+Asparagine H2O 1.86g+Aspartic acid 0.65g+Cysteine HCl 0.36g +glutamic acid 2.30g+Ornithine HCl 1.60g+Proline 4.45g+Serine 1.20g+Tyrosine 0.30g +N-Acetyl tyrosine 0.43g+Water for inj. Q.S. to 1000 ml




Isoleucine 2.55 g + Leucine 4.45 g + Lysine HCl 3.50 g + Methionine 1.90 g + Phenylalanine2.55 g + Threonine 2.05 g + Tryptophane 0.90 g + Valine 2.40 g + Arginine 4.60 g + Histidine 2.60 g + Alanine 6.85 g + Glycine 3.95 g + Asparagine H2O 1.86 g + Asp




IRAN DRUG LIST




دسترسی


Isoleucine 2.5g+Leucine 3.7g+Lysine(as monoacetate)3.3g+methionine2.15g+Phenylalanine2.55g+Threonine2.2g+Tryptophan1g+Valine3.1g+Arginine6g+Histidine1.5g+Glycine5.5g+Alanine7g+Proline5.6g+Serine3.25g+Tyrosin0.2g+Taurine0.5g and Water for inj. Q.S. to 1000 ml




IRAN DRUG LIST




دسترسی

Aminoacid 5% / Electrolyte INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01 1389/11/4

Isoleucine 2.55g+Leucine 4.45g+lysine HCl 3.50g+Methionine 1.90g+Phenylalanine 2.55g+Threonine 2.05g+Tryptophane 0.90g+Valine 2.40g+Arginine 4.60g+Histidine 2.60g+Alanine 6.85g+Glycine 3.95g+Asparagine H2O 1.86g+Asparatic acid 0.65g+Acetylcysteine 0.34g+Glutamic acid 2.30g+Ornithine HCl 1.60g+Proline 4.45g+Serine 1.20g+Tyrosine 0.30g+Acetyltyrosine 0.43g+Sodium acetate 3H2O 3.95g+Potassium acetate 2.454g+Magnesium acetate 4H2O 0.558g+Sodium dihydrogen phosphate dihydrate 1.4g+Malic acid 1.01g+Sodium hydroxide 0.2g Water for inj. Q.S. to 1000 ml




IRAN DRUG LIST




دسترسی

INJECTION,EMULSION INTRAVENOUS DRIP B05BA10 1389/11/4Aminoacid/Lipid/Glucose 1

nutriflex lipid plus: Isoleucine 2.26g +Leucine 3.01g+Lysine HCl 2.73g +Methionine 1.88g+Phenylalanine3.37g+Threonine 1.74g+Tryptophane 0.54g+Valine 2.50g+Arginine 2.59g+Histidine HCl monohydrate 1.62g+Alanine 4.66g+Glycine 1.58g+Aspartic acid 1.44g+Glutamic acid 3.37 g+Proline 3.26g+Serine 2.88+ Sodium Chloride 0.402g+Sodium acetate trihydrate 0.222g+ Potassium acetate 2.747g+ Magnesium Acetate tetrahydrate 0.686g + Calcium Chloride dihydrate 0.470g + Sodium hydroxide 0.781 g+Glucose monohydrate 132g+Sodium dihydrogen phosphate dihydrate 1.872g+Zinc acetate dihydrate 5.264g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml




IRAN DRUG LIST




دسترسی

INJECTION,EMULSION INTRAVENOUS DRIP B05BA10 1389/11/4Aminoacid/Lipid/Glucose 2

nutriflex lipid special: Isoleucine 3.28g + Leucine 4.38g + Lysine HCl 3.98g + Methionine 2.74g + Phenylalanine4.92g + Threonine 2.54g + Tryptophane 0.8g + Valine 3.6g + Arginine 3.780g + Histidine HCl monohydrate 2.37g + Alanine 6.79g + Glycine 2.31g + Aspartic acid 2.1g + Glutamic acid 4.91g +Proline 4.76g +Serine 4.2g + Sodium Chloride 0.378g+Sodium acetate trihydrate 0.25g+ Potassium acetate 3.689g+ Magnesium Acetate tetrahydrate 0.91g + Calcium Chloride dihydrate 0.623g + Sodium hydroxide 1.171 g+Glucose monohydrate 158.4g+Sodium dihydrogen phosphate dihydrate 2.496g+Zinc acetate dihydrate 7.02g+Triglyceride,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml




IRAN DRUG LIST




دسترسی

Aminoacid/Lipid/Glucose 3 INJECTION,EMULSION INTRAVENOUS DRIP B05BA10 1389/11/4

nutriflex lipid peri: Isoleucine 1.872g +Leucine 2.504g+Lysine HCl 2.272g +Methionine 1.568g+Phenylalanine2.808g+Threonine 1.456g+Tryptophane 0.456g+Valine 2.08g+Arginine 2.160g+Histidine HCl monohydrate 1.352g+Alanine 3.88g+Glycine 1.32g+Aspartic acid 1.20g+Glutamic acid 2.80 g+Proline 2.72g+Serine 2.40g+ Sodium Hydroxide 0.64g + Sodium Chloride 0.865g+Sodium acetate trihydrate 0.435g+ Potassium acetate 2.354g+ Magnesium Acetate 4H2o 0.515g + Calcium Chloride dihydrate 0.353g + Glucose monohydrate 70.4g +Sodium dihydrogen phosphate dihydrate 0.936g+Zinc acetate dihydrate 5.28g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml




IRAN DRUG LIST




دسترسیLOTION TOPICAL D02BA

Aminobezoic Acid 5% LOTION TOPICAL D02BA01 **Paba**

Aminoglutethimide 250 mg TABLET ORAL L02BG01 -

INJECTION PARENTERAL R03DA05 -

TABLET ORAL C01BD01 -

INJECTION, SOLUTION PARENTERAL C01BD01 1391/10/03

INJECTION PARENTERAL C01BD01


Aminobenzoic Acid/Padimate

Para Aminobenzoic Acid 5% w/w + Padimate O 3.2% w/w **(Paba-p)**

Aminophylline 25 mg/ml, 10ml

Amiodarone Hydrochloride 200 mg

Amiodarone Hydrochloride 150 mg/100ml

For the acute treatment and prophylaxis of life-threatening ventricular tachycardia or ventricular fibrillation.




Amiodarone Hydrochloride 50 mg/ml, 3ml





Amitriptyline Hydrochloride 10 mg

IRAN DRUG LIST




دسترسیTABLET ORAL N06AA09 -



Amlodipine 5 mg TABLET ORAL C08CA01 **(As Besylate)**

Amlodipine 10 mg TABLET ORAL C08CA01 **(As Besylate)**

Amlodipine 2.5 mg TABLET ORAL C08CA01 **(As Besylate)**

TABLET ORAL C10BX03

TABLET ORAL C10BX03

TABLET ORAL C10BX03

TABLET ORAL C09DB01 1390/07/04





Amlodipine/Atorvastatin 5/10 mg

**(Amlodipine As Besylate, Atorvastatin As Calcium)**





Amlodipine/ Valsartan 5/80 mg

Amlodipine (As Besilate) 5 mg/ Valsartan 80 mg به

داخل در تولید شرط




IRAN DRUG LIST




دسترسیTABLET ORAL C09DB01 1390/07/04



TABLET ORAL C09DX01 1392/03/11












داخل در تولید شرطAmlodipine/ Valsartan/Hydrochlortiazid 5mg/160mg/12.5mg

Amlodipine (As Besilate) 5 mg/ Valsartan 160 mg/Hydrochlortiazid 12.5mg

داخل در تولید شرط به

Amlodipine/ Valsartan/Hydrochlortiazid 5mg/160mg/25mg

Amlodipine (As Besilate) 5 mg/ Valsartan 160 mg/Hydrochlortiazid 25mg به


Amlodipine/ Valsartan/Hydrochlortiazid 10mg/160mg/12.5mg

Amlodipine (As Besilate) 10 mg/ Valsartan 160 mg/Hydrochlortiazid 12.5mg

داخل در تولید شرط به


Amlodipine (As Besilate) 10 mg/ Valsartan 160 mg/Hydrochlortiazid 25mg به


IRAN DRUG LIST




دسترسیAmmonium Alum BULK V03 -

Ammonium Chloride BULK V03 -

TABLET, DELAYED RELEASE ORAL G04BA01 -

Ammonium Hydroxide BULK V03 -

Amoxicillin 250 mg POWDER, FOR SUSPENSION ORAL J01CA04 -

Amoxicillin 125 mg TABLET, DISPERSIBLE ORAL J01CA04 **(As 3H2o)**

Amoxicillin 250 mg TABLET, CHEWABLE ORAL J01CA04 **(As 3H2o)**

Amoxicillin 250 mg TABLET, DISPERSIBLE ORAL J01CA04 **(As 3H2o)**

Amoxicillin 500 mg TABLET ORAL J01CA04 **(As 3H2o)**

Amoxicillin 125 mg/5ml POWDER, FOR SUSPENSION ORAL J01CA04 -

Amoxicillin 250 mg CAPSULE ORAL J01CA04 -

Amoxicillin 250 mg/5ml POWDER, FOR SUSPENSION ORAL J01CA04 -

Amoxicillin 400 mg/5ml POWDER, FOR SUSPENSION ORAL J01CA04

Amoxicillin 500 mg CAPSULE ORAL J01CA04 -




Ammonium Chloride 500 mg


IRAN DRUG LIST




دسترسی

INJECTION, POWDER PARENTERAL J02AA01

Amphotericin-B 50 mg PARENTERAL J02AA01

Amphotericin-B 50 mg PARENTERAL J02AA01

Amphotericin-B 0.4% GEL TOPICAL A01AB04 Nanoliposomal 1392/04/04

Ampicillin 1 g INJECTION, POWDER, PARENTERAL J01CA01 **(As Sodium)**

Ampicillin 250 mg INJECTION, POWDER, PARENTERAL J01CA01 **(As Sodium)**

Ampicillin 500 mg INJECTION, POWDER, PARENTERAL J01CA01 **(As Sodium)**

Ampicillin 125 mg/5ml POWDER, FOR SUSPENSION ORAL J01CA01 -

Ampicillin 250 mg CAPSULE ORAL J01CA01 -

Ampicillin 250 mg/5ml POWDER, FOR SUSPENSION ORAL J01CA01 -

Amphotericin B Liposome 50 mg

Treatment of invasive protothecosis.Treatment of invasive sporotrichosis.Treatment of invasive coccidioidomycosis.Treatment of invasive zygomycosis.Treatment of invasive candidiasis.Treatment of invasive fungal infections.

اختيار در فقطسالمت معاونت

گيرد قرار






As Complex with Sodium Cholesteryl Sulphate




IRAN DRUG LIST




Ampicillin 500 mgدسترسی CAPSULE ORAL J01CA01 -

INJECTION, POWDER PARENTERAL J01CR01

INJECTION, POWDER+C19 PARENTERAL J01CR01

Amyl Nitrite INHALER RESPIRATORY V03AB22

Anagrelide HCl 500 mcg CAPSULE ORAL L01XX35

Anthocyanoside A TABLET ORAL C04A

INJECTION INTRAMUSCULAR J06BB01 -

INTRAMUSCULAR J06BB01 -

INJECTION INTRAMUSCULAR J06BB01 -

INTRAMUSCULAR J06BB01 -

Ampicillin/Sulbactam 2 g /1 g ( 3g)

3 g : 2 g Ampicillin +1 g Sulbactam

Ampicillin/Sulbactam 1 g /0.5 g ( 1.5 g)

1.5 g : 1 g Ampicillin + 0.5 g Sulbactam

Treatment of cyanide poisoning



Myrtillus Anthocyanosidic Extract of Vaccinium Myrtillus 100mg + Betacarotene 5mg

Anti - D Immunoglobulin 250 mcg






IRAN DRUG LIST




دسترسیINJECTION INTRAVENOUS J06BB01

Anticoagulant POWDER NOT APPLICABLE B01

Antihemorrhoid OINTMENT RECTAL C05AD01

Antihemorrhoid SUPPOSITORY RECTAL C05AD01

CAPSULE, GELATIN COATED ORAL R01BA51

ORAL R01BA51

Anti - D Immunoglobulin 50 mcg/ml, 2ml

Treatment of immune thrombocytopenic purpura.

(Sodium citrate dehydrate 2.63 g + Citric acid anhydrous 0.299 g + Sodium biphosphate monohydrate 0.222 g + Dextrose monohydrate 3.19 g + Adenine 0.0275 g ) /100 ml BLOOD PACK

(Lidocaine 50mg+hydrocortisone acetate 2.75mg+aluminium subacetate 35mg+zinc oxide 180mg)/g


Lidocaine 60mg+hydrocortisone acetate 5mg+aluminium subacetate 50mg+zinc oxide 400mg


Antihistamine Decongestant*

Chlorpheniramine maleate 2 mg + Pseudoephedrine HCl 30 mg



CAPSULE, EXTENDED RELEASE

Brompheniramine Maleate 12mg+ Pseudoephedrine HCl 120 mg


IRAN DRUG LIST




دسترسیTABLET, EXTENDED RELEASE ORAL R01BA51

TABLET ORAL R01BA51

Antihistamine Decongestant TABLET ORAL R01BA53

INJECTION PARENTERAL L04AA03 -

INJECTION PARENTERAL L04AA03 -

INJECTION PARENTERAL J06AA -

Antisnake Aenom Serum INJECTION PARENTERAL J06AA03 -







Chlorpheniramine Maleate4mg/phenylephrine HCL 10mg


Antilymphocyte Immunoglobulin 20 mg/ml, 5ml

Antilymphocyte Immunoglobulin 50 mg/ml

Antiscorpion Aenom Serum

IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL L04AA04

PARENTERAL L04AA04


INJECTION PARENTERAL N04BC07

Aprepitant 125 mg CAPSULE ORAL A04AD12 -

Antithymocyte Immunoglobulin 20 mg/ml, 5ml

myelodys plastic syndrom(mds) allograft rejection, including solid organ(kidney,liver,heart,lung,pancreas)and bone marrow transplantation.

Antithymocyte Immunoglobulin 25 mg


Treatment of myelodysplastic syndrome (MDS)

Antithymocyte Immunoglobulin 50 mg/ml, 5ml

Treatment of myelodysplastic syndrome (MDS)

Apomorphine Hydrochloride 10 mg/ml

Treatment of the on-off fluctuations associated with late-stage Parkinson's disease.For the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain injury (traumatic or spontaneous)

IRAN DRUG LIST




Aprepitant 80 mgدسترسی CAPSULE ORAL A04AD12 -

Aprotinin 10,000 KIU/ml INJECTION PARENTERAL B02AB01

INJECTION PARENTERAL B02AB01

Arginine Hydrochloride INJECTION PARENTERAL B05XB01 **950 mOsmol/L**

For prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing cardiopulmonary bypass surgery in the course of repeat coronary artery bypass graft surgery, and in selected cases of primary c

Aprotinin 20,000 KIU/ml, 1ml

For prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing cardiopulmonary bypass surgery in the course of repeat coronary artery bypass graft surgery, and in selected cases of primary c

IRAN DRUG LIST




دسترسیArginine Hydrochloride INJECTION PARENTERAL B05XB01

POWDER ORAL B05XB01

INJECTION PARENTERAL B05XB01

Aripiprazole 5 mg TABLET ORAL N05AX12



Arsenic Trioxide 0.1% INJECTION PARENTERAL L01XX27

Treatment of sickle cell disease and beta thalassemia.


Arginine Hydrochloride 100 g

به مبتال بیماران برای فقط هیپرآمونمیا


Arginine Hydrochloride 100 mg/ml, 100ml



Treatment of malignant gliomaTreatment of chronic myeloid leukemiaTreatment of acute promyelocytic leukemiaTreatment of multiple myeloma.Treatment of liver cancerTreatment of chronic lymphocytic leukemiaTreatment of myelodysplastic syndrome.

IRAN DRUG LIST




دسترسی

Artemether 40 mg CAPSULE ORAL P01BE02

Artemether 80 mg INJECTION PARENTERAL P01BE02

Artesunate 200 mg INJECTION PARENTERAL P01BE03

Artesunate 200 mg TABLET ORAL P01BE03

INJECTION PARENTERAL N01BB58


Artificial Saliva SPRAY, SOLUTION ORAL A16AX -


در. فقط خاصمعاونت اختيار

گيرد قرار سالمتداروهاي فهرست


معاونت اختيارگيرد قرار سالمت

Immediate treatment of malaria


Immediate treatment of malaria

داروهاي فهرست (orphan) خاص

اختیار در فقطسالمت معاونت

گیرد قرارArticaine Hydrochloride/Epinephrine 4/0.001 %

**(Articaine Hydrochloride 4% + Epinephrine 1/100000)**

Articaine Hydrochloride/Epinephrine 4/0.002 %

**(Articaine Hydrochloride 4% + Epinephrine 1/200000)**


IRAN DRUG LIST




دسترسیArtificial Saliva GEL ORAL A16AX -

Artificial Tears GEL OPHTHALMIC S01XA20 -

Artificial Tears SOLUTION OPHTHALMIC S01XA20 -

Artisunate 100 mg TABLET ORAL P01BE03

Artisunate 200 mg INJECTION PARENTERAL P01BE03

Artisunate 50 mg SUPPOSITORY RECTAL P01BE03

Artisunate 60 mg/ml, 1ml INJECTION PARENTERAL P01BE03














IRAN DRUG LIST




دسترسیTABLET , ENTERIC-COATED ORAL B01AC06 کشور داخل در تولید شرط به 1391/11/02

TABLET, CHEWABLE ORAL B01AC06 -

TABLET ORAL N02BA01 Microcoated

TABLET, DELAYED RELEASE ORAL N02BA01 -

SUPPOSITORY RECTAL N02BA01 -

TABLET ORAL N02BA01 -

TABLET, EFFERVESCENT ORAL N02BA01 -

TABLET ORAL N02BA01 Microcoated

TABLET, DELAYED RELEASE ORAL B01AC06 -

ASA Codeine 500/10 mg TABLET ORAL N02BA71

ASA (Acetylsalicylic Acid) 81 mg


ASA (Acetylsalicylic Acid) 100 mg*
















ASA 500mg + -Codeine phosphate 10mg

IRAN DRUG LIST




دسترسیTABLET, EFFERVESCENT ORAL N02BA51

Asparaginase 10,000 U INJECTION, POWDER PARENTERAL L01XX02 -

Atenolol 100 mg TABLET ORAL C07AB03 -

Atomoxetine 10 mg CAPSULE ORAL N06BA09 1391/02/07





Atenolol 50 mg TABLET ORAL C07AB03 -

Atorvastatin 10 mg TABLET ORAL C10AA05 **(As Calcium)**



ASA/Ascorbic acid 400/240 mg

Acetylsalicylic acid 400mg+Ascorbic acid 240mg


کشور داخل در تولید شرط به (AS

Hydrochloride)کشور داخل در تولید شرط به

(AS Hydrochloride)


Hydrochloride)کشور داخل در تولید شرط به

(AS Hydrochloride)


Hydrochloride)

IRAN DRUG LIST




دسترسیTABLET ORAL P01AX

TABLET ORAL P01AX

TABLET ORAL P01AX

TABLET ORAL P01AX

INJECTION PARENTERAL M03AC04

Atovaquone/Chloroghanide Hydrochloride 250/100 mg

Prevention of Pneumocystis carinii pneumonia (PCP) in high-risk, HIV-infected patients

Atovaquone/Chloroghanide Hydrochloride 62.5/25 mg

Prevention of Pneumocystis carinii pneumonia (PCP) in high-risk, HIV-infected patients

Atovaquone/Proguanil Hydrochloride 250/100 mg

Atovaquone 250 mg + Proguanil Hydrochloride 100 mg



گيرد قرار سالمت

Atovaquone/Proguanil Hydrochloride 62.5/25 mg

Atovaquone 62.5 mg + Proguanil Hydrochloride 25 mg




Atracurium Besylate 10 mg/ml, 2.5ml




IRAN DRUG LIST




دسترسی


Atropine Sulfate 0.5 mg TABLET ORAL A03BA01 -

INJECTION PARENTERAL A03BA01 -

Atropine Sulfate 0.5% DROPS, SOLUTION OPHTHALMIC S01FA01 -


Atropine Sulfate 1% DROPS, SOLUTION OPHTHALMIC S01FA01 -

Atropine Sulfate 1% OINTMENT OPHTHALMIC S01FA01 -


INJECTION PARENTERAL A03BA01 In prefilled disposible syringe

Azathioprine 50 mg INJECTION, POWDER PARENTERAL L04AX01 **(As Sodium)**

Azathioprine 25 mg TABLET ORAL L04AX01

Azathioprine 50 mg TABLET ORAL L04AX01 -

Atracurium Besylate 10 mg/ml, 5ml




Atropine Sulfate 0.5 mg/ml, 1ml

Atropine Sulfate 1 mg/ml, 10ml

Atropine Sulfate 10 mg/ml, 2ml

Atropine Sulfate 2.5 mg/ml, 0.8ml

IRAN DRUG LIST




دسترسیAzelaic Acid BULK V03 -

Azelaic Acid 20% CREAM TOPICAL D10AX03 -

SPRAY NASAL R01AC03 1391/02/07

Azithromycin 1g/sachet POWDER, FOR SUSPENSION ORAL J01FA10 1392/03/21

Azithromycin 1% DROPS, SOLUTION OPHTHALMIC S01AA26 1390/1/29

Azithromycin 100 mg/5ml POWDER, FOR SUSPENSION ORAL J01FA10 **(As Dihydrate)**

Azithromycin 2 g POWDER, FOR SOLUTION ORAL J01FA10 **(As Dihydrate)**

Azithromycin 200 mg/5ml POWDER, FOR SUSPENSION ORAL J01FA10 **(As Dihydrate)**

Azithromycin 250 mg CAPSULE ORAL J01FA10 **(As Dihydrate)**

Azithromycin 250 mg TABLET ORAL J01FA10 **(As Dihydrate)**

Azithromycin 500 mg CAPSULE ORAL J01FA10 **(As Dihydrate)**

Azithromycin 500 mg INJECTION, POWDER PARENTERAL J01FA10 -

Azithromycin 500 mg TABLET ORAL J01FA10 **(As Dihydrate)**

Bacitracin 500 U/g OINTMENT OPHTHALMIC D06AX05 -


Azelastine Hydrochloride 125 mcg/Puff

(As base) Azelastine 125mcg /puff + Hydrochloride 15mcg/puff -%0.1

IRAN DRUG LIST




Baclofen 10 mgدسترسی TABLET ORAL M03BX01 -

Baclofen 25 mg TABLET ORAL M03BX01 -

Balanced Salt Solution SOLUTION OPHTHALMIC S01X

SOLUTION OPHTHALMIC S01X

Barium Sulfate 135 g POWDER, FOR SUSPENSION ORAL V08BA02 **SACHET**

SUSPENSION ORAL V08BA02 1390/06/14

Basiliximab 20mg INJECTION, POWDER PARENTERAL L04AC02 1391/12/23

BCG INTRAVESICAL L03AX03 -

NaCl 0.49% or 0.64% + KCl 0.075% + MgCl2, 6H2O 0.03% + CaCl2, 2 H2O 0.048% +Sodium Citrate, 2 H2O 0.17% + Sodium Acetate, 3H2O 0.39%

Balanced Salt Solution/Glutathion

Part 1:480ml (NaCl 7.44mg+KCl 0.395mg + Na2HPO4 0.433mg+ NaHCO3 2.19mg)/ml, Part 2:20ml (Glutathion Disulfide 4.6mg + Dextrose 23 mg +Calcium Chloride,2H2O 3.85mg + Magnesium Chloride,6H2O 5mg)/ml

Barium Sulfate 240 g/240 ml

از کشور داخل تولید شرط بهابتدا


IRAN DRUG LIST




دسترسیBCG INJECTION, POWDER J07AN -

NEBULISATION RESPIRATORY R03BA01 -

AEROSOL RESPIRATORY R03BA01 HFA Only 1389/8/24

AEROSOL RESPIRATORY R03BA01 -

INHALER RESPIRATORY R03BA01 -

INHALER NASAL R01AD01 -


Beclomethasone Dipropionate 0.8 mg/2ml

Beclomethasone Dipropionate 100 mcg/dose




IRAN DRUG LIST




دسترسی

Belladonna Pb ELIXIR ORAL A03CB02

Belladonna Pb TABLET ORAL A03CB02

Benzocaine 5% OINTMENT TOPICAL D04AB04 -

Benzocaine 7.5% GEL BUCCAL D04AB04 - 1390/1/29

Benzoic Acid BULK V03 -

Benzoin Tincture BULK V03 -

Benzoyl Peroxide 10% GEL TOPICAL D10AE01 -

Benzoyl Peroxide 10% LOTION TOPICAL D10AE01 **w/w or w/v**

Benzoyl Peroxide 10% SOAP TOPICAL D10AE01 **w/w**

Benzoyl Peroxide 5% GEL TOPICAL D10AE01 -

Benzoyl Peroxide 5% LOTION TOPICAL D10AE01 **w/w or w/v**

(Atropine Sulfate 19.4mcg+Hyoscine HBr 6.5mcg+Hyoscyamine Sulfate 103.7mcg+Phenobarbital 16.2mg)/5ml

Atropine Sulfate 19.4mcg+Hyoscine HBr 6.5mcg+Hyoscyamine Sulfate 103.7mcg+Phenobarbital 16.2mg




IRAN DRUG LIST




Benzoyl Peroxide 5%دسترسی SOAP TOPICAL D10AE01 **w/w**

INJECTION PARENTERAL N04AC01 -

Benztropine Mesylate 2 mg TABLET ORAL N04AC01 -

MOUTHWASH IRRIGATION A01AD02 -

Benzyl Benzoate BULK V03 -

Benzyl Benzoate 25% LOTION TOPICAL P03AX01 -

GRANULE ORAL P02CX02 -

Beractant 25 mg/ ml INJECTION,SUSPENSION INTRATRACHEAL

Betacarotene 15 mg CAPSULE ORAL A11CA02 -

Benztropine Mesylate 1 mg/ml, 2ml

Benzydamine Hydrochloride 0.15%


Bephenium Hydroxynaphthoate 5 g/SACHET

R07AA..(Survanta)

Treatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis.


IRAN DRUG LIST




Betacarotene 25 mgدسترسی CAPSULE ORAL A11CA02 -

Betacarotene 30 mg CAPSULE ORAL A11CA02 -

TABLET ORAL N07CA01 -


Betaine Anhydrous 1g POWDER FOR SOLUTION ORAL A16AA06

Betamethasone PARENTERAL H02AB01

Betamethasone BULK V03 -

Betamethasone 0.1% CREAM TOPICAL D07AC01 **(As Valerate)**

Betamethasone 0.1% LOTION TOPICAL D07AC01 w/w or w/v **(as Valerate)**

Betamethasone 0.1% OINTMENT TOPICAL D07AC01 **(As Valerate)**

Betamethasone 4 mg/ml INJECTION PARENTERAL H02AB01 **(As Disodium Phosphate)**

Betamethasone 0.5 mg TABLET ORAL H02AB01 -

Betahistine Dihydrochloride 8 mg

Betahistine Dihydrochloride 16 mg

به مبتال بیماران برای فقط هموسیستینوریا


INJECTION,SUSPENSION,EXTENDED RELEASE

(Betamethasone acetate 3mg+Betamethasone(as disodium phosphate) 3mg)/ml


IRAN DRUG LIST




دسترسیDROPS, SOLUTION OPHTHALMIC & OTIC S03

OINTMENT OPHTHALMIC S01BA06 -

Betaxolol 0.5% DROPS, SOLUTION OPHTHALMIC S01ED02 **(As Hydrochloride)**

TABLET ORAL N07AB02 -


PARENTERAL L01XC07

PARENTERAL L01XC07

Bicalutamide 50 mg TABLET ORAL L02BB03

Bicalutamide 150 mg TABLET ORAL L02BB03 1392/5/29

POWDER NOT APPLICABLE B05ZA For Haemodyalysis Machine

Betamethasone Disodium Phosphate 0.1%

**OPHTHALMIC and OTIC and NASAL DROPS**

Betamethasone Disodium Phosphate 0.1%

Bethanechol Chloride 10 mg

Bethanechol Chloride 25 mg

Bevacizumab 25 mg/ml, 16ml


مراکز دارای بیمارستانهای درسرطان درمان تخصصی


Bevacizumab 25 mg/ml, 4ml




Bicarbonate Concentrate 500 mg

IRAN DRUG LIST




دسترسیPOWDER NOT APPLICABLE B05ZA For Haemodyalysis Machine

POWDER NOT APPLICABLE B05ZA For Haemodyalysis Machine

Bimatoprost %0.01 Drops, Solution OPHTALMIC S01EE03 1393/01/24

Biotin 5 mg TABLET ORAL L01XC07 متابولیک بیماران برای فقط

Biotin 5 mg /ml INJECTION, SOLUTION INTRAMUSCULAR A11HA05 1392/04/04

TABLET, EXTENDED RELEASE ORAL N04AA02 -


Biperiden Lactate 5 mg/ml INJECTION PARENTERAL N04AA02 -

Bisacodyl 10 mg* SUPPOSITORY RECTAL A06AB02 -

Bisacodyl 5 mg SUPPOSITORY RECTAL A06AB02 -

Bisacodyl 5 mg* TABLET, DELAYED RELEASE ORAL A06AB02 -

Bismuth BULK V03 -




Biperiden Hydrochloride 4 mg

Biperiden Hydrochloride 2 mg




IRAN DRUG LIST




دسترسیBismuth Subcitrate 120 mg TABLET ORAL A02BX05 -

TABLET ORAL A02BX05 -

Bleomycin 15 U INJECTION, POWDER PARENTERAL L01DC01

Bleomycin 15 IU INJECTION PARENTERAL L01DC01

Borax BULK V03 -

Boric Acid BULK V03 -

Bortezomib 3.5mg PARENTERAL L01XX32

Bosentan 125 mg TABLET ORAL C02KX01

Bosentan 62.5 mg TABLET ORAL C02KX01


Bismuth Subcitrate Equ. To Bismuth Oxide** 120 mg

Treatment of malignant pleural effusion.Treatment of pancreatic cancer.

Equal with 15,000 U in UK (Pancreatic cancer)





داروهاي فهرست (Orphan )خاص

داروهاي فهرستخاص دسترسي با

رعايت شرط بهپروتكل

رعايت شرط بهپروتكل

IRAN DRUG LIST




دسترسیBotulinum A Toxin INJECTION PARENTERAL M03AX01

Botulinum A Toxin PARENTERAL M03AX01

Botulism Monovalent INJECTION PARENTERAL J06AA04 **Antitoxin**

INJECTION PARENTERAL J06AA04 **Antitoxin**

Bovactant 50 mg/1.2ml INJECTION INTRATRACHEAL R07AA30

Treatment of dynamic muscle contractures in pediatric cerebral palsy patients.Treatment of essential blepharospasm.Treatment of spasmodic torticollis (cervical dystonia).


Treatment of dynamic muscle contractures in pediatric cerebral palsy patients.Treatment of essential blepharospasm.Treatment of spasmodic torticollis (cervical dystonia). داروهاي فهرست



Botulism Polyvalent (A+B+E)



گيرد قرار سالمتTreatment of full-term newborn infants with respiratory failure caused by meconium aspiration syndrome, persistent pulmonary hypertension of the newborn, or pneumonia and sepsis.

IRAN DRUG LIST




دسترسیLYOPHYLIZED POWDER INTRATRACHEAL R07AA.. Newfactan

Brimonidine Tartrate 0.2% DROPS, SOLUTION OPHTHALMIC S01EA05 -

Brimonidine Tartrate 0.2% DROPS, SOLUTION OPHTHALMIC S01EA05

Brinzolamide 1% DROPS, SUSPENSION OPHTHALMIC S01EC04 -

DROPS, SUSPENTION OPHTHALMIC S01ED51 1391/07/25

INJECTION PARENTERAL R05CB02

TABLET ORAL R05CB02 -

ELIXIR ORAL R05CB02 -

Bovine Lung Surfactant 120 mg

Treatment of anterior ischemic optic neuropathy.


Brinzolamide/Timolol Maleate 10/5 mg/ml

Brinzolamide 10mg/ml + Timolol maleate 5mg/ml

Bromhexine Hydrochloride 2 mg/ml, 2 ml

Treatment of mild to moderate keratoconjunctivitis sicca in patients with Sjogren's syndrome.

Bromhexine Hydrochloride 8 mg


Bromhexine Hydrochloride 4 mg/5ml


IRAN DRUG LIST




دسترسیINJECTION PARENTERAL R05CB02 -

Bromocriptine 2.5 mg TABLET ORAL G02CB01 **(As Mesylate)**

Budesonide 0.5 mg/2ml NEBULISATION RESPIRATORY R03BA02 -

Budesonide 1 mg/2ml NEBULISATION RESPIRATORY R03BA02 -

Budesonide 100 mcg/dose INHALER RESPIRATORY R03BA02 -



Budesonide 64 mcg/dose INHALER NASAL R01AD05 -

INHALER RESPIRATORY R03BA

INHALER RESPIRATORY R03BA

Bromhexine Hydrochloride 2 mg/ml, 2 ml

Budesonide/Formoterol Fumarate (160 mcg/4.5mcg)/dos

(Budesonide 160mcg + Formoterol Fumarate 4.5mcg)

Budesonide/Formoterol Fumarate (320 mcg/9mcg)/dose


IRAN DRUG LIST




دسترسیINHALER RESPIRATORY R03BA





Budesonide/Formoterol Fumarate (80 mcg/4.5mcg)/dose


Bupivacaine Hydrochloride 0.25%, 10ml
















IRAN DRUG LIST




دسترسی

INJECTION INTRASPINAL N01BB01

Buprenorphine 0.4 mg CAPSULE SUBLINGUAL N02AE01 **(As Hydrochloride)**

Buprenorphine 0.4 mg TABLET SUBLINGUAL N07BC01 **(As Hydrochloride)**

Buprenorphine 2 mg TABLET SUBLINGUAL N07BC01 **(As Hydrochloride)**

Buprenorphine 8 mg TABLET SUBLINGUAL N07BC03 **(As Hydrochloride)**

INJECTION PARENTERAL N02AE01

TABLET SUBLINGUAL N07BC51

TABLET SUBLINGUAL N07BC51+E2152

TABLET, EXTENDED RELEASE ORAL N07BA02 -





Buprenorphine 0.3 m/ml, 1ml




Buprenorphine/Naloxone 2/0.5 mg

{Buprenorphine (As Hydrochloride) 2 mg + Naloxone (As Hydrochloride) 0.5 mg}

Buprenorphine/Naloxone 8/2 mg

{Buprenorphine (As Hydrochloride) 8 mg + Naloxone (As Hydrochloride) 2 mg}

Bupropion Hydrochloride 150 mg

IRAN DRUG LIST




دسترسیTABLET ORAL N07BA02 -


Burn Ointment OINTMENT TOPICAL D03AA

Buserelin 1 mg/ml, 5.5ml INJECTION PARENTERAL L02AE01 **(As Acetate)**

Buserelin 150 mcg/dose SPRAY NASAL L02AE01 **(As Acetate)**

TABLET ORAL N05BE01 -

TABLET ORAL N05BE01 -

Busulfan 2 mg TABLET ORAL L01AB01 -



Cod liver oil 50%+Zinc oxide 30%


Buspirone Hydrochloride 10 mg

Buspirone Hydrochloride 5 mg

IRAN DRUG LIST




دسترسی

Busulfan 6 mg/ml, 10ml INJECTION PARENTERAL L01AB01

Cabergoline 0.5 mg TABLET ORAL G02CB03 -

Cabergoline 1 mg TABLET ORAL G02CB03 -

Cabergoline 2 mg TABLET ORAL N04BC06 -

Cade Oil BULK V03 -

SOLUTION ORAL N06BC01

INJECTION, SOLUTION PARENTERAL N06BC01

Calamine 8% CREAM TOPICAL D02AB -

Calamine 8% LOTION TOPICAL D02AB -

Calcipotriol 50 mcg/g OINTMENT TOPICAL D05AX02 -

Calcipotriol 50 mcg/ml SOLUTION TOPICAL D05AX02 -

As preparative therapy in the treatment of malignancies with bone marrow transplantation.Treatment of primary brain malignancies.


Caffeine (As Citrate) 10mg/ml

تخصصان فوق تجویز تحت ً صرفابیمارستانها در توزیع و نوزادان


Caffeine (As Citrate) 10mg/ml, 3ml

تخصصان فوق تجویز تحت ً صرفابیمارستانها در توزیع و نوزادان




IRAN DRUG LIST




دسترسی

OINTMENT TOPICAL D05AX52 1389/7/17

GEL TOPICAL D05AX52 1390/3/9

Calcitonin 100 IU/ml INJECTION PARENTERAL H05BA03

Calcitonin 50 IU/ml INJECTION PARENTERAL H05BA03

SPRAY NASAL H05BA03

SPRAY NASAL H05BA03

SPRAY NASAL H05BA03 1387/05/06

Calcitriol 0.25 mcg CAPSULE ORAL A11CC04 -

Calcipotriol/Betamethasone Dipropionate 0.005%/0.064%

Calcipotriol 0.005% + Betamethasone (as Dipropionate) 0.05% داخل در تولید شرط به کشور


Calcipotriol 0.005% + Betamethasone (as Dipropionate) 0.05% داخل در تولید شرط به کشور Treatment of symptomatic Paget's disease

Treatment of symptomatic Paget's disease

Calcitonin, Salmon 100 IU/dose





Treatment of symptomatic Paget's disease Recombinant

IRAN DRUG LIST




دسترسیCalcitriol 1 mcg/ml, 1ml INJECTION PARENTERAL A11CC04

Calcitriol 2 mcg/ml, 1ml INJECTION PARENTERAL A11CC04

Calcium Acetate 667 mg TABLET ORAL A12AA12 -

INJECTION PARENTERAL A12A -

Calcium Dobesilate 250 mg TABLET ORAL A12AA04 -

Calcium Dobesilate 500 mg CAPSULE ORAL A12AA04

TABLET ORAL A12AA04 -

Calcium Folinate 10 mg/ml INJECTION PARENTERAL V03AF03 **(As Calcium)** 1390/1/29

Calcium Folinate 100 mg INJECTION, POWDER PARENTERAL V03AF03 **(As Calcium)**

INJECTION PARENTERAL V03AF03 **(As Calcium)**

Calcium Folinate 15 mg TABLET ORAL V03AF03 **(As Calcium)**


مراکز دارای بیمارستانهای درغدد و کلیه تخصصی فوق


مراکز دارای بیمارستانهای درغدد و کلیه تخصصی فوق


Calcium Chloride 100 mg/m, 10ml

Calcium Dobesilate Monohydrate 500 mg

Calcium Folinate 125 mg/ 5ml

IRAN DRUG LIST




دسترسیCalcium Folinate 3 mg/ml INJECTION PARENTERAL V03AF03 **(As Calcium)**

Calcium Folinate 30 mg INJECTION, POWDER, PARENTERAL V03AF03 **(As Calcium)**


INJECTION PARENTERAL A12AA03 -

Calcium Gluconate 2.5% GEL TOPICAL D11AX03 کشور داخل در تولید شرط به کار از ناشی ادث 1390/07/05

TABLET ORAL A11HA31 -

Camphor BULK V03 -

Capecitabine 150 mg TABLET ORAL L01BC06 -

Capecitabine 500 mg TABLET ORAL L01BC06 -

Capreomycin 1g INJECTION, POWDER, INTRAMUSCULAR J04AB30 **(As Sulfate)**

Captopril 25 mg TABLET ORAL C09AA01 -

Captopril 50 mg TABLET ORAL C09AA01 -

SUSPENSION ORAL N03AF01 -

SYRUP ORAL N03AF01 -

Calcium Gluconate 10%, 10ml

Calcium Pantothenate 100 mg



Carbamazepine 100 mg/5ml

Carbamazepine 100 mg/5ml

IRAN DRUG LIST




Carbamazepine 200 mgدسترسی TABLET ORAL N03AF01 -

Carbamazepine 200 mg TABLET, EXTENDED RELEASE ORAL N03AF01 -

Carbamazepine 400 mg TABLET, EXTENDED RELEASE ORAL N03AF01 -

Carbon [14C] Urea 5 micCi SOLUTION ORAL V04C -

INJECTION PARENTERAL L01XA02 -

PARENTERAL L01XA02 -

Carboplatin 10 mg/ml, 5ml INJECTION PARENTERAL L01XA02 -

INJECTION PARENTERAL L01XA02

Carboplatin 150 mg INJECTION, SOLUTION INTRAVENOUS DRIP L01XA02 -

Carboplatin 50 mg INJECTION, SOLUTION INTRAVENOUS DRIP L01XA02 -

INJECTION PARENTERAL G02AD04 **(As Tromethamine)**

Carglumic Acid 200 mg TABLET, DISPERSIBLE ORAL A16AA05 1393/01/24

راديو فهرستداروها

Carboplatin 10 mg/ml, 15ml




Carboprost 250 mcg/ml, 1ml


IRAN DRUG LIST




دسترسیCarmustine 100 mg INJECTION, POWDER PARENTERAL L01AD01

Carvedilol 12.5 mg TABLET ORAL C07AG02 -

Carvedilol 25 mg TABLET ORAL C07AG02 -

Carvedilol 3.125 mg TABLET ORAL C07AG02

Carvedilol 6.25 mg TABLET ORAL C07AG02 -

Casoni Test INJECTION PARENTERAL V04 -

Caspofungin 50 mg INJECTION, POWDER PARENTERAL J02AX04 **(As Acetate)**

Caspofungin 70 mg INJECTION, POWDER PARENTERAL J02AX04 **(As Acetate)**

Cefalexin 125 mg POWDER, FOR SUSPENSION ORAL J01DA01 **Sachet**

Cefalexin 125 mg/5ml POWDER, FOR SUSPENSION ORAL J01DA01 -

Cefalexin 250 mg CAPSULE ORAL J01DA01 -

Cefalexin 250 mg POWDER, FOR SUSPENSION ORAL J01DA01 **SACHET**

Cefalexin 250 mg TABLET ORAL J01DA01 -

Cefalexin 250 mg/5ml POWDER, FOR SUSPENSION ORAL J01DA01 -

Cefalexin 500 mg CAPSULE ORAL J01DA01 -

Cefalexin 500 mg TABLET ORAL J01DA01 -

Cefazolin 1 g INJECTION, POWDER PARENTERAL J01DA04 **(As Sodium)**

Cefazolin 250 mg INJECTION, POWDER PARENTERAL J01DA04 **(As Sodium)**

Treatment of intracranial malignancies.

IRAN DRUG LIST




Cefazolin 500 mgدسترسی INJECTION, POWDER PARENTERAL J01DA04 **(As Sodium)**

INJECTION, POWDER PARENTERAL J01DA24



Cefixime 100 mg POWDER, FOR SUSPENSION ORAL J01DA23 **Sachet**

Cefixime 100 mg/5ml POWDER, FOR SUSPENSION ORAL J01DA23 -

Cefixime 200 mg CAPSULE ORAL J01DA23 -

Cefixime 200 mg TABLET ORAL J01DA23 -

Cefixime 400 mg CAPSULE ORAL J01DA23 -

Cefixime 400 mg TABLET ORAL J01DA23 -

Cefepime (As Dihydrochloride or Hydrochloride Monohydrate) 500mg




Cefepime (As Dihydrochloride or Hydrochloride Monohydrate) 1 g




Cefepime (As Dihydrochloride or Hydrochloride Monohydrate) 2 g




IRAN DRUG LIST




Cefixime 50 mgدسترسی POWDER, FOR SUSPENSION ORAL J01DA23 **SACHET**

Cefotaxime 1 g INJECTION, POWDER PARENTERAL J01DA10 **(As Sodium)**

Cefotaxime 500 mg INJECTION, POWDER PARENTERAL J01DA10 **(As Sodium)**




Ceftizoxime 1 g INJECTION, POWDER PARENTERAL J01DA12 **(As Sodium)**

Ceftizoxime 500 mg INJECTION, POWDER PARENTERAL J01DA12 **(As Sodium)**

Ceftriaxone 250 mg INJECTION, POWDER PARENTERAL J01DD04 **(As Sodium)**

Ceftriaxone 500 g INJECTION, POWDER PARENTERAL J01DD04 **(As Sodium)**

Ceftriaxone 1 g INJECTION, POWDER PARENTERAL J01DD04 **(As Sodium)**

Ceftazidime (As Pentahydrate) 1 g








Ceftazidime (As Pentahydrate) 500 mg




IRAN DRUG LIST




Ceftriaxone 2 gدسترسی INJECTION, POWDER PARENTERAL J01DD04 **(As Sodium)**

Cefuroxime 1.5 g INJECTION, POWDER PARENTERAL J01DA06 **(As Sodium)**

Cefuroxime 125 mg TABLET ORAL J01DA06 **(As Axetil)**

Cefuroxime 125 mg/5ml POWDER, FOR SUSPENSION ORAL J01DA06 **(As Axetil)**

Cefuroxime 250 mg INJECTION, POWDER PARENTERAL J01DA06 **(As Sodium)**


Cefuroxime 250 mg/5ml POWDER, FOR SUSPENSION ORAL J01DA06 **(As Axetil)**

Cefuroxime 750 mg INJECTION, POWDER PARENTERAL J01DA06 **(As Sodium)**


Celecoxib 100 mg CAPSULE ORAL M01AH01 -

Celecoxib 200mg CAPSULE ORAL M01AH01 -

Cephalothin 1 g INJECTION, POWDER PARENTERAL J01DA04 **(As Sodium)**

TABLET, EXTENDED RELEASE ORAL R06AE

Cetirizine Dihydrochloride/Pseudoephedrine HCl 5/120 mg

Cetirizine Dihydrochloride 5mg (Immediate Relaese )+Pseudoephedrine Hydrochloride 120mg

IRAN DRUG LIST




دسترسیTABLET ORAL R06AE07 -

TABLET ORAL R06AE07 -

SYRUP ORAL R06AE07 -

CAPSULE, GELATIN COATED ORAL R06AE07 -

Cetrorelix 250 mcg INJECTION, POWDER PARENTERAL H01CC02 **(As Acetate)**

Cetrorelix 3 mg INJECTION, POWDER PARENTERAL H01CC02 **(As Acetate)**

Cetuximab 2mg/ml, 50ml INJECTION PARENTERAL L01XC06

Cetuximab 5mg/ml, 20 ml INJECTION PARENTERAL L01XC06

Charcoal Activated 250 mg TABLET ORAL A07BA01 -

Cetirizine Hydrochloride 5 mg


Cetirizine Hydrochloride 5mg/5ml


به مبتال بیماران برای فقطباالی سروگردن 65سرطان

با سال Karnofsky Performance status از 90باالتر به % مبتال بیماران برای فقط

باالی سروگردن 65سرطانبا سال

Karnofsky Performance status از 90باالتر %


IRAN DRUG LIST




دسترسیSUSPENSION ORAL A07BA01 -

Charcoal Activated 50 g POWDER, FOR SUSPENSION ORAL A07BA01 -

Children Cold* TABLET, CHEWABLE ORAL N02BE51

SOLUTION ORAL N05CC01 -

Chlorambucil 2 mg TABLET ORAL L01AA02 -

Chloramphenicol 1 g INJECTION, POWDER PARENTERAL J01BA01 **(As Sodium Succinate)**

SUSPENSION ORAL J01BA01 **(As Palmitate)**

Chloramphenicol 0.5% DROPS, SOLUTION OPHTHALMIC S01AA01 -

Chloramphenicol 250 mg CAPSULE ORAL J01BA01 -

Chlordiazepoxide 10 mg TABLET ORAL N05BA02 -

Chlordiazepoxide 5 mg TABLET ORAL N05BA02 -

Charcoal Activated 30 g/240ml



Acetaminophen 80mg + Chlorpheniramine maleate 0.5 mg + Pseudoephedrin HCl 7.5 mg


Chloral Hydrate 250 mg/5ml

تدوين شرط بهبا پروتکل،

در تجويز اولويتبرای کودکان

EEG

Chloramphenicol 150 mg/5ml

IRAN DRUG LIST




دسترسیSOLUTION TOPICAL D08AC02 -

TABLET ORAL G03FB03

INJECTION, POWDER PARENTERAL L01AA05 -

Chloroacetic Acid BULK V03 -

INJECTION PARENTERAL P01BA01 **(As Phosphate)**

INJECTION PARENTERAL P01BA01 **(As Phosphate)**

Chloroquine 50 mg/5ml SYRUP ORAL P01BA01 **(As Sulfate)**

Chloroquine 25 mg/5ml SYRUP ORAL P01BA01 **(As Sulfate)**

TABLET ORAL P01BA01 -

Chlorhexidine Gluconate 4%

Chlormadinone Acetate/Ethinyl Estradiol 2 / 0.03 mg

(Chlormadinone Acetate 2 mg + Ethinyl Estradiol 0.03 mg)

Chlormethine Hydrochlorid (Nitrogen mustard) 10 mg


Chloroquine 30 mg/ml, 5ml

Chloroquine 40 mg/ml, 5ml

Chloroquine Phosphate 250 mg

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL P01BA01 -

INJECTION PARENTERAL R06AB04 -

SYRUP ORAL R06AB04 -

TABLET ORAL R06AB04 -

TABLET, EXTENDED RELEASE ORAL R06AB04 -



INJECTION INTRAMUSCULAR N05AA01 -

Chlorpropamide 250 mg TABLET ORAL A10BB02 -

Chlorthalidone 100 mg TABLET ORAL C03BA04 -

Cholestyramine 4 g POWDER, FOR SUSPENSION ORAL C10AC01 **SACHET**

Chloroquine Sulfate 50 mg/ml, 5ml

Chlorpheniramine Maleate 10 mg/ml, 1ml

Chlorpheniramine Maleate 2 mg/5ml


Chlorpheniramine Maleate 4 mg


Chlorpheniramine Maleate 8 mg

Chlorpromazine Hydrochloride 100 mg

Chlorpromazine Hydrochloride 25 mg

Chlorpromazine Hydrochloride 25 mg/ml, 2ml

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL G03GA08

INJECTION, POWDER PARENTERAL G03GA01 -



Ciclesonide 160mcg/puff AEROSOL, METERED INHALATION R03BA08

Ciclesonide 80mcg/puff AEROSOL, METERED INHALATION R03BA08

SPRAY, SUSPENSION IntranasalR01AD** 1390/07/04

Ciclosporin 0.05% SOLUTION OPHTHALMIC S01XA18 -

Choriogonadotropin Alfa 500 mcg/ml, 0.5ml

Recombinant_Prefilled Disposable Syringe

Chorionic Gonadotrophin (Human) 1500 U



و کشور داخل در تولید شرط بهبالینی مطالعه انجام


Ciclesonide 50mcg/Actuation

50mcg/Actuation تولید شرط بهداخل

IRAN DRUG LIST




دسترسیCiclosporin 100 mg CAPSULE ORAL L04AA01

Ciclosporin 100 mg/ml SOLUTION ORAL L04AA01 -

Ciclosporin 2% SOLUTION OPHTHALMIC S01XA18

Ciclosporin 25 mg CAPSULE ORAL L04AA01

Ciclosporin 50 mg CAPSULE ORAL L04AA01

Ciclosporin 50 mg/ml INJECTION, SOLUTION INTRAVENOUS DRIP L04AA01 -

Ciclosporin 50 mg/ml, 5ml INJECTION, SOLUTION INTRAVENOUS DRIP L04AA01 -

Prophylaxis of organ rejection in patients receiving allogeneic lung transplant

Treatment of patients at high risk of graft rejection following penetrating keratoplasty.For use in corneal melting syndromes of known or presumed immunologic etiopathogenesis, including Mooren's ulcer.



IRAN DRUG LIST




دسترسیINJECTION PARENTERAL A02BA01 **(As Hydrochloride)**

Cimetidine 200 mg/5ml SYRUP ORAL A02BA01 **(As Hydrochloride)**

Cimetidine 200 mg TABLET ORAL A02BA01 -

Cinacalcet 30 mg TABLET ORAL H05BX01 **(As Hydrochloride)** 1391/02/07



Cinnarizine 25 mg TABLET ORAL N07CA02 -

Cinnarizine 75 mg TABLET ORAL N07CA02 -

Ciprofloxacin 0.3% DROPS, SOLUTION OPHTHALMIC S03AA07 **(As Hydrochloride)**

Ciprofloxacin 0.3% OINTMENT OPHTHALMIC S03AA07 **(As Hydrochloride)**

INJECTION, SOLUTION INTRAVENOUS J01MA02 **(As Lacate)**

INJECTION, SOLUTION INTRAVENOUS DRIP J01MA02 **(As Lacate)**

Ciprofloxacin 250 mg TABLET ORAL J01MA02 **(As Hydrochloride)**

Ciprofloxacin 500 mg TABLET ORAL J01MA02 **(As Hydrochloride)**

Ciprofloxacin 250 mg/5ml SUSPENSION ORAL J01MA02 1390/12/22

Cimetidine 100 mg/ml, 2ml

Ciprofloxacin 10 mg/ml, 20ml

Ciprofloxacin 2 mg/ml, 100ml

IRAN DRUG LIST




دسترسیDROPS, SUSPENSION OTIC S02AA 1386/12/26

INJECTION INTRAVENOUS DRIP J01MA02 **(As Lacate)** 1392/5/29

Cisapride 10 mg TABLET ORAL A03FA02 **(As Monohydrate)**

Cisapride 5 mg TABLET ORAL A03FA02 **(As Monohydrate)**




Ciprofloxacin/Dexamethasone 0.3/0.1%

{Ciprofloxacin (As Hydrochloride) 0.3% + Dexamethasone 0.1%}

Ciprofloxacin 400 mg/200ml

Cisatracurium (As Besylate) 2 mg/ml, 10ml




Cisatracurium (As Besylate) 2 mg/ml, 2.5ml








IRAN DRUG LIST




دسترسی


Cisplatin 0.5 mg/ml, 100ml INJECTION, SOLUTION INTRAVENOUS DRIP L01XA01 -

Cisplatin 0.5 mg/ml, 20ml INJECTION, SOLUTION INTRAVENOUS DRIP L01XA01 -

Cisplatin 1 mg/ml INTRAVENOUS DRIP L01XA01 1391/11/02

Cisplatin 10 mg INJECTION, POWDER, INTRAVENOUS DRIP L01XA01 -

Cisplatin 50 mg INJECTION, POWDER, INTRAVENOUS DRIP L01XA01 -

Citalopram 20 mg TABLET ORAL N06AB04 **(As Hydrobromide)**

Citalopram 40 mg TABLET ORAL N06AB04 **(As Hydrobromide)**

Citalopram 40 mg/ml DROPS, SOLUTION ORAL N06AB04 **(As Hydrobromide)**

Citicoline 125 mg/ml, 2ml INJECTION PARENTERAL N06BX06 **(As Sodium)**

Citric Acid BULK V03

Cisatracurium (As Besylate) 5 mg/ml




INJECTION, SOLUTION,CONCENTRATE

** Anhydrous or Monohydrate **


IRAN DRUG LIST




دسترسی

Cladribine 1mg/ml, 10ml INJECTION, SOLUTION INTRAVENOUS DRIP L01BB04

Cladribine 2 mg/ml, 5ml INJECTION, SOLUTION INTRAVENOUS DRIP L01BB04

POWDER, FOR SUSPENSION ORAL J01FA09 -

Clarithromycin 250 mg TABLET ORAL J01FA09 -

POWDER, FOR SUSPENSION ORAL J01AF09 -

GRANULE, FOR SUSPENSION ORAL J01FA09 -

Clarithromycin 500 mg TABLET ORAL J01FA09 -

Clemastine 1 mg/ml, 2ml INJECTION PARENTERAL R06AA04 **(As Fumarate)**

Treatment of acute myeloid leukemia.Treatment of the chronic progressive form of MSTreatment of non-Hodgkin's lymphoma.




Clarithromycin 125 mg/5ml

Clarithromycin 250 mg/5ml

Clarithromycin 250 mg/sachet

IRAN DRUG LIST




دسترسیClemastine 1mg TABLET ORAL R06AA04 (as Fumarate)

TABLET ORAL A03CA02

Clindamycin BULK V03 **(As Phosphate)**

Clindamycin 1% GEL TOPICAL D10AF01 **(As Phosphate)**

Clindamycin 10 mg/ml SOLUTION TOPICAL D10AF01 **(As Phosphate)**

Clindamycin 100 mg SUPPOSITORY VAGINAL G01AA10 **(As Phosphate)**

Clindamycin 150 mg CAPSULE ORAL J01FF01 **(As Hydrochloride)**

Clindamycin 2% CREAM VAGINAL G01AA10 **(As Phosphate)**

Clindamycin 75 mg/5ml SUSPENSION ORAL J01FF01

INJECTION PARENTERAL J01FF01 **(As Phosphate)**

Clindamycin 300 mg CAPSULE ORAL J01FF01 **(As Hydrochloride)**

INJECTION PARENTERAL J01FF01


Clidinium/Chlordiazepoxide 2.5/5 mg

Clidinium bromide 2.5mg + Chlordiazepoxide 5mg


**(As Palmitate Hydrochloride)**

Clindamycin 150 mg/ml, 4ml

داروخانه در فقطتوزيع بيمارستاني

.ميشود

Clindamycin (As Phosphate) 150 mg/ml, 2ml

Treatment of Pneumocystis carinii pneumonia associated with AIDS patients.


.ميشود

IRAN DRUG LIST




دسترسیGEL TOPICAL D10AF51

CREAM VAGINAL G01A 1392/03/21

Clobazam 10 mg TABLET ORAL N05BA09 -

CREAM TOPICAL D07AD01 -

LOTION TOPICAL D07AD01 -

OINTMENT TOPICAL D07AD01 -

INJECTION PARENTERAL R05DB03 -

TABLET ORAL R05DB03 -

DROPS, SOLUTION ORAL R05DB03 -

Clindamycin Phosphate/Tretinoin 1.2/0.025%

(Clindamycin Phosphate 1.2% + Tretinoin 0.025%)

Clindamycin /Clotrimazole 2%

Clindamycin(as Phosphate )2% + Clotrimazole2% W/W

Clobetasol Propionate 0.05%



Clobutinol Hydrochloride 10 mg/ml, 2ml

Clobutinol Hydrochloride 40 mg

Clobutinol Hydrochloride 60 mg/ml

IRAN DRUG LIST




دسترسی

Clofazimine 100 mg CAPSULE ORAL J04BA01

Clofazimine 50 mg CAPSULE ORAL J04BA01

Clofibrate 500 mg CAPSULE ORAL C10AB01 -

Clomiphene Citrate 50 mg TABLET ORAL G03GB02 -




Treatment of lepromatous leprosy, including dapsone-resistant lepromatous leprosy and lepromatous leprosy complicated by erythema nodosum leprosum.




Clomipramine Hydrochloride 10 mg



IRAN DRUG LIST





Clonazepam 1 mg TABLET ORAL N03AE01 -

Clonazepam 2 mg TABLET ORAL N03AE01 -

TABLET ORAL N02CX02 -

PATCH, EXTENDED RELEASE TRANSDERMAL N02CX02 -

Clopidogrel 75 mg TABLET ORAL B01AC04 as Bisulfate

Clopidogrel 300 mg TABLET ORAL B01AC04 as Bisulfate 1390/3/9

Clotrimazole 1% CREAM TOPICAL D01AC01

Clotrimazole 1% SOLUTION TOPICAL D01AC01

Clotrimazole 1% CREAM VAGINAL G01AF02 -


Clonidine Hydrochloride 0.2 mg

Clonidine Hydrochloride 0.2 mg/24h




Topical treatment of children and adults with pouchitis

Topical treatment of children and adults with pouchitis

IRAN DRUG LIST




Clotrimazole 100 mgدسترسی SUPPOSITORY VAGINAL G01AF02 -

Clotrimazole 100 mg TABLET VAGINAL G01AF02 -

Clotrimazole 2% CREAM VAGINAL G01AF02 -

Clotrimazole 200 mg SUPPOSITORY VAGINAL G01AF02 -

Clotrimazole 500 mg SUPPOSITORY VAGINAL G01AF02 -

Clotrimazole 500 mg TABLET VAGINAL G01AF02 -

CREAM TOPICAL D07CC01

LOTION TOPICAL D07CC01

Cloxacillin 1g INJECTION, POWDER, PARENTERAL J01CF02 **(As Sodium)**

Cloxacillin 250 mg CAPSULE ORAL J01CF02 **(As Sodium)**

Cloxacillin 250 mg INJECTION, POWDER, PARENTERAL J01CF02 **(As Sodium)**

Cloxacillin 250 mg TABLET ORAL J01CF02 **(As Sodium)**

Cloxacillin 500 mg CAPSULE ORAL J01CF02 **(As Sodium)**

Cloxacillin 500 mg INJECTION, POWDER, PARENTERAL J01CF02 **(As Sodium)**

Cloxacillin 500 mg TABLET ORAL J01CF02 **(As Sodium)**

Clozapine 100 mg TABLET ORAL N05AH02 -

Clotrimazole/Betamethasone 1/0.05%

Clotrimazole 1% + Betamethasone (As Dipropionate) 0.05%

Clotrimazole/Betamethasone 1/0.05%

Clotrimazole 1% + Betamethasone (As Dipropionate) 0.05%

IRAN DRUG LIST




Clozapine 25 mgدسترسی TABLET ORAL N05AH02 -

Coal Tar BULK V03 -

Coal Tar 5% LOTION TOPICAL D05AA -

POWDER, FOR SUSPENSION ORAL J01CR02



Co-amoxiclav 250/125 mg TABLET ORAL J01CR02

Co-amoxiclav 250/62.5 mg POWDER, FOR SUSPENSION ORAL J01CR02


Co-amoxiclav 125/31.25 mg

(Amoxicillin(as trihydrate) 125mg+Clavulanic acid(as potassium) 31.25mg)/Sachet

Co-amoxiclav 125/31.25 mg/5ml

(Amoxicillin(as trihydrate) 125mg+Clavulanic acid(as potassium) 31.25mg)/5ml


(Amoxicillin(as trihydrate) 200mg+Clavulanic acid(as potassium) 28.5 mg)/5ml

Amoxicillin(as trihydrate) 250mg+Clavulanic acid(as potassium) 125mg

(Amoxicillin(as trihydrate) 250mg+Clavulanic acid(as potassium) 62.5mg)/Sachet

IRAN DRUG LIST




دسترسیPOWDER, FOR SUSPENSION ORAL J01CR02




Co-amoxiclav 500/125 mg TABLET, DISPERSIBLE ORAL J01CR02

POWDER, FOR SUSPENSION ORAL J01CR02 1390/3/9


(Amoxicillin(as trihydrate) 250mg+Clavulanic acid(as potassium) 62.5mg)/5ml

Co-amoxiclav 400/57 mg/5ml

(Amoxicillin(as trihydrate) 400mg+Clavulanic acid(as potassium) 57 mg)/5ml


Dispersible Amoxicillin(as trihydrate) 500mg+Clavulanic acid(as potassium) 125mg


Co-amoxiclav 600/42.9 mg /5ml

Treatment of otitis media and sinusitis in Pediatric patients (Amoxicillin(as trihydrate) 600mg+Clavulanic acid(as potassium) 42.9mg)/ 5ml کشور داخل در تولید شرط به

IRAN DRUG LIST




دسترسیCo-amoxiclav 250/125 mg TABLET ORAL J01CR02

Co-amoxiclav 500/100 mg PARENTERAL J01CR02 1392/03/21

Co-amoxiclav 1000/200 mg PARENTERAL J01CR02 1392/03/21

Codeine Phosphate 30 mg TABLET ORAL R05DA04 -

Colchicine 1 mg TABLET ORAL M04AC01

Collagen BULK V03 -

Collodion SOLUTION TOPICAL V03


INJECTION, POWDER, FOR SOLUTION

Amoxicillin(as sodium)500mg+Clavulanic acid(as potassium)100mg



Treatment of familial Mediterranean feverFor arresting the progression of neurologic disability caused by chronic progressive multiple sclerosis.For the treatment of Behcet's Syndrome.


(Pyroxylin 40g+Ether 750 ml+Alcohol 250 ml )/1000 ml


IRAN DRUG LIST




دسترسیCollodion BULK V03

TABLET ORAL G03CA57 -

CREAM VAGINAL G03CA57 -

TABLET ORAL G03CA57 -

INJECTION PARENTERAL G03CA57 -

Contraceptive DE TABLET ORAL G03AA09


Contraceptive HD TABLET ORAL G03FA04

(Pyroxylin 40g+Ether 750 ml+Alcohol 250 ml)/1000 ml


Conjugated Estrogens 0.625 mg

Conjugated Estrogens 0.625 mg/g

Conjugated Estrogens 1.25 mg

Conjugated Estrogens 5 mg/ml, 5ml

Desogestrel 0.15mg+Ethinylestradiol 20mcg ابتدا از تولید شرط به

کشور داخل در


Desogestrel 0.15mg+Ethinylestradiol 30mcg


Norgestrel (or 1/2 amount of levonorgestrel) 0.5mg+Ethinylestradiol 50mcg


IRAN DRUG LIST




دسترسیContraceptive LD* TABLET ORAL G03FA04

Contraceptive LD/Fe* TABLET ORAL G03AA06

Contraceptive Triphasic TABLET ORAL G03AA06

Copper and Zinc Sulfate LOTION TOPICAL D11

Copper Sulfate BULK V03 -

Corticotrophin 40 U/ml INJECTION PARENTERAL H01AA01 -



21 Tab. [Norgestrel (or 1/2 amount of levonorgestrel) 0.3mg+Ethinylestradiol 30mcg] + [ 7 Tab. of 24.65 mg Iron as Ferrous Sulfate or Fumarate )]


6 Tab: (Levonorgestrel 0.05mg + Ethinylestradiol 30mcg) + 5 Tab: (Levonorgestrel 0.075mg + Ethinylestradiol 40mcg) + 10 Tab: (Levonorgestrel 0.125mg + Ethinylestrdiol 30mcg)


Copper Sulfate 1 g + Zinc Sulfate 1.5 g + Concentrated Comphor Water 2.5 ml + water qs to 100 ml



IRAN DRUG LIST




Corticotrophin 80 U/mlدسترسی INJECTION PARENTERAL H01AA01 -

Co-trimoxazole 100/20 mg TABLET ORAL J01EE01

SUSPENSION ORAL J01EE01

INJECTION, SOLUTION INTRAVENOUS DRIP J01EE01

Co-trimoxazole 400/80 mg TABLET ORAL J01EE01

TABLET ORAL J01EE01

Cream Base BULK V03 -

Cresol BULK V03 -

INHALER RESPIRATORY R03BC01 -

NEBULISATION RESPIRATORY R03BC01 Nebulisation

Sulfamethoxazole 100mg+Trimethoprim 20mg

Co-trimoxazole 200/40 mg/5ml

(Sulfamethoxazole 200mg+Trimethoprim 40mg)/5ml

Co-trimoxazole 400/80 mg/5ml

(Sulfamethoxazole 400mg+Trimethoprim 80mg)/5ml


Co-trimoxazole 800/160 mg




Cromolyn Sodium 1 mg/dose

Cromolyn Sodium 10 mg/ml

IRAN DRUG LIST




دسترسیNEBULISATION RESPIRATORY R03BC01 -

INHALER RESPIRATORY R03BC01 -

SPRAY, SOLUTION NASAL R01AC01 -

SOLUTION OPHTHALMIC S01GX01

Crotamiton 10% CREAM TOPICAL P03AX -

Cumarin 100 mg TABLET, EXTENDED RELEASE ORAL C05CA -

SOLUTION OPHTHALMIC S01FA04 -

Cyclophosphamide 200 mg INJECTION, POWDER, PARENTERAL L01AA01 -

Cyclophosphamide 50 mg TABLET ORAL L01AA01 **(As Monohydrate)**

Cyclophosphamide 500 mg INJECTION, POWDER, PARENTERAL L01AA01 -

Cycloserine 250 mg CAPSULE ORAL J04AB01 -

Cromolyn Sodium 20 mg/2ml

Cromolyn Sodium 20 mg/capsule



Treatment of vernal keratoconjunctivitis.


Cyclopentolate Hydrochloride 1%

IRAN DRUG LIST




Cycloserine 250 mgدسترسی TABLET ORAL J04AB01 -

TABLET ORAL R06AX02 -

SOLUTION ORAL R06AX02

کشور داخل در تولید شرط به 1390/09/21

Cyproterone Acetate 50 mg TABLET ORAL G03AH01

TABLET ORAL G03AH01 کشور داخل در تولید شرط به 1391/02/25

Cyproterone Compound TABLET ORAL G03HB01

Cysteamine 150 mg CAPSULE Oral A16AA04

Cysteamine 50 mg CAPSULE Oral A16AA04

Cyproheptadine Hydrochloride 4 mg

Cyproheptadine Hydrochloride 2 mg/5 ml

Treatment of severe hirsutism.

Cyproterone Acetate 100 mg

Cyproterone acetate 2mg+Ethinylestradiol 35mcg

به مبتال بیماران برای فقطنفروپاتیک سیستینوزیس



(As Bitartarate)


IRAN DRUG LIST




دسترسی

Cysteamine 150 mg CAPSULE ORAL A16AA04

Cytarabine 500 mg INJECTION, POWDER, PARENTERAL L01BC01 1391/07/25

Cytarabine 1 g INJECTION, POWDER, PARENTERAL L01BC01 -

Cytarabine 100 mg INJECTION, POWDER, PARENTERAL L01BC01 -

PARENTERAL L01AX04 -

PARENTERAL L01AX04

Cytarabine 20 mg/ml, 5ml PARENTERAL L01AX04 -

CAPSULE ORAL B01AE07 1390/03/07

Dabigatran Etexilate 75 mg CAPSULE ORAL B01AE07 1390/03/07

Treatment of corneal cystine crystal accumulation in cystinosis patients.Treatment of nephropathic cystinosis.(As Bitartarate)


Cytarabine 20 mg/ml, 50ml INJECTION, SOLUTION, CONCENTRATE

Cytarabine 50 mg/ml, 20ml INJECTION, SOLUTION, CONCENTRATE


Dabigatran Etexilate 110 mg

در تولید شرط بهکشور داخل

در تولید شرط به

کشور داخل

IRAN DRUG LIST




دسترسیDabigatran Etexilate 150mg CAPSULE ORAL B01AE07


Dacarbazine 100 mg INJECTION, POWDER, PARENTERAL L01AX04 -



Daclizumab 5 mg/ml, 5ml PARENTERAL L04AA08

Dactinomycin 0.5 mg INJECTION, POWDER, PARENTERAL L01DA01 -





Prevention of acute renal allograft rejection.


Dalteparin Sodium 10000 U/ml












IRAN DRUG LIST




دسترسی


INJECTION PARENTERAL B01AB09 -

Danazol 100 mg CAPSULE ORAL G03XA01 -

Danazol 200 mg CAPSULE ORAL G03XA01 -

Dantrolene Sodium 20 mg INJECTION, POWDER PARENTERAL M03CA01

Dantrolene Sodium 25 mg CAPSULE ORAL M03CA01 -

Dapsone 100 mg TABLET ORAL J04BA02

Dapsone 50 mg TABLET ORAL J04BA02

Dalteparin Sodium 7500 U/0.3 ml




Danaparoid Sodium 1250 U/ml, 0.6ml

Treatment of the neuroleptic malignant syndrome.



For the combination treatment of Pneumocystis carinii pneumonia in conjunction with trimethoprim.




IRAN DRUG LIST




Dapsone 5%دسترسی GEL TOPICAL D10AX05 5% W/W 1392/04/04

Daunorubicin 20 mg INJECTION, POWDER, PARENTERAL L01DB02 **(As Hydrochloride)**

Deferasirox 125 mg TABLET, DISPERSIBLE ORAL V03AC03 -



Deferiprone 500 mg TABLET ORAL V03AC02 -

Deferiprone 500 mg TABLET, DELAYED RELEASE ORAL V03AC02 - 1389/9/22

Deferoxamine Mesylate 2 g PARENTERAL V03AC01 -

INJECTION, POWDER, PARENTERAL V03AC01 -

INJECTION PARENTERAL N06AA01 -


Desmopressin 120 mcg TABLET SUBLINGUAL H01BA02 **(As Acetate)**




Deferoxamine Mesylate 500 mg

Dehydroemetine Dihydrochloride 30 mg/ml

Desipramine Hydrochloride 25 mg

IRAN DRUG LIST




دسترسیTABLET ORAL H01BA02 -

TABLET ORAL H01BA02 -

SPRAY, SOLUTION NASAL H01BA02 -

INJECTION PARENTERAL H01BA02 -

INJECTION PARENTERAL H01BA02 -

Desogestrel 75mcg TABLET ORAL G03AC09 1390/12/22

Desonide 0.05% CREAM Topical D07AB08 کشور داخل در تولید شرط به 1389/10/25

INJECTION PARENTERAL H02AA03 -

Dexamethasone BULK V03 -

Dexamethasone 0.5 mg TABLET ORAL H02AB02 -

ELIXIR ORAL H02AB02 -

Desmopressin Acetate 0.1 mg

Desmopressin Acetate 0.2 mg

Desmopressin Acetate 10 mcg/dose

Desmopressin Acetate 15 mcg/ml

Desmopressin Acetate 4 mcg/ml

داروهای فهرستO.T.C

Desoxycorticosterone Acetate 5 mg/ml


Dexamethasone 0.5 mg/5ml

IRAN DRUG LIST




دسترسیDROPS, SOLUTION OPHTHALMIC & OTIC S03BA01 **(As Disodium)**

INJECTION PARENTERAL H02AB02 **(As Disodium)**

INJECTION PARENTERAL N05CM18 1391/02/07

Dexpanthenol 250mg/ml INJECTION, SOLUTION PARENTERAL A11HA30 - 1392/09/25

Dexpanthenol 5% CREAM TOPICAL D03AX03 -

INJECTION, SOLUTION INTRAVENOUS DRIP B05BB Dextran70 6% NaCl 0.9%



TABLET ORAL R05DA09 -

Dexamethasone Phosphate 0.1%

Dexamethasone Phosphate 4 mg/ml, 2ml

Dexmedetomidine Hydrochloride 100mcg/ml


Dextran/ NaCl 500 ml




Dextroamphetamine Sulfate 10 mg

Dextroamphetamine Sulfate 5 mg

Dextromethorphan Hydrobromide 15 mg


IRAN DRUG LIST




دسترسیDROPS, SOLUTION ORAL R05DA09 -

SYRUP ORAL R05DA09 -

CAPSULE, GELATIN COATED ORAL R05DA02 -

SYRUP ORAL R05DA20

Dextrose BULK V03 -

Dextrose 10%, 1lit INJECTION, SOLUTION INTRAVENOUS DRIP B05BA03

Dextrose 10%, 250ml INJECTION, SOLUTION PARENTERAL B05BA03

Dextrose 10%, 500ml INJECTION, SOLUTION INTRAVENOUS DRIP B05BA03

Dextromethorphan Hydrobromide 4 mg/ml


Dextromethorphan Hydrobromide 15 mg/5ml


Dextromethorphan Hydrobromide 15 mg


Dextromethorphan/Pseudoephedrine 15/30 mg/5ml

(Dextromethorphan HBr 15mg+Pseudoephedrine HCl 30mg)/5ml



Dextrose anhydrous or monohydrate Eq. to 10 g Dextrose/100 ml



IRAN DRUG LIST




دسترسیDextrose 20% , 50ml INJECTION, SOLUTION INTRAVENOUS DRIP B05CX03

Dextrose 20%, 1lit INJECTION, SOLUTION INTRAVENOUS DRIP B05CX03

Dextrose 20%, 500ml INJECTION, SOLUTION INTRAVENOUS DRIP B05CX03

Dextrose 5% , 250ml INJECTION, SOLUTION PARENTERAL B05BA03

Dextrose 5%, 100ml SOLUTION INTRAVENOUS DRIP B05BA03

Dextrose 5%, 1lit INJECTION, SOLUTION INTRAVENOUS DRIP B05BA03

Dextrose 5%, 500ml INJECTION, SOLUTION INTRAVENOUS DRIP B05BA03

Dextrose 50%, 1lit INTRAVENOUS DRIP B05CX01

INTRAVENOUS DRIP B05CX01




Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/ 100 mlDextrose anhydrous or monohydrate Eq. to 5 g Dextrose/ 100 ml Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/ 100 ml

Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/ 100 ml


Dextrose anhydrous or monohydrate Eq. to 50 g Dextrose/100 ml_ In 2000 ml Container

Dextrose 50%, 200ml in 2 litr bag


IRAN DRUG LIST




دسترسیINTRAVENOUS DRIP B05CX01

Dextrose 50%, 500ml INTRAVENOUS DRIP B05CX01

Dextrose 50%, 50ml INTRAVENOUS DRIP B05CX01

Dextrose 70%, 1lit PARENTERAL B05CX01 In 2000 ml Container

INJECTION, SOLUTION INTRAVENOUS DRIP B05BA10

INJECTION, SOLUTION INTRAVENOUS DRIP B05BB



Dextrose 50%, 400ml in 2 litr bag



Dextrose anhydrous or monohydrate Eq. to 50 g Dextrose/100 ml_In 1000 ml Container




Dextrose/ Ehthanol 5/5%, 1000ml

Dextrose 5% + EHTHANOL 5%

Dextrose/ NaCl 3.33/0.3%, 1000ml

Dextrose 3.33% NaCl 0.3% Dextrose anhydrous or monohydrate Eq. to 3.33% Dextrose/100 ml

Dextrose/ NaCl 3.33/0.3%, 500ml

Dextrose 3.33% NaCl 0.3% Dextrose anhydrous or monohydrate Eq. to 3.33% Dextrose/100 ml

Dextrose/ NaCl 5/0.45%, 1000ml

Dextrose 5% NaCl 0.45% Dextrose anhydrous or monohydrate Eq. to 5 g Dextrose/100 ml

IRAN DRUG LIST




دسترسیINJECTION, SOLUTION INTRAVENOUS DRIP B05BB




Diazepam 10 mg SUPPOSITORY RECTAL N05BA01 -

Diazepam 10 mg TABLET ORAL N05BA01 -









IRAN DRUG LIST




دسترسی

Diazepam 10 mg ENEMA RECTAL N05BA01


Diazepam 2 mg/5ml SOLUTION ORAL N05BA01 -

Diazepam 5 mg ENEMA RECTAL N05BA01 -

Diazepam 5 mg SUPPOSITORY RECTAL N05BA01 -


Diazepam 5 mg/ml, 2ml INJECTION PARENTERAL N05BA01 -

Diazoxide 100 mg CAPSULE ORAL C02DA01 -

Diazoxide 15 mg/ml, 20ml INJECTION PARENTERAL V03AH01

Diazoxide 50 mg CAPSULE ORAL V03AH01 -

Dichloroacetic Acid BULK V03 -

For the management of selected, refractory, patients with epilepsy, on stable regimens of antiepileptic drugs (AEDs), who require intermittent use of diazepam to control bouts of increased seizure activity.





IRAN DRUG LIST




دسترسیGEL TOPICAL M02AA15 -

TABLET ORAL M01AB05

Diclofenac Sodium 0.1% DROPS, SOLUTION OPHTHALMIC S01BC03 -

Diclofenac Sodium 100 mg ORAL M01AB05 -

Diclofenac Sodium 100 mg TABLET, EXTENDED RELEASE ORAL M01AB05

Diclofenac Sodium 100 mg SUPPOSITORY RECTAL M01AB05 -

Diclofenac Sodium 25 mg TABLET, DELAYED RELEASE ORAL M01AB05 -

INJECTION PARENTERAL M01AB05 -

Diclofenac Sodium 50 mg SUPPOSITORY RECTAL M01AB05 -

Diclofenac Diethylammonium Salt Eq To diclofenac s 1%


Diclofenac Potassium 50 mg

CAPSULE, EXTENDED RELEASE, PELLETS

Diclofenac Sodium 25 mg/ml, 3ml




IRAN DRUG LIST




دسترسیDiclofenac Sodium 50 mg TABLET, DELAYED RELEASE ORAL M01AB05 -

Diclofenac Sodium 1.5% SOLUTION TOPICAL M01AB05 1389/6/15

Diclofenac Sodium 75 mg ORAL M01AB05 -

PLASTER TOPICAL M02AA15 1392/5/29

ELIXIR ORAL A03AA07 -


INJECTION PARENTERAL A03AA07 -

Didanosine 200 mg CAPSULE ORAL J05AF02

TABLET, SUSTAINED RELEASE

Diclofenac Diethylamine 120 mg

Dicyclomine Hydrochloride 10 mg/5ml

Dicyclomine Hydrochloride 10 mg

Dicyclomine Hydrochloride 10 mg/ml, 2ml




IRAN DRUG LIST




دسترسی

Didanosine 200 mg TABLET ORAL J05AF02

Dienestrol 0.01% CREAM VAGINAL G03CB01 -

TABLET ORAL G03AA** 1391/02/07

TABLET ORAL P02CB02 -

Digestive TABLET, DELAYED RELEASE ORAL A09AA

Digoxin 0.05 mg/ml ELIXIR ORAL C01AA05 -

Digoxin 0.25 mg TABLET ORAL C01AA05 -

Digoxin 0.25 mg/ml, 2ml INJECTION PARENTERAL C01AA05

Digoxin 0.5 mg/ml DROPS, SOLUTION ORAL C01AA05 -




Dienogest/ Ethinylestradiol 2/ 0.03 mg


Diethylcarbamazine Citrate 50 mg

Pancreatin+simethicone 40 mg





IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL V03AB

INJECTION PARENTERAL N02CA01 -



SOLUTION ORAL A11CC02 -

Diloxanide Furoate 500 mg TABLET ORAL P01AC01 -

Digoxin Specific Antibody 40 mg

Treatment of potentially life threatening digitalis intoxication in patients who are refractory to management by conventional therapy.Treatment of life-threatening acute cardiac glycoside intoxication manifested by conduction disorders, ectopic ventricular activity and (in some cases) hyperkalemia.


Dihydroergotamine Mesylate 1 mg/ml

Dihydroergotamine Mesylate 2.5 mg

Dihydroergotoxine Mesylate 1.5 mg

Dihydrotachysterol 0.25 mg/ml

IRAN DRUG LIST




دسترسیINJECTION, POWDER, PARENTERAL C08DB01 -

INJECTION, SOLUTION PARENTERAL C08DB01 -

ORAL C08DB01 -

TABLET, EXTENDED RELEASE ORAL C08DB01 -

TABLET ORAL C08DB01 -

GEL TOPICAL 1390/09/21

Dimenhydrinate 50 mg TABLET ORAL -

INJECTION INTRAMUSCULAR V03AB09

Dimethicone 4% LOTION TOPICAL D02AA -

Diltiazem Hydrochloride 100 mg






Diltiazem Hydrochloride 2%

C05AE


Dimercaprol 100 mg/ml, 3ml




IRAN DRUG LIST




دسترسی

Dimethyl Sulfoxide 50% SOLUTION PARENTERAL G04BX13

TABLET ORAL R06AA02 -

INJECTION PARENTERAL R06AA02 -

SOLUTION ORAL R06AA02 -

CAPSULE, GELATIN COATED ORAL R06AA02 -

SYRUP ORAL R06AA52

Treatment of cutaneous manifestations of scleroderma.Treatment of palmar-plantar erythrodysethesia syndrome.


Diphenhydramine Hydrochloride 25 mg


Diphenhydramine Hydrochloride 50 mg/ml

Diphenhydramine Hydrochloride 12.5 mg/5ml


Diphenhydramine Hydrochloride 25 mg


Diphenhydramine/Ammonium chloride 12.5/125 mg

Diphenhydramine Compound is accepted for labeling. (Diphenhydramine HCl 12.5mg + Ammonium chloride 125mg) / 5ml

IRAN DRUG LIST




دسترسیDiphenoxylate TABLET ORAL A07DA01

INJECTION PARENTERAL J07AM02 -


Diphteria Antitoxin Equine INJECTION PARENTERAL J06AA01 -

INJECTION PARENTERAL J07


Diphenoxylate HCl 2.5mg+Atropine sulfate 25mcg

Diphteria & Tetanus toxoids Adsorbed (Dt)(for Pedi

Diphteria & Tetanus toxoids Adsorbed (Td)(for adul

Diphteria Toxoid /Tetanus Toxoid/Pertussis/Haemophilus Influenza Type B Vaccine

Diphteria Toxoid/Tetanus Toxoid/Pertussis Vaccine

IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL J07C

Dipyridamole 25 mg TABLET ORAL B01AC07 -

Dipyridamole 5 mg/ml, 2ml INJECTION PARENTERAL B01AC07

Dipyridamole 75 mg TABLET ORAL B01AC07 -

ORAL B01AC30 بالینی مطالعه انجام شرط به 1389/10/25

Disopyramide 100 mg CAPSULE ORAL C01BA03 **(As Phosphate)**

Distilled Water BULK V03 -

Disulfiram 200 mg TABLET ORAL N07BB01



Diphteria Toxoid/Tetanus Toxoid/Pertussis/Haemophilus Influenza Type B/Hepatitis B Vaccine




Dipyridamole/ASA 200/25 mg



IRAN DRUG LIST




دسترسیDithranol BULK V03 -

Dithranol 0.25% CREAM TOPICAL D05AC01 -

INTRAVENOUS DRIP C01CA07

INJECTION, SOLUTION INTRAVENOUS DRIP C01CA07

Docetaxel 160 mg/16ml INJECTION, SOLUTION INTRAVENOUS DRIP L01CD02 - 1389/11/4

Docetaxel 20 mg INJECTION, SOLUTION INTRAVENOUS DRIP L01CD02 -

Docetaxel 80 mg INJECTION, SOLUTION INTRAVENOUS DRIP L01CD02 -



ENEMA RECTAL A06AA02

TABLET ORAL A03FA03 -


Dobutamine (As HCL) 250 mg





Dobutamine (As HCL) 12.5 mg/ml, 20ml




Docusate Na & Sorbitol** 0.01/13.4 g

Docusate Na 0.01g+Sorbitol 13.4 g

Domperidone (As Maleate) 10 mg

IRAN DRUG LIST




دسترسیTABLET ORAL N06DA02 -

TABLET ORAL N06DA02 -

INJECTION PARENTERAL C01CA04

Dorzolamide 2% DROPS, SOLUTION OPHTHALMIC S01EC03 **(As Hydrochloride)**

DROPS, SOLUTION OPHTHALMIC S01ED51

INJECTION PARENTERAL R07AB01

Doxepin 10 mg CAPSULE ORAL N06AA12 **(As Hydrochloride)**

Doxepin 10 mg TABLET ORAL N06AA12 **(As Hydrochloride)**

Doxepin 25 mg CAPSULE ORAL N06AA12 **(As Hydrochloride)**

Doxepin 25 mg TABLET ORAL N06AA02 **(As Hydrochloride)**

Donepezil Hydrochloride 10 mg

Donepezil Hydrochloride 5 mg

Dopamine Hydrochloride 40 mg/ml, 5ml




Dorzolamide\Timolol 2\0.5 %

[Dorzolamide(As Hydrochloride) 2% + Timolol(As Maleate) 0.5%]

Doxapram Hydrochloride 20 mg/ml, 5ml




IRAN DRUG LIST




دسترسیINJECTION, POWDER, PARENTERAL L01DB01 -

INJECTION, LIPOSOMAL PARENTERAL L01DB01 Non-Pegylated 1389/6/15

PARENTERAL L01DB01 -

PARENTERAL L01DB01 -

INJECTION, POWDER, PARENTERAL L01DB01 -

Doxycycline 100 mg CAPSULE ORAL J01AA02 **(As Monohydrate)**

Doxycycline 100 mg TABLET ORAL J01AA02

Doxycycline 50 mg CAPSULE ORAL J01AA02 **(As Monohydrate)**

Doxycycline 100 mg/ Vial INJECTION PARENTERAL J01AA02

Doxorubicin Hydrochloride 10 mg

Doxorubicin Hydrochloride 2 mg/ml, 10ml





Doxorubicin Hydrochloride 50 mg

**(As Hyclate or Monohydrate)**




IRAN DRUG LIST




Doxycycline 100 mgدسترسی CAPSULE ORAL J01AA02 **(As Hyclate)** 1392/5/29


INJECTION PARENTERAL N01AX01

TABLET ORAL G03FA17

TABLET ORAL G03FA17

Duloxetine 20 mg CAPSULE, DELAYED RELEASE ORAL N06AX21 1390/3/7



Dydrogesterone 10 mg TABLET ORAL G03DB01 -

Droperidol Compound (Droperidol 25mg+Fentanyl(as citrate) 0.5mg)/10ml




Droperidol 2.5 mg/ml, 10ml




Drospirenone/Ethinyl Estradiol 3 / 0.03 mg

(Drospirenone 3 mg + Ethinyl Estradiol 0.03 mg)

Drospirenone/Ethinyl Estradiol 3/0.02 mg

(Drospirenone 3 mg + Ethinyl Estradiol 0.02 mg)

کشور داخل در تولید شرط به As Hydrochloride



IRAN DRUG LIST




Dydrogesterone 5 mgدسترسی TABLET ORAL G03DB01 -

DROPS, SOLUTION OPHTHALMIC S01EB03 -



INJECTION PARENTERAL

INJECTION PARENTERAL V03AB03


Edetate Sodium DROPS, SOLUTION OPHTHALMIC S01XA05 -

Echothiophate Iodide 0.06%



Edetate Calcium Disodium 50 mg/ml




Edetate Dicobalt 15 mg/ml, 20ml




Edetate Disodium 150 mg/ml




IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL V04CX

Efavirenz 100 mg CAPSULE ORAL J05AG03

Efavirenz 150 mg/ml SOLUTION ORAL J05AG03


Efavirenz 200 mg TABLET ORAL J05AG03

Edrophonium Chloride 10 mg/ml














IRAN DRUG LIST




دسترسی

Efavirenz 600 mg TABLET ORAL J05AG03


CREAM Topical D11AX16 کشور داخل در تولید شرط به 1389/10/25

Enalapril Maleate 10 mg TABLET ORAL C09AA02 -

Enalapril Maleate 2.5 mg TABLET ORAL C09AA02 -



INHALANT RESPIRATORY N01AB04






Eflornithine Hydrochloride 13.9%

Enflurane




IRAN DRUG LIST




دسترسی






Enoxaparin Sodium 100 mg/ml, 0.2 ml
















Enoxaparin Sodium 100 mg/ml, 1 ml




IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL B01AB05 1390/09/21

Eosin BULK V03 -

TABLET ORAL R03CA02 -

INJECTION PARENTERAL R03CA02 -

INJECTION PARENTERAL R03CA02 -

INJECTION PARENTERAL C01CA24 **(As Hydrochloride)**

Epinephrine 1 mg/ml INJECTION PARENTERAL C01CA24

Epinephrine 1 mg/ml, 2ml INJECTION PARENTERAL C01CA24

Epinephrine 1% DROPS, SOLUTION OPHTHALMIC S01EA01

PARENTERAL L01DB03 Treatment of breast cancer.

Enoxaparin Sodium 100 mg/ml, 3 ml

30,000U anti-xa/3ml(multi dose)




بالکEphedrine Hydrochloride 20 mg

Ephedrine Hydrochloride 50 mg/ml

Ephedrine Sulfate 50 mg/mlEpinephrine 0.1mg/ml, 10ml

**(As Acid Tartrate) or (As Hydrochloride)**

**(As Acid Tartrate) or (As Hydrochloride)** Disposable Injector

**(As Acid Tartrate) or (As Hydrochloride)**

Epirubicin Hdrochloride 2mg/ml, 25ml


IRAN DRUG LIST




دسترسیPARENTERAL L01DB03 Treatment of breast cancer.

INJECTION, POWDER PARENTERAL L01DB03 Treatment of breast cancer.



INJECTION, POWDER PARENTERAL L01DB03 Treatment of breast cancer.

Eplerenone 25 mg TABLET ORAL C03DA04 1392/12/11

Eplerenone 50 mg TABLET ORAL C03DA04 1392/12/11

Epoetin 1000 U/ ml INJECTION PARENTERAL B03XA01


Epirubicin Hdrochloride 2mg/ml, 5ml


Epirubicin Hydrochloride 10 mg

Epirubicin Hydrochloride 2mg/ml, 100ml


Epirubicin Hydrochloride 2mg/ml, 10ml


Epirubicin Hydrochloride 50 mg

Erythropoietin, Treatment of anemia associated with HIV infection


IRAN DRUG LIST




دسترسیEpoetin 2000 U/ ml, 0. 5 ml INJECTION PARENTERAL B03XA01


INJECTION PARENTERAL B03XA01

Epoetin 4000 U/ 0. 3 ml INJECTION PARENTERAL B03XA01





Eprosartan 300 mg TABLET ORAL C09CA02

Eprosartan 600 mg TABLET ORAL C09CA02



Epoetin 40,000 U/ ml, 0. 5 ml







IRAN DRUG LIST




دسترسیINJECTION PARENTERAL B01AC16

Eptifibatide 2mg/ ml(10 ml) INJECTION PARENTERAL B01AC16

INTRA-CAVITY V10AX04 For Therapeutic Use 1389/10/25

Ergotamine Compound TABLET ORAL N02CA52

TABLET ORAL N02CA72

Ergotamine Tartrate 2 mg TABLET SUBLINGUAL N02CA02 -

Erlotinib 100mg TABLET ORAL L01XE03 12/23/1991

Erlotinib 150mg TABLET ORAL L01XE03 12/23/1991

Erythromycin BULK V03 -

Erythromycin 1 g INJECTION, POWDER, PARENTERAL J01FA01 **(As Lactobionate)**

Erythromycin 200 mg TABLET ORAL J01FA01 **(As Ethylsuccinate)**

Eptifibatide 0. 75mg/ ml(100 ml)

Erbium (169Er) Citrate Colloid (5-10) mCi

INJECTION, SOLUTION

Ergotamine tartrate 2 mg + Caffeine 100mg + Cyclizine Hcl 50 mg

Ergotamine Tartarate/Caffeine 1/100 mg

Ergotamine tartrate 1mg+Caffeine 100mg

As Hydrochloride بهکشور داخل در تولید شرط

As Hydrochloride بهکشور داخل در تولید شرط


IRAN DRUG LIST




Erythromycin 200 mgدسترسی TABLET, CHEWABLE ORAL J01FA01 **(As Ethylsuccinate)**

Erythromycin 200 mg/5ml POWDER, FOR SUSPENSION ORAL J01FA01 **(As Ethylsuccinate)**

Erythromycin 400 mg TABLET ORAL J01FA01 **(As Ethylsuccinate)**

Erythromycin 0.5% OINTMENT OPHTHALMIC S01AA17 -

Erythromycin 2% GEL TOPICAL D10AF02 -

Erythromycin 2% SOLUTION TOPICAL D10AF02 -

Erythromycin 4% GEL TOPICAL D10AF02 -

Erythromycin 4% SOLUTION TOPICAL D10AF02 -

GEL TOPICAL D10AF52 1389/11/4

LOTION TOPICAL D10AF52 1389/11/4

GEL TOPICAL D10AF52

INJECTION PARENTERAL B03XA01 -

INJECTION PARENTERAL C07AB09 -

Erythromycin/Azelaic Acid 2/5%

Erythromycin 2% + Azelaic Acid 5%

Erythromycin/Azelaic Acid 2/5%

Erythromycin 2% + Azelaic Acid 5%

Erythromycin/Benzoyl peroxide 3/5 %

Erythromycin 3% + Benzoyl Peroxide 5%

Erythropoeitin 4000 U/0.4ml

Esmolol Hydrochloride 250 mg/ml, 10ml

IRAN DRUG LIST




دسترسیEsomeprazole 20 mg CAPSULE, DELAYED RELEASE ORAL A02BC05

Esomeprazole 40 mg CAPSULE, DELAYED RELEASE ORAL A02BC05

Esomeprazole 20 mg TABLET, DELAYED RELEASE ORAL A02BC05

Esomeprazole 40 mg TABLET, DELAYED RELEASE ORAL A02BC05

Estradiol 0.06% GEL VAGINAL G03CA03 -

Estradiol 0.06% GEL TOPICAL G03CA03 -

Estradiol 100 mcg/24h PATCH, EXTENDED RELEASE TRANSDERMAL G03CA03 -

Estradiol 10 mcg TABLET VAGINAL G03CA03 (as hemihydrate) 1391/07/25



Estradiol 500 mcg GEL TOPICAL G03CA03

PATCH, EXTENDED RELEASE TRANSDERMAL G03CA03 -

PATCH, EXTENDED RELEASE TRANSDERMAL G03CA03 -

Estrogen replacement therapywith Turner syndrome

Estradiol Hemihydrate 100 mcg/24h


IRAN DRUG LIST




دسترسیPATCH, EXTENDED RELEASE TRANSDERMAL G03CA03 -

Estradiol Valerate 1 mg TABLET ORAL G03CA03 -

INJECTION PARENTERAL G03CA03 -

Estradiol Valerate 2 mg TABLET ORAL G03CA03 -

CAPSULE ORAL L01XX11 -

Etanercept 25 mg INJECTION PARENTERAL L04AA11


Estradiol Valerate 10 mg/ml

Estramustine Sodium Phosphate 140 mg

Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs.

IRAN DRUG LIST




دسترسی

Etanercept 50 mg/ml INJECTION PARENTERAL L04AA11 1389/8/24

Etanercept 25 mg INJECTION, POWDER PARENTERAL L04AA11

Ethacridine Lactate BULK V03 **(Rivanol)**

Ethacrynic Acid 50 mg TABLET ORAL C03CC01 -

Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs. prefilled

Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs.


IRAN DRUG LIST




دسترسیTABLET ORAL J04AK02 -

TABLET ORAL J04AM06

TABLET ORAL J04AM06

Ethanol BULK V03

Ethanol * BULK V03

INHALANT RESPIRATORY N01AA

Etherified Starch INJECTION, SOLUTION PARENTERAL B05AA07 -

Ethinylestradiol 0.05 mg TABLET ORAL G03CA01

Ethinylestradiol 0.5 mg TABLET ORAL L02AA03

Ethambutol Hydrochloride 400 mg

Ethambutol/Isoniazid/Pirazinamide/Rifampin

(Ethambutol 275mg+Isoniazid 75mg+Pirazinamide 400mg +Rifampin 150mg)




Ethambutol/Isoniazid/Rifampin

(Ethambutol 275mg+Isoniazid 75mg+Rifampin 150mg)



گيرد قرار سالمتDenaturated for Medical Use **(Ethyl Alcohol)**


**(Denaturated For medical use)**


Ether




Treatment of Turner's syndrome.

Treatment of Turner's syndrome.

IRAN DRUG LIST




Ethiodized Oil INJECTIONدسترسی PARENTERAL V08AD01 **10ml**

Ethionamide 250 mg TABLET ORAL J04AD03 -

Ethosuxamide 250 mg CAPSULE, GELATIN COATED ORAL N03AD01 -

Ethosuximide 250 mg CAPSULE ORAL N03AD01 -

Ethosuximide 250 mg/5ml SYRUP ORAL M05BA01 -

TABLET ORAL M05BA01


Etoposide 100 mg CAPSULE ORAL L01CB01 -

Etoposide 20 mg/ml, 10ml INJECTION, SOLUTION PARENTERAL L01CB01 -

Etoposide 20 mg/ml, 5ml INJECTION, SOLUTION INTRAVENOUS DRIP L01CB01 -

Etidronate Disodium 200 mg

Treatment of hypercalcemia of malignancy inadequately managed by dietary modification and/or ORAL hydration.

Etomidate 2 mg/ml, 10ml




IRAN DRUG LIST




Etoposide 50 mgدسترسی CAPSULE ORAL L01CB01 -

Everolimus 0.25 mg TABLET ORAL L04AA18 کشور داخل در تولید شرط به 1390/07/05



Everolimus 5 mg TABLET ORAL L01XE10 کشور داخل در تولید شرط به 1390/07/05

Exemestane 25 mg TABLET ORAL L02BG06

Expectorant SYRUP ORAL R05CA

Expectorant Codeine SYRUP ORAL R05CA

Ezetimibe 10 mg TABLET ORAL C10AX09 -

Factor IX Complex PARENTERAL B02BD09

Factor VII 600 U PARENTERAL B02BD05 1389/11/18

Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.

(Guaifenesin 100mg + Chlorpheniramine maleate 2mg + Pseudoephedrine HCl 30 mg ) / 5ml


(Guaifenesin 100mg + Pseudoephedrine HCl 30 mg + Codeine phosphate 10mg)/5ml


INJECTION, POWDER, For SOLUTION

Human Coagulation factor VII ( IV Injection)

IRAN DRUG LIST




Factor VIIa 1 mgدسترسی INJECTION PARENTERAL B02BD05 Room Temperature

Factor VIIa 1.2 mg PARENTERAL B02BD05 -

Factor VIIa 2 mg INJECTION PARENTERAL B02BD05 Room Temperature



Factor VIII 250 U PARENTERAL B02BD02

Factor VIII 500 U PARENTERAL B02BD02

PARENTERAL B02BD06 1391/10/03

Factor XIII Powder for INJECTION PARENTERAL B02BD07

Famotidine 20 mg TABLET ORAL A02BA03 -

Famotidine 20 mg/50ml INJECTION , SOLUTION INTRAVENOUS DRIP A02BA03 in sodium chloride 1391/05/02

Famotidine 40 mg TABLET ORAL A02BA03 -






Factor VIII/Von Willbrand 1000 U

INJECTION,SOLUTION, POWDER

Treatment of patients with von Willebrand's disease Factor VIII 1000 U +Von Willbrand factor 1000 U

Human Fibrin-stabilising Factor

داروهای فهرست(Orphan) خاص

IRAN DRUG LIST




دسترسی

TABLET, CHEWABLE Oral A02BA53 1389/10/25

Fampridine 10 mg TABLET, EXTENDED RELEASE Oral N07XX07 کشور داخل در تولید شرط به 1391/12/23

Fenofibrate 100 mg CAPSULE ORAL C10AB05 -

Fenofibrate 200 mg CAPSULE ORAL C10AB05 -

Fentanyl 100 mcg/h PATCH TOPICAL N02AB03 -

Fentanyl 25 mcg/h PATCH TRANSDERMAL N02AB03 -

Fentanyl 50 mcg/h PATCH TRANSDERMAL N02AB03 -

Fentanyl 75 mcg/h PATCH TOPICAL N02AB03 -



Famotidine/Calcium Carbonate/Magnesium Hydroxide 10 mg/800 mg/165 mg


Fentanyl (As Citrate) 50 mcg/ml, 5ml




Fentanyl (As Citrate) 50 mcg/ml, 1ml




IRAN DRUG LIST




دسترسی



INJECTION PARENTERAL B03AC01 1391/02/25

INJECTION PARENTERAL B03AC06 -

SYRUP ORAL B03AA02 40 mg Fe 2+(Elemental)/5ml

CAPSULE, ENTERIC COATED ORAL B03AA02 100 mg Fe 2+(base)

CAPSULE ORAL B03AA02

TABLET ORAL R06AX26 کشور داخل در تولید شرط به 90/3/23

Fentanyle (As Citrate) 50 mcg/ml, 2ml








Ferric Carboxy Maltose 50 mg ferric/ml

Ferric Oxide Saccharated 20 mg/ml

Ferrous sulfate 200mg/5ml, 60 ml

Ferrous-glycine-sulfate 567.66 mg

Ferrous-glycine-sulfate/Folic Acid

Ferrous-glycine-sulfate 454.13 mg + Folic Acid 1 mg 80 mg Fe 2+ elemental

Fexofenadine Hydrochloride 120 mg

IRAN DRUG LIST




دسترسیTABLET ORAL R06AX26 کشور داخل در تولید شرط به 90/3/23

TABLET ORAL R06AX26 کشور داخل در تولید شرط به 90/3/23

TABLET ORAL R06AX26 1392/10/23

SUSPENSION ORAL R06AX26


Fibrinogen 1 g INJECTION, POWDER PARENTERAL B02BC10

OINTMENT TOPICAL B01AD05 90/3/23



Fexofenadine Hydrochloride 30 mgFexofenadine Hydrochloride 30 mg/5 ml

For the control of bleeding and prophylactic treatment of patients deficient in fibrinogen.


Fibrinolysin / Desoxyribonuclease

(Fibrinolysin 1U+Desoxyribonuclease 666U)/g **(Human)**

IRAN DRUG LIST




دسترسی


PARENTERAL L03AA02

Finasteride 1 mg TABLET ORAL G04CB01 -

Filgrastim 300 mcg/ml, 1ml

Reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia.Treatment of patients with AIDS who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir.

Filgrastim 600 mcg/ml, 0.5ml

INJECTION, Prefilled Disposable Syringe

Reduction in the duration of neutropenia, fever, antibiotic use, and hospitalization, following induction and consolidation treatment for acute myeloid leukemia.Treatment of patients with AIDS who, in addition, are afflicted with cytomegalovirus retinitis and are being treated with ganciclovir.

IRAN DRUG LIST




Finasteride 5 mgدسترسی TABLET ORAL G04CB01 -

Finasteride %1 GEL TOPICAL D11AX10 1392/03/11

Fingolimod 0.5 mg CAPSULE ORAL L04AA27 1390/3/7

Flecainide Acetate 100 mg TABLET ORAL C01BC04 -

Fluconazole 50 mg TABLET ORAL J02AC01 -

Fluconazole 100 mg CAPSULE ORAL J02AC01 -




INJECTION PARENTERAL J02AC01 کشور داخل در تولید شرط به 1390/3/9

INJECTION PARENTERAL J02AC01 کشور داخل در تولید شرط به 1390/3/9


کشور داخل در تولید شرط به **(As Hydrochloride)**

Fluconazole 2 mg/ml , 100ml




Fluconazole 2 mg/ml , 200ml




IRAN DRUG LIST




Fluconazole 200 mgدسترسی TABLET ORAL J02AC01 -

Fluconazole 200 mg/5ml SUSPENSION ORAL J02AC01 -


Flucytosine 500 mg TABLET ORAL J02AX01 -

INJECTION, POWDER INTRAVENOUS DRIP L01BB05

TABLET ORAL L01BB05 11/2/1991

INJECTION, SOLUTION PARENTERAL L01BB05

TABLET ORAL H02AA02 -

Fludarabine Phosphate 50 mg

Treatment of chronic lymphocytic leukemia (CLL), including refractory CLL.Treatment and management of patients with non-Hodgkins lymphoma.

Fludarabine Phosphate 10 mg

Fludarabine Phosphate 25mg/ml, 2ml

(Chronic lymphocytic leukemia (CLL) , including refractory CLLa, treat and manage non- Hodykin lyxphome)

Fludrocortisone Acetate 0.1 mg

IRAN DRUG LIST




دسترسیFlumazenil 0.1 mg/ml, 5ml INJECTION PARENTERAL V03AB25 -

CREAM TOPICAL D07AC04 -

OINTMENT TOPICAL D07AC04 -

Fluorescein Sodium 1 mg STRIP OPHTHALMIC S01JA01 **1 mg/strip**

Fluorescein Sodium 10% INJECTION PARENTERAL S01JA01 -

Fluoride 0.25 mg TABLET ORAL A01AA01 (As Sodium)

Fluoride 1 mg TABLET ORAL A01AA01 (As Sodium)

Fluoride 1.23% GEL DENTAL A01AA01 (As Acidulated Phosphate)

Fluoride Sodium 0.2% MOUTHWASH DENTAL A01AA01 -

DROPS, SOLUTION ORAL A01AA01 -

Fluoride Sodium 20 mg TABLET ORAL A12CD51 -

Fluocinolone Acetonide 0.025%

Fluocinolone Acetonide 0.025%





Fluoride Sodium 1.1 mg/ml

IRAN DRUG LIST




دسترسیDROPS, SOLUTION ORAL A01AA01 -

Fluorometholone 0.1% DROPS, SUSPENSION OPHTHALMIC S01BA07 -

Fluorouracil 5% CREAM TOPICAL L01BC02 -

Fluorouracil 5% OINTMENT TOPICAL L01BC02 -

Fluorouracil 50 mg/ml INJECTION PARENTERAL L01BC02

Fluoxetine 10 mg CAPSULE ORAL N06AB03 **(As Hydrochloride)**

Fluoxetine 20 mg CAPSULE ORAL N06AB03 **(As Hydrochloride)**

SYRUP ORAL N06AB03

Flupenthixol 0.5 mg TABLET ORAL N05AF01 **(As Dihydrochloride)**

Flupenthixol 3 mg TABLET ORAL N05AF01 **(As Dihydrochloride)**

Fluoride Sodium 550 mcg/0.15ml

For use in combination with interferon alpha-2a, recombinant, for the treatment of esophageal carcinoma.For use in combination with interferon alpha-2a, recombinant, for the treatment of advanced colorectal carcinoma.

Fluoxetine (As Hydrochloride) 20 mg/5ml

Treatment of body dysmorphic disorder in children

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL N05AF01 -

Fluphenazine 1 mg TABLET ORAL N05AB02 **(Dihydrochloride)**

Fluphenazine 2.5 mg TABLET ORAL N05AB02 **(Dihydrochloride)**

INJECTION PARENTERAL N05AB02 -

Flurazepam 15 mg CAPSULE ORAL N05CD01 **(As Hydrochloride)**

Flutamide 250 mg TABLET ORAL L02BB01 -

INHALER INTRANASAL R01AD08



INHALER NASAL R01AD08 -


Flupenthixol Decanoate 20 mg/ml

Fluphenazine Decanoate 25 mg/ml

Fluticasone Furoate 27.5 mcg/dose

Fluticasone Propionate 125 mcg/dose


Fluticasone Propionate 50 mcg/ dose


IRAN DRUG LIST




دسترسیTABLET ORAL N06AB08 -


Folic Acid 1 mg TABLET ORAL B03BB01 -


Folic Acid 5 mg/ml, 10ml INJECTION PARENTERAL B03BB01 -

PARENTERAL G03GA05

INJECTION PARENTERAL G03GA05

Fluvoxamine Maleate 100 mg

Fluvoxamine Maleate 50 mg

Follitropin Alfa 600 IU/ml, 0.5ml

INJECTION, Recombinant_Prefilled Disposable Pen

For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism. AMENDED indication 6/27/00: For the induction of spermatogenesis in men with primary testicular failure

Follitropin Alfa 600 U/ml, 0.75ml

Recombinant_Prefilled Disposable Pen

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL G03GA05

Follitropin Alfa 75 IU INJECTION, POWDER PARENTERAL G03GA05 -

Follitropin Beta 75 IU INJECTION PARENTERAL G03GA06

Follitropin Beta 833 IU/ml INJECTION PARENTERAL G03GA06 1390/1/29

INJECTION, POWDER PARENTERAL G03GA30 1392/08/20

Fomepizole 1 g/ml, 1.5ml INJECTION PARENTERAL V03AB34

Formaldehyde BULK V03 -

INHALER RESPIRATORY R03AC13 -



Follitropin Alfa 600 U/ml, 1.5ml

Recombinant- Prefilled Disposable Pen



Follitropin Alfa/Lutropin Alfa 150 U/75U

Recombinant, Follitropin Alfa 150U+Lutropin Alfa 75 U

Treatment of methanol or ethylene glycol poisoning.



Formoterol Fumarate 12 mcg/capsule

Formoterol Fumarate 12 mcg

Formoterol Fumarate 4.5 mcg

IRAN DRUG LIST




دسترسیINHALER RESPIRATORY R03AC13 -

Fosfestrol 120 mg TABLET ORAL L02AA04 **(As Tetra Sodium)**

Fosfestrol 50 mg/ml, 5ml INJECTION PARENTERAL L02AA04 **(As Tetra Sodium)**

Furazolidone 100 mg TABLET ORAL G01AX06 -

Furazolidone 50 mg/15ml SUSPENSION ORAL G01AX06 -

INJECTION, SOLUTION INTRAVENOUS DRIP C03CA01 -

Furosemide 10 mg/ml, 2ml INJECTION PARENTERAL C03CA01 -

Furosemide 10 mg/ml, 4ml INJECTION PARENTERAL C03CA01 -

Furosemide 40 mg TABLET ORAL C03CA01 -

Gabapentin 100 mg CAPSULE ORAL N03AX12



Formoterol Fumarate 9 mcg

Furosemide 10 mg/ml, 25ml

Treatment of amyotrophic lateral sclerosis.



IRAN DRUG LIST




دسترسیGabapentin 600 mg TABLET ORAL N03AX12


Gabapentin 800 mg TABLET ORAL N03AX12

INJECTION PARENTERAL V08CA09 Prefilled Disposable syringe

INJECTION PARENTERAL V08CA09 -

Gadodiamide 287 mg/ml INJECTION PARENTERAL V08CA03 -


Galantamine 20 mg/5ml SOLUTION ORAL N06DA04 **(As Hydrobromide)**

Galantamine 4 mg TABLET ORAL N06DA04 **(As Hydrobromide)**

Galantamine 8 mg TABLET ORAL N06DA04 **(As Hydrobromide)**




Gadobutrol 604.72 mg/ml (1mmol/ml) , 7.5ml

Gadobutrol 604.72 mg/ml (1mmol/ml), 15ml

Gadopentetate Dimeglumine 469 mg/ml

IRAN DRUG LIST




Galantamine 12 mgدسترسی TABLET ORAL N06DA04 **(As Hydrobromide)**

Galantamine 16 mg ORAL N06DA04 **(As Hydrobromide)**

Galantamine 24 mg CAPSULE, DELAYED RELEASE ORAL N06DA04 **(As Hydrobromide)**

Galantamine 8 mg ORAL N06DA04 **(As Hydrobromide)**

INJECTION INTRAVENOUS BOLUS V09HX01 -

INJECTION INTRAVENOUS BOLUS V09HX01 -

Gallium(68 Ga)-Octrotate PARENTERAL V09X 1391/9/1

Galsulfase 1mg/ml INJECTION PARENTERAL A16AB08 1391/02/07

Ganciclovir 500 mg PARENTERAL J05AB06

Ganciclovir 0.15% GEL OPHTHALMIC S01AD09 1.5 mg/g 1390/09/21

INJECTION PARENTERAL H01CC01



Gallium[67ga]citrate 10 mCi


Gallium[67ga]citrate 5 mCi




داروهاي فهرست - (orphan) خاص

بیمار 35برای میگردد .ثبت


Treatment of acute herpetic keratitis (dendritic and geographic ulcers)

Ganirelix 500 mcg/ml, 0.5ml

**(As Acetate)**Prefilled Disposible Syringe

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL J06AA05 -

Gefitinib 250mg TABLET ORAL LO1XE02 کشور داخل در تولید شرط به 23/12/91

Gelatin Modified INJECTION, SOLUTION INTRAVENOUS DRIP B05AA06

Gelatin Modified 4% INJECTION PARENTERAL B05AA06

Gemcitabine 1 g PARENTERAL L01BC05 As Hydrochloride

Gemcitabine 1 g PARENTERAL L01BC05 As Hydrochloride 1390/03/23

Gemcitabine 200 mg PARENTERAL L01BC05 As Hydrochloride

Gemcitabine 200 mg PARENTERAL L01BC05 As Hydrochloride 1390/03/23

Gemcitabine 2g/52.6ml INJECTION PARENTERAL L01BC05 As Hydrochloride 1390/09/21

Gemfibrozil 300 mg CAPSULE ORAL C10AB04 -

Gemfibrozil 450 mg TABLET ORAL C10AB04 -

Gemifloxacin 320 mg TABLET ORAL J01MA15

Gentamicin 3 mg/g OINTMENT OPHTHALMIC S01AA11 **(As Sulfate)**

Gaseous Gangrene Antitoxin

(Gelatin Succinylate 30g + NaCl 4.51g + CaCl2,2H20 0.21g) / 1000 ml

(Gelatin Succinylated 40g (4%) + Na+ 154 mmol + Cl- 120 mmol )/lit


INJECTION, SOLUTION CONCENTRATE



کشور داخل در تولید شرط به **(As Mesilate)**

IRAN DRUG LIST




Gentamicin 3 mg/mlدسترسی DROPS, SOLUTION OPHTHALMIC S03AA06 **(As Sulfate)**

Gentamicin 40 mg/ml, 1ml INJECTION PARENTERAL J01GB03 **(As Sulfate)**


INJECTION PARENTERAL J01GB03 1390/3/9


Gentian Violet BULK V03 -

Gentian Violet 1% SOLUTION TOPICAL D01AE02






ميشود

Gentamicin 0.8 mg/ml , 100 ml

(As Sulfate) in sodium chloride 0.9% (premixed) در تولید شرط به

کشور داخل






داروهاي ميشود فهرستبالک

Crystal Violet 1 g + Ethanol 96% (8-10)ml + water qs to 100 ml

IRAN DRUG LIST




دسترسیGENERATOR*

_

V09X 1391/9/1

INJECTION PARENTERAL L02AB03 -

INJECTION PARENTERAL L03AX13

Glibenclamide 5 mg TABLET ORAL A10BB01 -

Gliclazide 30 mg TABLET, EXTENDED RELEASE ORAL A10BB09 -

Gliclazide 80 mg TABLET ORAL A10BB09 -

Glucagon 1 mg INJECTION, POWDER, PARENTERAL H04AA01 **(As Hydrochloride)**

Glycerin BULK V03 -

Glycerin 1 g SUPPOSITORY RECTAL A06AX01 -

Glycerin 1.2 mg SUPPOSITORY RECTAL A06AX01 -

Glycerin 2 g SUPPOSITORY RECTAL A06AX01 -

Glycerin 3.4 mg SUPPOSITORY RECTAL A06AX01 -

Glycine 1.5% SOLUTION IRRIGATION B05CX03 **(Aminoacetic Acid)**

Germanium(68 Ge)/Gallium(68 Ga) Generator

منبع عنوان به ژنراتور سامانه- گالیوم انواع 68تولید تولید برای

گالیوم* - حاوی داروهای رادیورود 68 می کار به


Gestonorone Caproate 100 mg/ml, 2ml

Glatiramer Acetate 20 mg/1 ml






IRAN DRUG LIST




دسترسیGlycolic Acid BULK V03 -

Glycolic Acid 70% SOLUTION TOPICAL D -

INJECTION PARENTERAL A03AB02 -


INJECTION PARENTERAL M01CB01 -






Glycopyrronium Bromide 200 mcg/ml, 1ml

Glycopyrronium Bromide 200 mcg/ml, 5ml

Gold Sodium Thiomalate 50 mg/ml, 10ml

Gold Sodium Thiomalate 100 mg/ml, 0,5ml



Gold Sodium Thiomalate 20 mg/ml, 0.5ml

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL M01CB01 -







Gonadorelin 100 mcg INJECTION, POWDER, PARENTERAL V04CM01 -








IRAN DRUG LIST




دسترسی

Gonadorelin Acetate 0.8 mg INJECTION, POWDER PARENTERAL H01CA01

Gonadorelin Acetate 3.2 mg INJECTION, POWDER PARENTERAL H01CA01

Goserelin 3.6mg IMPLANT PARENTERAL L02AE03 As Acetate 1391/12/23

Goserelin 10.8mg IMPLANT PARENTERAL L02AE03 As Acetate 1391/12/23

Granisetron 1 mg TABLET ORAL A04AA02 **(As Hydrochloride)**

Granisetron 1 mg/ml, 3ml INJECTION, SOLUTION INTRAVENOUS DRIP A04AA02 **(As Hydrochloride)**

Granisetron 1mg/ml, 1ml INJECTION, SOLUTION INTRAVENOUS DRIP A04AA02 **(As Hydrochloride)**

For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion.

For induction of ovulation in women with hypothalamic amenorrhea due to a deficiency or absence in the quantity or pulse pattern of endogenous GnRH secretion.

IRAN DRUG LIST




دسترسیGranisetron 3.1mg/24h PATCH, EXTENDED RELEASE TRANSDERMAL _ 34.3 mg/52 cm2 1390/09/21

Griseofulvin 125 mg TABLET ORAL D01AA08 -

Griseofulvin 500 mg TABLET ORAL D01AA08 -

Guaifenesin 100 mg/5ml SYRUP ORAL R05CA03 -

CAPSULE, GELATIN COATED ORAL R05CA03 کشور داخل در تولید شرط به 1390/09/21

CAPSULE, GELATIN COATED ORAL R05CA03 کشور داخل در تولید شرط به 1390/09/21

INJECTION, POWDER PARENTERAL J07AG01 -

SOLUTION FOR INJECTION PARENTERAL J07AG01 -

Haloperidol 2 mg/ml SOLUTION ORAL N05AD01 **(As Lacate)**

Haloperidol 5 mg/ml INJECTION PARENTERAL N05AD01 **(As Lacate)**

Haloperidol 50 mg/ml INJECTION PARENTERAL N05AD01 **(As Decanoate)**

Haloperidol 0.5 mg TABLET ORAL N05AD01 -

Haloperidol 2 mg TABLET ORAL N05AD01 -

Haloperidol 5 mg TABLET ORAL N05AD01 -


Guaifenesin 100 mg داروهاي فهرستOTC

Guaifenesin 200 mg داروهاي فهرستOTC

Haemophilus Influenza Type B

Haemophilus Influenza Type B

IRAN DRUG LIST




دسترسی


Hematinic CAPSULE ORAL B03AD

Hematinic CAPSULE, GELATIN COATED ORAL B03AD

SOLUTION, CONCENTRATE UNASSIGNED B05ZA


Halothane 250 ml/bottle




VIT. B12 15mcg+Ferrous Fumarate 350 mg+VIT.C 150mg+Folic Acid 1mg




Hemodialysis Concentrated I

(Na+4725mEq + Mg++35mEq + K+ 35mEq + Ca++ 87.5mEq + Cl- 3657.5mEq + Acetate 1225 mEq + Dextrose 70 g)/ L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml

Hemodialysis Concentrated I,without Dextrose

(Na+ 4725 mEq + Mg ++35 mEq + K+ 35mEq + Ca++ 87.5 mEq + Cl- 3657.5 mEq + Acetate 1225mEq )/ L

IRAN DRUG LIST




دسترسی




Hemodialysis Concentrated II

(Na+ 4725 mEq+MG++ 35mEq + K+ 70mEq+Ca++ 87.5mEq+ Cl- 3692.5 mEq + Acetate 1225mEq + Dextrose 70 g) / L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml

Hemodialysis Concentrated II ,Acidic

(Na+3710mEq + Mg++35mEq + K+ 70mEq + Ca++ 87.5mEq + Cl- 3902.5 mEq + CH3Coo- 122.5 mEq + Dextrose 70 g)/ L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml

Hemodialysis Concentrated III

(Na+4725mEq + Mg++35mEq + K+ 105mEq + Ca++ 87.5mEq + Cl- 3745 mEq + Acetate 1225 mEq + Dextrose 70 g)/ L Dextrose anhydrous or monohydrate Eq. to 70 g Dextrose/1000 ml

IRAN DRUG LIST




دسترسیSOLUTION UNASSIGNED B05ZB 1392/06/12



Heparin Sodium 5000 U/ml INJECTION PARENTERAL B01AB01


Hemofiltration & Haemodiafiltration

(Na+125-150mEq + Mg++0.5-3 mEq + K+0- 4.5 mEq + Ca++ 2-5 mEq + Cl- 90-120 mEq + Acetate and or lactate and or Hydrogen Carbonate 30-60 mEq + Glucose 0-25 mmol)/ L

Heparin Sodium 10,000 U/ml




Heparin Sodium 10,000 U/ml, 1ml






ميشود

Heparin Sodium 5000 U/ml, 1ml




IRAN DRUG LIST




دسترسی


INJECTION PARENTERAL J06BB04

INJECTION PARENTERAL J06BB04 IV, No volume defined

Hepatitis B Virus INJECTION PARENTERAL J07BC01 -

CAPSULE ORAL L01XX03 -

Holmium(166Ho)chitosan INJECTION PARENTERAL V10XX 1391/9/1

DROPS, SOLUTION OPHTHALMIC S01FA05 -

Human Papiloma Virus VaccinINJECTION PARENTERAL J07BM01 Polyvalent *Prefilled Syringe* 1390/07/05

Hyaluronic Acid BULK V03 -

Heparin Sodium 5000 U/ml, 5ml




Hepatitis B immune globulin At least 200 IU/ml

Prophylaxis against hepatitis B virus reinfection in liver transplant patients.

Hepatitis B Immune Globulin(humam) 50 IU/ml

Hexamethylmelamine 100 mg


Homatropine Hydrobromide 2%


IRAN DRUG LIST




دسترسیINJECTION, POWDER PARENTERAL C02DB02 -

PARENTERAL C02DB02 -




Hydrochloric Acid BULK V03 -

Hydrochlorothiazide 50 mg TABLET ORAL C03AA03 -

Hydrocortisone 1% CREAM TOPICAL D07AA02

Hydrocortisone 100 mg INJECTION, POWDER, PARENTERAL H02AB09 **(As Sodium Phosphate)**

INJECTION PARENTERAL H02AB09 **(As Sodium Phosphate)**

Hydrocortisone 10 mg TABLET ORAL H02AB09 -

Hydralazine Hydrochloride 20 mg







Hydrocortisone 50 mg/ml, 2ml

IRAN DRUG LIST




دسترسیENEMA RECTAL A07EA02 -

Hydrocortisone * 100 mg INJECTION, POWDER, PARENTERAL H02AB09 **(As Sodium succinate)**

INJECTION PARENTERAL H02AB09 **(As Sodium succinate)**

Hydrocortisone Acetate 1% CREAM TOPICAL D07AA02 -

Hydrocortisone Acetate 1% OINTMENT OPHTHALMIC S01BA02 -

Hydrocortisone Acetate 1% OINTMENT TOPICAL D07AA02 -

DROPS, SOLUTION OTIC S02CA03

BULK V03 **(30% w/W H2O2 )**

Hydromorphone 2 mg TABLET ORAL N02AA03 -

Hydromorphone 4 mg TABLET ORAL N02AA03 -

Hydrocortisone 100 mg/60ml

Hydrocortisone * 50 mg/ml, 2ml

Hydrocortisone/Acetic Acid 1/2%

**(Hydrocortisone 1% + Acetic Acid 2%)**

Hydrogen Peroxide Concentrate


IRAN DRUG LIST




دسترسیHydrophilic Petrolatum BULK V03

Hydroquinone BULK V03 -

Hydroquinone 2% CREAM TOPICAL D11AX11 -

Hydroquinone 4% CREAM TOPICAL D11AX11 -

TABLET ORAL P01BA02 -

INJECTION PARENTERAL G03DA03 -

Hydroxyurea 250 mg CAPSULE ORAL L01XX05

(White Petrolatum86%+White Wax8%+Strearyl Alcohol3%+Cholestrol3%)



Hydroxychloroquine Sulfate 200 mg

Hydroxyprogesteron Caproate 250 mg/ml

Treatment of pediatric patients with sickle cell anemia.Treatment of patients with sickle cell anemia as shown by the presence of hemoglobin S.

IRAN DRUG LIST




دسترسی

Hydroxyurea 500 mg CAPSULE ORAL L01XX05

SYRUP ORAL N05BB01 -

TABLET ORAL N05BB01 -

TABLET ORAL N05BB01 -

SUPPOSITORY RECTAL A03BB01 -

TABLET ORAL A03BB01 -

INJECTION PARENTERAL A03BB01 -

SUPPOSITORY RECTAL A03BB01 -

Treatment of pediatric patients with sickle cell anemia.Treatment of patients with sickle cell anemia as shown by the presence of hemoglobin S.

Hydroxyzine Hydrochloride 10 mg/5ml

Hydroxyzine Hydrochloride 10 mg

Hydroxyzine Hydrochloride 25 mg

Hyoscine-n-butyl Bromide 10 mg

Hyoscine-n-butyl Bromide 10 mg

Hyoscine-n-butyl Bromide 20 mg/ml

Hyoscine-n-butyl Bromide 7.5 mg

IRAN DRUG LIST




دسترسی

Ibuprofen 5mg/ml, 2ml INJECTION INTRAVENOUS C01EB16

Ibuprofen 100mg/ml, 4ml INJECTION PARENTERAL M01AE01 1390/06/14

Ibuprofen 100mg/ml, 8ml INJECTION PARENTERAL M01AE01 1390/06/14

Ibuprofen 100 mg/5ml SUSPENSION ORAL M01AE01 -

Ibuprofen 10 mg/ml INJECTION PARENTERAL C01EB16 (As Lysine) 1390/09/21

Ibuprofen 200 mg* CAPSULE ORAL M01AE01 -

تخصص فوق دارای مراکز درقلب تخصص فوق و نوزادان

دستگاه به مجهز و کودکانتشخیص جهت اکوکاردیوگرافی

PDA (Patent ductus arterious)


فهرست

خاص داروهایداروهاي فهرست



داروهاي ميشود فهرستدسترسي با






داروهای فهرست

داروهاي خاص فهرستOTC

IRAN DRUG LIST




دسترسیIbuprofen 200 mg* TABLET ORAL M01AE01 -

Ibuprofen 400 mg CAPSULE, GELATIN COATED ORAL M01AE01 -

Ibuprofen 400 mg TABLET ORAL M01AE01 -

Ibuprofen 5% GEL TOPICAL M02AA13

INJECTION , SOLUTION PARENTERAL M01AE01 1392/5/29

Ibuprofen Lysine 342 mg TABLET Oral M01AE01 1392/7/22

Ibuprofen Lysine 684 mg TABLET Oral M01AE01 1392/7/22

Ichthyol BULK V03 **(Ichthammol)**

Ichthyol 10% OINTMENT TOPICAL D10BX **(Ichthammol)**



Ibuprofen Lysine 400 mg/3ml




داروهای فهرست

خاص


IRAN DRUG LIST




دسترسی

PARENTERAL L01DB06

PARENTERAL L01DB06

Idoxuridine 0.1% DROPS, SOLUTION OPHTHALMIC S01AD01 -

Ifosfamide 40mg/ml, 25ml INJECTION, SOLUTION PARENTERAL L01AA06 10/3/1991

Ifosfamide 1 g INJECTION, POWDER PARENTERAL L01AA06

Idarubicin Hydrochloride 10 mg


Treatment of acute lymphoblastic leukemia in pediatric patients.Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.


Idarubicin Hydrochloride 5 mg




Treatment of testicular cancer.Treatment of bone sarcomasTreatment of soft tissue sarcomas.


IRAN DRUG LIST




دسترسی

Ifosfamide 2 g INJECTION, POWDER PARENTERAL L01AA06

INJECTION PARENTERAL J06BA02 -

Imatinib 50 mg CAPSULE ORAL L01XE01


Igm-enriched Human (Immune globulin)*

Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemiaTreatment of Philadelphia-positive ALLTreatment of dermatofibrosarcoma protuberansTreatment of gastrointestinal stromal tumors

IRAN DRUG LIST




دسترسی

Imatinib 100 mg CAPSULE ORAL L01XE01

Imatinib 400 mg TABLET ORAL L01XE01 1392/09/25

(As Mesylate)Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemiaTreatment of Philadelphia-positive ALLTreatment of dermatofibrosarcoma protuberansTreatment of gastrointestinal stromal tumors

(As Mesylate)Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemiaTreatment of Philadelphia-positive ALLTreatment of dermatofibrosarcoma protuberansTreatment of gastrointestinal stromal tumors

IRAN DRUG LIST




دسترسی

Imatinib 100 mg TABLET ORAL L01XE01

Imiglucerase 200 U INJECTION, POWDER PARENTERAL A16AB02

Imiglucerase 400 U INJECTION, POWDER PARENTERAL A16AB02

INJECTION, POWDER PARENTERAL J01DH51

(As Trihydrate)Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemiaTreatment of Philadelphia-positive ALLTreatment of dermatofibrosarcoma protuberansTreatment of gastrointestinal stromal tumors

Replacement therapy in patients with types I, II, and III Gaucher's disease.




Imipenem /Cilastatin 250/250 mg

Imipenem(as Monohydrate) 250 mg + Cilastatin(as Sodium) 250 mg




IRAN DRUG LIST




دسترسی







Imiquimod 5% CREAM TOPICAL D06BB10 -











Imipramine Hydrochloride 10 mg

Imipramine Hydrochloride 12.5 mg/ml, 2ml



IRAN DRUG LIST




دسترسی

Immune Globulin PARENTERAL J06BA02

INJECTION PARENTERAL J06BA02



INJECTION INTRAVENOUS J06BA02


Treatment of multifocal motor neuropathy, Guillain Barre Syndrome, polymyositis/dermatomyositis

Immune Globulin 100 mg/ml, 100ml








IRAN DRUG LIST




دسترسی






Indapamide 1.5 mg TABLET, EXTENDED RELEASE ORAL C03BA11 -





Immune Globulin 50mg/ml, 100ml






IRAN DRUG LIST




دسترسیPARENTERAL V09 For Diagnostic Use 1389/10/25



PARENTERAL V09AX01 For Diagnostic Use 1389/10/25

Indocyanine Green 25 mg Powder for INJECTION PARENTERAL V04CX

Indometacin 50 mg/2ml INJECTION, SOLUTION PARENTERAL M01AB01 1390/3/7

Indomethacin 100 mg SUPPOSITORY RECTAL M01AB01 -

Indomethacin 25 mg CAPSULE ORAL M01AB01 -

Indomethacin 50 mg SUPPOSITORY RECTAL M01AB01 -

Indomethacin 75 mg ORAL M01AB01 -

Indium (111In) Chloride 10 mCi

INJECTION, SOLUTION

Indium (111In) Ibritumomab Tiuxetan

INJECTION, SOLUTION

Indium (111In) Oxyquinoline 1 mCi/ml

INJECTION, SOLUTION

Indium (111In) Pentetate 1 mCi/ml

INJECTION, SOLUTION

داروهاي فهرست"orphan" خاص

تخصص فوق دارای مراکز درقلب تخصص فوق و نوزادان

دستگاه به مجهز و کودکانتشخیص جهت اکوکاردیوگرافی




IRAN DRUG LIST




دسترسیIndomethacin 75 mg TABLET, EXTENDED RELEASE ORAL M01AB01 -

Indomethacin 80 mg TABLET, EXTENDED RELEASE ORAL M01AB01 -

Infliximab 100 mg INJECTION, POWDER PARENTERAL L04AA12

Influenza Virus INJECTION PARENTERAL J07BB01 **(Killed)**


Insulin Aspart 100 U/ml INJECTION, SOLUTION PARENTERAL A10AB05

Treatment of moderately to severely active Crohn's disease for the reduction of the signs and symptoms, in patients who have an inadequate response to conventional therapy; and treatment of patients with fistulizing Crohn's disease.Treatment of chronic sarcoidosisTreatment of giant cell arteritis


Insulin (Regular)* 100 IU/ml

recombinant in 3 ml prefilled pen

IRAN DRUG LIST




دسترسی

Insulin Aspart 100 U/ml INJECTION, SUSPENSION PARENTERAL A10AB05

INJECTION PARENTERAL A10AB30

INJECTION, SUSPENSION PARENTERAL A10AB30

INJECTION PARENTERAL A10AB30

Insulin Detemir 100 IU/ml INJECTION, SOLUTION PARENTERAL A10AE05 1392/12/11

INJECTION PARENTERAL A10AE01 Recombinant

INJECTION PARENTERAL A10AE01 Prefilled Disposable Pen

INJECTION PARENTERAL A10AE01 -

recombinant in 3 ml prefilled pen (30% soluble Insulin Aspart + 70% Insulin Aspart crystallised wiyh Protamine)

Insulin Biphasic Isophane 100 IU/ml, 3ml

(Isophane Insulin 70% + Insulin Reg 30%) in Cartridge for PEN

Insulin Biphasic Isophane 100 IU/ml, 3ml

( Isophane Insulin 75% + Insulin Regular 25%) in Cartridge for PEN

Insulin Biphasic isophane 100 IU/ml

Isophane Insulin 70% + Insulin Reg 30%

Insulin Glargine 100 IU/ml, 10ml



IRAN DRUG LIST




دسترسیInsulin Glulisin 100 IU/ml INJECTION, SOLUTION PARENTERAL A10AB06 1392/12/11

INJECTION PARENTERAL A10AE01 **(NPH)**

Insulin Zinc 100 IU/ml INJECTION PARENTERAL A10AE01 -

INJECTION PARENTERAL L03AB04

Insulin Isophane 100 IU/ml

Interferon Alfa-2a 6 Million U/ml,0.5ml

For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer.Treatment of AIDS related Kaposi's sarcoma.For the treatment of metastatic malignant melanoma in combination with Teceleukin.

IRAN DRUG LIST




دسترسی


INJECTION PARENTERAL L03AB05 1391/02/25

Interferon Alfa-2a 9 Million U/ml,0.5ml

For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer.Treatment of AIDS related Kaposi's sarcoma.For the treatment of metastatic malignant melanoma in combination with Teceleukin.

Interferon Alfa-2b 3 Million U

Treatment of AIDS-related Kaposi's sarcoma.Treatment of acute hepatitis B.Treatment of primary malignant brain tumors.Treatment of carcinoma in situ of the urinary bladder.Treatment of chronic delta hepatitis.

IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL L03AB05 1391/02/25

INJECTION, POWDER PARENTERAL L03AB05





IRAN DRUG LIST




دسترسی




Interferon Alfa-2b 10MillionU/ml,2.5ml


Interferon Beta-1a 12 Million U, 44 mcg

For the systemic treatment of cutaneous malignant melanoma.Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3.Treatment of acute non-A, non-B hepatitis.

Interferon Beta-1a 12 MillionU/ml,0.5ml, 30 mcg

For the systemic treatment of cutaneous M MelanomaTreatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells Treatment of acute non-A, non-B hepatitis.

IRAN DRUG LIST




دسترسی


Interferon Beta-1b 250 mcg INJECTION, POWDER PARENTERAL L03AB07

Interferon Beta-1a 6 Million U, 30 mcg



IRAN DRUG LIST




دسترسی



Iobenguane (123I ) 10 mCi PARENTERAL V09 For Diagnostic Use 1389/10/25

PARENTERAL V10XA02 For Therapeutic Use 1389/10/25


Interferon Beta-1b 9.6 Million U, 300 mcg


Interferon Gamma-1b 100 mcg

renal cell carcinoma/chronic granuloma+ous diseasea/delaying time to dieseas progressin in patients with severe, malignant osteoperosisa, diopathic pulomonary fibrosis

INJECTION, SOLUTION

Iobenguane (131I ) (50-300) mCi

INJECTION, SOLUTION

Iobenguane (131I) (0.5-1) mCi

INJECTION, SOLUTION

IRAN DRUG LIST




دسترسیCAPSULE TRANSDERMAL V09GB02 **Implant**

SOLUTION ORAL V09FX03 -

CAPSULE ORAL V09FX03 -







Iodine BULK V03 -

Iodide [125I] (0.281-0.878) mCi


Iodide [131i] Sodium 100 mCi


Iodide [131i] Sodium 100 micCi















IRAN DRUG LIST




دسترسیPARENTERAL V10XA53 For Diagnostic Use 1389/10/25

Iodixanol 150 mgI/ml INJECTION PARENTERAL V08AB09 **305 mg/ml**



Iodoquinol 210 mg TABLET ORAL G01AC01

Iohexol 240 mgI/ml, 100ml INJECTION PARENTERAL V08AB02 518 mg/ml






Iodine (131I) Tositumomab 5 mCi

INJECTION, SOLUTION

**(Di,iodohydroxyquinoline)**

IRAN DRUG LIST




دسترسیIohexol 300 mgI/ml, 10ml INJECTION PARENTERAL V08AB02 647 mg/ml








INJECTION PARENTERAL V08AB04 **612mg/ml**

INJECTION PARENTERAL V08AB04 **612 mg/ml**

Iopamidol 300 mgI/ml, 100ml


IRAN DRUG LIST




دسترسیINJECTION PARENTERAL V08AB04 **612mg/ml**

Iopamidol 300mgI/ml SOLUTION ORAL V08AB04 -


INJECTION PARENTERAL V08AB04 **755mg/ml**


Iopanoic Acid 500 mg TABLET ORAL V08AC06 -

INJECTION PARENTERAL V08AB05 -









Iopromide 300 mgI/ml, 100ml





IRAN DRUG LIST




دسترسیINJECTION PARENTERAL V08AB05 -




INJECTION PARENTERAL V08AC02 -

Ipecac 0.14% SYRUP ORAL V03AB01 0.14%Total Alkaloids

INHALER RESPIRATORY R01AX03 -

NEBULISATION RESPIRATORY R01AX03 Nebulisation

NEBULISATION RESPIRATORY R01AX03 Nebulisation

INHALER RESPIRATORY R01AX03 -





Iotroxate Meglumine 50 mgI/ml, 100ml

Ipratropium Bromide 20 mcg/dose

Ipratropium Bromide 250 mcg/ml, 1ml

Ipratropium Bromide 250 mcg/ml, 2ml

Ipratropium Bromide 40 mcg/dose

IRAN DRUG LIST




دسترسی

AEROSOL, METERED RESPIRATORY R03AK04 1389/8/24

AEROSOL, METERED RESPIRATORY R03AK04

NEBULISATION RESPIRATORY R03AK04

INJECTION PARENTERAL L01XX19

INJECTION PARENTERAL L01XX19 -

INJECTION PARENTERAL L01XX19 - 1390/1/29

Ipratropium bromide/Fenoterol Hydrobromide 20/50 mcg/dose

{Ipratropium bromide 20 mcg + Fenoterol hydrobromide 50 mcg}/dose HFA only

Ipratropium bromide/Salbutamol 20/100 mcg/dose

{Ipratropium bromide 20 mcg + Salbutamol ( As sulfate ) 100 mcg}/dose

Ipratropium bromide/Salbutamol 200mcg/1mg

{Ipratropium bromide 200 mcg + Salbutamol ( As sulfate ) 1 mg}/ml

Irinotecan Hydrochioride 20 mg/ml, 15 ml

Irinotecan Hydrochioride 20 mg/ml, 5ml

Irinotecan Hydrochloride 20 mg/ml, 2ml

IRAN DRUG LIST




دسترسیINTRAVENOUS DRIP L01XX19 -

INTRAVENOUS DRIP L01XX19 -

Iron 50 mg/ml, 5ml INJECTION INTRAMUSCULAR B03AC03 **(As Sorbitol)**

Iron 20 mg/ml, 5ml INJECTION INTRAVENOUS B03AC03 **(As Sucrose)**

Iron 100mg/ml INJECTION PARENTERAL B03AC 1391/05/02

Iron 25 mg/ml DROPS, SOLUTION ORAL B03AA02 -

Isocarboxazid 10 mg TABLET ORAL N06AF01 -


Isoniazid 100 mg TABLET ORAL J04AC01 -

Isoniazid 100 mg/ml, 10ml INJECTION PARENTERAL J04AC01 -

Irinotecan Hydrochloride 100MG, 5ML

INJECTION, POWDER FOR RECONSTITUTION

Irinotecan Hydrochloride 40mg, 2ML


**(as isomaltoside 1000)** داخل تولید شرط به

ابتدا از کشورداروهاي فهرست

OTC

Isoflurane




IRAN DRUG LIST




Isoniazid 300 mgدسترسی TABLET ORAL J04AC01 -

TABLET ORAL J04AM05

TABLET ORAL J04AM02

Isopropyl Alcohol BULK V03 -

INJECTION PARENTERAL R03CB01 -


SPRAY, SOLUTION TOPICAL C01DA08 -

Isosorbide Dinitrate 10 mg TABLET ORAL C01DA08 -

Isosorbide Dinitrate 40 mg TABLET, EXTENDED RELEASE ORAL C01DA08 -

Isoniazid/Prazinamide/Rifampin

Isoniazid/Rifampin 75/150 mg

Isoniazid 50 mg + Pyrazinamide 300 mg + Rifampin 120 mg




بالکIsoproterenol Hydrochloride 1 mg/ml, 2ml

Isoproterenol Hydrochloride 0.2 mg/ml

Isosorbide Dinitrate 1.25mg/Dose

IRAN DRUG LIST




دسترسیIsosorbide Dinitrate 5 mg TABLET SUBLINGUAL C01DA08 -

ORAL C01DA08 Modified(30/70)

TABLET, EXTENDED RELEASE ORAL C01DA08 -

Isotretinoin 0.05% GEL TOPICAL D10AD04 -

Isotretinoin 10 mg CAPSULE ORAL D10BA01 -

Isotretinoin 16 mg CAPSULE, LIQUID FILLED ORAL D10BA01 - 1389/9/22

Isotretinoin 20 mg CAPSULE ORAL D10BA01 -

Isotretinoin 8 mg CAPSULE, LIQUID FILLED ORAL D10BA01 - 1389/9/22

TABLET ORAL C04AA01 -

Itraconazole 100 mg CAPSULE ORAL J02AC02 -


Ketoconazole BULK V03 -

Isosorbide Mononitrate 50 mg


Isosorbide Mononitrate 60 mg

Isoxsuprine Hydrochloride 10 mg

Ketamine (As HCl ) 50 mg/ml, 10 ml




بالک

IRAN DRUG LIST




Ketoconazole 2%دسترسی CREAM TOPICAL D01AC08 -

Ketoconazole 2% LOTION TOPICAL D01AC08 -

Ketoconazole 2% SHAMPOO TOPICAL D01AC08 -

Ketoconazole 200 mg TABLET ORAL J02AB02 -

DROPS, SOLUTION OPHTHALMIC S01BC05 -

TABLET ORAL M01AB15 کشور داخل در تولید شرط به

INJECTION, SOLUTION PARENTERAL M01AB15

INJECTION PARENTERAL M01AB15 1392/5/29

Ketotifen 1 mg TABLET ORAL R06AX17 **(As Fumarate)**

Ketotifen 1 mg/ ml DROPS, SOLUTION ORAL R06AX17 **(As Fumarate)**

Ketotifen 1 mg/5 ml SYRUP ORAL R06AX17 **(As Fumarate)**

Ketotifen 0.025% DROPS, SOLUTION OPHTHALMIC S01GX08 **(As Fumarate)**

Ketorolac Trometamol 0.5%

Ketorolac Trometamol 10 mg

Ketorolac Trometamol 30 mg/ml




Ketorolac Tromethamine 15 mg/ml




IRAN DRUG LIST




دسترسیKojic Acid BULK V03 -

Krypton [81mKr] Gas 4 mCi INHALER RESPIRATORY V09EX01 **Generator**

Krypton [81mKr] Gas 8 mCi INHALER RESPIRATORY V09EX01 **Generator**

Labetalol 5 mg/ml, 20ml INJECTION PARENTERAL C07AG01 **(As Hydrochloride)**

INJECTION PARENTERAL C07AG01

Lactic Acid BULK V03 -

Lactose BULK V03 -

Lactulose 10 g POWDER, FOR SOLUTION ORAL A06AD11 -

Lactulose 10 g/15 ml SYRUP ORAL A06AD11 -

Lamivudine 10 mg/ml SOLUTION ORAL J05AF05 -

Lamivudine 100 mg TABLET ORAL J05AF05 -

Lamivudine 150 mg TABLET ORAL J05AF05 -

Lamotrigine 10 mg/ml SOLUTION ORAL N03AX09 -




Labetolol (As Hydrochloride) 5 mg/ml, 20ml




بالکداروهاي فهرست

بالک

IRAN DRUG LIST




Lamotrigine 100 mgدسترسی TABLET ORAL N03AX09 -

Lamotrigine 25 mg TABLET ORAL N03AX09 -

Lamotrigine 50 mg TABLET ORAL N03AX09 -

Lanolin BULK V03 -

Lansoprazole 15 mg CAPSULE, DELAYED RELEASE ORAL A02BC03

Lansoprazole 30 mg CAPSULE, DELAYED RELEASE ORAL A02BC03

Laronidase 2.9mg/ml INJECTION PARENTERAL A16AB05

Latanoprost 50 mcg/ml SOLUTION OPHTHALMIC S01EX03 -

Latanoprost/Timolol DROPS, SOLUTION OPHTHALMIC S01ED51

L-Carnitine 1 g TABLET, CHEWABLE ORAL A16AA01 -

L-Carnitine 1 g TABLET, CHEWABLE ORAL A16AA01 As L-Tartrate

L-Carnitine 100 mg/ml SOLUTION ORAL A16AA01 -

L-Carnitine 200 mg/ml, 5ml INJECTION PARENTERAL A16AA01 -

L-Carnitine 250 mg TABLET ORAL A16AA01 -

L-Carnitine 250 mg TABLET ORAL A16AA01 As L-Tartrate

L-Carnitine 330 mg TABLET ORAL A16AA01


به مبتال بیماران برای فقطساکاریدوز موکوپلی


Latanoprost 50 mcg + Timolol (As Maleate) 5 mg

IRAN DRUG LIST




Leishmanin SUSPENSIONدسترسی INTRADERMAL V04CX Diagnostic

Letrozole 2.5 mg TABLET ORAL L02BG04 -

Leucovorin 3 mg/ml INJECTION PARENTERAL V03AF03

Leucovorin 30 mg INJECTION, POWDER PARENTERAL V03AF03

Leucovorin 125/ml, 5ml INJECTION PARENTERAL V03AF03

INJECTION, POWDER PARENTERAL L02AE02

Leuprorelin Acetate 7.5 mg INJECTION, POWDER PARENTERAL L02AE02 -

Levamisole 50 mg TABLET ORAL P02CE01 **(As Hydrochloride)**

Levamisole 40 mg/5ml SYRUP ORAL P02CE01 **(As Hydrochloride)**

Levetiracetam 100 mg/ml PARENTERAL N03AX14 1392/09/25

Levetiracetam 250 mg TABLET ORAL N03AX14

For rescue use after high dose methotrexate therapy in the treatment of osteosarcoma.



Leuprorelin Acetate 3.75 mg

Treatment of central precocious puberty.


IRAN DRUG LIST




Levetiracetam 500 mgدسترسی TABLET ORAL N03AX14

ORAL Solution ORAL N03AX14


Levetiracetam 1000 mg TABLET ORAL N03AX14 1391/06/13

TABLET ORAL R06AE07 -

Levodopa 500 mg TABLET ORAL N04BA01 -

TABLET ORAL N04BA03 1389/8/24

TABLET ORAL N04BA03



Levetiracetam 500 mg/ 5 ml

Levocetirizine Dihydrochloride 5 mg

Levodopa/ Carbidopa/ Entacapon 125/ 31.25/ 200 mg

Levodopa/ Carbidopa/ Entacapon 50/ 12. 5/ 200 mg

Levodopa/ Carbidopa/ Entacapon 200/ 50/ 200 mg

Levodopa/ Carbidopa/ Entacapon 75/ 18.75/ 200 mg

IRAN DRUG LIST




دسترسیTABLET ORAL N04BA03

TABLET ORAL N04BA03

TABLET ORAL N04BA02

TABLET ORAL N04BA02

TABLET ORAL N04BA02

TABLET ORAL N04BA02

TABLET ORAL N04BA02

TABLET ORAL N04BA02

Levodopa/ Carbidopa/ Entacapon, 100/ 25/ 200 mg

Levodopa/ Carbidopa/ Entacapon, 150/ 37. 5/ 200 mg

Levodopa/Benserazide 100/25 mg

Levodopa 100 mg+Benserazide (as Hydrochloride) 25

Levodopa/Benserazide Forte 200/50 mg

Levodopa 200 mg+Benserazide (as Hydrochloride) 50

Levodopa/Beserazide 50/12.5 mg

Levodopa 50 mg+Benserazide (as Hydrochloride) 12.5

Levodopa/Carbidopa 100/10 mg

Levodopa 100 mg+Carbidopa (as Monohydrate) 10 mg



Levodopa/Carbidopa Forte 250/25 mg


IRAN DRUG LIST




دسترسیTABLET, EXTENDED RELEASE ORAL N04BA02 1392/5/29

TABLET, EXTENDED RELEASE ORAL N04BA02 1392/5/29

Levofloxacin 250 mg TABLET Oral J01MA12 کشور داخل در تولید شرط به 1389/10/25


INJECTION , SOLUTION INTRAVENOUS DRIP J01MA12 in dextrose 1391/05/02


DROPS, SOLUTION OPHTHALMIC S01AX19 5mg/ml 1390/1/29

Levofloxacin 25mg/ml PARENTRAL J01MA12 1392/04/04

Levonorgestrel 30 mcg TABLET ORAL G03AC03 -

Levonorgestrel 36 mg IMPLANT TRANSDERMAL G03AC03 - 6X36 mg

Levonorgestrel 75 mg IMPLANT TRANSDERMAL G03AC03 - 1390/1/29

Levonorgestrel 750 mcg TABLET ORAL G03AC03 -

Levonorgestrel 1.5 mg TABLET ORAL G03AC03





Levofloxacin 500 mg/100ml

Levofloxacin Hemihydrate 0.5%


2 X 75 mg شرط به

داخل تولید

IRAN DRUG LIST




دسترسیCAPSULE, GELATIN COATED ORAL H03AA01 -


CAPSULE, GELATIN COATED ORAL H03AA01 -



SPRAY, SOLUTION TOPICAL D04AB01 Lidocaine 10%

SPRAY, SOLUTION TOPICAL D04AB01 Lidocaine 10%

INJECTION PARENTERAL C01BB01

INJECTION PARENTERAL C01BB01 -

Levothyroxine Sodium 100 mcg





Lidocaine 10 mg/dose, 100ml

Lidocaine 10 mg/dose, 50ml

Lidocaine Hydrochloride 1%, 50ml


IRAN DRUG LIST




دسترسیINJECTION PARENTERAL C01BB01 **Cartridge (carpool)**

GEL TOPICAL D04AB01 -


INJECTION, SOLUTION PARENTERAL C01BB01 -

SOLUTION TOPICAL D04AB01 -

INJECTION, SOLUTION PARENTERAL N01BB52 -

INJECTION PARENTERAL C01BB01

SPRAY, SOLUTION TOPICAL D04AB01 -

Lidocaine Hydrochloride 2%








Lidocaine Hydrochloride 6.5%

IRAN DRUG LIST




دسترسی

INJECTION INTRASPINAL N01BB52

Lidocaine/Chlorhexidine GEL TOPICAL N01BB52

Lidocaine/Epinephrine INJECTION PARENTERAL N01BB52

Lidocaine/Epinephrine INJECTION PARENTERAL N01BB52

OINTMENT RECTAL N01BB52

CREAM TOPICAL D04AB

Lindane 1% LOTION TOPICAL P03AB02 -

Lindane 1% SHAMPOO TOPICAL P03AB02 -

Linezolide 400 mg TABLET ORAL J01XX08 1391/12/23

Linezolide 600 mg TABLET ORAL J01XX08 1391/12/23

Linezolide 100 mg/5ml POWDER, SUSPENSION ORAL J01XX08 1391/12/23

Lidocaine Hydrochoride 5%

(Lidocaine HCl 5%+Dextrose 7.5%)




Lidocaine Hydrochloride 2%+Chlorhexidine Dihydrochloride 0.05%

Lidocaine HCl 10mg+Epinephrine (As Bitartrate) 5mcg/ml

(Lidocaine HCl 20mg+Epinephrine (As Bitartrate) 12.5 mcg)/ ml

Lidocaine/Hydrocortisone Acetate 5/0.5 %

Lidocaine 5%+Hydrocortisone Acetate 0.5%

Lidocaine/Prilocaine 2.5%/2.5%

Lidocaine 2.5% + Prilocaine 2.5%

IRAN DRUG LIST




دسترسیLinezolide 600mg/300ml INJECTION, SOLUTION PARENTERAL J01XX08 1391/12/23


Lipid Infusion 10% INJECTION, SOLUTION INTRAVENOUS DRIP B05BA02


Liraglutide 6 mg/ml INJECTION, SOLUTION PARENTERAL A10BX07 1391/02/07

Lisinopril 10 mg TABLET ORAL C09AA03 -



TABLET ORAL C09BA03

TABLET ORAL C09BA03

TABLET ORAL C09BA03

Lithium Carbonate 300 mg TABLET ORAL N05AN01 -

Liothyronine Sodium 25 mcg

و کشور داخل در تولید شرط بهبالینی کارآزمایی انجام

** Disposable Pen**

Lisinopril/Hydrochlorothiazide 10/12.5 mg

Lisinopril 10mg + Hydrochlorothiazide 12.5mg

Lisinopril/Hydrochlorothiazide 20/12.5 mg

Lisinopril 20mg + Hydrochlorothiazide 12.5mg

Lisinopril/Hydrochlorothiazide 20/25 mg

Lisinopril 20mg + Hydrochlorothiazide 25mg

IRAN DRUG LIST




دسترسیLithium Carbonate 400 mg ORAL N05AN01 -

Lithium Carbonate 400 mg TABLET, EXTENDED RELEASE ORAL N05AN01 -

Lomustine 40 mg CAPSULE ORAL L01AD02 -

SOLUTION ORAL A07DA03 -

CAPSULE ORAL A07DA03 -

TABLET ORAL A07DA03 -

CAPSULE, LIQUID FILLED ORAL J05AE

TABLET ORAL J05AE


Loperamide Hydrochloride 1 mg/5ml*


Loperamide Hydrochloride 2 mg*


Loperamide Hydrochloride 2 mg*


Lopinavir/Ritonavir 133.3/33.3 mg

**(Lopinavir 133.3mg+Ritonavir 33.3mg)**




Lopinavir/Ritonavir 200/50 mg

**(Lopinavir 200mg+Ritonavir 50mg)**




IRAN DRUG LIST




دسترسی

SOLUTION ORAL J05AE

Loratadine 10 mg TABLET ORAL R06AX13 -

Loratadine 10 mg TABLET, ORODISPERSIBLE ORAL R06AX13 -

Loratadine 10 mg CAPSULE, GELATIN COATED ORAL R06AX13 - 90/3/23

Loratadine 5 mg/5ml SYRUP ORAL R06AX13 -

TABLET, EXTENDED RELEASE ORAL R01BA52 1389/7/17

Lorazepam 1 mg TABLET ORAL N05BA06 -

Lorazepam 2 mg TABLET ORAL N05BA06 -

Lorazepam 2 mg/ml INJECTION PARENTERAL N05BA06 -

Lorazepam 4 mg/ml INJECTION PARENTERAL N05BA06 -

Lorenzos Oil 500 ml OIL ORAL __

Lopinavir/Ritonavir 400/100 mg/5ml

**(Lopinavir 400mg+Ritonavir 100mg)/5ml**




تولید شرط بهداخل

Loratadine/Pseudoephedrine Sulfate 5/120 mg

Loratadine 5 mg + Pseudoephedrine Sulfate 120 mg داخل در تولید شرط بهکشور

به مبتال بیماران برای فقط آدرنولکودیستروفی(Adrenoleucodystrophy)Early stages Only

داروهاي فهرستمتابوليک

IRAN DRUG LIST




دسترسیLosartan Potassium 25 mg TABLET ORAL C09CA01 -

Losartan Potassium 50 mg TABLET ORAL C09CA01 -

TABLET ORAL C03AX01

Suspension,Drops Ophthalmic S01BA14

Lovastatin 20 mg TABLET ORAL C10AA02 -

Low Sodium Salt 5 g/sachet POWDER ORAL A12CA

INJECTION PARENTERAL V10B 1391/9/1

Lutropin Alfa 75 IU INJECTION, POWDER PARENTERAL G03GA07 -

Lynestrenol 0.5 mg TABLET ORAL G03AC02 -

Losartan Potassium/Hydrochlorothiazide 50/12.5 mg

( Losartan Potassium 50mg + Hydrochlorothiazide 12.5mg)

Loteprednol etabonate 0.005

[Kcl(670 mg-700 mg) + Nacl(300 mg-330 mg) + Mgco3 (4 mg-5 mg)] / g

Lutetium(177Lu)ethylenediamine tetramethylene phosphonate


IRAN DRUG LIST




دسترسیMafenide Acetate 112 mg/g CREAM TOPICAL D06BA03 ** eq to 85 mg ( Base )/g**

Magnesium Hydroxide 8% SUSPENSION ORAL A02AA04 -

Magnesium Oxide 400 mg TABLET ORAL A02AA04 **250 mg elemental**

INJECTION PARENTERAL A12CC02 **7H2O**






Mannitol 10% INJECTION, SOLUTION INTRAVENOUS DRIP B05BC01 -

Mannitol 20% INJECTION, SOLUTION INTRAVENOUS DRIP B05BC01 -


Magnesium Sulfate 10%, 10ml






IRAN DRUG LIST






Measles Vaccine INJECTION PARENTERAL J07BD01

PARENTERAL J07BD53 M.R. Virus alive

INJECTION PARENTERAL J06BB14 -

PARENTERAL J07BD52 M.M.R.

Mebendazole 100 mg* TABLET, CHEWABLE ORAL P02CA01 -


ORAL A03AA04 -


Maprotiline Hydrcochloride 25 mg

Maprotiline Hydrcochloride 75 mg

**(Rubeola) Virus live Attenuated**

Measles and rubella Vaccine


Measles Immune globulin 200 IU/ml

Measles, Mumps, and rubella Vaccine



Mebeverine Hydrochloride 135 mg

Mebeverine Hydrochloride 200 mg


Medroxyprogesterone Acetate 100 mg/ml, 5ml


IRAN DRUG LIST




دسترسیINJECTION PARENTERAL G03AC06

TABLET ORAL G03AC06 -

TABLET ORAL G03DA02 -

INJECTION PARENTERAL G03AA08

Mefenamic Acid 250 mg CAPSULE ORAL M01AG01 -

Mefloquine 250 mg TABLET ORAL D07AD01 -

Megestrol Acetate 15 mg TABLET ORAL L02AB01

Medroxyprogesterone Acetate 150 mg/ml


Medroxyprogesterone Acetate 250 mg

Medroxyprogesterone Acetate 5 mg

Medroxyprogestrone Acetate/Estradiol Cypionate 50/10 mg/ml, 0.5 ml

Depot Medroxyprogesterone Acetate 25mg + Estradiol Cypionate 5mg/0.5ml

Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome.

IRAN DRUG LIST




دسترسی



SUSPENSION ORAL L02AB01

INJECTION PARENTERAL P01CB01 -

INJECTION PARENTERAL V08AA01

Meglumine Compound 76% SOLUTION ORAL V08AA01



Megestrol Acetate 40 mg/ml


Meglumine Antimonate 300 mg/ml, 5ml

Meglumine Compound 60%, 20ml

Meglumine Diatrizoate 52.1%+Sodium Diatrizoate 7.9%

Meglumine Diatrizoate 66%+Sodium Diatrizoate 10%

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL V08AA01

INJECTION PARENTERAL V08AA01








Meglumine Compound 76%, 100 ml


Meglumine Compound 76%, 20ml


Meglumine Gadoterate 377 mg/ml, 10ml



Meglumine/ Sodium ioxaglate 320 10 ml

Meglumine Ioxaglate 393 mg/ml + Sodium Ioxaglate 196.5 mg/ml

Meglumine/ Sodium ioxaglate 320 20 ml


Meglumine/Sodium Ioxaglate 320 100 ml




IRAN DRUG LIST




دسترسیINJECTION PARENTERAL V08AB03

Meloxicam 15 mg TABLET ORAL M01AC06 -

Meloxicam 7.5 mg TABLET ORAL M01AC06 -

Melphalan INJECTION, POWDER PARENTERAL L01AA03

Melphalan 2 mg TABLET ORAL L01AA03 -

Melphalan 50 mg INJECTION, POWDER, PARENTERAL L01AA03 -

TABLET ORAL N06DX01 -

CAPSULE,EXTENDED RELEASE ORAL N06DX01 - 1390/1/29

SOLUTION ORAL N06DX01 - 1390/1/29



Treatment of patients with multiple myeloma for whom ORAL therapy is inappropriate.For use in hyperthermic regional limb perfusion to treat metastatic melanoma of the extremity.

Memantine Hydrochloride 10 mg


Memantine Hydrochloride 2 mg/ml

IRAN DRUG LIST




دسترسیSOLUTION ORAL N06DX01 کشور داخل در تولید شرط به 1390/09/21

TABLET ORAL N06DX01 - 1390/1/29

CAPSULE,EXTENDED RELEASE ORAL N06DX01 - 1390/1/29

TABLET ORAL N06DX01 -

Meningococcal Vaccine INJECTION PARENTERAL J07AH05 ** Polyvalent**

Menotropins PARENTERAL G03GA02 75 IU FSH+75 IU LH

Menthol BULK V03 -

Menthol Salicylate OINTMENT TOPICAL M02AC

OINTMENT TOPICAL D02AB 1389/7/17

Memantine Hydrochloride 10mg/g






Methyl Salicylate 15%+Menthol 10%


Menthol/Zinc oxide/Calamine (0.44/20.625/10)g/100g

(Menthol 0.44 g + Zinc oxide 20.625 g + Calamine 10 g)/100g داخل در تولید شرط بهکشور


IRAN DRUG LIST




دسترسی


INJECTION PARENTERAL N01BB03 90/3/23

INJECTION PARENTERAL N01BB03 90/3/23

Mequinol 10% OINTMENT TOPICAL D11AX06 -

Mequinol-T 2% + 0. 01% Solution Topical D10AD51

Mercaptopurine 50 mg TABLET ORAL L01BB02 -

Meropenem 500 mg INJECTION, POWDER PARENTERAL J01DH02

Mepivacaine Hydrochloride 2%, 20ml




Mepivacaine Hydrochloride 3%, 1.7ml

برای فقطمصرف

دندانپزشکی


برای فقطمصرف

دندانپزشکی

Mequinol 2% + Tretinoin 0. 01%


Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms.

در . فقطداروخانه

توزيع بيمارستاني.ميشود

IRAN DRUG LIST




دسترسی


Mesalazine 1000 mg RECTAL A07EC02 -

Mesalazine 1g/sachet ORAL A07EC02 -

Mesalazine 250 mg TABLET, DELAYED RELEASE ORAL A07EC02 -

Mesalazine 250 mg TABLET, EXTENDED RELEASE ORAL A07EC02 -

Mesalazine 4 g/100ml ENEMA RECTAL A07EC02 -


Mesalazine 500 mg SUPPOSITORY RECTAL A07EC02 -


Mesalazine 500 mg TABLET, EXTENDED RELEASE ORAL A07EC02 -

Mesalazine 500 mg ORAL A07EC02 - 1392/05/01


Meropenem (As Trihydrate) 1 g

Management of acute pulmonary exacerbations, in cystic fibrosis patients, due to respiratory tract infection with susceptible organisms.


.ميشود

SUPPOSITORY, EXTENDED RELEASE

GRANULE, EXTENDED RELEASE


IRAN DRUG LIST




دسترسی

Mesna 100 mg/ml, 4ml INJECTION PARENTERAL V03AF01


TABLET ORAL R03CB03 -

TABLET ORAL A10BD02 1389/6/29

TABLET ORAL A10BD02 - 1389/6/29


For use as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis.Inhibition of the urotoxic effects induced by oxazaphosphorine compounds such as cyclophosphamide.

Metaproterenol Sulfate 0.5 mg/ml

Metaproterenol Sulfate 20 mg

Metformin HCL/Glibenclamide 500 mg/2.5 mg

Metformin HCL/Glibenclamide 500 mg/5 mg

Metformin HCL/Pioglitazone 500 mg/15 mg

Metformin HCL 500 mg + Pioglitazone 15 mg به

کشور داخل در تولید شرط

IRAN DRUG LIST




دسترسیTABLET Extended release ORAL A10BA02 1391/07/25

TABLET ORAL A10BA02 -

TABLET ORAL A10BA02 -

TABLET Extended release ORAL A10BA02 1391/07/25

INHALER RESPIRATORY V04CX Diagnosetic

TABLET, DISPERSIBLE ORAL N07BC02 -

TABLET ORAL N07BC02 -


POWDER ORAL N07BC02 -

Metformin Hydrochloride 500 mg

از کشور داخل در تولید شرط بهابتدا




از کشور داخل در تولید شرط بهابتدا

Methacholine Chloride 100 mg/20ml

Methadone Hydrochloride 40 mg



Methadone Hydrochloride 1g/ SUCHET

IRAN DRUG LIST




دسترسیTABLET, DISPERSIBLE ORAL N07BC02 -

SOLUTION ORAL N07BC02 -


SOLUTION ORAL N07BC02 -



Methimazole 5 mg TABLET ORAL H03BB02 -


Methadone Hydrochloride 25 mg/5ml


Methadone Hydrochloride 5mg/5ml

Methadone Hydrochloride 10 mg/ml








IRAN DRUG LIST




دسترسیINJECTION PARENTERAL M03EA03 -

Methocarbamol 500 mg TABLET ORAL M03EA03 -

Methotrexate 100 mg/ml INJECTION PARENTERAL L01BA01

Methotrexate 5 mg PARENTERAL L01BA01


Methotrexate 50 mg PARENTERAL L01BA01

Methotrexate 1 g PARENTERAL L01BA01


Methotrexate 2.5 mg TABLET ORAL L01BA01 As Sodium 1389/6/29

Methotrexate 2.5 mg TABLET ORAL L01BA01 -

Methotrexate 2.5 mg/ml INJECTION PARENTERAL L01BA01


Methotrexate 5 mg TABLET ORAL L01BA01 -

Methoxsalen 1% SOLUTION TOPICAL D05AD02 -

Methocarbamol 100 mg/ml, 10ml

**(As Sodium) with and without preservative**











IRAN DRUG LIST




دسترسی

Methoxsalen 10 mg TABLET ORAL D05AD02

Methyl Salicylate 30% OINTMENT TOPICAL M02AC -

Methylcellulose GRANULE ORAL A06AC06 -

Methyldopa 250 mg TABLET ORAL C02AB02 -


TABLET ORAL G02AB01 -

INJECTION PARENTERAL G02AB01 -


TABLET, EXTENDED RELEASE ORAL N06BA04 -

INJECTION, POWDER, PARENTERAL H02AB04 **(As Sodium Succinate)**

For use in conjunction with the UVAR photopheresis system to treat graft versus host disease.


Methylene Blue 10 mg/ml, 10 ml

Methylergonovine Maleate 0.125 mg

Methylergonovine Maleate 0.2 mg/ml

Methylphenidate Hydrochloride 10 mg

Methylphenidate Hydrochloride 20 mg

Methylprednisolone 1000 mg

IRAN DRUG LIST




دسترسیINJECTION, POWDER, PARENTERAL H02AB04 **(As Sodium Succinate)**

Methylprednisolone 40 mg INJECTION, POWDER PARENTERAL H02AB04 **(As Sodium Succinate)**

INJECTION, POWDER, PARENTERAL H02AB04 **(As Sodium succinate)**

INJECTION PARENTERAL H02AB04 -

Methyltestosterone 25 mg TABLET ORAL G03BA02 -

INJECTION PARENTERAL A03FA01 **(As hydrochloride)**

CAPSULE, GELATIN COATED ORAL A03FA01 -

TABLET ORAL A03FA01 -

DROPS, SOLUTION ORAL A03FA01 -



Methylprednisolone Acetate 40 mg/ml, 1ml

Metoclopramide 5 mg/ml, 2ml

Metoclopramide Hydrochloride 10 mg

Metoclopramide Hydrochloride 10 mg

Metoclopramide Hydrochloride 4 mg/ml, 15ml

IRAN DRUG LIST




دسترسیTABLET, EXTENDED RELEASE ORAL C07AB02 -

TABLET, EXTENDED RELEASE ORAL C07AB02 -

TABLET, EXTENDED RELEASE ORAL C07AB02 -

Metoprolol Succinate 95 mg TABLET, EXTENDED RELEASE ORAL C07AB02 -

TABLET ORAL C07AB02 -


Metoprolol Tartrate 50 mg TABLET ORAL C07AB02 -

SUSPENSION ORAL P01AB01 **(As Benzoate)**

Metronidazole 0.75% GEL VAGINAL G01AF01 -

Metronidazole 0.75% GEL TOPICAL D06BX01

Metoprolol Succinate 190 mg

Metoprolol Succinate 23.75 mg

Metoprolol Succinate 47.5 mg

Metoprolol Tartrate 100 mg

Metoprolol Tartrate 1mg/ml, 5ml

Metronidazole 125 mg/5ml

Treatment of grade III and IV, anaerobically infected, decubitus ulcers.Treatment of acne rosacea.

IRAN DRUG LIST




Metronidazole 250 mgدسترسی TABLET ORAL P01AB01 -

INJECTION, SOLUTION INTRAVENOUS DRIP J01XD01 -

Metronidazole 500 mg SUPPOSITORY VAGINAL G01AF01 -

Metronidazole 500 mg TABLET VAGINAL G01AF01 -

Metyrapone 250 mg TABLET ORAL V04CD01 -

Mexiletine 100 mg CAPSULE ORAL C01BB02 -

Mexiletine 200 mg CAPSULE ORAL C01BB02 -

Miconazole Nitrate 100 mg SUPPOSITORY VAGINAL G01AF0 -

Miconazole Nitrate 2% CREAM TOPICAL D01AC02 -

Miconazole Nitrate 2% CREAM VAGINAL G01AF04 -

TAMPON TOPICAL B02BC07



Metronidazole 5 mg/ml, 100ml

Microfibrillar Collagen Hemostat 14.8 mg/cm3

**0.15 cm thikness - Registered as ANTEMA**

Microfibrillar Collagen Hemostat 15.5 mg/cm3

** Cillender 8 cm x 3 cm diameter - Registered as ANTEMA**

Microfibrillar Collagen Hemostat 22.3mg/cm3

**0.5 cm thickness - Registered as ANTEMA**

IRAN DRUG LIST




دسترسی

Midazolam 10 mg/ml, 5ml SOLUTION BUCCAL N05CD08 **(As Hydrochloride)**

INJECTION PARENTERAL N05CD08





Midazolam (As Hydrochloride) 5 mg/ml, 1ml

Treatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam




Midazolam (As Hydrochloride) 5 mg/ml, 2 ml





IRAN DRUG LIST




دسترسی



SYRUP ORAL N05CD08 -

Midazolam (As Hydrochloride) 5 mg/ml, 3 ml





Midazolam (As Hydrochloride) 1 mg/ml, 5ml





Midazolam Hydrochloride 2 mg/ml




IRAN DRUG LIST




دسترسی

Midodrine HCl 2. 5 mg TABLET ORAL C01CA17

Midodrine HCl 5 mg TABLET ORAL C01CA17

INJECTION, SOLUTION PARENTERAL C01CE02

INJECTION PARENTERAL C01CE02

Mineral Oil BULK V03 **(liquid Paraffin )**

Minoxidil BULK V03 -

Minoxidil 2% AEROSOL,FOAM TOPICAL D11AX01 - 1391/05/02

Minoxidil 5% AEROSOL,FOAM TOPICAL D11AX01 1391/05/02

داروهاي فهرست "orphan" خاص

( در فقطهاي بيمارستانقلب (تخصصي

داروهاي فهرست "orphan" خاص

( در فقطهاي بيمارستانقلب (تخصصي

Milrinone 1 mg/ml, 10ml









بالک

IRAN DRUG LIST




Minoxidil 10 mgدسترسی TABLET ORAL C02DC01 -

Minoxidil 20 mg/ml SOLUTION TOPICAL D11AX01 -

Minoxidil 50 mg/ml SOLUTION TOPICAL D11AX01 -

SOLUTION TOPICAL D11AX 1389/11/4

SOLUTION TOPICAL D11AX 1389/11/4

Misoprostol 100 mcg TABLET ORAL A02BB01



Minoxidil/Azelaic Acid/Betamethasone Valerate 5/5/0.025%

Minoxidil 5% + Azelaic Acid 5% + Betamethasone Valerate 0.025%

Minoxidil/Azelaic Acid/Tretinoin/Betamethasone Valerate 5/5/0.025/0.025%

Minoxidil 5% + Azelaic Acid 5% + Tretinoin 0.025% + Betamethasone Valerate 0.025%

Treatment of intrauterine fetal death not accompanied by complete expulsion of the products of conception in the second and third trimesters of pregnancy.

داروهای فهرستدسترسی با

در. فقط خاصو بیمارستانها

های داروخانهتحت و منتخب

می توزیع نظارتنسخه. با شود

و زنان متخصصزایمان

IRAN DRUG LIST




دسترسی

Misoprostol 200 mcg TABLET ORAL A02BB01

Mitomycin 40 mg INJECTION, POWDER INTRACAVITARY L01DC03 -

Mitomycin 10 mg INJECTION, POWDER, PARENTERAL L01DC03 -



Mitotane 500 mg TABLET ORAL L01XX23 -

INJECTION PARENTERAL L01DB07

INJECTION, POWDER, PARENTERAL M03AC10

Moclobemide 150 mg TABLET ORAL N06AG02 -

intravtrine fetal death,not accompanied by complete expulsion of the products of conception in the secend and third trimeters of pregnancy






Mitoxantrone (As Hydrochloride) 2 mg/ml, 10ml

Treatment of hormone refractory prostate cancer.Treatment of progressive-relapsing multiple sclerosis.

Mivacurium Chloride 2 mg/ml




IRAN DRUG LIST




دسترسیModafinil 100 mg TABLET ORAL N06BA07

Modafinil 200 mg TABLET ORAL N06BA07

Molgramostim 0.4 mg INJECTION, POWDER PARENTERAL L03AA03

INJECTION, POWDER PARENTERAL L03AA03

SUSPENTION NASAL SPRAY NASAL R01AD09 -

Mometasone Furoate 0. 1% Ointment Topical D07AC13

Mometasone Furoate 0. 1% CREAM Topical D07AC13

Mometasone Furoate 0. 1% Lotion Topical D07AC13

به مربوط برچسب الصاقضروری کنترل تحت داروهای

.استداروهای فهرست

خاص دسترسی به با مربوط برچسب الصاقضروری کنترل تحت داروهای


خاص دسترسی با

Treatment of AIDS patients with neutropenia due to the disease, AZTor ganciclovir.Treatment of aplastic anemia.

Molgramostim (GMCSF) 0.15 mg

Treatment of AIDS patients with neutropenia due to the disease, AZTor ganciclovir.Treatment of aplastic anemia.

Mometasone Furoate 0.05%

IRAN DRUG LIST




دسترسیPOWDER, INHALATION RESPIRATORY R03BA07 1392/5/29

POWDER, INHALATION RESPIRATORY R03BA07 1392/5/29

POWDER, INHALATION RESPIRATORY R03BA07 1392/5/29

AEROSOL, INHALATION RESPIRATORY R03AK07 1392/5/29



Monobenzone 20% CREAM TOPICAL D11AX13 -

Montelukast 10 mg TABLET ORAL R03DC03 **(As Sodium)**

Montelukast 4 mg/Sachet GRANULE ORAL R03DC03 **(As Sodium)**

Montelukast 5 mg TABLET, CHEWABLE ORAL R03DC03 **(As Sodium)**

Mometasone Furoate 100 mcg Mometasone Furoate 200 mcg

Mometasone Furoate 400 mcg

Mometasone Furoate/Formoterol Fumarate 50 mcg/5mcg

Mometasone Furoate50 mcg+Formoterol Fumarate 5mcg





IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL N02AA01 1389/8/24

INJECTION PARENTERAL N02AA01


Morphine Sulfate 10 mg SUPPOSITORY RECTAL N02AA01 -

Morphine Sulfate 10 mg TABLET ORAL N02AA01 -


Moxifloxacin 400 mg TABLET ORAL J01MA14 1390/3/7

SOLUTION OPHTHALMIC S01AX22 As Hydrochloride 1390/07/04

Morphine Hydrochloride 10 mg/ml

**Without preservative** کشور داخل در تولید شرط به




Morphine Sulfate 25mg/ml, 4ml

بیمارستانی مراکز در مصرفشهید بنیاد به وابسته


Morphine Sulfate 50mg/ml, 10ml

بیمارستانی مراکز در مصرفشهید بنیاد به وابسته


Morphine Sulfate 10 mg/ml




As Hydrochloride در تولید شرط به

کشور داخل


تجويزتنها. ميشودمتخصصين توسط

ريه و عفونياست .مجاز

Moxifloxacin 0.5%

IRAN DRUG LIST




دسترسی

Multivitamin Pediatric INJECTION INTRAVENOUS A11AE

Multivitamin Therapeutic CAPSULE ORAL A11AA

(Vit.B1 2.5mg + Vit.B2 3.6mg + Vit. B6 4mg + Vit. B12 5mcg + Niacin 40mg + Pantothenic Acid 15mg + Biotin 60mcg + Vit.C 100mg+Folic Acid 400mcg)/10ml INTERAVENOUSو بیمارستانها در فقط توزیع

تخصص فوق توسط تجویز نوزادان


Vit.A 25000 IU+Vit.B1 20 mg+Vit.B2 5mg+Nicotinamide50 mg+Vit.B6 10mg+Vit.B12 5mcg+Vit.C 150mg+Biotin 0.25mg+Vit.D 1000IU+ Vit.E 10mg(IU)+Folic Acid 1mg+Calcium Pantothenate 11.6mg+Ca 100mg +Mg(As MgO) 5mg +Mn 0.5mg+Mo 0.1mg+Iron 10mg+Zn 0.5mg+P 77.27mg+Cu

IRAN DRUG LIST




دسترسی

Multivitamin Therapeutic TABLET ORAL A11AA

Mumps Mirus Vaccine INJECTION, POWDER, PARENTERAL J07BX Live

Mupirocin 2% OINTMENT NASAL R01AX06 **(As Calcium)**

Mupirocin 2% OINTMENT TOPICAL D06AX09 -

CAPSULE ORAL L04AA06 -

TABLET ORAL L04AA06 -

Vit.A25000 IU+Vit.B1 20mg+Vit.B2 5mg+Nicotinamide 50mg+Vit. B6 10mg+Vit. B12 5mcg+ Vit.C 150mg+Biotin 0.25mg+Vit.D 500IU+Vit.E 10mg(IU)+Folic Acid 1mg+Calcium Pantothenate 11.6mg +Ca HPO4,2H2O129mg +MnSO4,4H2O 2.05mg+MgO 30mg+CuSO4,5H2O 3.9mg+Sodium molib

Mycophenolate Mofetil 250 mg

Mycophenolate Mofetil 500 mg

IRAN DRUG LIST




دسترسیMycophenolic acid 360 mg TABLET, DELAYED RELEASE ORAL L04AA06

Mycophenolic acid 180 mg TABLET, DELAYED RELEASE ORAL L04AA06

Nafcillin Sodium 1 g INJECTION, POWDER, PARENTERAL J01CF -

Nafcillin Sodium 500 mg INJECTION, POWDER, PARENTERAL J01CF -

Nalidixic Acid 500 mg TABLET ORAL J01MB02 -

Nalidixic Acid 60 mg/ml SUSPENSION ORAL J01MB02 -




POWDER FOR INJECTION PARENTRAL N07BB04 - 1392/05/01

Treatment of pemphigus vulgarisTreatment of myasthenia gravis

Treatment of pemphigus vulgarisTreatment of myasthenia gravis

Naloxone Hydrochloride 0.4 mg/ml

Naltrexone Hydrochloride 25 mg

Naltrexone Hydrochloride 50 mg

Naltrexone Hydrochloride 380 mg/vial

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL A14AB01 -


DROPS, SOLUTION NASAL R01AA08 -

DROPS, SOLUTION OPHTHALMIC S01GA01 -

SPRAY, SOLUTION NASAL R01AA08 -

DROPS, SOLUTION OPHTHALMIC S01GA51

Naphazoline Nitrate 0.05% DROPS, SOLUTION NASAL R01AA08 -

Naphazoline Nitrate 0.1% DROPS, SOLUTION OPHTHALMIC S01GA01 -

Naproxen 250 mg TABLET ORAL M01AE02 -

Nandrolone Decanoate 25 mg/ml

Nandrolone Phenpropionate 25 mg/ml

Naphazoline Hydrochloride 0.05%



Naphazoline Hydrochloride/Antazoline Phosphate 0.05/0.5 %

Naphazoline HCl 0.05%+Antazoline Phosphate 0.5%

IRAN DRUG LIST




Naproxen 375 mgدسترسی TABLET ORAL M01AE02 -

Naproxen 500 mg SUPPOSITORY RECTAL M01AE02 -

Naproxen 500 mg TABLET, DELAYED RELEASE ORAL M01AE02 -

Naproxen 200 mg CAPSULE, SOFT GELATIN ORAL M01AE02

Natalizumab 20 mg/ ml PARENTERAL L04AA23 کشور داخل در تولید شرط به 1390/07/05

Natamycin 5% DROPS, SOLUTION OPHTHALMIC S01AA10 -

Nelfinavir 250 mg TABLET ORAL J05AE04 **(As Mesylate)**

TABLET ORAL J05AE04

POWDER ORAL J05AE04

SOLUTION ORAL J01GB05 -

Neomycin Sulfate 500 mg TABLET ORAL J01GB05 -

Equivalent to 220 mg Naproxen sodium


Nelfinavir, (As Mesylate) 625 mg

سالمت معاونت اختیار در فقطگیرد قرار


Nelfinavir, (As Mesylate) 50 mg/g



Neomycin Sulfate 125 mg/5ml

IRAN DRUG LIST




دسترسی





Nevirapine 200 mg TABLET ORAL J05AG01

Nevirapine 50 mg/ml SUSPENSION ORAL J05AG01

Niacinamide 500 mg TABLET ORAL A11HA01 -

Niclosamide 500 mg TABLET, CHEWABLE ORAL P02DA01 -

Nicorandil 10 mg TABLET ORAL C01DX16

Nicorandil 20 mg TABLET ORAL C01DX16

Neostigmine Methylsulfate 2.5 mg/mlL, 5ml




Neostigmine Bromide 15 mg

Neostigmine Methylsulfate 0.5 mg/ml




Neostigmine Methylsulfate 2.5 mg/ml, 1ml



توزيع بيمارستانيسالمت ميشود معاونت اختیار در فقط

گیرد قرارداروهاي فهرست

خاص دسترسي باسالمت معاونت اختیار در فقط


خاص دسترسي با

IRAN DRUG LIST




دسترسیNicotine 10 mg/ml, 10ml SPRAY, SOLUTION NASAL N07BA01 -

Nicotine 14mg/24h PATCH, EXTENDED RELEASE TRANSDERMAL N07BA01 -

Nicotine 15 mg/16h PATCH, EXTENDED RELEASE TRANSDERMAL N07BA01 #VALUE!

Nicotine 2 mg GUM ORAL N07BA01 -

Nicotine 2 mg TABLET SUBLINGUAL N07BA01 -



Nicotine 1mg LOZENGE ORAL N07BA01 1391/06/13



Nicotinic Acid 100 mg TABLET ORAL C10AD02 -

Nicotinic Acid 25 mg TABLET ORAL C04AC01 -

Nicotinic Acid 500 mg TABLET ORAL C10AD02 -

Nifedipine 10 mg CAPSULE ORAL C08CA05 -








داخل در ابتدا از تولید شرط بهکشور



IRAN DRUG LIST




Nifedipine 10 mgدسترسی TABLET ORAL C08CA05 -

Nifedipine 20 mg ORAL C08CA05 -

Nifedipine 20 mg TABLET, EXTENDED RELEASE ORAL C08CA05 -

Nifedipine 30 mg CAPSULE ORAL C08CA05 -

Nifedipine 30 mg TABLET ORAL C08CA05 -

Nilotinib 150 mg CAPSULE ORAL L01XE08 90/3/23

Nilotinib 200 mg Capsule ORAL L01XE08

Nimodipine 0.2 mg/ml INJECTION, SOLUTION INTRAVENOUS DRIP C08CA06 -

Nimodipine 30 mg TABLET ORAL C08CA06 -

Nitisinone 10 mg CAPSULE ORAL C08CA06

Nitisinone 10 mg TABLET ORAL C08CA06



As Hydrochloride Monohydrate

تولید شرط بهداخل

As Hydrochloride Monohydrate

به مبتال بیماران برای فقط(Tyrosinemia type I) تیروزینمیا






IRAN DRUG LIST




دسترسیNitisinone 2 mg CAPSULE ORAL C08CA06

Nitisinone 5 mg CAPSULE ORAL C08CA06


Nitrazepam 5 mg TABLET ORAL N05CD02 -

Nitrofurantoin 100 mg TABLET ORAL J01XB01 -

Nitrofurantoin 25 mg/5ml SUSPENSION ORAL J01XE01 -

Nitrofurazone 0.2% CREAM TOPICAL D09AA03 -

Nitroglycerin 2.6 mg ORAL C01DA02 -

Nitroglycerin 0.4 mg CAPSULE ORAL C01DA02 -

Nitroglycerin 0.4 mg TABLET ORAL C01DA02 -

INJECTION PARENTERAL C01DA02








Nitroglycerin 1 mg/ml, 10ml




IRAN DRUG LIST




دسترسی

Nitroglycerin 1 mg/ml, 2ml INJECTION PARENTERAL C01DA02

Nitroglycerin 1 mg/ml, 5ml INJECTION PARENTERAL C01DA02

Nitroglycerin 10 mg/24h PLASTER TRANSDERMAL C01DA02 -

Nitroglycerin 10 mg/24hr PATCH, EXTENDED RELEASE TRANSDERMAL C01DA02 -

Nitroglycerin 2% OINTMENT TOPICAL C01DA02 -


Nitroglycerin 2.5 mg TABLET, EXTENDED RELEASE ORAL C01DA02 -


SPRAY, SOLUTION RESPIRATORY C01DA02 -

Nitroglycerin 5 mg/24h PLASTER TRANSDERMAL C01DA02 -






ميشود


Nitroglycerin 400 mcg/dose

IRAN DRUG LIST




دسترسیNitroglycerin 5 mg/24hr PATCH, EXTENDED RELEASE TRANSDERMAL C01DA02 -

INJECTION PARENTERAL C01DA02 -

Nitroglycerin 5 mg/ml, 1ml INJECTION PARENTERAL C01DA02 -

Nitroglycerin 5 mg/ml, 2ml INJECTION PARENTERAL C01DA02 -





INJECTION, POWDER PARENTERAL C02DD01

Nitrous Oxide 1000 PPM INHALER RESPIRATORY N01AX13

Nitroglycerin 5 mg/ml, 10ml



Nitroprusside Sodium 50 mg

Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage.


IRAN DRUG LIST




دسترسیINHALANT RESPIRATORY N01AX13

GAS, MEDICINAL INHALATION N01AX63

Nonoxynol-9 5% CREAM VAGINAL G02BB -

Norepinephrine 0.1% INJECTION PARENTERAL C01CA03 (As Bitartrate)

Nortriptyline 10 mg TABLET ORAL N06AA10 **(As Hydrochloride)**

Nortriptyline 25 mg TABLET ORAL N06AA10 **(As Hydrochloride)**

Nystatin 100,000 U TABLET VAGINAL G01AA01 -

Nystatin 100,000 U/g OINTMENT TOPICAL D01AA01 -

Nystatin 100,000 U/ml POWDER, FOR SUSPENSION LOCAL ORAL A07AA03 -

Nystatin 500,000 U TABLET ORAL A03AA03 -


INJECTION PARENTERAL V03AB13 In prefilled disposible syringe

Nitrous Oxide داروهاي فهرست

خاص دسترسي با

Nitrous oxide/Oxygen 50%V/V / 50%V/V

Entonox داخل در تولید شرط بهکشور




Obidoxime Chloride 250 mg/ml

Obidoxime Chloride 275 mg/ml, 0.8ml

IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL H01CB02



Octreotide (As Acetate) 100 mcg/ml

Treatment of acromegaly.Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma).Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.





IRAN DRUG LIST




دسترسی

PARENTERAL H01CB02

PARENTERAL H01CB02

Ofloxacin 0.30% DROPS, SOLUTION OTIC SO2AA16 -

Ofloxacin 3mg/ml DROPS, SOLUTION OPHTALMIC SO1AX11 - 1391/06/13

Ofloxacin 200 mg TABLET ORAL J01MA01 -

Octreotide,(As Acetate) 20 mg

INJECTION,POWDER,EXTENDED RELEASE


Octreotide,(As Acetate) 30 mg


Powder for injectable suspension vial with prefilled syring of diluent Treatment of acromegaly.Treatment of diarrhea associated with vasoactive intestinal peptide tumors (VIPoma).Treatment of severe diarrhea and flushing associated with malignant carcinoid tumors.

تولید شرط بهاز کشور درداخل

ابتدا

IRAN DRUG LIST




Ofloxacin 300 mgدسترسی TABLET ORAL J01MA01 -

Ofloxacin 400 mg TABLET PARENTERAL J01MA01 -

Olanzapine 10 mg PARENTERAL N05AH03 1392/03/21

Olanzapine 10 mg TABLET ORAL N05AH03 -


Olanzapine 2.5 mg TABLET ORAL N05AH03 -


Eye Drop OPHTALMIC S01GX09

SPRAY, SOLUTION INTRANASAL R01AC08 1390/06/14

Omalizumab 75mg INJECTION, POWDER PARENTERAL R03DX05 کشور داخل در تولید شرط به 1391/12/23

Omalizumab 150mg INJECTION, POWDER PARENTERAL R03DX05 کشور داخل در تولید شرط به 1391/12/23

Omeprazole 20 mg ORAL A02BC01 -

Omeprazole 20 mg POWDER, FOR SUSPENSION ORAL A02BC01 -


Olopatadine Hydrochloride 5 mg/ 5 ml

Olopatadine Hydrochloride 0.6%(665 mcg/puff)

CAPSULE, DELAYED RELEASE PELLETS

IRAN DRUG LIST




دسترسیOndansetron 2 mg/ml, 2ml INJECTION PARENTERAL A04AA01 **(As Hydrochloride)**

Ondansetron 2 mg/ml, 4ml INJECTION PARENTERAL A04AA01 **(As Hydrochloride)**

Ondansetron 4 mg TABLET ORAL A04AA01 **(As Hydrochloride)**

Ondansetron 4 mg/5ml SOLUTION ORAL A04AA01 **(As Hydrochloride)**

Ondansetron 32 mg/50ml INJECTION,SOLUTION INTRAVENOUS DRIP A04AA01 **(As Hydrochloride)** 1391/10/03

Ophthalmic Bath Solution SOLUTION OPHTHALMIC S01AX07 Boric Acid 1610 mg/100 ml

Opium 10 mg/ml, 1000 ml TINCTURE ORAL N02AA02

Opium 10 mg/ml, 250 ml TINCTURE ORAL N02AA02 1389/7/17

Orlistat 120 mg CAPSULE ORAL A08AB01 -



در. فقط خاصاختيارمراکز

سوء درمانقرار مواد مصرف

داروهاي گيرد فهرستدسترسي با

در. فقط خاصاختيارمراکز

سوء درمانقرار مواد مصرف

گيرد

IRAN DRUG LIST




دسترسیOrlistat 60 mg CAPSULE ORAL A08AB01 -

ORS POWDER, FOR SOLUTION ORAL A07CA

ORS TABLET, EFFERVESCENT ORAL A07CA

ORS SOLUTION ORAL A07CA

Oseltamivir 30 mg CAPSULE ORAL J05AH02


Oseltamivir 60 mg/5ml POWDER, FOR SOLUTION ORAL J05AH02 **(As phosphate)**

Oseltamivir 60 mg/5ml POWDER, FOR SUSPENSION ORAL J05AH02 **(As phosphate)** 1391/06/13


(Na 75 mmol + K 20 mmol + Cl 65 mmol + citrate 10 mmol + Dextrose 75 mmol ) / L


(Na 75 mmol + K 20 mmol + Cl 65 mmol + citrate 10 mmol + Dextrose 75 mmol )/4 tablet







خاص دسترسي بااختیار در فقط

سالمت معاونتگیرد قرار

IRAN DRUG LIST




دسترسی


Oxaliplatin 100 mg PARENTERAL L01XA03 -

Oxaliplatin 5 mg/ml, 10ml PARENTERAL L01XA03 -

Oxaliplatin 5 mg/ml, 20ml PARENTERAL L01XA03 -

Oxaliplatin 50 mg PARENTERAL L01XA03 -

Oxandrolone 2.5 mg TABLET ORAL A14AA08 -

Oxazepam 10 mg TABLET ORAL N05BA04 -

Oxcarbazepine 150 mg TABLET ORAL N03AF02 -



Oxybutynin Chloride 5 mg TABLET ORAL G04BD04 -

TABLET, EXTENDED RELEASE ORAL G04BD04 - 1392/7/22



گیرد قرارINJECTION, POWDER, LYOPHILIZED




Oxybutynin Hydrochloride 10 mg

IRAN DRUG LIST




دسترسیTABLET, EXTENDED RELEASE ORAL G04BD04 - 1392/7/22

TABLET, EXTENDED RELEASE ORAL N02AA05

TABLET ORAL N02AA05


TABLET ORAL N02AA05


TABLET ORAL N02AA05


Spray, Solution NASAL S01GA04 کشور داخل در تولید شرط به 1389/6/29

Oxybutynin Hydrochloride 15 mg

Oxycodone Hydrochloride 10 mg




























Oxymetazoline Hydrochloride 0.05%

IRAN DRUG LIST




دسترسیSpray, Solution NASAL S01GA04 کشور داخل در تولید شرط به 1389/6/29

Oxymetholone 50 mg TABLET ORAL A14AA05 -

Oxytocin 10 U/ml INJECTION PARENTERAL H01BB02 -

Oxytocin 5 U/ml, 1ml INJECTION PARENTERAL H01BB02 -

Paclitaxel 6 mg/ml, 5ml INJECTION PARENTERAL L01CD01

Paclitaxel 6 mg/ml, 16.7ml INJECTION PARENTERAL L01CD01


Oxymetazoline Hydrochloride 0.1%

Treatment of AIDS-related Kaposi's sarcoma.Treatment of non-superficial urothelial cancer



IRAN DRUG LIST




دسترسی


Paclitaxel 100 mg PARENTERAL L01CD01 Albumin band (Nano) 1392/06/12

INJECTION PARENTERAL M05BA03 -




PARENTERAL M05BA03 -




INJECTION, POWDER, FOR SUSPENSION

Pamidronate Disodium 15 mg/ml, 2ml




Pamidronate Disodium 30 mg


Pamidronate Disodium 90 mg


Pamidronate Disodium 9mg/ml, 10ml


IRAN DRUG LIST




دسترسیPancreatin TABLET, DELAYED RELEASE ORAL A09AA -

Pancreatin CAPSULE ORAL A09AA -


Pantoprazole 20 mg TABLET, DELAYED RELEASE ORAL A02BC02

Pantoprazole 40 mg INTRAVENOUS DRIP A02BC02 **(As Sodium)**

Pantoprazole 40 mg TABLET, DELAYED RELEASE ORAL A02BC02

Pantoprazole 15 mg CAPSULE, DELAYED RELEASE ORAL A02BC02 **(As Sodium Sequihydrate)**



INJECTION PARENTERAL G04BE02 -

Para aminosalicylic acid 4 g GRANULE ORAL J04AA01


Pancuronium Bromide 2 mg/ml, 2ml




**(As Sodium sesquihydrate)**

INJECTION, POWDER, LYOPHILIZED,

**(As Sodium sesquihydrate)**

Papaverine Hydrochloride 40 mg/ml

Treatment of tuberculosis infections

IRAN DRUG LIST




دسترسیPara-Aminobenzoic Acid BULK V03 **PABA**

Parathormon 100 uspU/ml INJECTION PARENTERAL H05AA01 -

SYRUP ORAL A07AA06 **(As Sulfate)**

Paromomycin 250 mg CAPSULE ORAL A07AA06 **(As Sulfate)**

Paromomycin/Urea OINTMENT TOPICAL D06AX

Patent Blue V 2.5%, 2ml INJECTION PARENTERAL V04CX -

Pediatric Grippe* SYRUP ORAL R06AB54

Pegaspargase 3750 IU INJECTION, POWDER PARENTERAL L01XX24 -

INJECTION PARENTERAL L01XX24 Acute lymphocytic leukemia



Paromomycin 125 mg/ 5ml

( Paromomycin 15 g + Urea 10 g ) / 100 g

(Chlorpheniramine Maleate 0.67mg + Pseudoephedrine HCl 10 mg)/5ml



Pegaspargase 750 IU/ml, 5ml


Peginterferon Alfa-2a 360 mcg/ml, 0.5ml

Treatment of chronic myelogenous leukemia.Treatment of renal cell carcinoma.

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL L03AB11


PARENTERAL L03AB10

PARENTERAL L03AB10

PARENTERAL L03AB10

PARENTERAL L03AB10

Peginterferon Alfa-2a 180 mcg/ml


Peginterferon alfa-2a 270 mcg/ml, 0.5ml


Peginterferon Alfa-2b 100 mcg












IRAN DRUG LIST




دسترسیPARENTERAL L03AB10

Pemetrexed 100 mg PARENTERAL L01BA04 **(as disodium)** 1390/07/05

Pemetrexed 500 mg PARENTERAL L01BA04 **(as disodium)** 1390/07/05

Penicillamine 250 mg CAPSULE ORAL M01CC01 -

Penicillamine 250 mg TABLET ORAL M01CC01 -

Penicillin 6-3-3 INJECTION, POWDER, PARENTERAL J01RA01

PARENTERAL J01RA01 -

PARENTERAL J01RA01 -

INJECTION, POWDER, PARENTERAL J01CE01 -

INJECTION, POWDER PARENTERAL J01CE01 -






Benzathine penicillin G 600,000U+Potassium Penicillin G 300,000U+Procaine Penicillin G 300,000U

Penicillin G Benzathin 1,200,000 U


Penicillin G Benzathine 600,000 U


Penicillin G Potassium 1,000,000 U

Penicillin G Potassium 5000000 U

IRAN DRUG LIST




دسترسیINJECTION, POWDER, PARENTERAL J01RA01

INJECTION, POWDER, PARENTERAL J01RA01

INJECTION, POWDER, PARENTERAL J01RA01 -

Penicillin V 125 mg/5ml POWDER, FOR SOLUTION ORAL J01RA01

Penicillin V 250 mg/5ml POWDER, FOR SUSPENSION ORAL J01RA01 **(As Potassium)**

Penicillin V 500 mg TABLET ORAL J01RA01

POWDER, FOR SUSPENSION ORAL J01RA01 -

POWDER, FOR SUSPENSION ORAL J01RA01 -

INJECTION PARENTERAL V04CG04 -

PARENTERAL P01CX01 -

Penicillin G Procaine 400,000 U

Potassium Penicillin G 100,000U+Procaine Penicillin G 300,000U

Penicillin G procaine 800,000 U

Potassium Penicillin G 200,000U+ Procaine Penicillin G 600,000U

Penicillin G Sodium 5,000,000 U

**(As Potassium) 200,000 U**

**(As Potassium) 800,000 U**

Penicillin V Benzathine 200,000 IU/5ml

Penicillin V Benzathine 400,000 IU/5ml

Pentagastrin 0.25 mg/ml, 2ml

Pentamidine Isoethionate 300 mg


IRAN DRUG LIST




دسترسیTABLET ORAL N02AD01 -

INJECTION PARENTERAL N02AD01

Pentoxifylline 400 mg TABLET, EXTENDED RELEASE ORAL C04AD03 -

Peritoneal Dialysis I SOLUTION PARENTERAL B05D

SOLUTION PARENTERAL B05D 1389/8/24

Pentazocine Hydrochloride 50 mg

Pentazocine 30 mg/ml, 1ml , (As Lacate)




Na+ 132 mEq/L + Ca++ 3.5 mEq/L + Mg++ 1.5 mEq/L + Cl- 102 mEq/L + Lactate 35 mEq/L+ Dextrose anhydrous or monohydrate Eq. to 13.62 g/L Dextrose+Water For Inj. Q.S.To 1000ml

شرکت توسطسازنده دارویی

در مستقیمابیماران اختیارصفاقی دیالیز

گیرد می قرار

Peritoneal Dialysis I Bicarbonate Based

Glucose anhydrous 75.5 mmol/L Na+ 132 mmol/L + Ca++ 1,25 mmol/L + Mg++ 0.25 mmol/L + Cl- 95 mmol/L + (S)-Lactate 15 mmol/L+ HCo3- 25mmol/L




IRAN DRUG LIST




دسترسی

Peritoneal Dialysis II SOLUTION PARENTERAL B05D


Peritoneal Dialysis III SOLUTION PARENTERAL B05D





Peritoneal Dialysis II Bicarbonate Based

Glucose anhydrous 126 mmol/L Na+ 132 mmol/L + Ca++ 1,25 mmol/L + Mg++ 0.25 mmol/L + Cl- 95 mmol/L + (S)-Lactate 15 mmol/L HCo3-25mmol/L




Na+ 132 mEq/L + Ca++ 3.5 mEq/L + Mg++ 1.5 mEq/L + Cl- 102 mEq/L + Lactate 35 mEq/L+Dextrose anhydrous or monohydrate Eq. to 38.60 g/L Dextrose+Water For Inj. Q.S.To 1000ml




IRAN DRUG LIST




دسترسی


SOLUTION PARENTERAL B05D

Permethrin 1% SHAMPOO TOPICAL P03AC04 -

Permethrin 1% CREAM TOPICAL Rinse-1% W/W

Permethrin 5% CREAM TOPICAL P03AC04 -

Perphenazine 2 mg TABLET ORAL N05AB03 -


Perphenazine 5 mg/ml INJECTION PARENTERAL N05AB03 -


Peritoneal Dialysis III Bicarbonate Based

Glucose anhydrous 214 mmol/L Na+ 132 mmol/L + Ca++ 1,25 mmol/L + Mg++ 0.25 mmol/L + Cl- 95 mmol/L + (S)-Lactate 15 mmol/L + HCo3-25mmol/L




Peritoneal Dialysis IV Icodextrine Based

Icidextrine 75 g/L+ Na+ 133 mmol/L + Ca++ 1,75 mmol/L + Mg++ 0.25 mmol/L + Cl- 96 mmol/L + Lactate 40 mmol/L

خاص دسترسیدر مستقیما

بیماران اختیارصفاقی دیالیزگیرد قرار


IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL N02AB02



TABLET ORAL G04BX06 -

Phenobarbital 100 mg TABLET ORAL N03AA02 -




Pethidine Hydrochloride 25 mg/ml, 1ml












Phenazopyridine Hydrochloride 100 mg

Phenobarbital (As Sodium) 200 mg/ml, 1ml

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL N03AA02 -


Phenol BULK V03 -

Phenol Glycerin 6.4% DROPS, SOLUTION OTIC D08AE03

INJECTION PARENTERAL V04CH03 -

CAPSULE ORAL C04AX02 -




DROPS, SOLUTION NASAL R01AA04 -

Phenobarbital Sodium 100 mg/ml

Phenobarbital Sodium 200 mg/ml, 1ml


Phenol 6.4 g + Glycerin qs 100 g


Phenolsulphonphthalein 6 mg/ml

Phenoxybenzamine Hydrochloride 10 mg

Phentolamine Mesylate 10 mg/ml

Phenylephrine Hydrochloride 0.25%






IRAN DRUG LIST




دسترسیDROPS, SOLUTION NASAL R01AA04 -

INJECTION PARENTERAL C01CA06 -

DROPS, SOLUTION OPHTHALMIC S01GA55 -

Phenylephrine Zinc DROPS, SOLUTION OPHTHALMIC S01GA55

Phenytoin 125 mg/5ml SUSPENSION ORAL N03AB02 1392/03/11

Phenytoin 30 mg/5ml SUSPENSION ORAL N03AB02 -

Phenytoin Sodium 1% CREAM TOPICAL D03 -

Phenytoin Sodium 100 mg CAPSULE ORAL N03AB02 -

Phenytoin Sodium 50 mg CAPSULE ORAL N03AB02 -

INJECTION PARENTERAL N03AB02 -

TABLET ORAL N03AB52



Phenylephrine Hydrochloride 10 mg/ml

Phenylephrine Hydrochloride 5%

Phenylephrine HCl 0.12%+ Zinc Sulfate 0.25%

Phenytoin Sodium 50 mg/ml, 5ml

Phenytoin/Phenobarbital 100/50 mg

Phenytoin Sodium 100mg+ Phenobarbital 50mg

IRAN DRUG LIST




دسترسیPhosphate (Organic) INJECTION PARENTERAL B05XA14

SOLUTION ORAL V10XX01 -

Phosphate, Potassium INJECTION PARENTERAL B05XA06

BULK V03 **(KH2po4)**

TABLET ORAL A12BA -

BULK V03 **(Na2hpo4)**

BULK V03 **(Nah2po4)**

Phosphate, Sodium* TABLET, EFFERVESCENT ORAL A12BA

CAPSULE ORAL A16AA04 Treatment of cystinosis.

POWDER ORAL A16AA04 Treatment of cystinosis.

(Sodium Glycerophosphate anhydrose 216mg)/ml

Phosphate [32p] Sodium 5 mCi


(KH2PO4 225mg+ K2HPO4 236mg) / ml

Phosphate, Potassium Monobasic


Phosphate, Potassium Monobasic 500 mg

Phosphate, Sodium Dibasic داروهاي فهرست

بالک

Phosphate, Sodium monobasic


NaH2PO4 1936 mg+ NaHCO3 350 mg+KHCO3 315 mg

Phosphocysteamine 150 mg

Phosphocysteamine 150 mg

IRAN DRUG LIST




دسترسیINJECTION INTRACAVITARY V10AX01 -

DROPS, SOLUTION OPHTHALMIC S01BB01 -

DROPS, SOLUTION OPHTHALMIC S01BB01 -

Pilocarpine Nitrate 1% DROPS, SOLUTION OPHTHALMIC S01BB01 -

Pilocarpine Nitrate 2% DROPS, SOLUTION OPHTHALMIC S01BB01 -

Pilocarpine Nitrate 4% DROPS, SOLUTION OPHTHALMIC S01BB01

DROPS, SOLUTION OPHTHALMIC S01BB01

Pimecrolimus 1% , 15 g CREAM Topical D11AX15

Pimecrolimus 1% , 30g CREAM Topical D11AX15

Phosphorous [32P] Chromic Phosphate Colloid 5 mCi


Pilocarpine Hydrochloride 1%


Treatment of xerostomia induced by radiation therapy for head and neck cancer.Treatment of xerostomia and keratoconjunctivitis sicca in Sjogren's syndrome patients.



Treatment of xerostomia induced by radiation therapy for head and neck cancer.Treatment of xerostomia and keratoconjunctivitis sicca in Sjogren's syndrome patients.

IRAN DRUG LIST




Pimozide 4 mgدسترسی TABLET ORAL N05AG02 -

Pioglitazone 15 mg TABLET ORAL A10BG03 **(As Hydrochloride)**



PARENTERAL M03AC06


INJECTION, POWDER, PARENTERAL J01CR05



Pipecuronium Bromide 4 mg





Piperacillin Sodium/Tazobactam Sodium 2g/250mg

Piperacillin (as Sodium ) 2g + Tazobactam (as Sodium ) 250mg



توزيع بيمارستاني Piperacillinميشود

Sodium/Tazobactam Sodium 3g/375mg




توزيع بيمارستاني Piperacillinميشود

Sodium/Tazobactam Sodium 4g/500mg





Piperacillin 1 g




IRAN DRUG LIST




دسترسی


TABLET ORAL P02CB01 **(As Citrate or Phosphate)**

SYRUP ORAL P02CB01 **(As Citrate)**

Piracetam 33.33% LIQUID ORAL N06BX03 -

Piracetam 800 mg TABLET ORAL N06BX03 -

Piroxicam 0.5% GEL TOPICAL M02AA07 -

Piroxicam 10 mg CAPSULE ORAL M01AC01 -

Piroxicam 20 mg SUPPOSITORY RECTAL M01AC01 -

Piroxicam 20 mg/ml INJECTION PARENTERAL M01AC01

Plastibase OINTMENT TOPICAL D 1390/1/29

Piperacillin 2 g




Piperazine Hexahydrate 500 mg

Piperazine Hexahydrate 750 mg/5ml





BULK( base for Ointment) داروهای فهرست بالک

IRAN DRUG LIST




دسترسی

Plerixafor 20mg/ml INJECTION, SOLUTION PARENTERAL A03AX16 1393/01/24

Pneumococcal Vaccine INJECTION PARENTERAL J07AL02 **Polyvalent**

Podophyllin BULK V03 -

Poliomyelitis Vaccine INJECTION PARENTERAL J07BF03 ** Trivalent Killed (Salk)**

Poliovirus Vaccine SOLUTION ORAL J07BF01 Live

Poly Ethylene Glycol POWDER ORAL A06AD15 Macrogol 4000

Poly Ethylene Glycol BULK V03 Macrogol 4000






IRAN DRUG LIST




دسترسی

POWDER, FOR SOLUTION ORAL A06AD65

POWDER, FOR SOLUTION ORAL A06AD65

INJECTION PARENTERAL S01AA18

DROPS, SOLUTION OTIC S02AA11

DROPS, SUSPENSION OTIC S02AA11

Poly Ethylenglycol - electrolyte 1*

(Macrogol 3350, 3.9 mmol, Sodium 65 mmol, Chloride 53 mmol, Bicarbonate 17 mmol, potassium 5.4 mmol ) / Lit.

Poly Ethylenglycol - electrolyte 2*

(Macrogol 3350, 17.6 mmol, Sodium 125 mmol, Sulfate 40 mmol, Chloride 35 mmol, Bicarbonate 20 mmol, potassium 10 mmol ) / Lit.

Polymyxin B Sulfate 500,000 U

**INJECTION/OPHTHALMIC DROPS**




Polymyxin B Sulfate/Neomycin Sulfate/Hydrocortison

(Polymyxin B sulfate 10,000 U + Neomycin Sulfate 5 mg + Hydrocortisone 10 mg)/1 ml

Polymyxin B Sulfate/Neomycin Sulfate/Hydrocortison

(Polymyxin B sulfate 10,000 U + Neomycin Sulfate 5 mg + Hydrocortisone 10 mg)/1 ml

IRAN DRUG LIST




دسترسیPolysorbate 80 BULK V03 -

Poractant Alfa 80 mg/ ml SUSPENSION FOR INJECTION INTRATRACHEAL R07AA.. Curosurf

Potassium acetate PARENTERAL B05XA17

POWDER ORAL D11 **Paba-k**

TABLET ORAL D11 **Paba-k**

POWDER ORAL A12CC -

Potassium Chloride 500 mg TABLET, EXTENDED RELEASE ORAL A12BA01 -

Potassium Chloride 600 mg TABLET, EXTENDED RELEASE ORAL A12BA01 -



ميشود


(2Meq potassium + 2Meq acetate)/ml, 100 ml




Potassium Aminobenzoic Acid 3 g/sachet

Potassium Aminobenzoic Acid 500 mg

Potassium Chloride 20 mEq/sachet

IRAN DRUG LIST




دسترسیINTRAVENOUS DRIP B05XA01 -

INTRAVENOUS DRIP B05XA01 -

INTRAVENOUS DRIP B05XA01 -

Potassium Chloride INJECTION INTRAVENOUS DRIP B05XA01 1392/5/29

Potassium Citrate BULK V03 -

Potassium Citrate 10 mEq TABLET ORAL A12BA02

POWDER ORAL A12BA02

Potassium Chloride Concentrated 1 mEq/ml, 10ml






Potassium Chloride 0.3 % in Dextrose 5 %


For the dissolution and control of uric acid and cysteine calculi in the urinary tract.

Potassium Citrate 10 mEq/Sachet


IRAN DRUG LIST




دسترسیPotassium Citrate 5 mEq TABLET ORAL A12BA02

Potassium Iodide BULK UNASSIGNED A12BA02

Potassium Iodide BULK V03 -

Potassium Iodide 130 mg TABLET ORAL V03AB21 1391/02/25

Potassium Iodide 65 mg TABLET ORAL V03AB21 1390/3/9

Potassium Permanganate BULK V03 -


For use as a thyroid blocking agent in pediatric patients exposed to radiactive iodine


Thyroid blocking agent in radiation emergencies(Release of radioactive iodine) Thyroid blocking agent in radiation emergencies(Release of radioactive iodine) در تولید شرط به

کشور داخلداروهاي فهرست

بالک

IRAN DRUG LIST




دسترسی

Potassium phosphate PARENTERAL B05XA

Povidone Iodine 0.7% SOLUTION TOPICAL D09AA09 Scrub solution

Povidone Iodine 10% GEL VAGINAL G01AX11 -

Povidone Iodine 10% OINTMENT TOPICAL D09AA09 -

Povidone Iodine 10% SOLUTION TOPICAL D08AG02 -

Povidone Iodine 2.5% SPRAY, SOLUTION TOPICAL D09AA09 -

Povidone Iodine 200 mg SUPPOSITORY VAGINAL G01AX11 -

Povidone Iodine 3 mg/cm2 TISSUE TOPICAL D09AA09 -

Povidone Iodine 7.5% SPONGE TOPICAL D09AA09 -

Povidone Iodine 7.5% SHAMPOO TOPICAL D09AA09 -

Povidone Iodine 7.5% SOLUTION TOPICAL D09AA09 Surgical Scrub


(4.4Meq potassium + 3mmol phosphate)/ml, 100 ml




OTC










IRAN DRUG LIST




دسترسیPovidone Iodine 10% DOUCHE VAGINAL G01AX11 1392/5/29

Pralidoxime Chloride 1 g INJECTION, POWDER, PARENTERAL V03AB04 -

TABLET ORAL N04BC05

TABLET ER ORAL N04BC05 1389/6/15




TABLET ORAL N04BC05

TABLET ORAL N04BC05

TABLET ORAL N04BC05


Pramipexole - 2 HCl 1H20 0. 125 mg

Equivalent to 0.088 mg Pramipexole





Pramipexole - 2 HCl 1H20 1.5 mg


Pramipexole - 2 HCl 1H20 3 mg


Pramipexole - 2HCl 1H20 0. 25 mg


Pramipexole - 2HCl 1H20 0. 5 mg


Pramipexole - 2HCl 1H20 1 mg


IRAN DRUG LIST




دسترسیPrasugrel 5 mg TABLET ORAL B01AC22 1390/07/05

Prasugrel 10 mg TABLET ORAL B01AC22 1390/07/05

Praziquantel 600 mg TABLET ORAL P02BA01

Prazosin 1 mg TABLET ORAL C02CA01 **(As Hydrochloride)**

Prazosin 5 mg TABLET ORAL C02CA01 **(As Hydrochloride)**

Prednimustine 10 mg CAPSULE ORAL L01AA08 -

Prednimustine 10 mg TABLET ORAL L01AA08 -



Prednimustine 50 mg CAPSULE ORAL L01AA08 -


Prednisolone 20 mg TABLET ORAL H02AB06 -


Prednisolone 5 mg TABLET,ADHESIVE BUCCAL DO7AA03 - 1392/03/11


Prednisolone Acetate 1% DROPS, SUSPENSION OPHTHALMIC S01BA04 ** microfine**

Prednisone 1 mg TABLET ORAL H02AB07 -

**(As Hydrochloride)** کشور داخل در تولید شرط به

**(As Hydrochloride)** کشور داخل در تولید شرط بهTreatment of neurocysticercosis.


IRAN DRUG LIST




Prednisone 20 mgدسترسی TABLET ORAL H02AB07 -



Pregabalin 100 mg Capsule ORAL N03AX16





Pregabalin 50mg Capsule ORAL N03AX16

Pregabalin 75mg Capsule ORAL N03AX16

Prilocaine/ Felypressin INJECTION PARENTERAL N01BB

TABLET ORAL P01BA03

Cartridge__(Prilocaine HCl 30mg+Felypressin (0.03 IU.) 0.54 mcg)/ ml

Primaquine (As Phosphate) 15 mg

For use in combination with clindamycin hydrochloride in the treatment of Pneumocystis carinii pneumonia associated with AIDS.

IRAN DRUG LIST




دسترسی

TABLET ORAL P01BA03

Primidone 125 mg/5ml SUSPENSION ORAL N03AA03 -

Primidone 250 mg TABLET ORAL N03AA03 -

Primidone 250 mg/5ml SUSPENSION ORAL N03AA03 -

INJECTION PARENTERAL C01BA02 -

CAPSULE ORAL C01BA02 -

Procarbazine 50 mg CAPSULE ORAL L01XB01 **(As Hydrochloride)**

Progesterone BULK V03 -

Progesterone 100 mg CAPSULE, LIQUID FILLED VAGINAL or ORAL G03DA04 1389/11/4

Progesterone 200 mg CAPSULE, LIQUID FILLED VAGINAL or ORAL G03DA04 1389/11/4

Progesterone 100 mg SUPPOSITORY VAGINAL or RECTAL G03DA04 -


Primaquine (As Phosphate) 7.5 mg

For use in combination with clindamycin hydrochloride in the treatment of Pneumocystis carinii pneumonia associated with AIDS.

Procainamide Hydrochloride 100 mg/ml, 10ml

Procainamide Hydrochloride 500 mg


MICRONISED MICRONISED

IRAN DRUG LIST




Progesterone 25 mg/mlدسترسی INJECTION PARENTERAL G03DA04 -


Progesterone 50 mg/ml INJECTION PARENTERAL G03DA04 -

Progesterone 100 mg TABLET VAGINAL G03DA04 -

Proguanil 100 mg TABLET ORAL P01BB01


Promethazine 5 mg/5ml SYRUP ORAL R06AD02 **(As Hydrochloride)**

TABLET ORAL R06AD02 -

INJECTION PARENTERAL R06AD02 -






Promethazine Hydrochloride 25 mg

Promethazine Hydrochloride 25 mg/ml, 2ml

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL R06AD02 -

TABLET ORAL C01BC03 -

TABLET ORAL C01BC03 -

DROPS, SOLUTION OPHTHALMIC S01AX15 -

TABLET ORAL A03AB05 -



Promethazine Hydrochloride 25 mg/ml, 1ml

Propafenone Hydrochloride 150 mg

Propafenone Hydrochloride 300 mg

Propamidine Isethionate 0.1%

Propantheline Bromide 15 mg

propofol 10 mg/ml, 100ml




Propofol 10 mg/ml, 20ml




IRAN DRUG LIST




دسترسی




INJECTION PARENTERAL C07AA05 -

TABLET, EXTENDED RELEASE ORAL C07AA05 -


TABLET, EXTENDED RELEASE ORAL C07AA05 -






propofol 20mg/ml, 50ml




Propranolol Hydrochloride 20 mg

Propranolol Hydrochloride 1 mg/ml





IRAN DRUG LIST




دسترسیTABLET ORAL C07AA05 -

Propylene Glycol BULK V03 -

Propylthiouracil 50 mg TABLET ORAL H03BA02 -

INJECTION PARENTERAL C01EA01

Prostaglandin E1 20 mcg INJECTION, POWDER PARENTERAL C01EA01

Prostaglandin E1 20 mcg INJECTION, SOLUTION PARENTERAL C01EA01



Prostaglandin E1 0.5 mg/ml

(Alprostadil):Treatment of severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated.


(Alprostadil):Treatment of severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated.


Treatment of severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated.


IRAN DRUG LIST




دسترسی

Prostaglandin E2 GEL VAGINAL G02AB02 **(Dinoprostone)**

INJECTION PARENTERAL G02AB02 **(Dinoprostone)**

Prostaglandin E2 3 mg TABLET VAGINAL G02AB02 **(Dinoprostone)**






Prostaglandin E2 10 mg/ml, 0.5ml





و زنان متخصصداروهای زایمان فهرست

دسترسی بادر. فقط خاصو بیمارستانها




IRAN DRUG LIST




دسترسیInjection Parenteral G02AD01 1389/10/25


Prothionamide 125 mg TABLET ORAL J04AD01 -

Prothionamide 250 mg TABLET ORAL J04AD01 -

INJECTION, POWDER PARENTERAL B02BD -

Protirelin 0.2 mg/ml INJECTION PARENTERAL V04CJ02 -

SYRUP ORAL R01BA02 -

CAPSULE, GELATIN COATED ORAL R01BA02 -

Purified Talc 5 g Strile Powder for INJECTION PARENTERAL ____

Pyrantel 250 mg/5ml SUSPENSION ORAL P02CC01 **(As Pamoate)**

Pyrantel 125 mg TABLET ORAL P02CC01 **(As Pamoate)**

Pyrazinamide 500 mg TABLET ORAL J04AK01 -

Prostaglandin F2 α 5mg/ml

Dinoprost Tromethamine F1071

داروخانه در فقطتوزیع بیمارستانی

شود میProtamine Sulfate 1000 UAH/ml, 5ml

Prothrombin Complex Concentrated 500 IU

Pseudoephedrine Hydrochloride 30 mg/5ml

Pseudoephedrine Hydrochloride 30 mg

IRAN DRUG LIST





TABLET, Sustained Release ORAL N07AA02


Pyrimethamine 25 mg TABLET ORAL P01BD01 -

Pyrvinium 50 mg TABLET ORAL P02CX01 **(As Pamoate)**

Pyrvinium 50 mg/5ml SUSPENSION ORAL P02CX01 **(As Pamoate)**

TABLET ORAL

TABLET ORAL

TABLET ORAL

TABLET ORAL

Quetiapine 50 mg TABLET, EXTENDED RELEASE ORAL N05AH04 1390/09/21

Pyridostigmine Bromide 10 mgPyridostigmine Bromide 180 mg

Pyridostigmine Bromide 60 mg

Quetiapine (as Fumarate) 100 mg

N05AH04ارائه به منوط

پروتکل



پروتکل



پروتکل



پروتکل**(As Fumarate)** در تولید شرط به

کشور داخل

IRAN DRUG LIST




دسترسیQuetiapine 200 mg TABLET, EXTENDED RELEASE ORAL N05AH04 1390/09/21

Quetiapine 300 mg TABLET, EXTENDED RELEASE ORAL N05AH04 1391/05/02

TABLET ORAL P01AX05 **(Dihydrochloride)**

Quinidine Bisulfate 250 mg TABLET, EXTENDED RELEASE ORAL C01BA01 **EQ. TO 200 mg SULFATE**

Quinidine Sulfate 200 mg CAPSULE ORAL P01BC01 -

Quinidine Sulfate 200 mg TABLET ORAL C01BA01 -

Quinine 250 mg/ml INJECTION PARENTERAL P01BC01 -

TABLET ORAL P01BC01 -

TABLET ORAL P01BC01 -

Quinine Sulfate 200 mg TABLET ORAL P01BC01

**(As Fumarate)** در تولید شرط به

کشور داخل**(As Fumarate)** داخل تولید شرط به

ابتدا ازQuinacrine Hydrochloride 100 mg

Quinine Hydrochloride 100 mg

Quinine Hydrochloride 250 mg



IRAN DRUG LIST




دسترسیRabeprazole Sodium 20 mg TABLET, DELAYED RELEASE ORAL A02BC04 -

Rabies Immune globulin INJECTION PARENTERAL J06BB05 **(Human)**

Rabies Vaccine INJECTION PARENTERAL J07BG

Rabies Vero Vaccine INJECTION PARENTERAL J07BG -

TABLET ORAL G03XC01

Ranitidine 150 mg TABLET ORAL A02BA02 **(As Hydrochloride)**

Ranitidine 150 mg TABLET, EFFERVESCENT ORAL A02BA02 **(As Hydrochloride)**

Ranitidine 25 mg/ml, 2ml INJECTION PARENTERAL A02BA02 **(As Hydrochloride)**

Ranitidine 300 mg TABLET, EFFERVESCENT ORAL A02BA02 **(As Hydrochloride)**

Ranitidine 50 mg/50ml INJECTION PARENTERAL A02BA02 1390/3/9

Ranitidine 150 mg CAPSULE, GELATIN COATED ORAL A02BA02 **(As Hydrochloride)**

Ranitidine 300 mg TABLET ORAL A02BA02 **(As Hydrochloride)**

**HDC (Freeze-dried Killed Virus)**

Raloxifene Hydrochloride 60 mg

Reduction of the risk of breast cancer in postmenopausal women

(As Hydrochloride) in sodium chloride 0.45% (premixed)

کشور داخل در تولید شرط به




IRAN DRUG LIST




دسترسیRanitidine 300 mg CAPSULE, GELATIN COATED ORAL A02BA02 1389/8/24

Ranitidine 75mg/5ml SOLUTION ORAL A02BA02 **(As Hydrochloride)**

Rasburicase 1.5 mg INJECTION, POWDER PARENTERAL V03AF07

Remifentanil HCl 1 mg INJECTION, POWDER, PARENTERAL N01AH06



Repaglinide 0.5 mg TABLET ORAL A10BX02 -

Repaglinide 1 mg TABLET ORAL A10BX02 -

Repaglinide 2 mg TABLET ORAL A10BX02 -

Reserpine 0.1 mg TABLET ORAL C02AA02 -

**(As Hydrochloride)** داخل در تولید شرط بهکشور

اصغر علی بیمارستان برای فقطمحک و

داروهاي فهرستخاص دسترسي داروهاي با فهرست








ميشود

IRAN DRUG LIST




دسترسیResorcinol BULK V03 **(Resorcin)**

INJECTION, POWDER PARENTERAL B01AD07

PARENTERAL V10BX03 For Therapeutic Use 1389/10/25



Ribavirin 100 mg INJECTION PARENTERAL J05AB04

Ribavirin 200 mg CAPSULE ORAL J05AB04


Reteplase 10.4 U




Rhenium (186 Re) Etidronate (80-180) mCi INJECTION, SOLUTION

Rhenium (186Re) Sulfur Colloid (5-10) mCi

INJECTION, SOLUTION

Rhenium (188 Re) Etidronate (80-180) mCi

INJECTION, SOLUTION






IRAN DRUG LIST




دسترسی

Ribavirin 200 mg TABLET ORAL J05AB04

Rifabutin 150 mg CAPSULE ORAL J04AB04

Rifabutin 300 mg TABLET ORAL J04AB02

Rifampicin 150 mg CAPSULE ORAL J04AB02 -

Rifampicin 153 mg/ml DROPS, SOLUTION ORAL J04AB02 -

Rifampicin 300 mg CAPSULE ORAL J04AB02 -

Rifampicin 600 mg INJECTION, POWDER PARENTERAL J04AB02

Rifampicin 20 mg/ml SYRUP ORAL J04AB02 1391/11/02

Rifaximin 200mg TABLET ORAL A07AA11 کشور داخل در تولید شرط به 1391/02/07

Riluzole 50 mg TABLET ORAL N07XX02 -









For antituberculosis treatment where use of the ORAL form of the drug is not feasible.


IRAN DRUG LIST




دسترسیRinger Lactate 1000 ml INJECTION, SOLUTION INTRAVENOUS DRIP B05BB01

Ringer Lactate 250 ml INJECTION, SOLUTION INTRAVENOUS DRIP B05BB01


Ringers 1000 ml INJECTION, SOLUTION INTRAVENOUS DRIP B05BB01

Ringers 250 ml INJECTION, SOLUTION PARENTERAL B05BB01

Ringers 500 ml INJECTION, SOLUTION INTRAVENOUS DRIP B05BB01

Risedronate Sodium 35 mg TABLET ORAL M05BA07

Risedronate Sodium 5 mg TABLET ORAL M05BA07

Risperidone 1 mg TABLET ORAL N05AX08 -


(Na+130mEq + Ca++3mEq + K +4mEq + Cl-109mEq + Lactate 28mEq)/L



(Na+147mEq + Ca++ 4.5mEq + K+4mEq +Cl-156mEq)/L



IRAN DRUG LIST




Risperidone 3 mgدسترسی TABLET ORAL N05AX08 -


Risperidone 25 mg PARENTERAL N05AX08 1390/3/7

Risperidone 37.5 mg PARENTERAL N05AX08 1390/3/7

Risperidone 50 mg PARENTERAL N05AX08 1390/3/7

Risperidone 1 mg/ml SOLUTION ORAL N05AX08 1391/02/25

Ritodrine 10 mg/ml, 5ml INJECTION PARENTERAL G02CA01 **(Hydrochloride)**

Ritodrine 10 mg TABLET ORAL G02CA01 **(Hydrochloride)**

Rituximab 10 mg/ml, 10ml INJECTION PARENTERAL L01XC02

INJECTION, POWDER, SUSTAINED RELEASE



Treatment of immune thrombocytopenic purpuraTreatment of non-Hodgkin's B-cell lymphoma.Treatment of chronic lymphocytic leukemia

IRAN DRUG LIST




دسترسی

Rituximab 10mg/ml, 50ml INJECTION PARENTERAL L01XC02

Rivastigmine 1.5 mg CAPSULE ORAL N06DA03 **(As Hydrogen Tartrate )**

Rivastigmine 4.5 mg CAPSULE ORAL N06DA03 **(As Hydrogen Tartrate )**

Rivastigmine 6 mg CAPSULE ORAL N06DA03 **(As Hydrogen Tartrate )**

Rivastigmine 3 mg CAPSULE ORAL N06DA03 **(As Hydrogen Tartrate )**

Rizatriptan 10 mg TABLET ORAL N02CC04 **(As Benzoate)**

Rizatriptan 10 mg ORAL N02CC04 1390/1/29

Rizatriptan 5 mg TABLET ORAL N02CC04 **(As Benzoate)**

Ropinirole 5 mg TABLET ORAL N04BC04 **(As Hydrochloride)**

Ropinirole 0.25 mg TABLET ORAL N04BC04 **(As Hydrochloride)**

Ropinirole 0.5 mg TABLET ORAL N04BC04 **(As Hydrochloride)**

Ropinirole 1 mg TABLET ORAL N04BC04 **(As Hydrochloride)**

Treatment of immune thrombocytopenic purpuraTreatment of non-Hodgkin's B-cell lymphoma.Treatment of chronic lymphocytic leukemia

TABLET, ORALLY DISINTEGRATING

IRAN DRUG LIST




Rosuvastatin 5 mgدسترسی TABLET ORAL C10AA07 **(As Calcium)** 1392/12/11

Rosuvastatin 10 mg TABLET ORAL C10AA07 **(As Calcium)** 1392/12/11



Rubella Virus Vaccine INJECTION, POWDER, PARENTERAL J07BJ01 Live

Rubidium (82Rb) Chloride PARENTERAL V09 For Diagnostic Use 1389/10/25

Salbutamol 0.5 mg/ml, 1ml INJECTION PARENTERAL R03CC02 **(As Sulfate)**

Salbutamol 2 mg TABLET ORAL R03CC02 **(As Sulfate)**

Salbutamol 2 mg/5ml SYRUP ORAL R03CC02 **(As Sulfate)**

Salbutamol 5 mg/ml INHALER RESPIRATORY R03AC02 **(As Sulfate)**

Salbutamol 100 mcg/dose INHALER RESPIRATORY R03AC02 **200 dose**

Salbutamol 2.5 mg/2.5ml INHALER RESPIRATORY R03AC02 **(As Sulfate)**

INHALER RESPIRATORY R03AC02 (as sulfate)

INJECTION, SOLUTION

Salbutamol 100 mcg/metered inhalation

IRAN DRUG LIST




دسترسیINHALER RESPIRATORY R03AK04 -

Salicylic Acid BULK V03 -

Salicylic Acid (12-40)% PLASTER TOPICAL D01AE12 -

Salicylic Acid Compound SOLUTION TOPICAL D01AE12

Salmeterol 25 mcg/dose INHALER RESPIRATORY R03AC12 **(As Xinafoate)**

Salmeterol 50 mcg/dose INHALER RESPIRATORY R03AC12 **(As Xinafoate)**

AEROSOL,METERED RESPIRATORY R03AK06

AEROSOL,METERED RESPIRATORY A03AK06

AEROSOL,METERED RESPIRATORY R03AK06

Salbutamol/Beclomethasone Dipropionate 100/50 mcg



Salicylic Acid 16.7g+Lactic Acid 16.7g + Collodion qs to 100g


Salmeterol / Fluticasone Propionate 25/125

Salmeterol(as Xinafoate) 25mcg + Fluticasone Propionate 125mcg


Salmeterol (as Xinafoate) 25mcg +Fluticasone Propionate 250mcg


Salmeterol (as Xinafoate) 25mcg +Fluticasone Propionate 50mcg

IRAN DRUG LIST




دسترسیDISC RESPIRATORY R03AK06 1389/11/4

DISC RESPIRATORY R03AK06 1389/11/4

DISC RESPIRATORY R03AK06 1389/11/4


TABLET ORAL _____

Sarcoidosis Test INJECTION PARENTERAL V04CX **(Kveim) Diagnostic**

Schick Test INJECTION PARENTERAL V04CX **Diagnostic**

Scopolamine 1 mg/72h PATCH, EXTENDED RELEASE TRANSDERMAL N05CM05 -

Secretin 100 U PARENTERAL V04CK01 -

Salmeterol / Fluticasone Propionate 50/100 mcg/dose

Salmeterol(as Xinafoate) 50mcg + Fluticasone Propionate 100mcg /dose





Samarium (153 Sm) Lexidronam (70-300)mCi

INJECTION, SOLUTION

Sapropterin Dihydrochloride 50 mg

فنیل به مبتال بیماران برای فقط(Phenylketonuria) کتونوریاIn patients responsive to tetrahydrobiopterin



IRAN DRUG LIST




دسترسی

TABLET ORAL N04BD01

Selenium 50 mcg/ml INJECTION PARENTERAL A12CE02 90/3/23

Selenium Sulfide, %2. 5 Lotion(Shampoo) Topical D01AE13

Serine 600 mg CAPSULE ORAL _____

Sertaconazole Nitrate 2% CREAM TOPICAL D01AC14 -

TABLET VAGINAL G01AF -

TABLET VAGINAL G01AF -

Sertraline 100 mg CAPSULE ORAL N06AE06 **(As Hydrochloride)**

Sertraline 100 mg TABLET ORAL N06AE06 **(As Hydrochloride)**

Selegiline Hydrochloride 5 mg

As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism.

As Sodium Selenite Pentahydrate




کمبود به مبتال بیماران برای فقط(Serine deficiency) سرین


Sertaconazole Nitrate 300 mg

Sertaconazole Nitrate 500 mg

IRAN DRUG LIST




Sertraline 25 mgدسترسی TABLET ORAL N06AE06 **(As Hydrochloride)**

Sertraline 50 mg CAPSULE ORAL N06AE06 **(As Hydrochloride)**

Sertraline 50 mg TABLET ORAL N06AE06 **(As Hydrochloride)**

Sevelamer 800 mg TABLET ORAL V03AE02 **(As Hydrochloride)**

Sevelamer 800 mg TABLET ORAL V03AE02 1390/07/04

TABLET ORAL V03AE021390/07/04

POWDER , FOR SUSPENSION ORAL V03AE021392/06/12

Sevoflurane 250 mg INHALER RESPIRATORY N01AB08 **250ml/flacon**

Sildenafil 100 mg TABLET ORAL G04BE03 **(As Citrate)**



Sildenafil Citrate 1% GEL TOPICAL G04BE03 1% W/W 1392/5/29

Silver Nitrate BULK V03 -

Silver Sulfadiazine 10 mg/g CREAM TOPICAL D06BA01 -

Sevelamer Carbonate 800 mg

Sevelamer Carbonate 2.4 g/Sachet



IRAN DRUG LIST




دسترسی

CREAM TOPICAL D06BA51

CAPSULE, GELATIN COATED ORAL A07D -

CAPSULE, GELATIN COATED ORAL A07D کشور داخل در تولید شرط به

TABLET, CHEWABLE ORAL A07D -

DROPS, SUSPENSION ORAL A07D -

DROPS, SOLUTION ORAL A07D -

Silver Sulfadiazine/EGF (Silver Sulfadiazine1% + Epidermal Growth Factor 0.001%)

For promotion of cutaneous wound healing in extreme burn treatment protocols.


Simethicone (Dimethicone Activated) 125 mg






Simethicone (Dimethicone Activated) 40 mg/ml


Simethicone (Dimethicone Activated) 41.2 mg/ml


IRAN DRUG LIST




دسترسیSimple Eye Oint* OINTMENT OPHTHALMIC S01XA

Simvastatin 10 mg TABLET ORAL C10AA01 -

Simvastatin 20 mg TABLET ORAL C10AA01 -

Simvastatin 40 mg TABLET ORAL C10AA01

Sirolimus 1 mg TABLET ORAL L04AA10 -

Sitagliptin 25 mg TABLET ORAL A10BH01 As Phosphate 1392/12/11

Sitagliptin 50 mg TABLET ORAL A10BH01 As Phosphate 1392/12/11


Sodium acetate PARENTERAL B05XA08

TABLET ORAL J04AA02 Treatment of Crohn's disease.

Sodium Benzoate 500 mg TABLET ORAL ____ 1392/7/22

Yellow soft paraffin 80 g + Wool fat 10 g + Liquid paraffin q.s. 100 g


Sitagliptin/Metformin Hydrochloride 50/500 mg

Sitagliptin (as Phosphate) 50 mg+ Metformin Hydrochloride 500 mg


(2Meq sodium + 2Meq acetate)/ml, 100 ml




Sodium Aminosalicylate 500 mg

Rare metabolic conditions for children


IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL ____

SOLUTION ORAL ____

Sodium Bicarbonate BULK V03 -



Sodium Benzoate/Sodium Phenylacetate 10%/10%

(Grade III and VI hepatic encephalopathy) برای فقط

هیپرآمونمیا به مبتال بیماران(Hyperammonemia)






Sodium Bicarbonate 7.5%, 10ml








IRAN DRUG LIST




دسترسی



Sodium Chloride BULK V03 -

Sodium Chloride 0.65% SPRAY, SOLUTION NASAL R01AX -

Sodium Chloride 0.9% SPRAY, SOLUTION NASAL R01AX -

SOLUTION NASAL & OPHTHALMIC S01XA Single dose

INJECTION, SOLUTION INTRAVENOUS DRIP B05XA03 Half Saline

INJECTION, SOLUTION INTRAVENOUS DRIP B05XA03 Half Saline

Sodium Chloride 0.65% DROPS, SOLUTION NASAL R01AX -










OTC


Sodium Chloride 0.9%, 5ml




IRAN DRUG LIST




دسترسیSodium Chloride 0.9% SOLUTION IRRIGATION B05CB01 -

INJECTION, SOLUTION INTRAVENOUS DRIP B05XA03 -


INJECTION, SOLUTION PARENTERAL B05xA03 -


Sodium Chloride 0.9%, 5ml INJECTION, SOLUTION PARENTERAL B05XA03 -

INJECTION, SOLUTION PARENTERAL B05XA03 -

Sodium Chloride 5% DROPS, SOLUTION OPHTHALMIC S01XA03 -

Sodium Chloride 5% OINTMENT OPHTHALMIC S01XA03 -


Sodium Chloride 5%, 50ml INJECTION, SOLUTION INTRAVENOUS DRIP B05Xa03 -






Sodium Chloride 0.90% , 250ml

Sodium Chloride 5%, 500ml

IRAN DRUG LIST




دسترسیSodium Citrate BULK V03 -

SOLUTION NOT APPLICABLE D08AX07 -

Sodium Lactate 1/6 molar INJECTION PARENTERAL B05XA -


INJECTION PARENTERAL A16AX03

TABLET ORAL A16AX03


Sodium Hypochlorite 0.55% (AVAILABLE Cl)

Sodium Nitrite 30 mg/ml, 10ml



Sodium Phenylbutyrate 200 mg/ml,10ml

(Sodium phenylbutyrate: Adjunctive to surgery, radiation therapy, and chemotherapy for primary or recurrent malignant gliome) مبتال بیماران برای فقط

هیپرآمونمیا به(Hyperammonemia)


Sodium Phenylbutyrate 500 mg

(Sodium phenylbutyrate: Adjunctive to surgery, radiation therapy, and chemotherapy for primary or recurrent malignant gliome) مبتال بیماران برای فقط

هیپرآمونمیا به(Hyperammonemia)


IRAN DRUG LIST




دسترسی

Sodium phosphate PARENTERAL B05XA09

ENEMA RECTAL A06AG01

POWDER, FOR SUSPENSION ORAL V03AE01 -

Sodium Salicylate 300 mg TABLET, DELAYED RELEASE ORAL N02BA04 -



Sodium Thiosulfate BULK V03 **(Sodium Hyposulfite)**


(4Meq sodium + 3mmol phosphate)/ml, 100 ml




Sodium phosphate dibasic heptahydrate/Sodium phosphate monobasic monohydrate(7g/118ml;19g/118ml)

Sodium Polystyrene Sulfonate 454 g

Sodium Tetradecyl Sulfate 1%, 2ml

Sodium Tetradecyl Sulfate 3%, 2ml


IRAN DRUG LIST




دسترسیINJECTION PARENTERAL V03AB06

Solifenacin Succinate 10 mg TABLET ORAL G04BD080 کشور داخل در تولید شرط به 1390/3/7

Solifenacin Succinate 5 mg TABLET ORAL G04BD080 کشور داخل در تولید شرط به 1390/3/7

Somatostatin 0.25 mg INJECTION, POWDER PARENTERAL H01CB01

Somatostatin 3 mg PARENTERAL H01CB01

Sodium Thiosulfate (As Sodium Hyposulfite) 250 mg/ml, 50ml



Treatment of bleeding esophageal varices.


INJECTION, POWDER,FOR SOLUTION

Treatment of bleeding esophageal varices. شرط به

داخل تولیدداروهاي فهرست

(orphan) خاص

IRAN DRUG LIST




دسترسی

INJECTION, POWDER PARENTERAL H01AC01Somatropin 4 U, (Biosynthesis produced)

Treatment of short stature in patients with Noonan syndrome Treatment of short stature associated with Turner's syndrome. Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures.

IRAN DRUG LIST




دسترسی

PARENTERAL H01AC01Somatropin 12 U, (Biosynthesis produced)



IRAN DRUG LIST




دسترسی

Somatropin 15 IU/ 1. 5 ml INJECTION PARENTERAL H01AC01


IRAN DRUG LIST




دسترسی

Somatropin 15 U/ml, 1ml INJECTION PARENTERAL H01AC01


IRAN DRUG LIST




دسترسی

Somatropin 22.5 U/1.5 ml INJECTION,SOLUTION PARENTERAL H01AC01 1390/07/04

Cartridge with pen-type syringe. Treatment of short stature in patients with Noonan syndrome Treatment of short stature associated with Turner's syndrome. Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures. شرط به

تولید قرارداد ارائه

IRAN DRUG LIST




دسترسی

Somatropin 30 U/1.5 ml INJECTION,SOLUTION PARENTERAL H01AC01 1392/07/22

Sorafenib tosilate 200mg TABLET ORAL L01XE05

Sorbitol 5 g/sachet POWDER ORAL A06AD18 -

Sorbitol 70% SOLUTION ORAL A06AD18 -


Cartridge with pen-type syringe. Treatment of short stature in patients with Noonan syndrome Treatment of short stature associated with Turner's syndrome. Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures.



Sotalol Hydrochloride 40 mg

IRAN DRUG LIST




دسترسیTABLET ORAL C07AA07 -

Spectinomycin 2 g INJECTION, POWDER, PARENTERAL J01XX04 **(As Dihydrochloride)**

Spiramycin 500 mg TABLET ORAL J01FA02 -

Spironolactone 100 mg TABLET ORAL C03DA01 -

Spironolactone 25 mg TABLET ORAL C03DA01 -

Starch BULK V03 -

Stavudine 40 mg CAPSULE ORAL J05AF04

Stavudine 40 mg TABLET ORAL J05AF04

Stavudine 5 mg/5ml POWDER, FOR SOLUTION ORAL J05AF04

Stearic Acid BULK V03 -

Sotalol Hydrochloride 80 mg










بالک

IRAN DRUG LIST




دسترسیINJECTION PARENTERAL P01CB02

INJECTION, POWDER, PARENTERAL B01AD01

PARENTERAL B01AD01


Streptomycin 1 g INJECTION, POWDER, PARENTERAL J01GA01 **(As Sulfate)**

Streptozocin 1 g INJECTION, POWDER, PARENTERAL L01AD04 -


Stibogluconate Sodium 100 mg/ml

**(Eq. To Pentavalent Antimony)**

Streptokinase 1,500,000 IU




Streptokinase 250,000 IU INJECTION, POWDER, LYOPHILIZED




Streptokinase 750,000 IU




Strontium (89Sr) Chloride 1 mCi/ml

INJECTION, SOLUTION

IRAN DRUG LIST




دسترسیSuccimer 100 mg CAPSULE ORAL V03AB

Succimer 200 mg CAPSULE ORAL V03AB

INJECTION, POWDER, PARENTERAL M03AB01


INJECTION PARENTERAL M03AB01


Treatment of lead poisoning in children.


Treatment of lead poisoning in children.


Succinylcholine Chloride 1 g




Succinylcholine Chloride 100 mg




Succinylcholine Chloride 100 mg/ml, 10ml




Succinylcholine Chloride 20 mg/ml




IRAN DRUG LIST




دسترسی




Sucralfate 1 g TABLET ORAL A02BX02 -

Sucralfate 1 g/sachet POWDER, FOR SUSPENSION ORAL A02BX02









Succinylcholine Chloride 500 mg




OTC

Treatment of ORAL complications of chemotherapy in bone marrow transplant patients.Treatment of ORAL ulcerations and dysphagia in patients with epidermolysis bullosa.

IRAN DRUG LIST




دسترسیSucralfate 500 mg TABLET ORAL A02BX02 -

Sufentanil 5 mcg/ml, 2ml INJECTION PARENTERAL N01AH03 As Citrate

Sufentanil 5 mcg/m, 5ml INJECTION PARENTERAL N01AH03 As Citrate

Sufentanil 5 mcg/ml, 10ml INJECTION PARENTERAL N01AH03 As Citrate

Sufentanil 50 mcg/ml INJECTION PARENTERAL N01AH03 As Citrate 1389/6/29

Sulfacetamide Sodium 10% DROPS, SOLUTION OPHTHALMIC S01AB04 -

Sulfacetamide Sodium 20% DROPS, SOLUTION OPHTHALMIC S01AB04 -

داروهاي فهرستOTC داروهاي فهرست











IRAN DRUG LIST




دسترسی

Sulfadiazine 500 mg TABLET ORAL J01BC02

TABLET ORAL P01BD51

ENEMA RECTAL A07EC01 -

Sulfasalazine 500 mg TABLET ORAL A07EC01 -

Sulfasalazine 500 mg TABLET, DELAYED RELEASE ORAL A07EC01 -

Sulfur BULK V03 **(Precipitated)**

Sumatriptan 100 mg TABLET ORAL N02CC01 **(As Succinate)**

Sumatriptan 50 mg TABLET ORAL N02CC01 **(As Succinate)**

INJECTION PARENTERAL N02CC01 **(As Succinate)**

TABLET ORAL N02CC

For use in combination with pyrimethamine for the treatment of Toxoplasma gondiiencephalitis in patients with and without AIDS.

Sulfadoxine/Pyrimethamine 500/25 mg

Sulfadoxine 500 mg+Pyrimethamine 25 mg

Sulfasalazine 30 mg/ml, 100ml


Sumatriptan 12 mg/ml, 0.5ml

Sumatriptan/Naproxen 85/500 mg

sumatriptan( As Succinate)85mg/naproxen Sodium500mg

IRAN DRUG LIST




دسترسیSunitinib 12.5 mg CAPSULE ORAL L01XE04 1391/12/23

Sunitinib 25 mg CAPSULE ORAL L01XE04 1391/12/23

Sunitinib 50 mg CAPSULE ORAL L01XE04 1391/12/23

Surfactant 27 mg/ml INJECTION , SUSPENSION INTRATRACHEAL R07AA02 1391/05/02

Surfactant TA 120 mg LYOPHYLIZED POWDER INTRATRACHEAL R07AA.. Surfacten

Tacrolimus 0.5 mg CAPSULE ORAL L04AA05 -

As Malate در تولید شرط بهکشور داخل



bovine lipid extract

IRAN DRUG LIST




دسترسیTacrolimus 5 mg/ml, 1ml PARENTERAL L04AA05

Tacrolimus 0. 5 mg Capsule, Sustained Release ORAL L04AD02

Tacrolimus 0.03% OINTMENT TOPICAL D11AX14 **(As Monohydrate)**

Tacrolimus 0.1% Ointment Topical L04AD02

Tacrolimus 1 mg Capsule, sustained Release ORAL L04AD02

Tacrolimus 5 mg Capsule, sustained Release ORAL L04AD02

CAPSULE ORAL L04AA05

CAPSULE ORAL L04AA05

Tadalafil 10 mg TABLET ORAL G04BE

Tadalafil 20 mg TABLET ORAL G04BE

Tamoxifen 20 mg TABLET ORAL L02BA01 **(As Citrate)**

Tamoxifen 10 mg TABLET ORAL L02BA01 **(As Citrate)**


Prophylaxis of organ rejection in patients receiving heart transplants.

Tacrolimus (As Monohydrate) 5 mg


Tacrolimus (As Monohydrate) 1 mg


Treatment of pulmonary arterial hypertension

Treatment of pulmonary arterial hypertension

IRAN DRUG LIST




دسترسیORAL G04CA02 -

TABLET, EXTENDED RELEASE ORAL G04CA02 -

Tartaric Acid BULK V03 -

PARENTERAL V09H 1391/9/1

INTRAVENOUS BOLUS V09HA01 -

INTRAVENOUS BOLUS V09HA01

INTRAVENOUS BOLUS V09 -


Tamsulosin Hydrochloride 0.4 mg


Tamsulosin Hydrochloride 0.4 mg


Technetium [99mTc]ciprofluxacin



Technesium [99mTc]Human Immunoglobulin G (15-25) mCi



Technesium [99mTc]Tyrosine Octreotate (15-25) mCi



Technesium [99mTc]Tyrosine Octreotide (15-25) mCi



Technetium (99mTc) EDDA-tricine-HYNIC-bombesin (15-20) mCi

INJECTION,POWDER LYOPHILIZED

IRAN DRUG LIST




دسترسیINHALER RESPIRATORY V09EA For Diagnostic Use 1389/10/25

INJECTION SUBCUTANEOUS V09DB -

INTRAVENOUS BOLUS V09AA02 -

INTRAVENOUS BOLUS V09CA -

INTRAVENOUS BOLUS V09BA -


Technetium (99mTc) Pentetate (25-30) mCi

Technetium [99mtc]antimony Sulfur Colloid (5 - 50) mCi


Technetium [99mtc]bicisate (10 - 100) mCi



Technetium [99mtc]ethylenedicystein (10 - 100) mCi



Technetium [99mtc]etidronate (up to 150) mCi



Technetium [99mtc]exzametazine (10 - 30) mCi



IRAN DRUG LIST




دسترسیINTRAVENOUS BOLUS V09CA04 -

PARENTERAL V09CA04

INTRAVENOUS BOLUS V09EB01 -

INTRAVENOUS BOLUS V09DA04 -

INTRAVENOUS BOLUS V09BA02 -

INTRAVENOUS BOLUS V09CA03 -

Technetium [99mtc]glucoheptonate (up to 150) mCi



TECHNETIUM [99mTc]Human Immunoglobulin G (15-25) mCi

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

داروهاي فهرست(orphan) خاص ،


Technetium [99mtc]macrosalb (5 - 30) mCi



Technetium [99mtc]mebrofenin (up to 100) mCi



Technetium [99mtc]medronate (up to 300) mCi



Technetium [99mtc]mertiatide (10 - 100) mCi



IRAN DRUG LIST




دسترسیINTRAVENOUS BOLUS V09CA01 -

INJECTION INTRAVENOUS BOLUS V09FX01 **Generator**




INTRAVENOUS BOLUS V09DB07 -

Technetium [99mtc]pentate (up to 300) mCi



Technetium [99mtc]Pertechnetate 100 mCi








Technetium [99mtc]phytate (up to 100) mCi



IRAN DRUG LIST




دسترسیINJECTION INTRAVENOUS BOLUS V09BA03 -

INTRAVENOUS BOLUS V09GA03 -





Technetium [99mtc]pyrophosphate (up to 80) mCi


Technetium [99mtc]sestamibi (20-100) mCi



Technetium [99mtc]stannous Agent labelled Cells (10-100) mCi



Technetium [99mtc]succimer (up to 40) mCi



Technetium [99mtc]sulfur Colloid (10-100) mCi



Technetium [99mtc]tin Colloid (up to 100) mCi



IRAN DRUG LIST




دسترسیINTRAVENOUS BOLUS V09IA03 -

PARENTERAL V09H 1391/9/1

Teicoplanin 200 mg INJECTION, POWDER, PARENTERAL J01XA02 -

Teicoplanin 400 mg INJECTION, POWDER, PARENTERAL J01XA02 -

Temozolomide 5 mg CAPSULE ORAL L01AX03 کشور داخل در تولید شرط به 1389/10/25




Temozolomide 140 mg CAPSULE ORAL L01AX03 1392/08/20

Temozolomide 100mg INJECTION, POWDER PARENTERAL L01AX03 1392/04/04

Teniposide 10 mg/ml, 5ml INJECTION PARENTERAL L01CB02

Technetium[99mtc]pentavalent Succimer (20-80) mCi



Technetium[99mtc]tricine-hynic-ubiquicidine(29-41)



Treatment of refractory childhood acute lymphocytic leukemia.


IRAN DRUG LIST




دسترسی

TABLET ORAL J05AF07 245 mg Tenofovir disoproxil

Terazosin 10 mg TABLET ORAL G04CA03 **(As Hydrochloride)**



Terbinafine 250 mg TABLET ORAL D01BA02 **(As Hydrochloride)**

Terbinafine 1% SOLUTION TOPICAL D01AE15 **(As Hydrochloride)**

CREAM TOPICAL D01AE15 -

SPRAY, SOLUTION TOPICAL D01AE15 -

Terbutaline Sulfate NEBULISATION RESPIRATORY R03CC03 -

INJECTION PARENTERAL R03CC03 -

Terbutaline Sulfate 5 mg TABLET ORAL R03CC03 -

Tenofovir disoproxil fumarate 300 mg




Terbinafine Hydrochloride 1%

Terbinafine Hydrochloride 1%

Terbutaline Sulfate 0.5 mg/ml

IRAN DRUG LIST




دسترسی

PARENTERAL H05AA02

PARENTERAL H05AA02

INJECTION PARENTERAL G03BA03 -

INJECTION PARENTERAL G03BA03 -

Teriparatide 250 mcg/ml, 2.4 ml

INJECTION, Prefilled Disposable Pen

Diagnostic agent to assist in establishing the diagnosis in patients presenting with clinical and laboratory evidence of hypocalcemia due to either hypoparathyroidism or pseudohypoparathyroidism.Treatment of idiopathic osteoporosis.

Teriparatide 250 mcg/ml, 3ml

INJECTION, Prefilled Disposable Pen

Diagnostic agent to assist in establishing the diagnosis in patients presenting with clinical and laboratory evidence of hypocalcemia due to either hypoparathyroidism or pseudohypoparathyroidism.Treatment of idiopathic osteoporosis.

Testosterone Enantate 100 mg/ml

Testosterone Enantate 250 mg/ml

IRAN DRUG LIST




دسترسیCAPSULE ORAL G03BA03

Tetanus Antitoxin uine* INJECTION PARENTERAL J06AA02 -

INJECTION PARENTERAL J06BB02 -

Tetanus Toxoid Adsorbed INJECTION PARENTERAL J07AM01 T.T.

Tetrabenazine 25 mg TABLET ORAL N05AK01

INJECTION PARENTERAL N01BA03 -

DROPS, SOLUTION OPHTHALMIC S01AA09 -

INJECTION PARENTERAL H01AA02 **(As Acetate)**

INJECTION, SUSPENSION PARENTERAL H01AA02

Testosterone Undecanoate 40 mg

Treatment of weight loss in AIDS patients with HIV-associated wasting.


Tetanus Immune globulin* 250 IU

Treatment of Huntington's disease.Treatment of moderate/severe tardive dyskinesia.

Tetracaine Hydrochloride 1%

Tetracaine Hydrochloride 0.5%

Tetracosactide 250 mcg/ml, 1ml

Tetracosactide Acetate 1 mg/ml

**With ZINC PHOSPHATE COMPLEX**

IRAN DRUG LIST




دسترسیOINTMENT OPHTHALMIC S01AA06 -

CAPSULE ORAL J01AA07 -

OINTMENT TOPICAL D06AA04 -

Thalidomide 100 mg CAPSULE ORAL L04AX02

Thalidomide 100 mg TABLET ORAL L04AX02

INJECTION INTRAVENOUS BOLUS V09GX01 -

INJECTION INTRAVENOUS BOLUS V09GX01 -

Theophylline 100 mg TABLET, EXTENDED RELEASE ORAL R03DA04 -

Theophylline 200 mg ORAL R03DA04 -

Theophylline 200 mg TABLET ORAL R03DA04 -

Theophylline 200 mg TABLET, EXTENDED RELEASE ORAL R03DA04 -

Tetracycline Hydrochloride 1%

Tetracycline Hydrochloride 250 mg

Tetracycline Hydrochloride 3%


به مبتال بیماران برای فقطمیلوما مولتیپل


به مبتال بیماران برای فقطمیلوما مولتیپل


Thallium [201Tl] Chloride 10 mCi


Thallium [201Tl] Chloride 5 mCi



IRAN DRUG LIST




دسترسیSOLUTION ORAL R03DA54

Thiabendazole 500 mg TABLET, CHEWABLE ORAL P02CA02 -

Thiamine HCl 100 mg/ ml INJECTION INTRAVENOUS DRIP A11DA01

Thiethylperazine 6.5 mg TABLET ORAL R06AD03 **(As Dimaleate)**

INJECTION INTRAMUSCULAR R06AD03 **(As Dimaleate)**

Thioguanine 40 mg TABLET ORAL L01BB03 -

Thiopental Sodium 1 g INJECTION, POWDER, PARENTERAL N01AF03

INJECTION PARENTERAL N01AF03

Theophylline/Guaifenesin 50/30 mg/5ml

(Theophylline anhydrous 50 mg+Guaifenesin 30 mg) / 5 ml

aa،انفوزیون الزم 30زمانمیباشد .دقیقه



توزيع بيمارستاني.ميشود

Thiethylperazine 6.5 mg/ml




Thiopental Sodium 25 mg/ml, 20ml




IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL N01AF03

Thiopental Sodium 500 mg INJECTION, POWDER, PARENTERAL N01AF03

TABLET ORAL N05AC02 -



Thiothixene 5 mg CAPSULE ORAL N05AF04 -

Thyrotrophin 10 U PARENTERAL V04CJ01

Thiopental Sodium 50 mg/ml, 20ml





ميشود

Thioridazine Hydrochloride 10 mg




Treatment of well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid.As an adjunct in the diagnosis of thyroid cancer.

IRAN DRUG LIST




دسترسیThyrotropin Alfa 1.1 mg PARENTERAL V04CJ01

Thyrotropin Alfa 900 mcg PARENTERAL V04CJ01

TABLET ORAL B01AC05 -

Tilactase 3000 FCC U TABLET ORAL A09AA04 Lactase

Timolol 0.5% SOLUTION OPHTHALMIC S01ED01 **(As Maleate)**

Tinidazole 500 mg TABLET ORAL P01AB02

INHALER RESPIRATORY R03BB04


مراکز دارای بیمارستانهای درسرطان تشخیص تخصصی




مراکز دارای بیمارستانهای درسرطان تشخیص تخصصی



Ticlopidine Hydrochloride 250 mg


Treatment of intestinal amebiasis and amebic liver abcess caused by E. histolytica in both adults and pediatric patients older than three years of age. It is not indicated for the treatment of asymptomatic cyst passage.

Tiotropium 18 mcg/capsule

**(As Bromide Monohydrate)**

IRAN DRUG LIST




دسترسیINJECTION, SOLUTION PARENTERAL B01AC17 1389/6/29

INJECTION, SOLUTION PARENTERAL B01AC17

INJECTION, SOLUTION PARENTERAL BO1AC17 1389/6/29

Titanium Dioxide LOTION TOPICAL D02AB

Titanium Dioxide BULK V03 -

TABLET ORAL M03BX02

Tobramycin 28 mg POWDER RESPIRATORY J01GB01 - 1392/7/22

Tobramycin 10 mg/ml, 2ml INJECTION PARENTERAL J01GB01 **(As Sulfate)**

Tobramycin 40 mg/ml, 2ml INJECTION PARENTERAL J01GB01 **(As Sulfate)**

INJECTION PARENTERAL J01GB01 **(As Sulfate)**

Tirofiban Hydrochloride 0.25mg/ml, 50ml

**(As Hydrochloride Monohydrate)**

Tirofiban Hydrochloride 0.25mg/ml, 25ml


Tirofiban Hydrochloride 5mg/100ml


Titanium Oxide 3.6% + Zinc Oxide 14%


Tizanidine (As Hydrochloride) 4 mg

Treatment of spasticity associated with multiple sclerosis and spinal cord injury.

Tobramycin 50 mg / ml, 1.5ml

IRAN DRUG LIST




دسترسیTobramycin 60 mg/ml, 5ml NEBULISATION RESPIRATORY J01GB01 -

Tobramycin 75mg/ml, 4ml NEBULISATION RESPIRATORY J01GB01 -

Tobramycin 300mg/4ml NEBULISATION INHALATION JO1GBO1

Tobramycin 300mg/5ml NEBULISATION INHALATION JO1GBO1

Tobramycin 0.3% OINTMENT OPHTHALMIC S01AA12 کشور داخل در تولید شرط به 1390/07/05

DROP, SUSPENTION OPHTHALMIC S01CA01 1391/10/03

INJECTION, POWDER, PARENTERAL C04AB02 -

Tolmetin 200 mg TABLET ORAL M01AB03 **(As Sodium)**

Tolnaftate 1% CREAM TOPICAL D01AE18 -

Tolnaftate 1% SOLUTION TOPICAL D01AE18 -

Bronchiectasis patients injected with pseadornonas aeruginosa)


Bronchiectasis patients injected with pseadornonas aeruginosa)


Tobramycin/Dexamethason %0.3/%0.1

Tobramycin0.3%+Dexamethason0.1%

Tolazoline Hydrochloridel 10 mg

IRAN DRUG LIST




دسترسیTolterodine Tartarate 1 mg TABLET ORAL G04BD07 -

Tolterodine Tartarate 2 mg TABLET ORAL G04BD07 -

Tolterodine Tartarate 2 mg CAPSULE ER ORAL G04BD07 1389/6/15

Tolterodine Tartarate 4 mg CAPSULE ER ORAL G04BD07 1389/6/15

Topiramate 100 mg TABLET ORAL N03AX11




Trace Metal Combination 1 INJECTION PARENTERAL A12CX

Treatment of Lennox-Gastaut syndrome.




{Chromium(0.17-10 mcg) +Copper(0.02-1.3mg)+ Iodine(0.013-63.51mg) +Manganese(0.001-0.27mg)+ Selenium (2-36.73 mcg)+ Zinc(0.05-6.5mg)}/ml

IRAN DRUG LIST




دسترسی



TABLET, EXTENDED RELEASE ORAL N02AX02


{Chromium (0.17-10mcg)+copper(0.02-1.3mg)+Fe2+(0.045-1.1mg)+fluoride (0.057-0.95mg)+Iodine (0.013-63.5mcg)+manganese(0.001-0.27mg)+molybdenium(0.001-19mcg)+selenium(2-36.73mcg)+zinc (0.05-6.5mg) }/ml

(Zinc Chloride 521mcg + Copper Chloride 2H2O 53.7mcg + Manganese Chloride 4H2O 3.6mcg + Sodium Selenite 5H2O 6.66mcg + Sodium Fluoride 126mcg + Potassium Iodide 1.31mcg)ml

Tramadol Hydrochloride 100 mg

Treatment of painful HIV-associated neuropathy

Tramadol Hydrochloride 50 mg/ml, 1ml

Treatment of painful HIV-associated neuropathy

IRAN DRUG LIST




دسترسیTABLET ORAL N02AX02 -

CAPSULE ORAL N02AX02 -

TABLET ORAL N02AX02 -


INJECTION PARENTERAL B02AA02








Tranexamic Acid 100 mg/ml, 10ml

Treatment of patients undergoing prostatectomy where there is hemorrhage or risk of hemorrhage as a result of increased fibrinolysis or fibrinogenolysis.Treatment of hereditary angioneurotic edema.

IRAN DRUG LIST




دسترسی

INJECTION PARENTERAL B02AA02

Tranexamic Acid 250 mg CAPSULE ORAL B02AA02 -


Tranexamic Acid 500 mg TABLET ORAL B02AA02 -

Tranylcypromine 10 mg TABLET ORAL N06AF04 **(As Sulfate)**

Trastuzumab 150 mg PARENTERAL L01XC03

Trastuzumab 440 MG PARENTERAL L01XC03

TABLET ORAL N06AX05 -


Treatment of patients undergoing prostatectomy where there is hemorrhage or risk of hemorrhage as a result of increased fibrinolysis or fibrinogenolysis.Treatment of hereditary angioneurotic edema.



Treatment of patients with pancreatic cancer that overexpress p185HER2.


Treatment of patients with pancreatic cancer that overexpress p185HER2.

Trazodone Hydrochloride 50 mg

IRAN DRUG LIST




دسترسیTretinoin BULK V03 -

Tretinoin 0.025% GEL TOPICAL D10AD01 -

Tretinoin 0.05% CREAM TOPICAL D10AD01 -

Tretinoin 0.05% GEL TOPICAL D10AD01 -

Tretinoin 0.05% LOTION TOPICAL D10AD01 -

Tretinoin 10 mg Capsule ORAL L01XX14

CREAM TOPICAL D07AB09 -

GEL TOPICAL D07AB09 -

OINTMENT TOPICAL D07AB09 -

PASTE ORAL A01AC01 -

INJECTION PARENTERAL R03BA06 -


Triamcinolone Acetonide 0.1%




Triamcinolone Acetonide 40 mg/ml, 1ml

IRAN DRUG LIST




دسترسیSPRAY NASAL RO1AD11 کشور داخل در تولید شرط به 1391/05/02

Triamcinolone NN* CREAM TOPICAL D07BB03

Triamcinolone NN* OINTMENT TOPICAL D07BB03

TABLET ORAL C03DB02

Triclabendazole 250 mg TABLET ORAL P02BX04 -

CAPSULE ORAL V03AB 1389/10/25

Trifluoperazine 1 mg TABLET ORAL N05AB06 **(As Dihydrochloride)**

Trifluoperazine 1 mg/ml INJECTION INTRAMUSCULAR N05AB06 **(As Dihydrochloride)**


Triamcinolone Acetonide 55mcg/actuation

(Triamcinolone Acetonide 1mg + Neomycin (As Sulfate) 2.5mg +Nystatin 100,000 U) / g

(Triamcinolone Acetonide 1mg + Neomycin (As Sulfate) 2.5mg +Nystatin 100,000 U) / g

Triamterene/Hydrochlorothiazide 50/25 mg

Triamterene 50 mg+Hydrochlorothiazide 25 mg

Trientine Dihydrochloride 300 mg

Treatment of Wilson disease in patients intolerance of penicillamine


IRAN DRUG LIST




دسترسیTrifluoperazine 2 mg TABLET ORAL N05AB06 **(As Dihydrochloride)**


Trifluridine 1% DROPS, SOLUTION OPHTHALMIC S01AD02 -



INJECTION PARENTERAL C02BA01 -

Trimethoprim 100 mg TABLET ORAL J01EA01 -

Trimipramine 100 mg TABLET ORAL N06AA06 **(As Maleate)**

Trimipramine 25 mg TABLET ORAL N06AA06 **(As Maleate)**

Trimipramine 4% DROPS, SOLUTION ORAL N06AA06 **(As Mesylate)**

Triple Sulfa CREAM VAGINAL G01AE10

Triple Sulfa TABLET VAGINAL G01AE10

Trihexyphenidyl Hydrochloride 5 mg

Trihexyphenidyl Hydrochloride 2 mg

Trimethaphan Camsylate 50 mg/ml, 10ml

Sulfathiazole 3.42 %+Sulfacetamide 2.86 %+Sulfabenzamide 3.7%

Sulfathiazole 172.5 mg+Sulfacetamide 143.75 mg+Sulfabenzamide 184 mg

IRAN DRUG LIST




دسترسیPARENTERAL L02AE04

INJECTION PARENTERAL L02AE04

PARENTERAL L02AAE04

PARENTERAL L02AE0

Tropicamide 0.5%, 10ml DROPS, SOLUTION OPHTHALMIC S01FA06 -

Tropicamide 1%, 10ml SOLUTION OPHTHALMIC S01FA06 -

Tropisetron 5 mg CAPSULE ORAL A04AA03 **(As Hydrochloride)**

Tropisetron 1 mg/ml, 5ml INJECTION PARENTERAL A04AA03 **(As Hydrochloride)**

Triptorelin (As Acetate) 3.75 mg


For use in the palliative treatment of advanced ovarian carcinoma of epithelial origin.

Triptorelin (As Acetate) 95.6 mcg


Triptorelin (As pamoate) 11.25 mg



Triptorelin (As Pamoate) 3.75 mg



IRAN DRUG LIST




دسترسیTrypan Blue 0.1% INJECTION INTRAOCULAR S01JA

Tuberculin ppd* INJECTION PARENTERAL V04CF01 -

Typhoid Vaccine CAPSULE, DELAYED RELEASE ORAL J07AP -

Urea BULK V03 -

Urea More than 30% CREAM TOPICAL D02AE01 -

Uridine 1 mg TABLET ORAL ____

Urofollitropin 75 IU FSH INJECTION, POWDER INTRAMUSCULAR G03GA04

Selectively staining epiretinal membranes during ophthalmic surgical victrectomy procedures



(Cystic fibrosis, facilitate removal of lung secvetions in primary ciliary dyskinesia

به مبتال بیماران برای فقطیوروتیک Orotic) اسیدوری

Aciduria)


For the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary dysfunction, hypogonadotropic hypogonadism.

IRAN DRUG LIST




دسترسی

PARENTERAL B01AD04


CAPSULE ORAL A05AA02

TABLET ORAL A05AA02


TABLET ORAL A05AA02

TABLET ORAL A05AA02 1389/6/29

Valacyclovir 500 mg TABLET ORAL J05AB11 1391/02/07

Urokinase 250,000 IU INJECTION, POWDER, LYOPHILIZED




Urokinase 75,000 IU




Ursodeoxycholic Acid 250 mg

Management of the clinical signs and symptoms associated with primary biliary cirrhosis.Ursodeoxycholic Acid 250

mg

Management of the clinical signs and symptoms associated with primary biliary cirrhosis.Ursodeoxycholic Acid 300

mg

Management of the clinical signs and symptoms associated with primary biliary cirrhosis.





کشور داخل در تولید شرط به(As Hydrochloride)

IRAN DRUG LIST




دسترسیValacyclovir 1000 mg TABLET ORAL J05AB11 1391/02/07

Valganciclovir 450 mg TABLET ORAL J05AB14 As Hydrochloride

Valganciclovir 250 mg/5ml POWDER ,FOR SOLUTION ORAL J05AB14 As Hydrochloride 1391/10/03

TABLET, DELAYED RELEASE ORAL N03AG01



INJECTION, SOLUTION PARENTERAL N03AG01 -

INJECTION, SOLUTION PARENTERAL N03AG01 -

INJECTION, SOLUTION PARENTERAL N03AG01 - 1392/09/25



مرکز زیرنظر ،مدیریت

بیماریهای واگیردار

Valproate Semisodium 125 mg

Divalproex Sodium is accepted for labeling Eq with 125 mg Valproic Acid





Valproate Sodium 100 mg/ml, 10ml


Valproate Sodium 100 mg/ml,4ml

IRAN DRUG LIST




دسترسیINJECTION, SOLUTION PARENTERAL N03AG01 -

Valproate Sodium 200 mg TABLET, DELAYED RELEASE ORAL N03AG01 -

SYRUP ORAL N03AG01 -

Valproate Sodium 300 mg ORAL N03AG01 -

SYRUP ORAL N03AG01 -

Valproate Sodium 400 mg INJECTION, POWDER PARENTERAL N03AG01 -

Valproate Sodium 500 mg TABLET, EXTENDED RELEASE ORAL N03AG01

Valproic Acid 100 mg CAPSULE LIQUID FILLED ORAL N03AGO1 کشور داخل در تولید شرط به 1391/11/02



Valsartan 160 mg CAPSULE ORAL C09CA03 -


Valproate Sodium 200 mg/5ml


Valproate Sodium 300 mg/5ml

Sodium Valproate 333mg+ Valproic Acid 145mg

IRAN DRUG LIST




دسترسیValsartan 160 mg TABLET ORAL C09CA03 -

Valsartan 40 mg TABLET ORAL C09CA03 -



Valsartan 80 mg TABLET ORAL C09CA03 -

TABLET ORAL C09DA03 1392/09/25





Valsartan/Hydrochlorothiazide80/12.5 mg

Valsartan 80 mg+ Hydrochlorothiazide 12.5 mg

Valsartan/Hydrochlorothiazide 160/12.5 mg

Valsartan 160 mg+ Hydrochlorothiazide 12.5 mg داخل تولید شرط به

Valsartan/Hydrochlorothiazide 160/25 mg

داخل تولید شرط بهValsartan 160 mg+ Hydrochlorothiazide 25 mg

Valsartan/Hydrochlorothiazide 320/12.5 mg

داخل تولید شرط بهValsartan 320 mg+ Hydrochlorothiazide 12.5 mg

Valsartan/Hydrochlorothiazide 320/25 mg

داخل تولید شرط بهValsartan 320 mg+ Hydrochlorothiazide 25 mg

IRAN DRUG LIST




دسترسیVancomycin 250 mg CAPSULE LIQUID FILLED ORAL A07AA09 1389/8/24

Vancomycin 500 mg/6ml POWDER, FOR SUSPENSION ORAL A07AA09 **(As Hydrochloride)**

INJECTION, POWDER, PARENTERAL A07AA09


Varicella-Zoster Vaccine INJECTION PARENTERAL J07BK01

Vaseline Officinal BULK V03 -

INJECTION PARENTERAL H01BA01 **(Lypressin)**

**(As Hydrochloride)** داخل در تولید شرط بهکشور

Vancomycin (As Hydrochloride) 1 g




Vancomycin (As Hydrochloride) 500 mg




Passive immunization for the treatment of exposed, susceptible individuals who are at risk of complications from varicella



Vasoperssin 20 pressorU/ml

IRAN DRUG LIST




Venlafaxine 150 mgدسترسی Capsule, Sustained Release ORAL N06AX16

Venlafaxine 37. 5 mg TABLET ORAL N06AX16

Venlafaxine 37. 5 mg Capsule ORAL N06AX16

Venlafaxine 37. 5 mg Capsule, extended Release ORAL N06AX16 کشور داخل در تولید شرط به

Venlafaxine 75 mg TABLET ORAL N06AX16

Venlafaxine 75 mg Capsule ORAL N06AX16

Venlafaxine 75 mg Capsule, Extended Release ORAL N06AX16 1389/6/29

TABLET, EXTENDED RELEASE ORAL C08DA02 -

INJECTION PARENTERAL C08DA02 -

TABLET ORAL C08DA02 -

TABLET ORAL C08DA02 -

Verteporfin 15 mg Sterile Powder for INJECTION PARENTERAL S01LA01 Antineovascularization

Vigabatrin 500 mg TABLET ORAL N01AG03

Verapamil Hydrochloride 240 mg

Verapamil Hydrochloride 2.5 mg/ml, 2ml




IRAN DRUG LIST




دسترسیVinblastine Sulfate 10 mg INJECTION, POWDER, PARENTERAL L01CA01 -

Vincristine Sulfate 1 mg INJECTION, POWDER, PARENTERAL L01CA02 -

Vincristine Sulfate 1 mg/ml INJECTION PARENTERAL L01CA02 -

Vindesine Sulfate 5 mg INJECTION, POWDER, PARENTERAL L01CA03 -

Vinorelbine 10 mg/ml, 1ml PARENTERAL L01CA04 **(As Tartarate)**

Vinorelbine 10 mg/ml, 5ml PARENTERAL L01CA04 **(As Tartarate)**

Vinorelbine 20 mg CAPSULE ORAL L01CA04 **(As Tartarate)**

Vinorelbine 30 mg CAPSULE ORAL L01CA04 **(As Tartarate)**

Vitamin A 25,000 U CAPSULE ORAL A11CA01 -

Vitamin A 25,000 U TABLET, CHEWABLE ORAL A11CA01 -

Vitamin A 250 U/g OINTMENT OPHTHALMIC S01XA02 -

Vitamin A 50,000 U CAPSULE ORAL A11CA01 -

Vitamin A 50,000 U TABLET ORAL A11CA01 -

Vitamin A 50,000 U/ml DROPS, SOLUTION ORAL A11CA01 -

Vitamin A 50,000 U/ml INJECTION PARENTERAL A11CA01 -




IRAN DRUG LIST




دسترسیVitamin A+D OINTMENT TOPICAL A11CB (Vit. A 850 IU+Vit. D 85 IU) / g

Vitamin B Complex INJECTION PARENTERAL A11EA

Vitamin B1 100 mg TABLET ORAL A11DA01 -

Vitamin B1 300 mg TABLET ORAL A11DA01 -

INJECTION PARENTERAL A11DB

Vitamin B12 100 mcg/ml INJECTION PARENTERAL B03BA01 -

INJECTION PARENTERAL B03BA01 **(Cyanocobalamin)**

INJECTION,SOLUTION PARENTERAL B03BA01 1392/05/01

Vitamin B2 5 mg/ml, 2ml INJECTION PARENTERAL A11HA04 -

Vitamin B6 100 mg/ml, 3ml INJECTION PARENTERAL A11HA02 -


(Vit.B1 10 mg + Vit.B2 4 mg + Vit.B6 4 mg + Dexpanthenol 6 mg + Nicotinamide 40 mg)/2ml


Vitamin B1/Vitamin B6/Vitamin B12

**(Vit.B1 100 mg + Vit.B6 100mg + Vit.B12 1000mcg)/3ml**

Vitamin B12 1000 mcg/ml, 1ml

Vitamin B12 1000 mcg/4ml

**(Cyanocobalamin)**بشرطداخل توليد

IRAN DRUG LIST




دسترسیVitamin B6 50 mg/ml, 2ml INJECTION PARENTERAL A11HA02 -

Vitamin C BULK V03 **(Ascorbic Acid)**

Vitamin C 100 mg/ml, 5ml INJECTION PARENTERAL A11GA01 -

Vitamin D3 300,000 U INJECTION PARENTERAL A11CC05 -

Vitamin D3 50,000 U CAPSULE ORAL A11CC05 -

Vitamin E 100 IU/ml INJECTION PARENTERAL A11HA03 -

Vitamin K1 10 mg TABLET ORAL B02BA01 **(Phytonadione )**

Vitamin K1 10 mg TABLET, CHEWABLE ORAL B02BA01 **(Phytonadione )**

Vitamin K1 10 mg/ml INJECTION PARENTERAL B02BA01 **(Phytonadione )**

Vitamin K1 2 mg/ml, 0.5ml INJECTION PARENTERAL B02BA01 **(Phytonadione )**

Voriconazole 200 mg INJECTION, POWDER PARENTERAL J02AG03


به مبتال بیماران برای فقطبخش در قارچی شدید عفونت

عفونی و انکولوژی پیوند، (Invasive Fungal Infections)


IRAN DRUG LIST




دسترسیVoriconazole 200 mg TABLET ORAL J02AG03

Voriconazole 50 mg TABLET ORAL J02AG03

Warfarin Sodium 1 mg TABLET ORAL B01AA03 -



Warfarin Sodium 2.5 mg TABLET ORAL B01AA03 -





Warfarin Sodium 7.5 mg TABLET ORAL B01AA03 -

Water 10 ml INJECTION PARENTERAL V07 -







IRAN DRUG LIST




دسترسی

Water 1000 ml INJECTION PARENTERAL V07




Water 500 ml INJECTION PARENTERAL V07

White Wax BULK V03 -

Xenon (133Xe) (10-20) mCi PARENTERAL V09EX03 For Diagnostic Use 1389/10/25

Xylene BULK V03 -

Yellow Fever Vaccine INJECTION PARENTERAL J07BL01 -







بالک

INJECTION, SOLUTION


IRAN DRUG LIST




دسترسیTABLET ORAL G04BE04 -

TABLET ORAL G04BE04 -

INJECTION PARENTERAL V10XX 1391/9/1

Yttrium (90Y)Glass Beads INJECTION PARENTERAL V10XX 1391/9/1

INJECTION PARENTERAL V10AA 1391/9/1

INTRA-CAVITY V10AA01 For Therapeutic Use 1389/10/25

PARENTERAL V10XX02 For Therapeutic Use 1389/10/25

Zafirlukast 20 mg TABLET ORAL R03DC01 -

Zanamivir 5 mg/Blister INHALER RESPIRATORY J05AH01 -

Zidovudine 100 mg CAPSULE ORAL J05AF01

Zidovudine 300 mg CAPSULE ORAL J015AF0

Yohimbine Hydrochloride 2 mg

Yohimbine Hydrochloride 5.4 mg

Yttrium (90Y)DOTA-Tyr3-Otreotide



Yttrium (90Y)hydroxy apatite


Yttrium (90Y) Citrate Colloid (5-6) mCi

INJECTION, SOLUTION

Yttrium (90Y) Ibritumomab Tiuxetan (30-40) mCi

INJECTION, SOLUTION

Treatment of AIDS related complex.




IRAN DRUG LIST




دسترسیZidovudine 300 mg TABLET ORAL J05AF01

Zidovudine 50 mg/5ml SYRUP ORAL J05AF01

Zinc Oxide BULK V03 -

Zinc Oxide 25% Ointment Topical D02AB

Zoledronic Acid 4 mg/5ml INJECTION PARENTERAL M05BA08 **(As Monohydrate)**

SOLUTION FOR INFUSION PARENTERAL M05BA08

Zoledronic Acid 4mg PARENTERAL M05BA08 1390/12/22

Zolmitriptan 2.5mg TABLET ORAL N02CC03 کشور درداخل تولید شرط به 1391/02/07

Zolmitriptan 5mg TABLET ORAL N02CC03 کشور درداخل تولید شرط به 1391/02/07

Zolpidem 10 mg TABLET ORAL N05CF02 -

Zolpidem 5 mg TABLET ORAL N05CF02 -

Zonisamide 100 mg CAPSULE ORAL N03AX15 -

Zonisamide 100 mg TABLET ORAL N03AX15 -








از کمتر آرایشی،% 25مقادیرشود می محسوب بهداشتی


Zoledronic Acid 5 mg/ 100 ml

INJECTION, POWDER FOR SOLUTION

ایران داروهای رسمی فهرست به شده اضافه داروهایدارو نام دارويي شکل مصرف راه دارو دسته توضيحات

Drug Name Dosage Form Route of Admin ATC Code Description

Salbutamol 100 mcg/metered inhalation INHALER RESPIRATORY R03AC02 (as sulfate)

Carvedilol 3.125 mg TABLET ORAL C07AG02


Diclofenac Potassium 50 mg TABLET ORAL M01AB05

Epirubicin Hydrochloride 2mg/ml, 10ml PARENTERAL L01DB03 Treatment of breast cancer.

Epirubicin Hydrochloride 2mg/ml, 100ml PARENTERAL L01DB03 Treatment of breast cancer.

Oxycodone Hydrochloride 10 mg TABLET, EXTENDED RELEASE ORAL N02AA05




Ketotifen 1 mg/ ml DROPS, SOLUTION ORAL R06AX17 **(As Fumarate)**

Bethanechol Chloride 25 mg TABLET ORAL N07AB02 -

Azathioprine 25 mg TABLET ORAL L04AX01

Amlodipine/Atorvastatin 10/10 mg TABLET ORAL C10BX03

Modafinil 200 mg TABLET ORAL N06BA07

L-Carnitine 250 mg TABLET ORAL A16AA01 As L-Tartrate

L-Carnitine 1 g TABLET, CHEWABLE ORAL A16AA01 As L-Tartrate

Oseltamivir 30 mg CAPSULE ORAL J05AH02 گیرد قرار سالمت معاونت اختیار در فقط

Oseltamivir 45 mg CAPSULE ORAL J05AH02 گیرد قرار سالمت معاونت اختیار در فقط

Amphotericin-B 50 mg PARENTERAL J02AA01 As Complex with Sodium Cholesteryl Sulphate

Fluticasone Furoate 27.5 mcg/dose INHALER INTRANASAL R01AD08




Calcium Dobesilate 500 mg CAPSULE ORAL A12AA04

Levonorgestrel 1.5 mg TABLET ORAL G03AC03





ضروری کنترل تحت داروهای به مربوط برچسب الصاق.است ضروری کنترل تحت داروهای به مربوط برچسب الصاق.است ضروری کنترل تحت داروهای به مربوط برچسب الصاق.است ضروری کنترل تحت داروهای به مربوط برچسب الصاق.است

**(Amlodipine As Besylate, Atorvastatin As Calcium)** ضروری کنترل تحت داروهای به مربوط برچسب الصاق.است


Streptokinase 1,500,000 IU

Lopinavir/Ritonavir 133.3/33.3 mg CAPSUL/LIQUID FILLED ORAL

Lopinavir/Ritonavir 200/5 mg TABLET ORAL

Lopinavir/Ritonavir 400/100 mg/5ml SOLUTION ORAL

Artisunate 200 mg TABLET ORAL P01BE03

Artesunate 200 mg Tablet ORAL P01BE03 Immediate treatment of malaria

Lopinavir/Ritonavir 133.3/33.3 mg CAPSULE, LIQUID FILLED ORAL J05AE **(Lopinavir 133.3mg+Ritonavir 33.3mg)**

Lopinavir/Ritonavir 200/50 mg Tablet ORAL J05AE **(Lopinavir 200mg+Ritonavir 50mg)**

Lopinavir/Ritonavir 400/100 mg/5ml Solution ORAL J05AE **(Lopinavir 400mg+Ritonavir 100mg)/5ml**

L-Carnitine 330 mg TABLET ORAL A16AA01

Hydrocortisone 1% CREAM TOPICAL D07AA02

Simvastatin 40 mg TABLET ORAL C10AA01

Vitamin K1 10 mg TABLET, CHEWABLE ORAL B02BA01 **(Phytonadione )**



Haemophilus Influenza Type B SOLUTION FOR INJECTION PARENTERAL J07AG01 -



Glatiramer Acetate 20 mg/1 ml INJECTION PARENTERAL L03AX13 89.3.29

Opium Tincture 10 mg/ml (1000 ml) SOLUTION ORAL N02AA02 89.3.29

Venlafaxine 37. 5 mg Capsule, extended release ORAL N06AX16 کشور داخل در تولید شرط به


CAPSULE, GELATIN COATED ORAL A07D کشور داخل در تولید شرط به

ENEMA RECTAL A06AG01

Dextrose 50%, 200ml in 2 litr bag INTRAVENOUS DRIP B05CX01

Dextrose 50%, 400ml in 2 litr bag INTRAVENOUS DRIP B05CX01


Diphteria Toxoid/Tetanus Toxoid/Pertussis/Haemophilus Influenza Type B Vaccine

Diphteria Toxoid/Tetanus Toxoid/Pertussis/Haemophilus Influenza Type B/Hepatitis B Vaccine

Vancomycin (As Hydrochloride) 1 g


Sodium phosphate dibasic heptahydrate/Sodium phosphate monobasic monohydrate(7g/118ml;19g/118ml)






Sodium Bicarbonate 7.5%, 10ml INJECTION PARENTERAL B05XA02 -

Sodium Bicarbonate 7.5%, 50ml INJECTION PARENTERAL B05XA02

Irinotecan Hydrochioride 20 mg/ml, 15 ml INJECTION PARENTERAL L01XX19

Carboplatin 10 mg/ml, 60ml INJECTION PARENTERAL L01XX19

Ketorolac Tromethamine 10 mg TABLET ORAL M01AB15 کشور داخل در تولید شرط به

Ketorolac Tromethamine 30 mg/ml INJECTION, SOLUTION INTRAMUSCULAR M01AB15

Ciclesonide 80mcg/puff AEROSOL, METERED INHALATION R03BA08 بالینی مطالعه انجام و کشور داخل در تولید شرط به

Gemifloxacin 320 mg TABLET ORAL J01MA15

Ciclesonide 160mcg/puff AEROSOL, METERED INHALATION R03BA08 بالینی مطالعه انجام و کشور داخل در تولید شرط به

Nitrous oxide/Oxygen 50%V/V / 50%V/V GAS, MEDICINAL INHALATION N01AX63

Pramipexole - 2 HCl 1H20 0. 375 mg TABLET ER ORAL N04BC05 Equivalent to 0.26 mg Pramipexole

Pramipexole - 2 HCl 1H20 0. 75 mg TABLET ER ORAL N04BC05 Equivalent to 0.52 mg Pramipexole

Pramipexole - 2 HCl 1H20 1.5 mg TABLET ER ORAL N04BC05 Equivalent to 1.05 mg Pramipexole

Pramipexole - 2 HCl 1H20 3 mg TABLET ER ORAL N04BC05 Equivalent to 2.10 mg Pramipexole

Doxorubicin Hydrochloride 2 mg/ml, 10ml INJECTION, LIPOSOMAL PARENTERAL L01DB01 -

Tolterodine Tartarate 2 mg CAPSULE ER ORAL G04BD07

Tolterodine Tartarate 4 mg CAPSULE ER ORAL G04BD07

Diclofenac Sodium 1.5% SOLUTION TOPICAL M01AB05

Ibuprofen 5% GEL TOPICAL M01AE01

Tirofiban Hydrochloride 5mg/100ml INJECTION, SOLUTION PARENTERAL BO1AC17 **(As Hydrochloride Monohydrate)**

TABLET ORAL A10BD02 -

TABLET ORAL A10BD02

Ursodeoxycholic Acid 500 mg TABLET ORAL A05AA02

Acetaminophen 160 mg TABLET, DISPERSIBLE ORAL N02BE01 -

Sufentanil 50 mcg/ml INJECTION PARENTERAL N01AH03 As Citrate

TABLET, EXTENDED RELEASE ORAL R01BA52

OINTMENT TOPICAL D02AB


کشور داخل در تولید شرط As)** بهMesilate)**

Entonox کشور داخل در تولید شرط به

Metformin HCL/Glibenclamide 500 mg/5 mgMetformin HCL/Glibenclamide 500 mg/2.5 mg


Loratadine /Pseudoephedrine Sulfate 5/120 mg

Loratadine 5 mg + Pseudoephedrine Sulfate 120 mg کشور داخل در تولید شرط به

Menthol /Zinc oxide/ Calamine (0.44/20.625/10)g/100g

(Menthol 0.44 g + Zinc oxide 20.625 g + Calamine 10 g)/100g شرط به

کشور داخل در تولید

TABLET ORAL G03FA17

Acetaminophen 125 mg TABLET, DISINTEGRATING ORAL N02BE01 کشور داخل در تولید شرط به



Opium Tincture 10 mg/ml (250 ml) SOLUTION ORAL N02AA02 1389.3.29

OINTMENT TOPICAL D05AX52

Metformin HCL/Pioglitazone 500 mg/15 mg TABLET ORAL A10BD05


Tablet ORAL N04BA03

Tablet ORAL N04BA03

Tablet ORAL N04BA03

Vancomycin 250 mg CAPSULE LIQUID FILLED ORAL A07AA09

AEROSOL RESPIRATORY R03BA01 HFA Only

Etanercept 50 mg/ml INJECTION PARENTERAL L04AA11

Ranitidine 300 mg CAPSULE, GELATIN COATED ORAL A02BA02

AEROSOL, METERED RESPIRATORY R03AK04



Drospirenone/Estradiol Hemihydrate 2/1 mg

(Drospirenone 2 mg + Estradiol Hemihydrate 1 mg) کشور داخل در تولید شرط به

Calcipotriol / Betamethasone Dipropionate 0.005%/0.064%

Calcipotriol 0.005% + Betamethasone (as Dipropionate) 0.05% کشور داخل در تولید شرط به Metformin HCL 500 mg + Pioglitazone 15 mg به


Morphine Hydrochloride 10 mg/ml**Without preservative** کشور داخل در تولید شرط به

Levodopa/ Carbidopa/ Entacapon 125/ 31.25/ 200 mgLevodopa/ Carbidopa/ Entacapon 75/ 18.75/ 200 mgLevodopa/ Carbidopa/ Entacapon 200/ 50/ 200 mg



Reduction in signs and symptoms of moderately to severely active polyarticular-course juvenile rheumatoid arthritis in patients who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs. prefilled


Ipratropium bromide/Fenoterol Hydrobromide 20/50 mcg/dose

{Ipratropium bromide 20 mcg + Fenoterol hydrobromide 50 mcg}/dose HFA only






Isotretinoin 8 mg CAPSULE, LIQUID FILLED ORAL D10BA01 -

Isotretinoin 16 mg CAPSULE, LIQUID FILLED ORAL D10BA01 -

Deferiprone 500 mg TABLET, DELAYED RELEASE ORAL V03AC02 -

Dipyridamole/Aspirin 200 mg/25 mg CAPSULE, EXTENDED RELEASE ORAL B01AC30 بالینی مطالعه انجام شرط به

Temozolomide 5 mg CAPSULE ORAL L01AX03 کشور داخل در تولید شرط به




Eflornithine Hydrochloride 13.9% Cream Topical D11AX16 کشور داخل در تولید شرط به

Injection Parenteral G02AD01

Tablet, Chewable Oral A02BA53 بالینی مطالعه انجام و کشور داخل در تولید شرط به

CAPSULE ORAL V03AB

Levofloxacin 250 mg Tablet Oral J01MA12 کشور داخل در تولید شرط به



Desonide 0.05% Cream Topical D07AB08 کشور داخل در تولید شرط به

Iobenguane (131I ) (50-300) mCi PARENTERAL V10XA02 For Therapeutic Use

Iobenguane (131I) (0.5-1) mCi PARENTERAL V09IX02 For Diagnostic Use

PARENTERAL V10 For Therapeutic Use

PARENTERAL V10BX03 For Therapeutic Use

Indium (111In) Ibritumomab Tiuxetan PARENTERAL V09 For Diagnostic Use

Xenon (133Xe) (10-20) mCi PARENTERAL V09EX03 For Diagnostic Use

Erbium (169Er) Citrate Colloid (5-10) mCi INTRA-CAVITY V10AX04 For Therapeutic Use

Rhenium (186Re) Sulfur Colloid (5-10) mCi INTRA-CAVITY V10AX05 For Therapeutic Use

Yttrium (90Y) Citrate Colloid (5-6) mCi INTRA-CAVITY V10AA01 For Therapeutic Use

Indium (111In) Oxyquinoline 1 mCi/ml PARENTERAL V09 For Diagnostic Use

(18F) Sodium Fluoride 10 mCi PARENTERAL V09IX06 For Diagnostic Use

Strontium (89Sr) Chloride 1 mCi/ml PARENTERAL V10BX01 For Therapeutic Use



Prostaglandin F2 α 5mg/ml Dinoprost Tromethamine E247

Famotidine/Calcium Carbonate/Magnesium Hydroxide 10 mg/800 mg/165 mg

Trientine Dihydrochloride 300 mg Treatment of Wilson disease in patients intolerance of penicillamine

INJECTION, SOLUTION

INJECTION, SOLUTION

Samarium (153 Sm) Lexidronam (70-300)mCi

INJECTION, SOLUTION


INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

PARENTERAL V09 For Diagnostic Use

Indium (111In) Chloride 10 mCi PARENTERAL V09 For Diagnostic Use

(18F) Fludeoxyglucose (10-30) mCi PARENTERAL V09IX04 For Diagnostic Use

PARENTERAL V10XX02 For Therapeutic Use

Indium (111In) Pentetate 1 mCi/ml PARENTERAL V09AX01 For Diagnostic Use

Rubidium (82Rb) Chloride PARENTERAL V09 For Diagnostic Use

Iodine (131I) Tositumomab 5 mCi PARENTERAL V10XA53 For Diagnostic Use

Iobenguane (123I ) 10 mCi PARENTERAL V09 For Diagnostic Use


PARENTERAL V10BX03 For Therapeutic Use


(123I) Sodium Iodide 2 mCi/ml SOLUTION ORAL V09FX02 For Diagnostic Use

(123I) Sodium Iodide 0.1 mCi CAPSULE ORAL V09FX02 For Diagnostic Use

(123I) Sodium Iodide 0.2 mCi CAPSULE ORAL V09FX02 For Diagnostic Use

(131I) Sodium Iodide (3.5-150) mCi SOLUTION ORAL V09FX02 For Therapeutic Use

Technetium (99mTc) Pentetate (25-30) mCi INHALER RESPIRATORY V09EA For Diagnostic Use

SOLUTION TOPICAL D11AX

SOLUTION TOPICAL D11AX

Erythromycin/Azelaic Acid 2/5% GEL TOPICAL D10AF52 Erythromycin 2% + Azelaic Acid 5%

Erythromycin/Azelaic Acid 2/5% LOTION TOPICAL D10AF52 Erythromycin 2% + Azelaic Acid 5%

Progesterone 100 mg CAPSULE, LIQUID FILLED VAGINAL or ORAL G03DA04

Progesterone 200 mg CAPSULE, LIQUID FILLED VAGINAL or ORAL G03DA04

DISC RESPIRATORY R03AK06



INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

Yttrium (90Y) Ibritumomab Tiuxetan (30-40) mCi

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

(64Cu) Diacetyl-bis(N4-methylthiosemicarbazone) (ATSM) (5-10) mCi

INJECTION, SOLUTION


Technetium (99mTc) EDDA-tricine-HYNIC-bombesin (15-20) mCi


Minoxidil/Azelaic Acid/Tretinoin/Betamethasone Valerate 5/5/0.025/0.025%

Minoxidil 5% + Azelaic Acid 5% + Tretinoin 0.025% + Betamethasone Valerate 0.025%

Minoxidil/Azelaic Acid/Betamethasone Valerate 5/5/0.025%

Minoxidil 5% + Azelaic Acid 5% + Betamethasone Valerate 0.025%

MICRONISED کشور داخل در تولید شرط به

MICRONISED کشور داخل در تولید شرط به






Docetaxel 160 mg/16ml INJECTION, SOLUTION INTRAVENOUS DRIP L01CD02 -

CAPSULE, GELATIN COATED ORAL N02BE71

Cytarabine 500 mg INJECTION, POWDER, PARENTERAL L01BC01

Factor VII 600 U PARENTERAL B02BD05 Human Coagulation factor VII ( IV Injection)

Follitropin Beta 833 IU/ml INJECTION PARENTERAL G03GA06 Recombinant_Prefilled Disposable Pen

Azithromycin 1% DROPS, SOLUTION OPHTHALMIC S01AA26

Rizatriptan 10 mg ORAL N02CC04

TABLET ORAL M05BB03 **(As Sodium Alendronate, 3H2O)**

Levofloxacin Hemihydrate 0.5% DROPS, SOLUTION OPHTHALMIC S01AX19

Benzocaine 7.5% GEL BUCCAL D04AB04 -

Levonorgestrel 75 mg IMPLANT TRANSDERMAL G03AC03 -

Memantine Hydrochloride 20 mg TABLET ORAL N06DX01 -

Memantine Hydrochloride 2 mg/ml SOLUTION ORAL N06DX01 -

Memantine Hydrochloride 14 mg CAPSULE,EXTENDED RELEASE ORAL N06DX01 -

Memantine Hydrochloride 21 mg CAPSULE,EXTENDED RELEASE ORAL N06DX01 -

Plastibase OINTMENT TOPICAL D

Aminoacid 10 % / Electrolyte INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01



Acetaminophen/ Codeine Phosphate 300/10 mg

Acetaminophen 300mg + Codeine Phosphate 10mg کشور داخل در تولید شرط به

INJECTION, POWDER, For SOLUTION

TABLET, ORALLY DISINTEGRATING


BULK( base for Ointment) فهرستبالک داروهای


Aminoacid 5 % / Electrolyte INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01

Solifenacin Succinate 5 mg TABLET ORAL G04BD080 کشور داخل در تولید شرط به

Solifenacin Succinate 10 mg TABLET ORAL G04BD080 کشور داخل در تولید شرط به

Duloxetine 20 mg CAPSULE, DELAYED RELEASE ORAL N06AX21



Icodextrin 7.5g/100 ml SOLUTION INTRAPERITONEAL B05DA

Risperidone 25 mg PARENTERAL N05AX08 کشور داخل در تولید شرط به

Risperidone 37.5 mg PARENTERAL N05AX08 کشور داخل در تولید شرط به

Risperidone 50 mg PARENTERAL N05AX08 کشور داخل در تولید شرط به

Indometacin 50 mg/2ml INJECTION, SOLUTION PARENTERAL M01AB01

Dabigatran Etexilate 75 mg CAPSULE ORAL B01AE07

Dabigatran Etexilate 110 mg CAPSULE ORAL B01AE07

Moxifloxacin 400 mg Tablet ORAL J01MA14

Fingolimod 0.5 mg CAPSULE ORAL L04AA27 کشور داخل در تولید شرط به

Clopidogrel Bisulfate 300 mg TABLET ORAL B01AC04

GEL TOPICAL D05AX52

Co-amoxiclav 600/42.9 mg /5ml POWDER, FOR SUSPENSION ORAL J01CR02

TABLET ORAL M05BB03

Isoleucine 2.50g+Leucine 4.45g+lysine HCl 4.28g+Methionine 2.20g+Phenylalanine 2.35g+Threonine 2.10g+Tryptophane 0.80g+Valine 3.10g+Arginine 5.75g+Histidine 1.50g+Alanine 5.25g+Glycine 6.00g+ Asparatic acid 2.80g+ Glutamic acid 3.60g +Proline 2.75g+Serine 1.15g+Tyrosine 0.40g+ Sodium acetate 3H2O 1.361g+ Sodium chloride 0.964g + Sodium hydroxide 0.140g+potassium acetate 2.453g+ Magnesium chloride 6H2O 0.508g+Disodium phosphate dodecahydrate 3.581g+ Water for inj. Q.S. to 1000 ml

کشور داخل در تولید شرط As بهHydrochloride



INJECTION, POWDER, SUSTAINED RELEASEINJECTION, POWDER, SUSTAINED RELEASE


قلب تخصص فوق و نوزادان تخصص فوق دارای مراکز درتشخیص جهت اکوکاردیوگرافی دستگاه به مجهز و کودکان

PDA (Patent ductus arterious) As Mesylate کشور داخل در تولید شرط بهAs Mesylate کشور داخل در تولید شرط بهAs Hydrochloride کشور داخل در تولید شرط به


Calcipotriol 0.005% + Betamethasone (as Dipropionate) 0.05% کشور داخل در تولید شرط به Treatment of otitis media and sinusitis in Pediatric patients (Amoxicillin(as trihydrate) 600mg+Clavulanic acid(as potassium) 42.9mg)/ 5ml کشور داخل در تولید شرط به


**(As Sodium Alendronate, 3H2O)** Colecalciferol 2800 IU کشور داخل در تولید شرط به

Potassium Iodide 65 mg TABLET ORAL V03AB21

Fluconazole 2 mg/ml , 100ml INJECTION PARENTERAL J02AC01 کشور داخل در تولید شرط به

Fluconazole 2 mg/ml , 200ml INJECTION PARENTERAL J02AC01 کشور داخل در تولید شرط به

Ranitidine 50 mg/50ml INJECTION PARENTERAL A02BA02

Gentamicin 0.8 mg/ml , 100 ml INJECTION PARENTERAL J01GB03

Gemcitabine 1 g PARENTERAL L01BC05 As Hydrochloride

Gemcitabine 200 mg PARENTERAL L01BC05 As Hydrochloride

Selenium 50 mcg/ml INJECTION PARENTERAL A12CE02 As Sodium Selenite Pentahydrate

Nilotinib 150 mg CAPSULE ORAL L01XE08 As Hydrochloride Monohydrate

Loratadine 10 mg CAPSULE, GELATIN COATED ORAL R06AX13 -

Barium Sulfate 240 g/240 ml SUSPENSION ORAL V08BA02

Ibuprofen 100mg/ml, 4ml INJECTION PARENTERAL M01AE01

Ibuprofen 100mg/ml, 8ml INJECTION PARENTERAL M01AE01

SPRAY, SOLUTION INTRANASAL R01AC08

Valsartan/Hydrochlorothiazide 160/12.5 mg TABLET ORAL C09DA03

Valsartan/Hydrochlorothiazide 160/25 mg TABLET ORAL C09DA03

Valsartan/Hydrochlorothiazide 320/12.5 mg TABLET ORAL C09DA03

Valsartan/Hydrochlorothiazide 320/25 mg TABLET ORAL C09DA03

Amlodipine/ Valsartan 5/80 mg TABLET ORAL C09DB01





Valproate Sodium 500 mg TABLET,EXTENDED RELEASE ORAL N03AG01 کشور داخل تولید شرط به

Ciclesonide 50mcg/Actuation SPRAY, SUSPENSION INTRANASAL R01AD**

Thyroid blocking agent in radiation emergencies(Release of radioactive iodine) شرط به

کشور داخل در تولید

(As Hydrochloride) in sodium chloride 0.45% (premixed) کشور داخل در تولید شرط به(As Sulfate) in sodium chloride 0.9% (premixed) کشور داخل در تولید شرط به



Olopatadine Hydrochloride 0.6%(665 mcg/puff)

Valsartan 160 mg+ Hydrochlorothiazide 12.5 mg بهکشور داخل در تولید شرط

کشور داخل در تولید شرط +Valsartan 160 mgبهHydrochlorothiazide 25 mg

کشور داخل در تولید شرط +Valsartan 320 mgبهHydrochlorothiazide 12.5 mg

کشور داخل در تولید شرط +Valsartan 320 mgبهHydrochlorothiazide 25 mg

Amlodipine (As Besilate) 5 mg/ Valsartan 80 mg بهکشور داخل در تولید شرط

Amlodipine (As Besilate) 5 mg/ Valsartan 160 mg بهکشور داخل در تولید شرط

Amlodipine (As Besilate) 5 mg/ Valsartan 320 mg کشور داخل در تولید شرط به



50mcg/Actuation بهکشور داخل تولید شرط

SOLUTION OPHTHALMIC S01AX22 As Hydrochloride

Sevelamer 800 mg TABLET ORAL V03AE02

Sevelamer carbonate 800 mg TABLET ORAL V03AE02

Ibuprofen 800 mg TABLET,EXTENDED RELEASE ORAL M01AE01

CAPSULE, GELATIN COATED ORAL N02BE71

Somatropin 22.5 U/1.5 ml INJECTION,SOLUTION PARENTERAL H01AC01

Alglucosidase Alfa 50 mg INJECTION, POWDER PARENTERAL A16AB07

Calcium Gluconate 2.5% GEL TOPICAL D11AX03 کشور داخل در تولید شرط به

Everolimus 0.25 mg TABLET ORAL L04AA18 کشور داخل در تولید شرط به



Everolimus 5 mg TABLET ORAL L01XE10 کشور داخل در تولید شرط به

Human Papiloma Virus Vaccine INJECTION PARENTERAL J07BM01 Polyvalent *Prefilled Syringe*

Natalizumab 20 mg/ ml PARENTERAL L04AA23 کشور داخل در تولید شرط به

Pemetrexed 100 mg PARENTERAL L01BA04 **(as disodium)**

Pemetrexed 500 mg PARENTERAL L01BA04 **(as disodium)**

Prasugrel 5 mg TABLET ORAL B01AC22

Prasugrel 10 mg TABLET ORAL B01AC22

Tobramycin 0.3% OINTMENT OPHTHALMIC S01AA12

Calcitonin, Salmon 200 IU/dose SPRAY NASAL H05BA03

Cyproheptadine Hydrochloride 2 mg/5 ml SOLUTION ORAL R06AX02 کشور داخل در تولید شرط به

Gemcitabine 2g/52.6 ml INJECTION PARENTERAL L01BC05 **(As Hydrochloride)**

CAPSULE, GELATIN COATED ORAL R05CA03کشور داخل در تولید شرط به

CAPSULE, GELATIN COATED ORAL R05CA03کشور درداخل تولید شرط به

Memantine Hydrochloride 10mg/g SOLUTION ORAL N06DX01 کشور داخل در تولید شرط به

SUSPENSION ORAL R06AX26 کشور داخل در تولید شرط به

Dabigatran Etexilate 150mg CAPSULE ORAL B01AE07 کشور داخل در تولید شرط به

Moxifloxacin 0.5%

کشور داخل تولید شرط به(MODIFIED RELEASE)

Acetaminophen/ Ibuprofen/ Caffeine 325/ 200/ 40 mg

Acetaminophen 325mg + Ibuprofen 200mg+ Caffeine 40 mg

Cartridge with pen-type syringe. Treatment of short stature in patients with Noonan syndrome Treatment of short stature associated with Turner's syndrome. Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures. تولید قرارداد ارائه شرط به


INJECTION, SOLUTION,CONCENTRATEINJECTION, POWDER, LYOPHILIZED


**(As Hydrochloride)** کشور داخل در تولید شرط به**(As Hydrochloride)** کشور داخل در تولید شرط به

Treatment of symptomatic Paget's disease Recombinant

Guaifenesin 100 mg

Guaifenesin 200 mg

Fexofenadine Hydrochloride 30 mg/5 ml

Quetiapine 50 mg TABLET, EXTENDED RELEASE ORAL N05AH04


Granisetron 3.1mg/24h PATCH, EXTENDED RELEASE TRANSDERMAL _ 34.3 mg/52 cm2

GEL TOPICAL

Ganciclovir 0.15% GEL OPHTHALMIC S01AD09 1.5 mg/g

Enoxaparin Sodium 100 mg/ml, 3 ml INJECTION PARENTERAL B01AB05 30,000U anti-xa/3ml(multi dose)

Ibuprofen 10 mg/ml INJECTION PARENTERAL C01EB16 **(As Lysine)**

Aminoacid 10 % INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01

Ciprofloxacin 250 mg/5ml SUSPENSION ORAL J01MA02

Desogestrel 75mcg TABLET ORAL G03AC09

Atomoxetine 10 mg CAPSULE ORAL N06BA09





Azelastine Hydrochloride 125 mcg/puff SPRAY NASAL R01AC03

Cinacalcet 30 mg TABLET ORAL H05BX01



INJECTION PARENTERAL N05CM18 بالینی مطالعه انجام و کشور داخل در تولید شرط به

Dienogest/ Ethinylestradiol 2/ 0.03 mg TABLET ORAL G03AA**

Galsulfase 1mg/ml INJECTION PARENTERAL A16AB08

Ketoprofen 100 mg PARENTERAL M01AE03 کشور داخل در تولید شرط به

Liraglutide 6 mg/ml INJECTION, SOLUTION PARENTERAL A10BX07

Rifaximin 200mg TABLET ORAL A07AA11 کشور داخل در تولید شرط به

Valacyclovir Hydrochloride 500 mg TABLET ORAL J05AB11 کشور داخل در تولید شرط به

Valacyclovir Hydrochloride 1000 mg TABLET ORAL J05AB11 کشور داخل در تولید شرط به

**(As Fumarate)** داخل در تولید شرط بهکشور

**(As Fumarate)** داخل در تولید شرط بهکشور

Diltiazem Hydrochloride 2% C05AE


کشور داخل در تولید شرط (AS Hydrochloride) به





کشور داخل در تولید شرط به 0.1 % ; **(As Base)**




Dexmedetomidine Hydrochloride 100mcg/ml


بالینی کارآزمایی انجام و کشور داخل در تولید شرط به** Disposable Pen**

Zolmitriptan 2.5mg TABLET ORAL N02CC03 کشور درداخل تولید شرط به

Zolmitriptan 5mg TABLET ORAL N02CC03 کشور درداخل تولید شرط به

Cyproterone Acetate 100 mg TABLET ORAL G03AH01 کشور درداخل تولید شرط به

Ferric Carboxy Maltose 50 mg ferric/ml INJECTION PARENTERAL B03AC01

Interferon Alfa-2b 3 Million U INJECTION PARENTERAL L03AB05

Interferon Alfa-2b 5 Million U INJECTION PARENTERAL L03AB05

Potassium Iodide 130 mg TABLET ORAL V03AB21

Risperidone 1 mg/ml SOLUTION ORAL N05AX08


Minoxidil 2% AEROSOL,FOAM TOPICAL D11AX01 -

Minoxidil 5% AEROSOL,FOAM TOPICAL D11AX01


Surfactant 27 mg/ml INJECTION , SUSPENSION INTRATRACHEAL R07AA02

Famotidine 20 mg/50ml INJECTION , SOLUTION INTRAVENOUS DRIP A02BA03 in sodium chloride

Levofloxacin 500 mg/100ml INJECTION , SOLUTION INTRAVENOUS DRIP J01MA12 in dextrose

Triamcinolone Acetonide 55mcg/actuation SPRAY NASAL RO1AD11 کشور داخل در تولید شرط به

Iron 100mg/ml INJECTION PARENTERAL B03AC

Aminoacid 10 % INJECTION, SOLUTION INTRAVENOUS DRIP B05BA01

SYRUP ORAL R05X

Nicotine 1mg LOZENGE ORAL N07BA01 کشور داخل در ابتدا از تولید شرط به




Thyroid blocking agent in radiation emergencies(Release of radioactive iodine)

Desogestrel 0.15mg+Ethinylestradiol 20mcg شرط بهکشور داخل در ابتدا از تولید

**(As Fumarate)** شرط بهابتدا از داخل تولید

bovine lipid extract کشور داخل در ابتدا از تولید شرط به

**(as isomaltoside 1000)** تولید شرط بهابتدا از کشور داخل


Acetaminophen/DiphenhydramineHCL/phenylephrine HCL

Acetaminophen160/DiphenhydramineHCL12.5/phenylephrine HCL2.5/5ml


TABLET ORAL R01BA53

Oseltamivir 60 mg/5ml POWDER, FOR SUSPENSION ORAL J05AH02 **(As phosphate)**


Ofloxacin 3mg/ml DROPS, SOLUTION OPHTALMIC SO1AX11 -

Metformin Hydrochloride 500 mg TABLET Extended release ORAL A10BA02 ابتدا از کشور داخل در تولید شرط به

Metformin Hydrochloride 1000 mg TABLET Extended release ORAL A10BA02 ابتدا از کشور داخل در تولید شرط به

Somatostatin 3 mg PARENTERAL H01CB01

Cytarabine 500 mg INJECTION, POWDER, PARENTERAL L01BC01

Estradiol 10 mcg TABLET VAGINAL G03CA03 (as hemihydrate)

Brinzolamide/Timolol Maleate 10/5 mg/ml DROPS, SUSPENTION OPHTHALMIC S01ED51

Ketoprofen 30 mg PLASTER TOPICAL M02AA10 کشور داخل در تولید شرط به

Ifosfamide 40mg/ml, 25ml INJECTION, SOLUTION PARENTERAL L01AA06

Amiodarone Hydrochloride 150 mg/100ml INJECTIONtSOLUTION, PARENTERAL C01BD01

Ondansetron 32 mg/50ml INJECTION, SOLUTION INTRAVENOUS DRIP A04AA01 **(As Hydrochloride)**

Tobramycin/Dexamethason %0.3/%0.1 DROP, SUSPENTION OPHTHALMIC S01CA01

Factor VIII/Von Willbrand 1000 U INJECTION,SOLUTION, POWDER PARENTERAL B02BD06

Valganciclovir 250 mg/5ml POWDER ,FOR SOLUTION ORAL J05AB14 As Hydrochloride

Fludarabine Phosphate 10 mg TABLET ORAL L01BB05

Valproic Acid 100 mg CAPSULE LIQUID FILLED ORAL N03AGO1 کشور داخل در تولید شرط به



Rifampicin 20 mg/ml SYRUP ORAL J04AB02

ASA (Acetylsalicylic Acid) 81 mg TABLET, ENTERIC COATED ORAL B01AC06 کشور داخل در تولید شرط به

Cisplatin 1 mg/ml INTRAVENOUS DRIP L01XA01

Telaprevir 375 mg TABLET ORAL J05AE11

Boceprevir 200 mg CAPSULE ORAL J05AE12

Basiliximab 20mg INJECTION, POWDER PARENTERAL L04AC02 ابتدا از کشور داخل تولید شرط به

Omalizumab 75mg INJECTION, POWDER PARENTERAL R03DX05 کشور داخل در تولید شرط به

Chlorpheniramine Maleate/phenylephrine HCL


INJECTION, POWDERFOR SOLUTION

Treatment of bleeding esophageal varices. شرط بهداخل تولید

Brinzolamide 10mg/ml + Timolol maleate 5mg/ml شرط بهکشور درداخل تولید



Tobramycin0.3%+Dexamethason0.1 % کشور داخل در تولید شرط بهTreatment of patients with von Willebrand's disease Factor VIII 1000 U +Von Willbrand factor 1000 U


Omalizumab 150mg INJECTION, POWDER PARENTERAL R03DX05 کشور داخل در تولید شرط به

Erlotinib 100mg TABLET ORAL L01XE03

Erlotinib 150mg TABLET ORAL L01XE03

Gefitinib 250mg TABLET ORAL LO1XE02 کشور داخل در تولید شرط به

Adalimumab 40mg/0.8ml INJECTION,SOLUTION PARENTERAL L04AB04

Goserelin 3.6mg IMPLANT PARENTERAL L02AE03

Goserelin 10.8mg IMPLANT PARENTERAL L02AE03

Sunitinib 12.5 mg CAPSULE ORAL L01XE04

Sunitinib 25 mg CAPSULE ORAL L01XE04

Sunitinib 50 mg CAPSULE ORAL L01XE04

Linezolide 400 mg TABLET ORAL J01XX08 کشور داخل در تولید شرط به

Linezolide 600 mg TABLET ORAL J01XX08 کشور داخل در تولید شرط به

Linezolide 100 mg/5ml POWDER, SUSPENSION ORAL J01XX08 کشور داخل در تولید شرط به

Linezolide 600mg/300ml INJECTION, SOLUTION PARENTERAL J01XX08 کشور داخل در تولید شرط به

Fampridine 10 mg TABLET, EXTENDED RELEASE Oral N07XX07 کشور داخل در تولید شرط به

Yttrium (90Y)hydroxy apatite INJECTION PARENTERAL V10AA

PARENTERAL V09H

Technetium [99mTc]ciprofluxacin PARENTERAL V09H

GENERATOR*_

V09X

Gallium(68 Ga)-Octrotate PARENTERAL V09X

INJECTION PARENTERAL V10B

Holmium(166Ho)chitosan INJECTION PARENTERAL V10XX

Yttrium (90Y)DOTA-Tyr3-Otreotide INJECTION PARENTERAL V10XX

Yttrium (90Y)Glass Beads INJECTION PARENTERAL V10XX

GRANULE ORAL G04BC

Phenytoin 125 mg/5ml SUSPENSION ORAL N03AB02

Finasteride %1 GEL TOPICAL D11AX10

TABLET ORAL C09DX01

As Hydrochloride کشور داخل در تولید شرط بهAs Hydrochloride کشور داخل در تولید شرط به

Pre-filled syringe کشور داخل در تولید شرط بهAs Acetate کشور داخل در تولید شرط بهAs Acetate کشور داخل در تولید شرط بهAs Malate کشور داخل در تولید شرط بهAs Malate کشور داخل در تولید شرط بهAs Malate کشور داخل در تولید شرط به




Germanium(68 Ge)/Gallium(68 Ga) Generator

- گالیوم تولید منبع عنوان به ژنراتور تولید 68سامانه برای- * گالیوم حاوی داروهای رادیو رود 68انواع می کار به


Lutetium(177Lu)ethylenediamine tetramethylene phosphonate

Potassium sodium hydrogen Citrate-2.4g/2.5g


Amlodipine (As Besilate) 5 mg/ Valsartan 160 mg/Hydrochlortiazid 12.5mg داخل در تولید شرط به

TABLET ORAL C09DX01

TABLET ORAL C09DX01

TABLET ORAL C09DX01

Ketoprofen 100 mg TABLET,Extended release ORAL M01AE03 Two layers 50/50

Prednisolone 5 mg TABLET,ADHESIVE BUCCAL DO7AA03 -

Azithromycin 1g/sachet POWDER, FOR SUSPENSION ORAL J01FA10

Olanzapine 10 mg PARENTERAL N05AH03 داخل توليد بشرط

Co-amoxiclav 500/100 mg PARENTERAL J01CR02

Co-amoxiclav 1000/200 mg PARENTERAL J01CR02

Clindamycin /Clotrimazole 2% CREAM VAGINAL G01A

Temozolomide 100mg INJECTION, POWDER PARENTERAL L01AX03

Amphotericin-B 0.4% GEL TOPICAL A01AB04 Nanoliposomal

Levofloxacin 25mg/ml PARENTRAL J01MA12

Dapsone 5% GEL TOPICAL D10AX05 5% W/W

Biotin 5 mg/ml INJECTION, SOLUTION INTRAMUSCULAR A11HA05

Naltrexone Hydrochloride 380 mg/vial PARENTRAL N07BB04 -

SYRUP ORAL R05X

Vitamin B12 1000 mcg/4ml INJECTION,SOLUTION B03BA01

Mesalazine 500 mg CAPSULE, EXTENDED RELEASE ORAL A07EC02 -

Ketorolac Tromethamine 15 mg/ml INJECTION PARENTERAL M01AB15

Doxycycline 100 mg CAPSULE ORAL J01AA02 **(As Hyclate)**

Potassium Chloride INJECTION INTRAVENOUS DRIP B05XA01 Potassium Chloride 0.3 % in Dextrose 5 %

Ciprofloxacin 400 mg/200ml INJECTION INTRAVENOUS DRIP J01MA02 **(As Lactate)**



Amlodipine (As Besilate) 5 mg/ Valsartan 160 mg/Hydrochlortiazid 25mg داخل در تولید شرط به


Amlodipine (As Besilate) 10 mg/ Valsartan 160 mg/Hydrochlortiazid 12.5mg داخل در تولید شرط به


Amlodipine (As Besilate) 10 mg/ Valsartan 160 mg/Hydrochlortiazid 25mg داخل در تولید شرط به






Clindamycin(as Phosphate )2% + Clotrimazole 2% W/W


INJECTION, POWDER , For SUSPENSION, EXTENDED RELEASE

Acetaminophen/Guaifensine/phenylephrine (125/50/2.5)/5ml

Acetaminophen125+Guaifenesine 50mg+phenylephrine2.5/5ml

PARENTERAL Or ORAL

**(Cyanocobalamin)** داخل توليد بشرط


Bicalutamide 150 mg TABLET ORAL L02BB03

Diclofenac Diethylamine 120 mg PLASTER TOPICAL M02AA15

Sildenafil Citrate 1% GEL TOPICAL G04BE03 1% W/W

Mometasone Furoate 100 mcg POWDER, INHALATION RESPIRATORY R03BA07



AEROSOL, INHALATION RESPIRATORY R03AK07



Povidone Iodine 10% DOUCHE VAGINAL G01AX11

Ibuprofen Lysine 400 mg/3ml INJECTION , SOLUTION PARENTERAL M01AE01

Levodopa/Carbidopa 100/25 mg TABLET, EXTENDED RELEASE ORAL N04BA02

Levodopa/Carbidopa 200/50 mg TABLET , EXTENDED RELEASE ORAL N04BA02

Azelastine Hydrochloride 125 mcg/Puff SPRAY NASAL R01AC03

Sevelamer Carbonate 2.4g/Sachet POWDER, FOR SUSPENSION ORAL V03AE02

Paclitaxel 100 mg PARENTERAL L01CD01

Hemofiltration & Haemodiafiltration SOLUTION UNASSIGNED B05ZB

Ibuprofen Lysine 342 mg TABLET Oral M01AE01

Ibuprofen Lysine 684 mg TABLET Oral M01AE01

Somatropin 30 U/1.5 ml INJECTION,SOLUTION PARENTERAL H01AC01

Sodium Benzoate 500 mg TABLET ORAL ____ Rare metabolic conditions for children

Tobramycin 28 mg POWDER RESPIRATORY J01GB01 -











(Na+125-150mEq + Mg++0.5-3 mEq + K+0- 4.5 mEq + Ca++ 2-5 mEq + Cl- 90-120 mEq + Acetate and or lactate and or Hydrogen Carbonate 30-60 mEq + Glucose 0-25 mmol)/ L

Cartridge with pen-type syringe. Treatment of short stature in patients with Noonan syndrome Treatment of short stature associated with Turner's syndrome. Adjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or unexplained infertility, who are undergoing in vivo or in vitro fertilization procedures.

Oxybutynin Hydrochloride 10 mg TABLET, EXTENDED RELEASE ORAL G04BD04 -

Oxybutynin Hydrochloride 15 mg TABLET, EXTENDED RELEASE ORAL G04BD04 -

Temozolomide 140 mg CAPSULE ORAL L01AX03

Follitropin Alfa/Lutropin Alfa 150 U/75U INJECTION, POWDER PARENTERAL G03GA30

Valproate Sodium 100 mg/ml,4ml INJECTION, SOLUTION PARENTERAL N03AG01 -

SYRUP ORAL R05X

Imatinib (As Mesylate) 400 mg TABLET ORAL L01XE01

Dexpanthenol 250mg/ml INJECTION, SOLUTION PARENTERAL A11HA30 -

Levetiracetam 100 mg/ml PARENTERAL N03AX14

TABLET ORAL R06AX26

TABLET ORAL C09DA03 Valsartan 80 mg+ Hydrochlorothiazide 12.5 mg

Rosuvastatin 5 mg TABLET ORAL C10AA07 **(As Calcium)**




Sitagliptin 25 mg TABLET ORAL A10BH01 As Phosphate

Sitagliptin 50 mg TABLET ORAL A10BH01 As Phosphate

TABLET ORAL A10BD07

Eplerenone 25 mg TABLET ORAL C03DA04

Eplerenone 50 mg TABLET ORAL C03DA04

Insulin Detemir 100 IU/ml INJECTION, SOLUTION PARENTERAL A10AE05

Insulin Glulisin 100 IU/ml INJECTION, SOLUTION PARENTERAL A10AB06

Bimatoprost %0.01 Drops, Solution OPHTALMIC S01EE03

Carglumic Acid 200 mg TABLET, DISPERSIBLE ORAL A16AA05

Plerixafor 20mg/ml INJECTION, SOLUTION PARENTERAL A03AX16

Recombinant, Follitropin Alfa 150U+Lutropin Alfa 75 U



Treatment of idiopathic hypereosinophilic syndrome including acute and chronic eosinophilic leukemiaTreatment of Philadelphia-positive ALLTreatment of dermatofibrosarcoma protuberansTreatment of gastrointestinal stromal tumors


Fexofenadine Hydrochloride 30 mgValsartan/Hydrochlorothiazide80/12.5 mg

Sitagliptin/Metformin Hydrochloride 50/500 mg

Sitagliptin (as Phosphate) 50 mg+ Metformin Hydrochloride 500 mg

ایران داروهای رسمی فهرست به شده اضافه داروهایدارويي فهرست تاریخ

List Name Date

20.8.88

20.8.88

20.8.88

20.8.88

20.8.88

20.8.88

خاص دسترسی با داروهای فهرست 20.8.88




20.8.88

20.8.88

20.8.88

20.8.88


20.8.88

20.8.88

خاص دسترسي با داروهاي فهرست 20.8.88

خاص دسترسي با داروهاي فهرست 20.8.88

20.8.88

20.8.88

4.9.88

4.9.88

4.9.88

7.10.88

7.10.88

خاص داروهاي (orphan) فهرست


. خاص دسترسي با داروهاي فهرستتوزيع بيمارستاني داروخانه در فقط

ميشود


ميشود

23.10.88

23.10.88

23.10.88

23.10.88

7.11.88

7.11.88

7.11.88

7.11.88

7.11.88

7.11.88

7.11.88

7.11.88

11.11.88

11.11.88

11.11.88

11.11.88

11.11.88

89.1.17

89.1.17

5.2.89

5.2.89

5.2.89

5.2.89

5.2.89

5.2.89

5.2.89

دسترسي با داروهاي فهرستسالمت. معاونت اختيار در فقط خاص

گيرد دسترسي قرار با داروهاي فهرستسالمت. معاونت اختيار در فقط خاص



گيرد قرارخاص داروهاي (orphan) فهرست

. خاص دسترسي با داروهاي فهرستقرار سالمت معاونت اختيار در فقط

.گيرد خاص دسترسي با داروهاي فهرستقرار سالمت معاونت اختيار در فقط

گيرد

دسترسي با داروهاي فهرستدرمان. اختيارمراکز در فقط خاص

گيرد قرار مواد مصرف سوء


ميشودداروهاي OTC فهرست

5.2.89

5.2.89

5.2.89

18.5.89

18.5.89

30.5.89

30.5.89

30.5.89

30.5.89

30.5.89

30.5.89

1389/6/15

1389/6/15

1389/6/15

1389/6/15

1389/6/15

1389/6/15

1389/6/15

1389/6/15

1389/6/15

1389/6/29

1389/6/29

1389/6/29

1389/6/29

1389/6/29

1389/6/29

1389/7/17

1389/7/17


ميشود


ميشود

داروهاي OTC فهرست. خاص دسترسي با داروهاي فهرست

توزيع بيمارستاني داروخانه در فقطميشود

داروهاي OTC فهرست

1389/7/17

1389/7/17

1389/7/17

1389/7/17

1389.7.17

1389/7/17

1389/8/24

1389/8/24

1389/8/24

1389/8/24

1389/8/24

1389/8/24

1389/8/24

1389/8/24

1389/8/24

1389/8/24

1389/8/24

1389/8/24




دسترسي با داروهاي فهرستدرمان. اختيارمراکز در فقط خاص

گيرد قرار مواد مصرف سوء


ميشود

سازنده دارویی شرکت توسطدیالیز بیماران اختیار در مستقیما

گیرد می قرار صفاقی



1389/8/24

1389/9/22

1389/9/22

1389/9/22

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25



توزیع بیمارستانی داروخانه در فقطشود می


1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/10/25

1389/11/4

1389/11/4

1389/11/4

1389/11/4

1389/11/4

1389/11/4

1389/11/4

1389/11/4

1389/11/4

1389/11/4

1389/11/4

1389/11/18

1390/1/29

1390/1/29

1390/1/29

1390/1/29

5mg/ml 1390/1/29

1390/1/29

1390/1/29

1390/1/29

1390/1/29

1390/1/29

1390/1/29

1390/1/29

1390/1/29

2 X 75 mg داخل تولید شرط به


ميشود

1390/1/29

1390/3/7

1390/3/7

1390/3/7

1390/3/7

1390/3/7

1390/3/7

1390/3/7

1390/3/7

1390/3/7

خاص دسترسي با داروهاي فهرست 1390/3/7

1390/3/7

1390/3/7

1390/3/7

1390/3/7

1390/3/9

1390/3/9

1390/3/9

1390/3/9


ميشود

خاص دسترسیدیالیز بیماران اختیار در مستقیما

گیرد قرار صفاقی

توزيع بيمارستاني داروخانه در فقطمتخصصين. توسط تجويزتنها ميشود

است مجاز ريه و .عفوني


ميشود

1390/3/9

1390/3/9

1390/3/9

1390/3/9

1390/3/9

90/3/23

90/3/23

90/3/23

داخل تولید شرط به 90/3/23

داخل تولید شرط به 90/3/23

1390/06/14

1390/06/14

1390/06/14

1390/06/14

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04


.ميشود خاص دسترسي با داروهاي فهرستتوزيع بيمارستاني داروخانه در فقط



ميشود


ميشود



ميشود

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/04

1390/07/05

کار از ناشی حوادث در مصرف برای 1390/07/05

1390/07/05

1390/07/05

1390/07/05

1390/07/05

1390/07/05

1390/07/05

1390/07/05

1390/07/05

1390/07/05

1390/07/05


1390/09/20

1390/09/21

1390/09/21

1390/09/21

1390/09/21

1390/09/21

1390/09/21

1390/09/21


**(As Hydrochloride)** کشور داخل در تولید شرط به**(As Hydrochloride)** کشور داخل در تولید شرط به



1390/09/21

1390/09/21

1390/09/21

1390/09/21

1390/0921

1390/09/21

1390/09/21

1390/09/21

1390/12/22

1390/12/22

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07

1391/02/07



داروهای فهرست ميشودخاص


ميشود

داروهای O.T.C فهرست

داروهاي OTC فهرستخاص داروهاي - (orphan) فهرست

گردد 35برای می ثبت بیمار .

1391/02/07

1391/02/07

1391/02/25

1391/02/25

1391/02/25

1391/02/25

1391/02/25

1391/02/25

1391/05/02

1391/05/02

1391/05/02

1391/05/02

1391/05/02

1391/05/02

1391/05/02

1391/05/02

1391/05/02

1391/5/4

1391/06/13

1391/06/13

1391/06/13



ميشود


1391/06/13

1391/06/13

1391/06/13

1391/06/13

ابتدا از کشور درداخل تولید شرط به 1391/06/13

1391/07/25

1391/07/25

1391/07/25

1391/07/25

1391/07/25

1391/07/25

10/3/1991

10/3/1991

1391/10/03

1391/10/03

1391/10/03

1391/10/03

1391/10/03

11/2/1991

11/2/1991

11/2/1991

11/2/1991

1391/11/02

1391/11/02

1391/11/02

1391/12/19

1391/12/19

1391/12/23

1391/12/23




ميشود

Tobramycin0.3%+Dexamethason0.1 % کشور داخل در تولید شرط به

، خاص دسترسي با داروهاي فهرستبیماریهای مدیریت مرکز زیرنظر

واگیردار


1391/12/23

12/23/1991

12/23/1991

23/12/91

1391/12/23

1391/12/23

1391/12/23

1391/12/23

1391/12/23

1391/12/23

1391/12/23

1391/12/23

1391/12/23

1391/12/23

1391/12/23

داروها راديو فهرست 1391/9/1









1391/9/1

1392/03/11

1392/03/11

1392/03/11

1392/03/11

1392/03/11

1392/03/11

1392/03/11

1392/03/11

1392/03/21

1392/03/21

1392/03/21

1392/03/21

1392/03/21

1392/04/04

1392/04/04

1392/04/04

1392/04/04

1392/04/04

1392/05/01

1392/05/01

1392/05/01

1392/05/01

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29



ميشود

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1392/5/29

1391/02/07

1392/06/12

1392/06/12

1392/06/12

1392/7/22

1392/7/22

1392/07/22

1392/7/22

1392/7/22



ميشود خاص داروهای فهرست


1392/7/22

1392/7/22

1392/08/20

1392/08/20

1392/09/25

1392/09/25

1392/09/25

1392/09/25

1392/09/25

1392/10/23

1392/09/25

1392/12/11

1392/12/11

1392/12/11

1392/12/11

1392/12/11

1392/12/11

1392/12/11

1392/12/11

1392/12/11

1392/12/11

1392/12/11

1393/01/24

1393/01/24

1393/01/24


خاص داروهاي (orphan) فهرست. خاص دسترسي با داروهاي فهرست


ايران داروهاي فهرست تغييراتدارو نام دارويي شکل مصرف راه

Drug Name Dosage Form Route of Admin

Hepatitis B Immune Globulin(humam) 50 IU/ml INJECTION PARENTERAL

Potassium Aminobenzoate 3 g/sachet POWDER ORAL

Potassium Aminobenzoate 500 mg TABLET ORAL

Capsule, Liquid filled ORAL

Gadobutrol 604.72 mg/ml (1mmol/ml) , 7.5ml INJECTION PARENTERAL

Gadobutrol 604.72 mg/ml (1mmol/ml), 15ml INJECTION PARENTERAL

Estradiol 0.06% GEL TOPICAL

Tenofovir disoproxil fumarate 300 mg Tablet ORAL

Oxymetazoline Hydrochloride 0.05% Spray, Solution NASAL


Tablet ORAL

Capsule, Liquid filled ORAL

Factor IX Complex PARENTERAL

Paclitaxel 6 mg/ml, 5ml INJECTION PARENTERAL

Paclitaxel 6 mg/ml, 16.7ml INJECTION PARENTERAL







Epirubicin Hdrochloride 2mg/ml, 25ml PARENTERAL

Epirubicin Hdrochloride 2mg/ml, 5ml PARENTERAL

Epirubicin Hydrochloride 10 mg INJECTION, POWDER PARENTERAL

Epirubicin Hydrochloride 50 mg INJECTION, POWDER PARENTERAL

ASA (Acetylsalicylic Acid) 100 mg* TABLET ORAL


Acetaminophen 150 mg/ml, 2ml INTRAVENOUS DRIP

Acetaminophen 150 mg/ml, 4ml INTRAVENOUS DRIP

Acetaminophen 150 mg/ml, 6.7ml INTRAVENOUS DRIP

Trace Metal Combination 1 INJECTION PARENTERAL

Trace Metal Combination 2 INJECTION PARENTERAL



Venlafaxine 75 mg Capsule, Extended Release ORAL

Laronidase 2.9mg/ml INJECTION PARENTERAL

Beclomethasone Dipropionate 0.8 mg/2ml NEBULISATION RESPIRATORY

Beclomethasone Dipropionate 250 mcg/dose AEROSOL RESPIRATORY

Beclomethasone Dipropionate 50 mcg/dose INHALER RESPIRATORY

INJECTION, SOLUTION, CONCENTRATEINJECTION, SOLUTION, CONCENTRATE




Aminoacid 10 % INTRAVENOUS DRIP


Lansoprazole 15 mg ORAL

Lansoprazole 30 mg ORAL

Ointment Topical

Cream Topical

Capsule ORAL

Capsule ORAL

Misoprostol 100 mcg TABLET ORAL


Prostaglandin E2 GEL VAGINAL

Prostaglandin E2 10 mg/ml, 0.5ml INJECTION PARENTERAL

Prostaglandin E2 3 mg TABLET VAGINAL


Methotrexate 10 mg/mlCAPSULE, DELAYED RELEASE

CAPSULE, DELAYED RELEASE

Mometasone Furoate 0. 1% Mometasone Furoate 0. 1%

Sibutramine Hydrochloride Monohydrate 15 mg


Aminoacid/Lipid 1 INJECTION,EMULSION INTRAVENOUS DRIP


INJECTION, SOLUTION INTRAVENOUS DRIP

INTRAVENOUS DRIP


Aminoacid 5% / Electrolyte

Aminoacid 10 % /Electrolyte INJECTION, SOLUTION, CONCENTRATE

Calcium Folinate 10 mg/ml

OINTMENT TOPICAL



Fexofenadine Hydrochloride 120 mg TABLET ORAL



INJECTION,EMULSION INTRAVENOUS DRIP



Co-trimoxazole 100/20 mg TABLET ORAL

Co-trimoxazole 400/80 mg TABLET ORAL

Co-trimoxazole 200/40 mg/5ml SUSPENSION ORAL

Co-trimoxazole 400/80 mg/5ml INJECTION, SOLUTION INTRAVENOUS DRIP

Ibuprofen 5mg/ml, 2ml INJECTION INTRAVENOUS

Ibuprofen 5% GEL TOPICAL

Fibrinolysin / Desoxyribonuclease

Mepivacaine Hydrochloride 3%, 1.7mlMepivacaine Hydrochloride 3%, 1.8ml

Aminoacid/Lipid/Glucose 1



Isosorbide Mononitrate 50 mg ORAL

Lidocaine 10 mg/dose, 100ml SPRAY, SOLUTION TOPICAL

Lidocaine 10 mg/dose, 50ml SPRAY, SOLUTION TOPICAL

Megestrol Acetate 40 mg/ml SUSPENSION ORAL

Human Papiloma Virus Vaccine INJECTION PARENTERAL

Gentamicin 40 mg/ml, 1ml INJECTION PARENTERAL


Gentamicin 0.8 mg/ml , 100 ml INJECTION PARENTERAL


Progesterone 100 mg CAPSULE, LIQUID FILLED VAGINAL or ORAL

Progesterone 200 mg CAPSULE, LIQUID FILLED VAGINAL or ORAL

Fingolimod 0.5 mg CAPSULE ORAL

Naproxen 200 mg CAPSULE, SOFT GELATIN ORAL

Meningococcal Vaccine INJECTION PARENTERAL

Mesalazine 1g/sachet ORAL

Midazolam 10 mg/ml, 5ml SOLUTION BUCCAL

Midazolam (As Hydrochloride) 5 mg/ml, 1ml INJECTION PARENTERAL

Midazolam (As Hydrochloride) 5 mg/ml, 2 ml INJECTION PARENTERAL



Midazolam Hydrochloride 2 mg/ml SYRUP ORAL

Ketorolac Trometamol 30 mg/ml INJECTION, SOLUTION PARENTERAL

TABLET ORAL

Ceftriaxone 250 mg INJECTION, POWDER PARENTERAL

Ceftriaxone 500 g INJECTION, POWDER PARENTERAL



Antihistamine Decongestant TABLET ORAL


GRANULE, EXTENDED RELEASE


Azelastine Hydrochloride 125 mcg/Puff SPRAY NASAL

Pancreatin CAPSULE ORAL

Cysteamine 50 mg CAPSULE Oral

Cysteamine 150 mg CAPSULE ORAL

DROPS, SUSPENSION OTIC

Valacyclovir 500 mg TABLET ORAL

Valacyclovir 1000 mg TABLET ORAL

Paclitaxel 100 mg PARENTERAL

Ciprofloxacin/Dexamethasone 0.3/0.1% DROPS, SUSPENSION OTIC

SOLUTION PARENTERAL

Sodium Bicarbonate 7.5%, 10ml INJECTION PARENTERAL




DROP, SUSPENTION OPHTHALMIC

Brinzolamide/Timolol Maleate 10/5 mg/ml DROPS, SUSPENTION OPHTHALMIC

CAPSULE, SOFT GEL ORAL




Multivitamin Pediatric INJECTION INTRAVENOUS

Norepinephrine 0.1% INJECTION PARENTERAL

Factor VIII 250 U PARENTERAL

Factor VIII 500 U PARENTERAL

Cinacalcet 30 mg TABLET ORAL



Adalimumab 40mg/0.8ml INJECTION,SOLUTION PARENTERAL

Linezolide 400 mg TABLET ORAL

Linezolide 600 mg TABLET ORAL

Linezolide 100 mg/5ml POWDER, SUSPENSION ORAL

Linezolide 600mg/300ml INJECTION, SOLUTION PARENTERAL

Ciprofloxacin/Dexamethasone Phosphate 0.3/0.1%


Peritoneal Dialysis IV Icodextrine Based

Tobramycin/Dexamethason %0.3/%0.1




Olanzapine 10 mg PARENTERAL

Risperidone 25 mg PARENTERAL

Risperidone 37.5 mg PARENTERAL

Risperidone 50 mg PARENTERAL

Goserelin 3.6mg IMPLANT PARENTERAL

Goserelin 10.8mg IMPLANT PARENTERAL

Dexmedetomidine Hydrochloride 100mcg/ml INJECTION PARENTERAL

Surfactant 27 mg/ml INJECTION , SUSPENSION INTRATRACHEAL





ايران داروهاي فهرست تغييراتدارو دسته توضيحات دارويي فهرست تاریخ

ATC Code Description List Name Date

J06BB04 IV, No volume defined 1388/08/20

D11 **PABA-k** 1388/09/04

D11 **PABA-k** 1388/09/04

R05X 1388/09/04

V08CA09 Prefilled Disposable syringe 1388/09/16

V08CA09 - 1388/09/16

G03CA03 - 1388/09/17

J05AF07 245 mg Tenofovir disoproxil 1388/10/23

S01GA04 - 1388/10/23

S01GA04 - 1388/10/23

R05X 1388/11/11

R05X 1388/11/11

B02BD09

L01CD01 1389/02/05

L01CD01 1389/02/05


As Analgesic: Acetaminophen ( 162.5 ,250, 300,325, 500, 650 mg) ,As Decongestant: Phenylephrine HCl (5,10 mg) or Pseudoephedrine (30,60mg) , As Antihistamine: Diphenhydramine HCl (12.5, 25 mg) or Chlorpheniramine maleate (2 , 4 mg) or Clemastine fumarate (0.335mg), The combinations to be exist in international Pharmacopoeia


. خاص دسترسي با داروهاي فهرستقرار سالمت معاونت اختيار در فقط

گيرد



As Decongestant: Phenylephrine HCl (5mg) or Pseudoephedrine HCl (30mg ,120mg) ,As Analgesic: Acetaminophen ( 250,325, 500 mg) or Ibuprofen(200mg) or Naproxen sodium( 200mg), The combinations to be exist in international Pharmacopoeia , if 120 mg Pseudoephedrine is in formulation it would be extended release




L01CD01 1389/02/05

L01CD01 1389/02/05

L01DB03 Treatment of breast cancer. 1389/02/05




N02BA01 Microcoated

N02BA01 Microcoated

N02BE01 -

N02BE01 -

N02BE01 -

A12CX 1389/05/18

A12CX 1389/05/18

S01GA04 کشور داخل در تولید شرط به 1389/06/29

S01GA04 کشور داخل در تولید شرط به 1389/06/29

N06AX16 1389/06/29

A16AB05 ساکاریدوز موکوپلی به مبتال بیماران برای فقط 1389/08/24

R03BA01 - 1389/08/24

R03BA01 - 1389/08/24

R03BA01 - 1389/08/24





. خاص دسترسي با داروهاي فهرستدر ، وريدي تزريق صورت به فقط

مورد پروتکل تهيه از پس و بيمارستانگيرد قرار .مصرف





{Chromium(0.17-10 mcg) +Copper(0.02-1.3mg)+ Iodine(0.013-63.51mg) +Manganese(0.001-0.27mg)+ Selenium (2-36.73 mcg)+ Zinc(0.05-6.5mg)}/ml

{Chromium (0.17-10mcg)+copper(0.02-1.3mg)+Fe2+(0.045-1.1mg)+fluoride (0.057-0.95mg)+Iodine (0.013-63.5mcg)+manganese(0.001-0.27mg)+molybdenium(0.001-19mcg)+selenium(2-36.73mcg)+zinc (0.05-6.5mg) }/ml


B05BA01 1389/08/24

L01BA01 **(As Sodium) with and without preservative** 1389/08/24

A02BC03 1389/08/24

A02BC03 1389/08/24

D07AC13 1389/08/24

D07AC13 1389/08/24

A08AA10 1389/08/24

A08AA10 1389/08/24

A02BB01 1389/10/25

A02BB01 1389/10/25

G02AB02 **(Dinoprostone)** 1389/10/25





ميشود


. خاص دسترسی با داروهای فهرستهای داروخانه و بیمارستانها در فقط

. شود می توزیع نظارت تحت و منتخبزایمان و زنان متخصص نسخه با










B05BA10 1389/11/04

B05BA10 1389/11/04

B05BA01 1389/11/04

B05BA01 1389/11/04

V03AF03 **(As Calcium)** 1390/01/29

nutriflex lipid plus: Isoleucine 2.26g +Leucine 3.01g+Lysine HCl 2.73g +Methionine 1.88g+Phenylalanine3.37g+Threonine 1.74g+Tryptophane 0.54g+Valine 2.50g+Arginine 2.59g+Histidine HCl monohydrate 1.62g+Alanine 4.66g+Glycine 1.58g+Aspartic acid 1.44g+Glutamic acid 3.37 g+Proline 3.26g+Serine 2.88+ Sodium Chloride 0.402g+Sodium acetate trihydrate 0.222g+ Potassium acetate 2.747g+ Magnesium Acetate tetrahydrate 0.686g + Calcium Chloride dihydrate 0.470g + Sodium hydroxide 0.781 g+Glucose monohydrate 132g+Sodium dihydrogen phosphate dihydrate 1.872g+Zinc acetate dehydrate 5.264g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml


ميشود

nutriflex lipid special: Isoleucine 3.28g + Leucine 4.38g + Lysine HCl 3.98g + Methionine 2.74g + Phenylalanine4.92g + Threonine 2.54g + Tryptophane 0.8g + Valine 3.6g + Arginine 3.780g + Histidine HCl monohydrate 2.37g + Alanine 6.79g + Glycine 2.31g + Aspartic acid 2.1g + Glutamic acid 4.91g +Proline 4.76g +Serine 4.2g + Sodium Chloride 0.378g+Sodium acetate trihydrate 0.25g+ Potassium acetate 3.689g+ Magnesium Acetate tetrahydrate 0.91g + Calcium Chloride dihydrate 0.623g + Sodium hydroxide 1.171 g+Glucose monohydrate 158.4g+Sodium dihydrogen phosphate dihydrate 2.496g+Zinc acetate dehydrate 7.02g+Triglyceride,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml


ميشود



ميشود



ميشود

B01AD05 1390/03/23

N01BB03 دندانپزشکی مصرف برای فقط 1390/03/23

N01BB03 دندانپزشکی مصرف برای فقط 1390/03/23

R06AX26 داخل داخل در تولید شرط به 1390/03/23



B05BA10 1390/03/23

B05BA10 1390/03/23

B05BA10 1390/03/23

J01EE01 Sulfamethoxazole 100mg+Trimethoprim 20mg 1390/09/20

J01EE01 Sulfamethoxazole 400mg+Trimethoprim 80mg 1390/09/20

J01EE01 (Sulfamethoxazole 200mg+Trimethoprim 40mg)/5ml 1390/09/20

J01EE01 (Sulfamethoxazole 400mg+Trimethoprim 80mg)/5ml 1390/09/20

C01EB16 1390/09/20

M02AA13 1390/09/20

(Fibrinolysin 1U+Desoxyribonuclease 666U)/g **(Human)**

داروهاي OTC فهرستداروهاي OTC فهرستداروهاي OTC فهرست

nutriflex lipid plus: Isoleucine 2.26g +Leucine 3.01g+Lysine HCl 2.73g +Methionine 1.88g+Phenylalanine3.37g+Threonine 1.74g+Tryptophane 0.54g+Valine 2.50g+Arginine 2.59g+Histidine HCl monohydrate 1.62g+Alanine 4.66g+Glycine 1.58g+Aspartic acid 1.44g+Glutamic acid 3.37 g+Proline 3.26g+Serine 2.88+ Sodium Chloride 0.402g+Sodium acetate trihydrate 0.222g+ Potassium acetate 2.747g+ Magnesium Acetate tetrahydrate 0.686g + Calcium Chloride dihydrate 0.470g + Sodium hydroxide 0.781 g+Glucose monohydrate 132g+Sodium dihydrogen phosphate dihydrate 1.872g+Zinc acetate dihydrate 5.264g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml


ميشود

nutriflex lipid special: Isoleucine 3.28g + Leucine 4.38g + Lysine HCl 3.98g + Methionine 2.74g + Phenylalanine4.92g + Threonine 2.54g + Tryptophane 0.8g + Valine 3.6g + Arginine 3.780g + Histidine HCl monohydrate 2.37g + Alanine 6.79g + Glycine 2.31g + Aspartic acid 2.1g + Glutamic acid 4.91g +Proline 4.76g +Serine 4.2g + Sodium Chloride 0.378g+Sodium acetate trihydrate 0.25g+ Potassium acetate 3.689g+ Magnesium Acetate tetrahydrate 0.91g + Calcium Chloride dihydrate 0.623g + Sodium hydroxide 1.171 g+Glucose monohydrate 158.4g+Sodium dihydrogen phosphate dihydrate 2.496g+Zinc acetate dihydrate 7.02g+Triglyceride,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml


ميشود

nutriflex lipid peri: Isoleucine 1.872g +Leucine 2.504g+Lysine HCl 2.272g +Methionine 1.568g+Phenylalanine2.808g+Threonine 1.456g+Tryptophane 0.456g+Valine 2.08g+Arginine 2.160g+Histidine HCl monohydrate 1.352g+Alanine 3.88g+Glycine 1.32g+Aspartic acid 1.20g+Glutamic acid 2.80 g+Proline 2.72g+Serine 2.40g+ Sodium Hydroxide 0.64g + Sodium Chloride 0.865g+Sodium acetate trihydrate 0.435g+ Potassium acetate 2.354g+ Magnesium Acetate 4H2o 0.515g + Calcium Chloride dihydrate 0.353g + Glucose monohydrate 70.4g +Sodium dihydrogen phosphate dihydrate 0.936g+Zinc acetate dihydrate 5.28g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml


ميشود

قلب تخصص فوق و نوزادان تخصص فوق دارای مراکز درتشخیص جهت اکوکاردیوگرافی دستگاه به مجهز و کودکان


خاص دسترسي با داروهاي فهرستخاص داروهای فهرست

C01DA08 Modified(30/70) 1390/09/20

D04AB01 Lidocaine 10% 1390/09/20

D04AB01 Lidocaine 10% 1390/09/20

L02AB01 1390/09/20

J07BM01 Polyvalent *Prefilled Syringe* 1390/09/21

J01GB03 **(As Sulfate)** 1390/12/22

J01GB03 **(As Sulfate)** 1390/12/22

J01GB03 1390/12/22

J01GB03 **(As Sulfate)** 1390/12/22

G03DA04 MICRONISED 1390/12/22

G03DA04 MICRONISED 1390/12/22

L04AA27 1391/02/19

M01AE02 Equivalent to 220 mg Naproxen sodium 1391/02/19

J07AH05 ** Polyvalent** 1391/02/25

A07EC02 - 1391/02/24

N05CD08 **(As Hydrochloride)** 1391/02/25

N05CD08 1391/02/25

N05CD08 1391/02/25

N05CD08 1391/02/25

N05CD08 1391/02/25

N05CD08 - 1391/02/25

M01AB15

R05X

J01DD04 **(As Sodium)**




R01BA53




ميشود(As Sulfate) in sodium chloride 0.9% (premixed) کشور داخل در تولید شرط به



ميشود

کشور داخل در تولید شرط As)** بهHydrochloride)**

دسترسي با داروهاي فهرستداروخانه. در فقط خاص

ميشود توزيع بيمارستانيTreatment of bouts of increased seizure activity in selected refractory patients with epilepsy who are on stable regimens of anti-epileptic drugs and who require intermittent use of midazolam


ميشود توزيع بيمارستاني









ميشود توزيع بيمارستانيدسترسي با داروهاي فهرست

داروخانه. در فقط خاصميشود توزيع .بيمارستاني خاص دسترسي با داروهاي فهرست






R01AC03 1391/02/07

A09AA - 1392/8/4

A16AA04 1392/8/4

A16AA04 1392/8/4

S02AA 1392/8/4

J05AB11 1392/08/08

J05AB11 1392/08/08

L01CD01 Albumin band (Nano) 1392/08/08

S02AA 1392/09/12

B05D 1392/10/03

B05XA02 - 1392/10/04

B05XA02 - 1392/10/04

B05XA02 - 1392/10/04

B05XA02 - 1392/10/04

S01CA01 1392/10/23

S01ED51 1392/10/23

N02BE71 1392/12/13

R06AX26 کشور داخل در تولید شرط به 1392/12/13



A11AE خاص دسترسي با داروهاي فهرست 1392/12/13

C01CA03 (As Bitartrate) 1392/12/18

B02BD02 1392/12/21

B02BD02 1392/12/21

H05BX01 **(As Hydrochloride)** 1393/01/24



L04AB04 1393/01/24

J01XX08 1393/01/24

J01XX08 1393/01/24

J01XX08 1393/01/24

J01XX08 1393/01/24



(As Bitartarate)خاص داروهاي (orphan) فهرست



{Ciprofloxacin (As Hydrochloride) 0.3% + Dexamethasone Phosphate (As Disodium) 0.1%}



{Ciprofloxacin (As Hydrochloride) 0.3% + Dexamethasone 0.1%}

Icidextrine 75 g/L+ Na+ 133 mmol/L + Ca++ 1,75 mmol/L + Mg++ 0.25 mmol/L + Cl- 96 mmol/L + Lactate 40 mmol/L

اختیار در مستقیما خاص دسترسیگیرد قرار صفاقی دیالیز بیماران





ميشودTobramycin0.3%+Dexamethason0.1%

Brinzolamide 10mg/ml + Timolol maleate 5mg/ml



(Vit.B1 2.5mg + Vit.B2 3.6mg + Vit. B6 4mg + Vit. B12 5mcg + Niacin 40mg + Pantothenic Acid 15mg + Biotin 60mcg + Vit.C 100mg+Folic Acid 400mcg)/10ml INTERAVENOUS

تخصص فوق توسط تجویز و بیمارستانها در فقط توزیع نوزادان

N05AH03 1393/01/24

N05AX08 1393/01/24

N05AX08 1393/01/24

N05AX08 1393/01/24

L02AE03 As Acetate 1393/01/24

L02AE03 As Acetate 1393/01/24

N05CM18 1393/01/24

R07AA02 bovine lipid extract 1393/01/24

دارو نام دارويي شکل دارو دسته توضيحات

Drug Name Dosage Form Route of Admin ATC Code Description


Estradiol 25 mcg TABLET VAGINAL G03CA03 -

Icodextrin 7.5g/100 ml SOLUTION B05DA

Valproate Sodium 500 mgORAL N03AG01

TABLET ORAL G03FA17

Ibuprofen 800 mg ORAL M01AE01 داخل تولید شرط به

GRANULE ORAL G04BC

Boceprevir 200 mg CAPSULE ORAL J05AE12

Telaprevir 375 mg TABLET ORAL J05AE11

Ketoprofen 100 mg ORAL M01AE03 Two layers 50/50

Ketoprofen 100 mg M01AE03

Ketoprofen 30 mg PLASTER TOPICAL M02AA10

راهمصرف


INTRAPERITONEAL

TABLET,EXTENDED RELEASE


Drospirenone/Estradiol Hemihydrate 2/1 mg

(Drospirenone 2 mg + Estradiol Hemihydrate 1 mg) در تولید شرط به

کشور داخلModified Release Tab.

Potassium sodium hydrogen Citrate-2.4g/2.5g

TABLET,Extended release


PARENTERAL



حذف تاریخ

List Name - Availability Level Date of Deletion

1389/10/25

1391/07/25

1390/03/07

1392/10/23

1392/10/23

1392/10/23

1393/01/24

1393/01/24

1393/01/24

1393/01/24

1393/01/24

1393/01/24

ايران داروهاي فهرست از شده حذف داروهایسطح - دارويي فهرستدسترسی

مستقیما خاص دسترسیگیرد قرار صفاقی دیالیز بیماران اختیار در

ايران داروهاي فهرست از شده حذف داروهای

OTC DRUGS' LIST

دارو نام دارويي شکل مصرف راه


A.C.A* TABLET ORAL

A.C.A* TABLET ORAL

Acetaminophen 325 mg ORAL

Acetaminophen 100 mg/ml SUSPENSION ORAL

Acetaminophen 100 mg/ml SOLUTION ORAL

Acetaminophen 120 mg/5ml SUSPENSION ORAL

Acetaminophen 120 mg/5ml SOLUTION ORAL

Acetaminophen 125 mg SUPPOSITORY RECTAL


Acetaminophen 160 mg TABLET, DISPERSIBLE ORAL


Acetaminophen 325 mg SUPPOSITORY RECTAL

Acetaminophen 325 mg TABLET ORAL

Acetaminophen 500 mg TABLET ORAL




Acetaminophen 80 mg TABLET, DISPERSIBLE ORAL

Acetaminophen/Caffeine 500/65 mg TABLET ORAL


CAPSULE, GELATIN COATED

TABLET, DISINTEGRATING



TABLET, EFFERVESCENT


Acetaminophen/Caffeine/Ibuprofen CAPSULE ORAL

Adult Cold Preparations_1: (Decongestant+ Analgesic) Tablet Oral

Adult Cold Preparations_1: (Decongestant+ Analgesic) Capsule, Liquid filled Oral

Tablet Oral

Capsule, Liquid filled Oral

Adult Cold Preparations_3: (Antihistamine + Analgesic ) Tablet Oral

Adult Cold Preparations_3: (Antihistamine + Analgesic ) Capsule, Liquid filled Oral

Tablet Oral


Tablet Oral







Tablet Oral


Tablet Oral



Tablet Oral

Aluminium Hydroxide 300 mg TABLET, CHEWABLE ORAL

Aluminium Hydroxide 320 mg/5ml SUSPENSION ORAL

Aluminium/Magnesium 200/200 mg TABLET, CHEWABLE ORAL

Aluminium/Magnesium 225/200 mg/5ml SUSPENSION ORAL

Aluminium/Magnesium 225/200 mg/5ml, 10ml SUSPENSION ORAL

Aluminium/Magnesium 564/174 mg ORAL








POWDER, FOR SUSPENSION

Aluminium/Magnesium/Simethicone SUSPENSION ORAL

Aluminium/Magnesium/Simethicone TABLET, CHEWABLE ORAL

Aluminium/Magnesium/Simethicone 10 ml SUSPENSION ORAL

Antihemorrhoid OINTMENT RECTAL

Antihemorrhoid SUPPOSITORY RECTAL

Antihistamine Decongestant* ORAL



Antihistamine Decongestant* TABLET ORAL

Artificial Saliva SPRAY, SOLUTION ORAL

Artificial Saliva GEL ORAL

Artificial Tears GEL OPHTHALMIC

Artificial Tears SOLUTION OPHTHALMIC

ASA (Acetylsalicylic Acid) 100 mg* TABLET, CHEWABLE ORAL

ASA (Acetylsalicylic Acid) 100 mg* ORAL


ASA (Acetylsalicylic Acid) 325 mg* SUPPOSITORY RECTAL





ASA/Ascorbic acid 400/240 mg ORAL

Benzocaine 5% OINTMENT TOPICAL

Betacarotene 15 mg CAPSULE ORAL

Bisacodyl 10 mg* SUPPOSITORY RECTAL



TABLET, EXTENDED RELEASE

TABLET, DELAYED RELEASE






Bisacodyl 5 mg SUPPOSITORY RECTAL

Bisacodyl 5 mg* ORAL

Bismuth BULK

Bismuth Subcitrate 120 mg TABLET ORAL

Bromhexine Hydrochloride 8 mg TABLET ORAL

Bromhexine Hydrochloride 4 mg/5ml ELIXIR ORAL

Burn Ointment OINTMENT TOPICAL

Calamine 8% CREAM TOPICAL

Calamine 8% LOTION TOPICAL

Calcium Pantothenate 100 mg TABLET ORAL

Charcoal Activated 250 mg TABLET ORAL

Charcoal Activated 30 g/240ml SUSPENSION ORAL

Charcoal Activated 50 g ORAL

Children Cold* TABLET, CHEWABLE ORAL

Chlorpheniramine Maleate 2 mg/5ml SYRUP ORAL

Chlorpheniramine Maleate 4 mg TABLET ORAL

Clemastine 1mg TABLET ORAL

Collodion SOLUTION TOPICAL

Contraceptive DE TABLET ORAL

Contraceptive HD TABLET ORAL

Contraceptive LD* TABLET ORAL

Contraceptive LD/Fe* TABLET ORAL


POWDER, FOR SUSPENSION

Contraceptive Triphasic TABLET ORAL

Copper and Zinc Sulfate LOTION TOPICAL

Crotamiton 10% CREAM TOPICAL

Dexpanthenol 5% CREAM TOPICAL

Dextromethorphan Hydrobromide 15 mg TABLET ORAL

Dextromethorphan Hydrobromide 4 mg/ml DROPS, SOLUTION ORAL

Dextromethorphan Hydrobromide 15 mg/5ml SYRUP ORAL

Dextromethorphan Hydrobromide 15 mg ORAL

Dextromethorphan/Pseudoephedrine 15/30 mg/5ml SYRUP ORAL

Diclofenac Diethylammonium Salt Eq To diclofenac s 1% GEL TOPICAL

Digestive ORAL

Dimenhydrinate 50 mg TABLET ORAL

Diphenhydramine Hydrochloride 25 mg TABLET ORAL

Diphenhydramine Hydrochloride 12.5 mg/5ml SOLUTION ORAL

Diphenhydramine Hydrochloride 25 mg ORAL

Expectorant SYRUP ORAL

Fluoride 0.25 mg TABLET ORAL

Fluoride 1 mg TABLET ORAL

Fluoride 1.23% GEL DENTAL

Fluoride Sodium 0.2% MOUTHWASH DENTAL

Glycerin 1 g SUPPOSITORY RECTAL

Glycerin 1.2 mg SUPPOSITORY RECTAL

Glycerin 2 g SUPPOSITORY RECTAL

Glycerin 3.4 mg SUPPOSITORY RECTAL

Guaifenesin 100 mg/5ml SYRUP ORAL

Hematinic CAPSULE ORAL

Hematinic ORAL





Ibuprofen 200 mg* CAPSULE ORAL

Ibuprofen 200 mg* TABLET ORAL

Iron 25 mg/ml DROPS, SOLUTION ORAL

Lidocaine Hydrochloride 2% GEL TOPICAL

Loperamide Hydrochloride 1 mg/5ml* SOLUTION ORAL

Loperamide Hydrochloride 2 mg* CAPSULE ORAL

Loperamide Hydrochloride 2 mg* TABLET ORAL

Magnesium Hydroxide 8% SUSPENSION ORAL

Mebendazole 100 mg* TABLET, CHEWABLE ORAL

OINTMENT TOPICAL

Menthol Salicylate OINTMENT TOPICAL

Methyl Salicylate 30% OINTMENT TOPICAL

Minoxidil 20 mg/ml SOLUTION TOPICAL

Minoxidil 50 mg/ml SOLUTION TOPICAL

Nicotine 10 mg/ml, 10ml SPRAY, SOLUTION NASAL

Nicotine 14mg/24h TRANSDERMAL

Nicotine 15 mg/16h TRANSDERMAL

Nicotine 2 mg GUM ORAL

Nicotine 2 mg TABLET SUBLINGUAL



Ophthalmic Bath Solution SOLUTION OPHTHALMIC

Orlistat 60 mg CAPSULE ORAL

ORS ORAL

ORS ORAL

ORS SOLUTION ORAL

Pancreatin ORAL

Pediatric Grippe* SYRUP ORAL

Menthol /Zinc oxide/ Calamine (0.44/20.625/10)g/100g

PATCH, EXTENDED RELEASE




POWDER, FOR SOLUTION



Permethrin 1% CREAM TOPICAL

Phenol Glycerin 6.4% DROPS, SOLUTION OTIC

Phenylephrine Hydrochloride 0.25% SPRAY, SOLUTION NASAL

Phenylephrine Hydrochloride 0.5% SPRAY, SOLUTION NASAL

Phenylephrine Hydrochloride 0.25% DROPS, SOLUTION NASAL

Phenylephrine Hydrochloride 0.50% DROPS, SOLUTION NASAL

Piroxicam 0.5% GEL TOPICAL

Povidone Iodine 10% OINTMENT TOPICAL

Povidone Iodine 10% DOUCHE VAGINAL

Povidone Iodine 10% GEL VAGINAL

Povidone Iodine 10% SPRAY, SOLUTION TOPICAL

Povidone Iodine 10% SOLUTION TOPICAL

Povidone Iodine 2.5% SPRAY, SOLUTION TOPICAL

Povidone Iodine 200 mg SUPPOSITORY VAGINAL

Povidone Iodine 3 mg/cm2 TISSUE TOPICAL

Povidone Iodine 7.5% SPONGE TOPICAL

Povidone Iodine 7.5% SHAMPOO TOPICAL

Povidone Iodine 7.5% SOLUTION TOPICAL

Salicylic Acid (12-40)% PLASTER TOPICAL

Salicylic Acid Compound SOLUTION TOPICAL

Silver Sulfadiazine 10 mg/g CREAM TOPICAL

Simethicone (Dimethicone Activated) 125 mg ORAL

Simethicone (Dimethicone Activated) 40 mg TABLET, CHEWABLE ORAL

Simethicone (Dimethicone Activated) 40 mg/ml DROPS, SUSPENSION ORAL

Simethicone (Dimethicone Activated) 41.2 mg/ml DROPS, SOLUTION ORAL

Simple Eye Oint* OINTMENT OPHTHALMIC

Sodium Chloride 0.65% SPRAY, SOLUTION NASAL

Sodium Chloride 0.9% SPRAY, SOLUTION NASAL


Sodium Chloride 0.65% DROPS, SOLUTION NASAL

Sodium Chloride 0.9% SOLUTION IRRIGATION

Sucralfate 1 g TABLET ORAL

Sucralfate 500 mg TABLET ORAL

Tetracycline Hydrochloride 3% OINTMENT TOPICAL

Tilactase 3000 FCC U TABLET ORAL

Vitamin A 250 U/g OINTMENT OPHTHALMIC

Vitamin A+D OINTMENT TOPICAL

Vitamin B1 100 mg TABLET ORAL

Zinc Oxide 0.25 OINTMENT TOPICAL

Acetaminophen/ Ibuprofen/ Caffeine 325/ 200/ 40 mg CAPSULE, GELATIN CO ORAL

ORAL

ORAL

Desogestrel 75mcg TABLET ORAL

Dienogest/ Ethinylestradiol 2/ 0.03 mg TABLET ORAL

Zinc Oxide 0.25 TABLET ORAL

Minoxidil 2% AEROSOL,FOAM TOPICAL

Minoxidil 5% AEROSOL,FOAM TOPICAL

Contraceptive DE TABLET ORAL

Acetaminophen/DiphenhydramineHCL/phenylephrSYRUP ORAL

Chlorpheniramine Maleate/phenylephrine HCL TABLET ORAL

ASA (Acetylsalicylic Acid) 81 mg TABLET ORAL

Acetaminophen/Guaifensine/phenylephrine SYRUP ORAL

Antihistamine Decongestant TABLET ORAL

Ibuprofen 5% GEL TOPICAL

Povidone Iodine 10% DOUCHE VAGINAL

SYRUP ORAL

CAPSULE, SOFT GEL ORAL

Guaifenesin 100 mg CAPSULE, GELATIN COATED

Guaifenesin 200 mg CAPSULE, GELATIN COATED



OTC DRUGS' LIST

دارو دسته توضيحات

ATC Code Description List Name

NO2BE51 Acetaminophen 250mg+caffeine 65mg+ASA 250mg

N02BE51 Acetaminophen 162.5mg+caffeine 32.5mg+ASA 325mg

N02BE01 -

N02BE01 -

N02BE01 -

N02BE01 -

N02BE01 -

N02BE01 -

N02BE01 کشور داخل در تولید شرط به



N02BE01 -

N02BE01 -

N02BE71 -

N02BE71 -

N02BE71 Soluble


N02BE01 -

N02BE51 Acetaminophen 500mg + Caffeine 65mg


دسترسی - سطح دارويي فهرست

M01AE51

R05X

R05X

R05X

R05X

R05X

R05X

R05X

R05X

R05X

Acetaminophen 325mg + Caffeine (30-40) mg + Ibuprofen 200mg

As Decongestant: Phenylephrine HCl (5mg) or Pseudoephedrine HCl (30mg ,120mg) ,As Analgesic: Acetaminophen ( 250,325, 500 mg) or Ibuprofen(200mg) or Naproxen sodium( 220mg), The combinations to be exist in international Pharmacopoeia

As Decongestant: Phenylephrine HCl (5mg) or Pseudoephedrine HCl (30mg ,120mg) ,As Analgesic: Acetaminophen ( 250,325, 500 mg) or Ibuprofen(200mg) or Naproxen sodium( 200mg), The combinations to be exist in international Pharmacopoeia








R05X

R05X

R05X

R05X

R05X

R05X

R05X

A02AB01 **(as Dried Gel)**

A02AB01 **(as Gel)**

A02AX

A02AX

A02AX

A02AX








Aluminium hydroxide 200mg + magnesium hydroxide 200mg

(Aluminium hydroxide 225mg+magnesium hydroxide 200)/5ml

(Aluminium hydroxide 225mg+magnesium hydroxide 200mg)/5ml **Sachet**

(Aluminium hydroxide 564mg + Magnesium hydroxide 174mg)/sachet

A02AF02

A02AF02

A02AF02

C05AD01

C05AD01

R01BA51

R01BA51

R01BA51

R01BA51

A16AX -

A16AX -

S01XA20 -

S01XA20 -

B01AC06 -

N02BA01 Microcoated

N02BA01 -

N02BA01 -

N02BA01 -

N02BA01 -

N02BA01 -

B01AC06 -

N02BA51 Acetylsalicylic acid 400mg+Ascorbic acid 240mg

D04AB04 -

A11CA02 -

A06AB02 -

(Aluminium hydroxide 225mg+magnesium hydroxide 200mg+simethicone 25mg)/5ml

Aluminium hydroxide 200mg+magnesium hydroxide 200mg+simethicone 25mg

(Aluminium hydroxide 225mg+magnesium hydroxide 200mg+simethicone 25mg)/5ml**SACHET**

(Lidocaine 50mg+hydrocortisone acetate 2.75mg+aluminium subacetate 35mg+zinc oxide 180mg)/g

Lidocaine 60mg+hydrocortisone acetate 5mg+aluminium subacetate 50mg+zinc oxide 400mg





A06AB02 -

A06AB02 -

V03 -

A02BX05 -

R05CB02 -

R05CB02 -

D03AA Cod liver oil 50%+Zinc oxide 30%

D02AB -

D02AB -

A11HA31 -

A07BA01 -

A07BA01 -

A07BA01 -

N02BE51

R06AB04 -

R06AB04 -

R06AA04 (as Fumarate)

V03 (Pyroxylin 40g+Ether 750 ml+Alcohol 250 ml )/1000 ml

G03AA09 Desogestrel 0.15mg+Ethinylestradiol 30mcg

G03FA04

G03FA04

G03AA06

Acetaminophen 80mg + Chlorpheniramine maleate 0.5 mg + Pseudoephedrin HCl 7.5 mg



21 Tab. [Norgestrel (or 1/2 amount of levonorgestrel) 0.3mg+Ethinylestradiol 30mcg] + [ 7 Tab. of 24.65 mg Iron as Ferrous Sulfate or Fumarate )]

G03AA06

D11

P03AX -

D03AX03 -

R05DA09 -

R05DA09 -

R05DA09 -

R05DA02 -

R05DA20

M02AA15 -

A09AA Pancreatin+simethicone 40 mg

-

R06AA02 -

R06AA02 -

R06AA02 -

R05CA

A01AA01 (As Sodium)

A01AA01 (As Sodium)

A01AA01 (As Acidulated Phosphate)

A01AA01 -

A06AX01 -

A06AX01 -

A06AX01 -

A06AX01 -

R05CA03 -

B03AD

B03AD

6 Tab: (Levonorgestrel 0.05mg + Ethinylestradiol 30mcg) + 5 Tab: (Levonorgestrel 0.075mg + Ethinylestradiol 40mcg) + 10 Tab: (Levonorgestrel 0.125mg + Ethinylestrdiol 30mcg)

Copper Sulfate 1 g + Zinc Sulfate 1.5 g + Concentrated Comphor Water 2.5 ml + water qs to 100 ml

(Dextromethorphan HBr 15mg+Pseudoephedrine HCl 30mg)/5ml

(Guaifenesin 100mg + Chlorpheniramine maleate 2mg + Pseudoephedrine HCl 30 mg ) / 5ml



M01AE01 -

M01AE01 -

B03AA02 -

D04AB01 -

A07DA03 -

A07DA03 -

A07DA03 -

A02AA04 -

P02CA01 -

D02AB

M02AC Methyl Salicylate 15%+Menthol 10%

M02AC -

D11AX01 -

D11AX01 -

N07BA01 -

N07BA01 -

N07BA01 -

N07BA01 -

N07BA01 -

N07BA01 -

N01BA01 -

S01AX07 Boric Acid 1610 mg/100 ml

A08AB01 -

A07CA

A07CA

A07CA -

A09AA

R06AB54 Rinse-1% W/W

(Menthol 0.44 g + Zinc oxide 20.625 g + Calamine 10 g)/100g به



(Na 75 mmol + K 20 mmol + Cl 65 mmol + citrate 10 mmol + Dextrose 75 mmol )/4 tablet

(Chlorpheniramine Maleate 0.67mg + Pseudoephedrine HCl 10 mg)/5ml

Phenol 6.4 g + Glycerin qs 100 g

D08AE03 -

R01AA04 -

R01AA04 -

R01AA04 -

R01AA04 -

M02AA07 -

D09AA09 -

G01AX11 -

G01AX11 -

D08AG02 -

D08AG02 -

D09AA09 -

D09AA09 -

D09AA09 -

D09AA09 -

D09AA09 Surgical Scrub

D09AA09 -

D01AE12

D01AE12 -

D06BA01 -

A07D -

A07D -

A07D -

A07D

S01XA -

R01AX -

R01AX -

Salicylic Acid 16.7g+Lactic Acid 16.7g + Collodion qs to 100g

Yellow soft paraffin 80 g + Wool fat 10 g + Liquid paraffin q.s. 100 g

R01AX -

B05CB01 -

A02BX02 -

A02BX02 -

D06AA04 Lactase

A09AA04 -

S01XA02 (Vit. A 850 IU+Vit. D 85 IU) / g

A11CB -

A11DA01

D02AB

N02BE71 Acetaminophen 325mg + Ibuprofen 200mg+ Caffeine 40 mg

R05CA03

R05CA03

G03AC09

G03AA**

G03AA09 Desogestrel 0.15mg+Ethinylestradiol 20mcg

D11AX01 -

D11AX01

G03AA09

R05X

R01BA53

B01AC06 کشور داخل در تولید شرط به

R05X

R01BA53 Chlorpheniramine Maleate4mg/phenylephrine HCL 10mg

M02AA13

G01AX11

R05X

N02BE71



داروهای O.T.C فهرست



Desogestrel 0.15mg+Ethinylestradiol 20mcg شرط بهکشور داخل در ابتدا از تولید داروهاي OTC فهرست

Acetaminophen160/DiphenhydramineHCL12.5/phenylephrine HCL2.5/5ml


Chlorpheniramine Maleate4mg+phenylephrine HCL 10mg



Acetaminophen125/Guaifenesine 50mg/phenylephrine2.5/5ml









تاریخ

Date

1389/7/17

1389/6/29

1389/7/17

1389/7/17

1389/7/17

1390/07/04

1390/09/21

1390/09/21

1390/12/22

1391/02/07

1391/05/02

1391/05/02

1391/05/02

1391/05/02

1391/06/13

1391/06/13

1391/11/02

1392/05/01

1392/05/29

1392/09/25

1390/07/04

خاص داروهای فهرستOrphan Drug List



Alglucosidase Alfa 50 mg INJECTION, POWDER PARENTERAL

Alprostadil 20 mcg INJECTION, POWDER PARENTERAL

Alprostadil 20 mcg INJECTION, SOLUTION PARENTERAL

Alteplase 10 mg INJECTION, POWDER PARENTERAL



Amyl Nitrite INHALER INHALATION

Anagrelide HCl 500 mg Capsule Oral

Artisunate 200 mg INJECTION PARENTERAL

Artisunate 60 mg/ml, 1 ml INJECTION PARENTERAL

Bevacizumab 25 mg/ml, 16 ml PARENTERAL

Bevacizumab 25 mg/ml, 4 ml PARENTERAL

Bortezomib 3.5 mg PARENTERAL

Cladribine 1 mg/ml, 10 ml INJECTION, SOLUTION IV INFUSION

Cladribine 2 mg/ml, 5 ml INJECTION, SOLUTION IV INFUSION

Clofazimine 100 mg CAPSULE ORAL

Clofazimine 50 mg CAPSULE ORAL



Cysteamine 150 mg CAPSULE ORAL

Daclizumab 5 mg/ml, 5 ml PARENTERAL





Dantrolene Sodium 20 mg INJECTION, POWDER, PARENTERAL

Dantrolene Sodium 20 mg CAPSULE ORAL

Dapsone 100 mg TABLET ORAL

Dapsone 50 mg TABLET ORAL

Digoxin Specific Antibody 40 mg INJECTION PARENTERAL

Dimethyl Sulfoxide 50% SOLUTION PARENTERAL

Factor XIII Powder for INJECTION PARENTERAL

Fibrinogen 1 g INJECTION, POWDER PARENTERAL

Fomepizole 1 g/ml, 1.5ml INJECTION PARENTERAL

Galsulfase 1mg/ml INJECTION PARENTERAL


Ibuprofen 10 mg/ml INJECTION, SOLUTION INTRAVENOUS DRIP

Idarubicin Hydrochloride 10 mg PARENTERAL

Idarubicin Hydrochloride 5 mg PARENTERAL

Imiglucerase 200 U INJECTION, POWDER PARENTERAL

Imiglucerase 400 U INJECTION, POWDER PARENTERAL

Indocyanine Green 25 mg INJECTION, POWDER PARENTERAL

Infliximab 100 mg INJECTION, POWDER PARENTERAL

Laronidase 2.9mg/ml INJECTION PARENTERAL

Mercaptamine 150 mg CAPSULE ORAL

Mercaptamine 150 mg POWDER ORAL



Midodrine Hydrochloride 2. 5 mg TABLET ORAL

Midodrine Hydrochloride B515 mg TABLET ORAL

Nitisinone 10 mg CAPSULE ORAL

Nitisinone 10 mg TABLET ORAL





Para-aminosalicylic Acid 4 g GRANULE ORAL

Pegaspargase 3750 IU INJECTION, POWDER PARENTERAL

Pegaspargase 750 IU/ml, 5ml INJECTION, SOLUTION PARENTERAL

Pilocarpine Nitrate 4% DROPS, SOLUTION OPHTHALMIC

Praziquantel 600 mg TABLET ORAL

Rifampicin 600 mg INJECTION, POWDER PARENTERAL

Sapropterin Hydrochloride 50 mg TABLET ORAL

Serine 600 mg CAPSULE ORAL

Sodium Benzoate 500 mg TABLET ORAL


SOLUTION ORAL

Sodium Nitrite 30 mg/ml, 10ml INJECTION, SOLUTION PARENTERAL

Sodium Nitroprusside 50 mg INJECTION, POWDER PARENTERAL

INJECTION, SOLUTION PARENTERAL

Sodium Phenylbutyrate 500 mg TABLET ORAL

Sodium Thiosulfate 250 mg/ml, 50ml INJECTION, SOLUTION PARENTERAL

Somatostatin 0.25 mg INJECTION, POWDER PARENTERAL

Somatostatin 3 mg PARENTERAL

Sorafenib tosilate 200 mg TABLET ORAL

Succimer 100 mg CAPSULE ORAL

Succimer 200 mg CAPSULE ORAL



Sodium Phenylbutyrate 200 mg/ml, 10ml

INJECTION, POWDER FOR SOLUTION

CREAM TOPICAL

INTRAVENOUS BOLUS

Teniposide 10 mg/ml, 5ml INJECTION, SOLUTION PARENTERAL

Testosterone Undecylate 40 mg CAPSULE ORAL

Thalidomide 100 mg CAPSULE ORAL

Thalidomide 100 mg TABLET ORAL

Thyrotropin Alfa 1.1 mg PARENTERAL

Thyrotropin Alfa 900 mcg PARENTERAL

Tobramycin 300 mg/4 ml NEBULISATION RESPIRATORY

Tobramycin 300 mg/5 ml NEBULISATION RESPIRATORY

Trientine Dihydrochloride 300 mg CAPSULE ORAL

Trypan Blue 0.1% INJECTION INTRAOCULAR

Uridine 1 mg TABLET ORAL

Varicella-Zoster Vaccine INJECTION PARENTERAL

Verteporfin 15 mg INJECTION, POWDER PARENTERAL

Zidovudine 100 mg CAPSULE ORAL

Zidovudine 300 mg CAPSULE ORAL

Zidovudine 300 mg TABLET ORAL

Zidovudine 50 mg/5 ml SYRUP ORAL

Carglumic Acid 200 mg TABLET, DISPERSIBLE ORAL

Sulfadiazine Silver/Epidermal Growth Factor 1%/0.92

Technetium [99mTc] Human Immunoglobulin G (15-25) mCi




خاص داروهای فهرست

دارو دسته توضيحاتتاریخ

ATC Code Description List Name Date

A16AB07 1390/07/05

C01EA01

C01EA01

B01AD02

B01AD02

B01AD02

V03AB22 Treatment of cyanide poisoning

L01XX35

P01BE03 گيرد قرار سالمت معاونت اختيار در فقط

P01BE03 -

L01XC07

L01XC07 سرطان درمان تخصصی مراکز دارای بیمارستانهای در

L01XX32 **(As Manitol baronic ester)**

L01BB04

L01BB04

J04BA01

J04BA01

A16AA04 نفروپاتیک سیستینوزیس به مبتال بیماران برای فقط

A16AA04 1392/8/4

A16AA04 1392/8/4

Prevention of acute renal allograft rejection.

سطح - دارويي فهرستدسترسی

متابولیک - داروهای خاص داروهای فهرستگردد 14جهت می ثبت بیمار .

Prostaglandin E1 Treatment of severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated.


Prostaglandin E1 Treatment of severe peripheral arterial occlusive disease (critical limb ischemia) in patients where other procedures, grafts or angioplasty, are not indicated.









خاص داروهاي (Orphan) فهرست

خاص داروهاي (orphan) فهرستگيرد قرار سالمت معاونت اختيار در فقط

خاص داروهاي (orphan) فهرستگيرد قرار سالمت معاونت اختيار در فقط



خاص داروهاي (Orphan) فهرستبیمارستانهای در مصرف برای فقط

سرطلن درمان تخصصی مراکز دارایTreatment of acute myeloid leukemia.Treatment of the chronic progressive form of MSTreatment of non-Hodgkin's lymphoma.










(As Bitartarate)خاص داروهاي (orphan) فهرست



L04AA08 L04AC01


M03CA01 Treatment of the neuroleptic malignant syndrome.

M03CA01 Treatment of the neuroleptic malignant syndrome.

J04BA02

J04BA02

G04BX13

B02BD07 Human Fibrin-stabilising Factor

B02BB01

V03AB34 Treatment of methanol or ethylene glycol poisoning.

A16AB08 1391/02/07

C01EB16 1390/09/20

B05BA01 **(as Lysine)** 1390/09/21

L01DB06

L01DB06

A16AB02

A16AB02

V04CX

L04AB02

A16AB05

A16AA04

A16AA04







V03AB V03AB24

Special available for Poisoning Center Treatment of potentially life threatening digitalis intoxication in patients who are refractory to management by conventional therapy.Treatment of life-threatening acute cardiac glycoside intoxication manifested by conduction disorders, ectopic ventricular activity and (in some cases) hyperkalemia.


Treatment of cutaneous manifestations of scleroderma.Treatment of palmar-plantar erythrodysethesia syndrome.


خاص داروهای (Orphan) فهرست

INNندارد For the control of bleeding and prophylactic treatment of patients deficient in fibrinogen .



خاص داروهاي برای - (orphan) فهرستگردد 35 می ثبت بیمار .

و کودکان قلب تخصص فوق و نوزادان تخصص فوق دارای مراکز درتشخیص جهت اکوکاردیوگرافی دستگاه به PDA (Patent مجهز

ductus arterious)

خاص دسترسي با داروهاي فهرستخاص داروهای فهرست

. فقط خاص دسترسي با داروهاي فهرستميشود توزيع بيمارستاني داروخانه در

خاص داروهای فهرستTreatment of acute lymphoblastic leukemia in pediatric patients.Treatment of acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia.








INNندارد خاص داروهاي (orphan) فهرست

Treatment of moderately to severely active Crohn's disease for the reduction of the signs and symptoms, in patients who have an inadequate response to conventional therapy; and treatment of patients with fistulizing Crohn's disease.Treatment of chronic sarcoidosisTreatment of giant cell arteritis


داروهای - فهرست ساکاریدوز موکوپلی به مبتال بیماران برای فقطمتابولیک

خاص داروهاي (orphan) فهرستمتابولیک داروهای فهرست

Phosphocysteamine Treatment of cystinosis.


Phosphocysteamine Treatment of cystinosis.


C01CA17 قلب تخصصی بیمارستانهای در مصرف جهت فقط

C01CA17 قلب تخصصی بیمارستانهای در مصرف جهت فقط

A16AX04

A16AX04

A16AX04

A16AX04

A16AX04

A16AX04

J04AA01

L01XX24 L-ASPARGINASE

L01XX24

S01EB01

P02BA01 Treatment of neurocysticercosis.

J04AB02

A16AX07

-

____ Rare metabolic conditions for children 1392/7/22

-

-

V03AB08

C02DD01

A16AX03

A16AX03

V03AB06

H01CB01 Treatment of bleeding esophageal varices.

H01CB01 1391/07/25

L01XE05

V03AB Treatment of lead poisoning in children.

V03AB Treatment of lead poisoning in children.

خاص داروهای (orphan) فهرستبیمارستانهای در مصرف جهت فقط

قلب تخصصیخاص داروهای (orphan) فهرستبیمارستانهای در مصرف جهت فقط

قلب تخصصیتيپ تیروزینمیا به مبتال بیماران برای 1فقط خاص داروهاي (orphan) فهرست

تيپ تیروزینمیا به مبتال بیماران برای 1فقط خاص داروهاي (orphan) فهرست





INN ندارد Treatment of tuberculosis infections



L-ASPARGINASE Acute lymphocytic leukemia


Treatment of xerostomia induced by radiation therapy for head and neck cancer-As BaseTreatment of xerostomia and keratoconjunctivitis sicca in Sjogren's syndrome patients.



For antituberculosis treatment where use of the ORAL form of the drug is not feasible.


کتونوریا فنیل به مبتال بیماران برای (Phenylketonuria) فقطIn patients responsive to tetrahydrobiopterin As Hydrochloride


سرین کمبود به مبتال بیماران برای (Serine deficiency) فقط خاص داروهاي (orphan) فهرست


INN ندارد (Grade III and VI hepatic encephalopathy) بیماران برای فقط

هیپرآمونمیا به .(Hyperammonemia) مبتالخاص داروهاي (orphan) فهرست

هیپرآمونمیا به مبتال بیماران برای .فقط INN ندارد خاص داروهاي (orphan) فهرست

INN ندارد Treatment of cyanide poisoning


INN ندارد Nitroprusside Sodium Treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage.


INN ندارد Sodium phenylbutyrate: Adjunctive to surgery, radiation therapy, and chemotherapy for primary or recurrent malignant gliome هیپرآمونمیا به مبتال بیماران برای فقط(Hyperammonemia)


INN ندارد Sodium phenylbutyrate: Adjunctive to surgery, radiation therapy, and chemotherapy for primary or recurrent malignant gliome هیپرآمونمیا به مبتال بیماران برای فقط(Hyperammonemia)


Sodium Hyposulfite INN As نداردThiosulfate Treatment of cyanide poisoning-AS PENTAHYDRATE



Treatment of bleeding esophageal varices. داخل تولید شرط خاص به داروهاي (orphan) فهرست

**(As Tosilate)** درمان تخصصی مراکز دارای بیمارستانهای در مصرف برای فقط سرطان

خاص داروهاي (orphan) فهرستبیمارستانهای در مصرف برای فقط

سرطلن درمان تخصصی مراکز دارایخاص داروهاي (orphan) فهرست


D06BA51

V09HA01

L01CB02

G03BA03

L04AX02 میلوما مولتیپل به مبتال بیماران برای فقط

L04AX02 میلوما مولتیپل به مبتال بیماران برای فقط

V04CJ01 سرطان تشخیص تخصصی مراکز دارای بیمارستانهای در

V04CJ01 سرطان تشخیص تخصصی مراکز دارای بیمارستانهای در

J01GB01

J01GB01

------1389/10/25

S01JA

J07BK01

S01LA01 Antineovascularization

J05AF01 Treatment of AIDS related complex.




A16AA05 1393/01/24

Silver (EGF نام INN ندارد)Sulfadiazine1% + Epidermal Growth Factor 0.92 For promotion of cutaneous wound healing in extreme burn treatment protocols.


INN ندارد خاص داروهاي (orphan) فهرست ،داروها راديو فهرست

Treatment of refractory childhood acute lymphocytic leukemia.


Testosterone Undecanoate As Base Treatment of weight loss in AIDS patients with HIV-associated wasting.




خاص داروهاي فهرست (Orphan) فهرستخاص دسترسي با داروهاي

Bronchiectasis patients injected with pseadornonas aeruginosa


Bronchiectasis patients injected with pseadornonas aeruginosa


Treatment of Wilson Disease in patients intolerance of penicillamine


INN ندارد Selectively staining epiretinal membranes during ophthalmic surgical victrectomy procedures


INN ندارد Cystic fibrosis, facilitate removal of lung secvetions in primary ciliary dyskinesia (Orotic Aciduria)

یوروتیک اسیدوری به مبتال بیماران برای فقطخاص داروهاي (orphan) فهرست

INN ندارد Passive immunization for the treatment of exposed, susceptible individuals who are at risk of complications from varicella








خاص دسترسي با داروهاي فهرستRESTRICTED AVAILABILITY LIST




Acetaminophen 10 mg/ml, 100ml INJECTION INTRAVENOUS

Acetaminophen 10 mg/ml, 50ml INJECTION, SOLUTION INTRAVENOUS

Acetaminophen 150 mg/ml, 2ml INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS DRIP

Acetaminophen 150 mg/ml, 4ml INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS DRIP

Acetaminophen 150 mg/ml, 6.7ml INJECTION, SOLUTION, CONCENTRATE PARENTERAL

Acetylcysteine 200 mg/ml INJECTION PARENTERAL

Aciclovir 250 mg INJECTION, POWDER, LYOPHILIZED PARENTERAL

Aciclovir 500 mg INJECTION, POWDER PARENTERAL


Albumin (Human) 20%, 100ml INJECTION, SOLUTION PARENTERAL




Albumin (Human) 20%, 50ML INJECTION, SOLUTION PARENTERAL

Albumin (Human) 5%, 100ML INJECTION, SOLUTION PARENTERAL


Abciximab 2 mg/ml, 5ml

Adenosine 3 mg/ml, 2ml


Alfentanil (as HCl) 0.5 mg/ml, 2ml INJECTION PARENTERAL

Alfentanil (as HCl) 0.5 mg/ml, 10ml INJECTION PARENTERAL

Alfentanil (as HCl) 0.5 mg/ ml, 5ml INJECTION PARENTERAL

Aminoacid 5 % / Electrolyte INJECTION, SOLUTION INTRAVENOUS DRIP

Aminoacid 10 % / Electrolyte INJECTION, SOLUTION INTRAVENOUS DRIP

Aminoacid 10 % INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS DRIP

Aminoacid 10 % /Electrolyte INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS DRIP

Aminoacid 5% INJECTION, SOLUTION INTRAVENOUS DRIP



Aminoacid 5% / Electrolyte INJECTION, SOLUTION INTRAVENOUS DRIP




Amiodarone Hydrochloride 50 mg/ml, 3ml INJECTION PARENTERAL

Amphotericin-B 50 mg INJECTION, POWDER, LYOPHILIZED PARENTERAL

Artemether 40 mg CAPSULE ORAL

Artemether 80 mg INJECTION PARENTERAL

Artisunate 100 mg TABLET ORAL

Artisunate 200 mg INJECTION PARENTERAL

Artisunate 50 mg SUPPOSITORY RECTAL

Artisunate 60 mg/ml, 1ml INJECTION PARENTERAL

TABLET ORAL

TABLET ORAL



Bortezomib 3.5mg INJECTION, POWDER, LYOPHILIZED PARENTERAL

Botulism Monovalent INJECTION PARENTERAL

Botulism Polyvalent (A+B+E) INJECTION PARENTERAL





INJECTION INTRASPINAL


Caffeine (As Citrate) 10mg/ml SOLUTION ORAL

Caffeine (As Citrate) 10mg/ml, 3ml INJECTION, SOLUTION PARENTERAL

Calcitriol 1 mcg/ml, 1ml INJECTION PARENTERAL

Calcitriol 2 mcg/ml, 1ml INJECTION PARENTERAL

Atovaquone/Proguanil Hydrochloride 250/100 mgAtovaquone/Proguanil Hydrochloride 62.5/25 mg

Atracurium Besylate 10 mg/ml, 2.5ml

Atracurium Besylate 10 mg/ml, 5ml






Buprenorphine 0.3 m/ml, 1ml

INJECTION, POWDER PARENTERAL






Ceftriaxone (As Sodium) 2 g INJECTION, POWDER PARENTERAL

Ceftriaxone (As Sodium) 250 mg INJECTION, POWDER PARENTERAL

Ceftriaxone (As Sodium) 500 mg INJECTION, POWDER PARENTERAL

Ceftriaxone (As Sodium) 1 g INJECTION, POWDER PARENTERAL





Clindamycin 150 mg/ml, 4ml INJECTION PARENTERAL

Clindamycin (As Phosphate) 150 mg/ml, 2ml INJECTION PARENTERAL

Clopidogrel Bisulfate 300 mg TABLET ORAL

Dalteparin Sodium 10000 U/ml INJECTION PARENTERAL



Dalteparin Sodium 7500 U/0.3 ml INJECTION PARENTERAL


Diazoxide 15 mg/ml, 20ml INJECTION PARENTERAL

Diclofenac Sodium 75 mg/3ml INJECTION PARENTERAL

Didanosine 200 mg CAPSULE ORAL

Didanosine 200 mg TABLET ORAL

Digoxin 0.25 mg/ml, 2ml INJECTION PARENTERAL

Dimercaprol 100 mg/ml, 3ml INJECTION INTRAMUSCULAR

Dipyridamole 5 mg/ml, 2ml INJECTION PARENTERAL

Dobutamine (As HCL) 250 mg INJECTION, POWDER, LYOPHILIZED INTRAVENOUS DRIP




Doxycycline 100 mg/ Vial Injection Parenteral


Cefepime (As Dihydrochloride or Hydrochloride Monohydrate) 500mgCefepime (As Dihydrochloride or Hydrochloride Monohydrate) 1 gCefepime (As Dihydrochloride or Hydrochloride Monohydrate) 2 g



Ceftazidime (As Pentahydrate) 500 mg


Cisatracurium (As Besylate) 2 mg/ml, 2.5ml


Cisatracurium (As Besylate) 5 mg/ml

Dextran/ NaCl 500 ml

Dobutamine (As HCL) 12.5 mg/ml, 20ml

Dopamine Hydrochloride 40 mg/ml, 5ml

Doxapram Hydrochloride 20 mg/ml, 5ml

Droperidol Compound


Edetate Calcium Disodium 50 mg/ml INJECTION PARENTERAL




Efavirenz 100 mg CAPSULE ORAL

Efavirenz 150 mg/ml SOLUTION ORAL


Efavirenz 200 mg TABLET ORAL

Efavirenz 600 mg TABLET ORAL


INHALANT RESPIRATORY

Enoxaparin Sodium 100 mg/ml, 0.2 ml INJECTION PARENTERAL




Enoxaparin Sodium 100 mg/ml, 1 ml INJECTION PARENTERAL

TABLET ORAL

Ethambutol/Isoniazid/Rifampin TABLET ORAL



Fentanyl (As Citrate) 50 mcg/ml, 5ml INJECTION PARENTERAL

Fentanyl (As Citrate) 50 mcg/ml, 1ml INJECTION PARENTERAL



Fluconazole 2 mg/ml , 100ml INJECTION PARENTERAL

Fluconazole 2 mg/ml , 200ml INJECTION PARENTERAL



Heparin Sodium 10,000 U/ml INJECTION PARENTERAL

Heparin Sodium 10,000 U/ml, 1ml INJECTION PARENTERAL

Heparin Sodium 5000 U/ml INJECTION PARENTERAL

Heparin Sodium 5000 U/ml, 1ml INJECTION PARENTERAL

Heparin Sodium 5000 U/ml, 5ml INJECTION PARENTERAL


Ibuprofen 100mg/ml, 4ml INJECTION PARENTERAL

Ibuprofen 100mg/ml, 8ml INJECTION PARENTERAL

Icodextrin 7.5g/100 ml SOLUTION INTRAPERITONEAL


Droperidol 2.5 mg/ml, 10ml

Edetate Dicobalt 15 mg/ml, 20ml

Edetate Disodium 150 mg/ml

Edrophonium Chloride 10 mg/ml

Enflurane

Ethambutol/Isoniazid/Pirazinamide/Rifampin

Ether

Etomidate 2 mg/ml, 10ml



Halothane 250 ml/bottle




Indometacin 50 mg/2ml INJECTION, SOLUTION PARENTERAL


Isoniazid/Rifampin 75/150 mg TABLET ORAL


Ketorolac Tromethamine 30 mg/ml INJECTION, SOLUTION INTRAMUSCULAR

Labetolol (As Hydrochloride) INJECTION 5 mg/ml, 20ml

Lidocaine Hydrochoride 5% INJECTION INTRASPINAL






INJECTION, SOLUTION PARENTERAL




INJECTION, POWDER, PARENTERAL


Morphine Sulfate 25mg/ml, 4ml INJECTION PARENTERAL

Morphine Sulfate 50mg/ml, 10ml INJECTION PARENTERAL


Moxifloxacin 400 mg Tablet ORAL

Multivitamin Pediatric INJECTION INTRAVENOUS

Nelfinavir, (As Mesylate) 625 mg TABLET ORAL

Nelfinavir, (As Mesylate) 50 mg/g POWDER ORAL

Neostigmine Methylsulfate 2.5 mg/mlL, 5ml INJECTION PARENTERAL

Neostigmine Methylsulfate 0.5 mg/ml INJECTION PARENTERAL

Neostigmine Methylsulfate 2.5 mg/ml, 1ml INJECTION PARENTERAL

Nevirapine 200 mg TABLET ORAL

Nevirapine 50 mg/ml SUSPENSION ORAL

Nitroglycerin 1 mg/ml, 10ml INJECTION PARENTERAL



Nitrous Oxide 1000 PPM INHALER RESPIRATORY




Isoflurane

Ketamine (As HCl ) 50 mg/ml, 10 ml

Mepivacaine Hydrochloride 2%, 20ml







Mivacurium Chloride 2 mg/ml

Morphine Hydrochloride 10 mg/ml

Morphine Sulfate 10 mg/ml

Nitrous Oxide

Nitrous oxide/Oxygen 50%V/V / 50%V/V GAS, MEDICINAL INHALATION

Opium 10 mg/ml (1000 ml) TINCTURE ORAL

Opium 10 mg/ml (250 ml) TINCTURE ORAL

Oseltamivir 75 mg CAPSULE ORAL



Peritoneal Dialysis I SOLUTION PARENTERAL

SOLUTION PARENTERAL

Peritoneal Dialysis II SOLUTION PARENTERAL

SOLUTION PARENTERAL

Peritoneal Dialysis III SOLUTION PARENTERAL

SOLUTION PARENTERAL




INJECTION, POWDER, LYOPHILIZED PARENTERAL






Piroxicam 20 mg/ml INJECTION PARENTERAL






Prostaglandin E2 GEL VAGINAL

Prostaglandin E2 10 mg/ml, 0.5ml INJECTION PARENTERAL

Prostaglandin E2 3 mg TABLET VAGINAL

Pancuronium Bromide 2 mg/ml, 2ml

Pentazocine 30 mg/ml, 1ml







Pipecuronium Bromide 4 mg

Piperacillin Sodium/Tazobactam Sodium 2g/250mgPiperacillin Sodium/Tazobactam Sodium 3g/375mgPiperacillin Sodium/Tazobactam Sodium 4g/500mg

Piperacillin 1 g

Piperacillin 2 g

Polymyxin B Sulfate 500,000 U


Propofol 10 mg/ml, 20ml


propofol 20mg/ml, 50ml

Quinine Sulfate 200 mg TABLET ORAL

Ranitidine 50 mg/50ml INJECTION PARENTERAL

Rasburicase 1.5 mg INJECTION, POWDER PARENTERAL

Remifentanil HCl 1 mg INJECTION, POWDER, PARENTERAL




Ribaverin 100 mg INJECTION PARENTERAL

Ribavirin 200 mg CAPSULE ORAL

Ribavirin 200 mg TABLET ORAL

Rifabutin 150 mg CAPSULE ORAL

Rifabutin 300 mg TABLET ORAL

Selenium 50 mcg/ml INJECTION PARENTERAL

Stavudine 40 mg CAPSULE ORAL

Stavudine 40 mg TABLET ORAL

Stavudine 5 mg/5ml POWDER, FOR SOLUTION ORAL



Succinylcholine Chloride 1 g INJECTION, POWDER, PARENTERAL

Succinylcholine Chloride 100 mg INJECTION, POWDER, PARENTERAL

Succinylcholine Chloride 100 mg/ml, 10ml INJECTION PARENTERAL

Succinylcholine Chloride 20 mg/ml INJECTION PARENTERAL



Succinylcholine Chloride 500 mg INJECTION, POWDER, PARENTERAL

Sufentanil 5 mcg/ml, 2ml INJECTION PARENTERAL

Sufentanil 5 mcg/m, 5ml INJECTION PARENTERAL

Sufentanil 5 mcg/ml, 10ml INJECTION PARENTERAL

Sufentanil 50 mcg/ml INJECTION PARENTERAL

Tenofovir disoproxil fumarate 300 mg Tablet Oral

Reteplase 10.4 U



Thiamine HCl 100 mg/ ml Injection Intravenous Drip

Thiopental Sodium 1 g INJECTION, POWDER, PARENTERAL

Thiopental Sodium 25 mg/ml, 20ml INJECTION PARENTERAL

Thiopental Sodium 50 mg/ml, 20ml INJECTION PARENTERAL

Thiopental Sodium 500 mg INJECTION, POWDER, PARENTERAL

Thyrotropin Alfa 1.1 mg INJECTION, POWDER, LYOPHILIZED PARENTERAL

Thyrotropin Alfa 900 mcg INJECTION, POWDER, LYOPHILIZED PARENTERAL





Voriconazole 200 mg INJECTION PARENTERAL

Voriconazole 200 mg TABLET ORAL

Voriconazole 50 mg TABLET ORAL

Water 1000 ml INJECTION PARENTERAL

Water 500 ml INJECTION PARENTERAL

Calcium Gluconate 2.5% GEL TOPICAL


Enoxaparin Sodium 100 mg/ml, 3 ml INJECTION PARENTERAL

Aminoacid 10 % INJECTION PARENTERAL

Ibuprofen 10 mg/ml INJECTION, SOLUTION INTRAVENOUS DRIP





Midazolam 10 mg/ml, 5ml SOLUTION BUCCAL





Midazolam Hydrochloride 2 mg/ml SYRUP ORAL


Urokinase 250,000 IU

Urokinase 75,000 IU

Vancomycin (As Hydrochloride) 500 mg

Ketorolac Trometamol 30 mg/ml INJECTION, SOLUTION PARENTERAL

Aminoacid 10 % INJECTION, SOLUTION INTRAVENOUS DRIP

Amiodarone Hydrochloride 150 mg/100ml SOLUTION, INJECTION PARENTERAL

Valganciclovir 250 mg/5ml POWDER ,FOR SOLUTION ORAL

Ketorolac Tromethamine 15 mg/ml INJECTION PARENTERAL

Ibuprofen Lysine 400 mg/3ml INJECTION , SOLUTION PARENTERAL





Plerixafor 20mg/ml INJECTION, SOLUTION PARENTERAL


توضيحات

ATC Code Description

B01AC13

N02BE01 -

N02BE01 -

N02BE01 -

N02BE01 -

N02BE01 -

V03AB23

J05AB01

J05AB01

C01EB10

B05AA01

B05AA01

B05AA01

B05AA01

B05AA01

B05AA01

B05AA01

دستهدارو

B05AA01

N01AH02

N01AH02

N01Ah02

B05BA01

B05BA01

Isoleucine 2.50g+Leucine 4.45g+lysine HCl 3.50g+Methionine 2.20g+Phenylalanine 2.35g+Threonine 2.10g+Tryptophane 0.80g+Valine 3.10g+Arginine 5.75g+Histidine 1.50g+Alanine 5.25g+Glycine 6.00g+ Asparatic acid 2.80g+ Glutamic acid 3.60g +Proline 2.75g+Serine 1.15g+Tyrosine 0.40g+ Sodium acetate 3H2O 1.361g+ Sodium chloride 0.964g + Sodium hydroxide 0.140g+potassium acetatc2/453g+ Magnesium chloride 4H2O 0.508g+Disodium phosphate dodecahydrate 3.581g+ Water for inj. Q.S. to 1000 ml


B05BA01

B05BA01

B05BA01

B05BA01

B05BA01

B05BA01

B05BA10



Isoleucine 2.55g+Leucine 4.45g+Lysine HCl 3.5g +Methionine 1.9g+Phenylalanine2.55g+Threonine 2.05g+Tryptophane 0.90g+Valine 2.40g+Arginine 4.60g+Histidine 2.6g+Alanine 6.85g+Aminoacetic acid 3.95g+Asparagine H2O 1.86g+Aspartic acid 0.65g+Cysteine HCl 0.3

Isoleucine 2.55g+Leucine 4.45g+Lysine HCl 3.5g +Methionine 1.9g+Phenylalanine2.55g+Threonine 2.05g+Tryptophane 0.90g+Valine 2.40g+Arginine 4.60g+Histidine 2.6g+Alanine 6.85g+Aminoacetic acid 3.95g+Asparagine H2O 1.86g+Aspartic acid 0.65g+Cysteine HCl 0.36g +glutamic acid 2.30g+Ornithine HCl 1.60g+Proline 4.45g+Serine 1.20g+Tyrosine 0.30g +N-Acetyl tyrosine 0.43g+Water for inj. Q.S. to 1000 ml

Isoleucine 2.5g+Leucine 3.7g+Lysine(as monoacetate)3.3g+methionine2.15g+Phenylalanine2.55g+Threonine2.2g+Tryptophan1g+Valine3.1g+Arginine6g+Histidine1.5g+Glycine5.5g+Alanine7g+Proline5.6g+Serine3.25g+Tyrosin0.2g+Taurine0.5g and Water for inj. Q.S. to 1000 ml


nutriflex lipid plus: Isoleucine 2.26g +Leucine 3.01g+Lysine HCl 2.73g +Methionine 1.88g+Phenylalanine3.37g+Threonine 1.74g+Tryptophane 0.54g+Valine 2.50g+Arginine 2.59g+Histidine HCl monohydrate 1.62g+Alanine 4.66g+Glycine 1.58g+Aspartic acid 1.44g+Glutamic acid 3.37 g+Proline 3.26g+Serine 2.88+ Sodium Chloride 0.402g+Sodium acetate trihydrate 0.222g+ Potassium acetate 2.747g+ Magnesium Acetate tetrahydrate 0.686g + Calcium Chloride dihydrate 0.470g + Sodium hydroxide 0.781 g+Glucose monohydrate 132g+Sodium dihydrogen phosphate dihydrate 1.872g+Zinc acetate dehydrate 5.264g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml

B05BA10

B05BA10

C01BD01

J02AA01

P01BE02

P01BE02

P01BE03

P01BE03

P01BE03

P01BE03

P01AX Atovaquone 250 mg + Proguanil Hydrochloride 100 mg

P01AX Atovaquone 62.5 mg + Proguanil Hydrochloride 25 mg

M03AC04

M03AC04

L01XX32

J06AA04 **Antitoxin**

J06AA04 **Antitoxin**

N01BB01

N01BB01

N01BB01

N01BB01

N01BB01

N02AE01

N06BC01

N06BC01

A11CC04

A11CC04

nutriflex lipid special: Isoleucine 3.28g + Leucine 4.38g + Lysine HCl 3.98g + Methionine 2.74g + Phenylalanine4.92g + Threonine 2.54g + Tryptophane 0.8g + Valine 3.6g + Arginine 3.780g + Histidine HCl monohydrate 2.37g + Alanine 6.79g + Glycine 2.31g + Aspartic acid 2.1g + Glutamic acid 4.91g +Proline 4.76g +Serine 4.2g + Sodium Chloride 0.378g+Sodium acetate trihydrate 0.25g+ Potassium acetate 3.689g+ Magnesium Acetate tetrahydrate 0.91g + Calcium Chloride dihydrate 0.623g + Sodium hydroxide 1.171 g+Glucose monohydrate 158.4g+Sodium dihydrogen phosphate dihydrate 2.496g+Zinc acetate dehydrate 7.02g+Triglyceride,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml

nutriflex lipid peri: Isoleucine 1.872g +Leucine 2.504g+Lysine HCl 2.272g +Methionine 1.568g+Phenylalanine2.808g+Threonine 1.456g+Tryptophane 0.456g+Valine 2.08g+Arginine 2.160g+Histidine HCl monohydrate 1.352g+Alanine 3.88g+Glycine 1.32g+Aspartic acid 1.20g+Glutamic acid 2.80 g+Proline 2.72g+Serine 2.40g+ Sodium Hydroxide 0.64g + Sodium Chloride 0.865g+Sodium acetate trihydrate 0.435g+ Potassium acetate 2.354g+ Magnesium Acetate 4H2o 0.515g + Calcium Chloride dihydrate 0.353g + Glucose monohydrate 70.4g +Sodium dihydrogen phosphate dihydrate 0.936g+Zinc acetate dehydrate 5.28g+Triglycerids,mediumchain 20g+Soya-bean oil,refined 20g+Water for inj. Q.S. to 1000 ml


J01DA24

J01DA24

J01DA24

J01DA11

J01DA11

J01DA11

J01DD04

J01DD04

J01DD04

J01DD04

M03AC11

M03AC11

M03AC11

M03AC11

J01FF01 **(As Phosphate)**

J01FF01 Treatment of Pneumocystis carinii pneumonia associated with AIDS patients.

B01AC04

B01AB04

B01AB04

B01AB04

B01AB04

B05BB Dextran70 6% NaCl 0.9%

V03AH01

M01AB05

J05AF02

J05AF02

C01AA05

V03AB09

B01AC07

C01CA07

C01CA07

C01CA04

R07AB01

J01AA02

N01AH51 (Droperidol 25mg+Fentanyl(as citrate) 0.5mg)/10ml

N01AX01

V03AB03

V03AB03

V04CX

J05AG03

J05AG03

J05AG03

J05AG03

J05AG03

J05AG03

N01AB04

B01AB05

B01AB05

B01AB05

B01AB05

B01AB05

J04AM06

J04AM06 (Ethambutol 275mg+Isoniazid 75mg+Rifampin 150mg)

N01AA

N01AX07

N01AH01

N01AH01

N01AH01

N01AH01

J02AC01 کشور داخل در تولید شرط بهJ02AC01 کشور داخل در تولید شرط به

J01GB03

N01AB01

B01AB01

B01AB01

B01AB01

B01AB01

B01AB01

M01AE01

M01AE01

M01AE01

B05DA

J01DH51

(Ethambutol 275mg+Isoniazid 75mg+Pirazinamide 400mg +Rifampin 150mg)

(As Sulfate) in sodium chloride 0.9% (premixed) در تولید شرط بهکشور داخل

J01DH51

J01DH51

M01AB01

N01AB06

J04AM02 Isoniazid 50 mg + Pyrazinamide 300 mg + Rifampin 120 mg

N01AX03

M01AB15

C07AG01

N01BB52 (Lidocaine HCl 5%+Dextrose 7.5%)

N01BB03

N01BB03

N01BB03

N07BC02

N07BC02

C01CE02

C01CE02

A02BB01

A02BB01

M03AC10

N02AA01

N02AA01

N02AA01

N02AA01

J01MA14

A11AE

J05AE04

J05AE04

N07AA01

N07AA01

N07AA01

J05AG01

J05AG01

C01DA02

C01DA02

C01DA02

N01AX13

N01AX13

دستگاه به مجهز و کودکان قلب تخصص فوق و نوزادان تخصص فوق دارای مراکز درتشخیص جهت PDA (Patent ductus arterious) اکوکاردیوگرافی



**Without preservative** کشور داخل در تولید شرط به

As Hydrochloride تولید شرط بهکشور داخل در

N01AX63

N02AA02

N02AA02

J05AH02

M03AC01

N02AD01

B05D

B05D

B05D

B05D

B05D

B05D

N02AB02

N02AB02

N02AB02

M03AC06

J01CR05 Piperacillin (as Sodium ) 2g + Tazobactam (as Sodium ) 250mg



J01CR05

J01CR05

M01AC01

S01AA18 **INJECTION/OPHTHALMIC DROPS**

N01AX10

N01AX10

N01AX10

N01AX10

G02AB02 **(Dinoprostone)**



Entonox کشور داخل در تولید شرط به





Na+ 132 mEq/L + Ca++ 3.5 mEq/L + Mg++ 1.5 mEq/L + Cl- 102 mEq/L + Lactate 35 mEq/L+Dextrose anhydrous or monohydrate Eq. to 38.60 g/L Dextrose+Water For Inj. Q.S.To 1000ml


P01BC01

A02BA02

V03AF07

N01AH06

N01AH06

N01AH06

B01AD07

J05AB04

J05AB04

J05AB04

J04AB04

J04AB02

A12CE02 As Sodium Selenite Pentahydrate

J05AF04

J05AF04

J05AF04

B01AD01

B01AD01

M03AB01

M03AB01

M03AB01

M03AB01

M03AB01

M03AB01

M03AB01

N01AH03 As Citrate

N01AH03 As Citrate

N01AH03 As Citrate

N01AH03 As Citrate

J05AF07 254 mg Tenofovir disoproxil

(As Hydrochloride) in sodium chloride 0.45% (premixed) داخل در تولید شرط بهکشور

A11DA01

N01AF03

N01AF03

N01AF03

N01AF03

V04CJ01

V04CJ01

N02AX02

B01AD04

B01AD04

A07AA09

J02AG03

J02AG03

J02AG03

V07

V07

D11AX03 کشور داخل در تولید شرط به

C01EB16

B01AB05 30,000U anti-xa/3ml(multi dose)

C01EB16

B05BA01 **(as Lysine)**

J01GB03 **(As Sulfate)**


J01GB03


N05CD08 **(As Hydrochloride)**

N05CD08

N05CD08

N05CD08

N05CD08

N05CD08 -

aa،انفوزیون الزم میباشد 30زمان دقیقه .

دستگاه به مجهز و کودکان قلب تخصص فوق و نوزادان تخصص فوق دارای مراکز درتشخیص جهت PDA (Patent ductus arterious) اکوکاردیوگرافی


(As Sulfate) in sodium chloride 0.9% (premixed) داخل در تولید شرط به کشور





M01AB15

B05BA01

C01BD01

J05AB14 As Hydrochloride M01AB15

M01AE01

B05XA02 -

B05XA02 -

B05XA02 -

B05XA02 -

A03AX16




دسترسي محل تاریخ

Availability Site Date

ميشود توزيع بيمارستاني داروخانه در فقط

ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط


. پس و بيمارستان در ، وريدي تزريق صورت به فقط خاص دسترسي با داروهاي فهرستگيرد قرار مصرف مورد پروتکل تهيه .از









1390/1/29

1390/1/29

. ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست


1389/8/24

1389/10/25




1389/10/25

1389/10/25





1389/10/25

1389/11/4


ميشود توزيع بيمارستاني داروخانه در فقطميگيرد قرار سالمت معاونت اختيار در فقطميگيرد قرار سالمت معاونت اختيار در فقطميگيرد قرار سالمت معاونت اختيار در فقطميگيرد قرار سالمت معاونت اختيار در فقطميگيرد قرار سالمت معاونت اختيار در فقطميگيرد قرار سالمت معاونت اختيار در فقط

ميگيرد قرار سالمت معاونت اختيار در فقط

ميگيرد قرار سالمت معاونت اختيار در فقط

ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

سرطان درمان تخصصي مراکز داراي بيمارستانهاي درگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقط



ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

بيمارستانها در توزيع و نوزادان تخصصان فوق تجويز تحت ً صرفابيمارستانها در توزيع و نوزادان تخصصان فوق تجويز تحت ً صرفاغدد و کليه تخصصي فوق مراکز داراي بيمارستانهاي درغدد و کليه تخصصي فوق مراکز داراي بيمارستانهاي در






ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط





1390/3/9

ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط




ميشود توزيع بيمارستاني داروخانه در .فقط

ميشود توزيع بيمارستاني داروخانه در .فقط


ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

گيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

گيرد قرار سالمت معاونت اختيار در فقط

گيرد قرار سالمت معاونت اختيار در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

1390/3/9

1390/3/9

1390/3/9

ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

1390/06/14

1390/06/14

1390/03/07


. ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست . ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست


و کودکان قلب تخصص فوق و نوزادان تخصص فوق داراي مراکز درتشخيص جهت اکوکارديوگرافي دستگاه به PDA (Patent ductus مجهز

arterious) . ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست . ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست

صفاقی دیالیز بیماران اختیار در مستقیما خاص دسترسیگیرد قرار


خاص دسترسي با داروهاي فهرست 1390/03/07

ميشود توزيع بيمارستاني داروخانه در فقطگيرد قرار سالمت معاونت اختيار در فقطميشود توزيع بيمارستاني داروخانه در فقط

ميشود توزيع بيمارستاني داروخانه در فقط 1389/5/30ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

دندانپزشکی در مصرف برای فقط 90/3/23دندانپزشکی در مصرف برای فقط 90/3/23


1389/10/25

1389/10/25

ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط 1389/8/24

شهيد بنياد به وابسته بيمارستاني مراکز در مصرفشهيد بنياد به وابسته بيمارستاني مراکز در مصرف


1390/3/7

نوزادان تخصص فوق توسط تجويز و بيمارستانها در فقط توزيعگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقط




گيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط


. تحت و منتخب های داروخانه و بیمارستانها در فقط خاص دسترسی با داروهای فهرست . زایمان و زنان متخصص نسخه با شود می توزیع نظارت


. ريه و عفوني متخصصين توسط تجويزتنها ميشود توزيع بيمارستاني داروخانه در فقطاست .مجاز

- - و تهران قلب رجايي شهيد قلب کودکان طبي مراکز درخميني امام و دانشوري مسيح بيمارستان

ميشود توزيع بيمارستاني داروخانه در فقط 1389/5/30

1389/7/17

گيرد قرار سالمت معاونت اختيار در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

گیرد می قرار صفاقی دیالیز بیماران اختیار در مستقیما سازنده دارویی شرکت توسط

گیرد می قرار صفاقی دیالیز بیماران اختیار در مستقیما سازنده دارویی شرکت توسط 1389/8/24









ميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

1389/10/25

1389/10/25

1389/10/25

. قرار مواد مصرف سوء درمان اختيارمراکز در فقط خاص دسترسي با داروهاي فهرستگيرد

. قرار مواد مصرف سوء درمان اختيارمراکز در فقط خاص دسترسي با داروهاي فهرستگيرد




گيرد قرار سالمت معاونت اختيار در فقط1390/3/9

محک و اصغر علي بيمارستان براي فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقطميشود توزيع بيمارستاني داروخانه در فقط

گيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقطگيرد قرار سالمت معاونت اختيار در فقط

90/3/23












ميشود توزيع بيمارستاني داروخانه در فقط 1389/6/29





سرطان تشخيص تخصصي مراکز داراي بيمارستانهاي درسرطان تشخيص تخصصي مراکز داراي بيمارستانهاي در




کار از ناشی حوادث در مصرف برای خاص دسترسی با داروهای فهرست 1390/07/05

خاص داروهای فهرست خاص دسترسي با داروهاي فهرست 1390/09/20

1390/09/21

1390/09/21

1390/09/21

1390/12/22

1390/12/22

1390/12/22

1390/12/22

1391/02/25

1391/02/25

1391/02/25

1391/02/25

1391/02/25

1391/02/25

. بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرستميشود .توزيع

پيوند، بخش در قارچي شديد عفونت به مبتال بيماران براي فقطعفوني و انکولوژي

(Invasive Fungal Infections)پيوند، بخش در قارچي شديد عفونت به مبتال بيماران براي فقط

عفوني و انکولوژي (Invasive Fungal Infections)

پيوند، بخش در قارچي شديد عفونت به مبتال بيماران براي فقطعفوني و انکولوژي

(Invasive Fungal Infections)



. ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرستخاص داروهای فهرست









1391/5/4

1391/10/03

واگیردار بیماریهای مدیریت مرکز زیرنظر ، خاص دسترسي با 1391/10/031392/5/29

1392/5/29

1392/10/04

1392/10/04

1392/10/04

1392/10/04

1393/01/24





خاص داروهای فهرست . ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست . ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست . ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست . ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست . ميشود توزيع بيمارستاني داروخانه در فقط خاص دسترسي با داروهاي فهرست

متابوليک داروهاي فهرستMETABOLIC DRUGS' LIST


No Drug Name Dosage Form Route of Admin ATC Code

1 Arginine Hydrochloride 100 g POWDER ORAL B05XB01

2 INJECTION PARENTERAL B05XB01

3 Betaine Anhydrous 1 g SOLUTION ORAL A16AA06

4 Biotin 5 mg TABLET ORAL L01XC07

5 Cysteamine 150 mg CAPSULE ORAL A16AA04

6 Cysteamine 150 mg POWDER ORAL A16AA04

7 Cysteamine 50 mg CAPSULE ORAL A16AA04

8 Glycine 1 g POWDER ORAL B05CX03

9 Imiglucerase 200 U INJECTION, POWDER PARENTERAL A16AB02

10 Imiglucerase 400 U INJECTION, POWDER PARENTERAL A16AB02

11 Laronidase 2.9mg/ml, 5ml INJECTION PARENTERAL A16AB05

12 Lorenzos Oil 500 ml OIL ORAL __

13 Nitisinone 10 mg CAPSULE ORAL C08CA06

14 Nitisinone 10 mg TABLET ORAL C08CA06





19 Phosphocysteamine 150 mg CAPSULE ORAL A16AA04

20 Phosphocysteamine 150 mg POWDER ORAL A16AA04

21 Sapropterin Dihydrochloride 50 mg TABLET ORAL _____

22 Serine 600 mg CAPSULE ORAL _____

23 SOLUTION ORAL ____

24 INJECTION PARENTERAL ____

25 INJECTION PARENTERAL A16AX03

26 Sodium Phenylbutyrate 500 mg TABLET ORAL A16AX03

27 Uridine 1 mg TABLET ORAL ____

رديف

دستهدارو

Arginine Hydrochloride 100 mg/ml, 100ml

Sodium Benzoate/Sodium Phenylacetate 10%-10%Sodium Benzoate/Sodium Phenylacetate 10%-10%Sodium Phenylbutyrate 200 mg/ml,10ml

28 Alglucosidase Alfa 50 mg INJECTION, POWDER PARENTERAL A16AB07

29 Sodium Benzoate 500 mg TABLET ORAL ____

30 Carglumic Acid 200 mg TABLET, DISPERSIBLE ORAL A16AA05

متابوليک داروهاي فهرستMETABOLIC DRUGS' LIST

توضيحات ورود تاریخ

Description Date

متابوليک بيماران براي فقط

سيستينوزيس به مبتال بيماران براي فقطسيستينوزيس به مبتال بيماران براي فقط

هيپرآمونميا به مبتال بيماران براي فقط(Hyperammonemia)


هموسيستينوريا به مبتال بيماران براي فقط(Homocystinuria)

**(As Bitartrate)** به مبتال بيماران براي فقطسيستينوزيس

(Cystinosis, Nephropathic)**(As Bitartrate)** به مبتال بيماران براي فقط

سيستينوزيس (Cystinosis, Nephropathic)

**(As Bitartrate)** به مبتال بيماران براي فقطسيستينوزيس

(Cystinosis, Nephropathic)ايزولريک اسيدمي به مبتال بيماران براي Isovaleric) فقط

Acidemia) غير مزمن گوشه سندرم به مبتال بيماران براي فقطکليوي

(Non-neuropathic Gaucher's disease, chronic) غير مزمن گوشه سندرم به مبتال بيماران براي فقطکليوي

(Non-neuropathic Gaucher's disease, chronic)ساکاريدوز موکوپلي به مبتال بيماران براي فقط

(Mucopolysaccharidosis, Type I and Scheie form )

آدرنولکوديستروفي به مبتال بيماران براي فقط(Adrenoleucodystrophy)

Early stages Onlyتيروزينميا به مبتال بيماران براي Tyrosinemia type) فقط

I) تيروزينميا به مبتال بيماران براي Tyrosinemia type) فقطI) تيروزينميا به مبتال بيماران براي Tyrosinemia type) فقطI) تيروزينميا به مبتال بيماران براي Tyrosinemia type) فقطI) تيروزينميا به مبتال بيماران براي Tyrosinemia type) فقطI)

تيروزينميا به مبتال بيماران براي Tyrosinemia type) فقطI)

کتونوريا فنيل به مبتال بيماران براي فقط(Phenylketonuria)

In patients responsive to tetrahydrobiopterin سرين کمبود به مبتال بيماران براي Serine) فقط

deficiency)





يوروتيک اسيدوري به مبتال بيماران براي Orotic) فقطAciduria)

1390/07/05

1392/7/22

1393/01/24

متابولیک - داروهای خاص داروهای فهرستگردد 14جهت می ثبت بیمار .

Rare metabolic conditions for childrenخاص داروهاي (orphan) فهرست

Rare metabolic conditions for childrenخاص داروهاي (orphan) فهرست

داروها راديو فهرستRADIOPHARMACEUTICALS' LIST

دارو نام دارويي شکل

Drug Name Dosage Form

(123I) Sodium Iodide 0.1 mCi CAPSULE

(123I) Sodium Iodide 0.2 mCi CAPSULE

(123I) Sodium Iodide 2 mCi/ml SOLUTION

(131I) Sodium Iodide (3.5-150) mCi SOLUTION

(18F) Fludeoxyglucose (10-30) mCi(18F) Sodium Fluoride 10 mCi

(64Cu) Diacetyl-bis(N4-methylthiosemicarbazone) (ATSM) (5-10) mCiErbium (169Er) Citrate Colloid (5-10) mCi

Gallium[67ga]citrate 10 mCi INJECTION

Gallium[67ga]citrate 5 mCi INJECTION

Indium (111In) Chloride 10 mCiIndium (111In) Ibritumomab Tiuxetan Indium (111In) Oxyquinoline 1 mCi/mlIndium (111In) Pentetate 1 mCi/mlIobenguane (123I ) 10 mCiIobenguane (131I ) (50-300) mCiIobenguane (131I) (0.5-1) mCi

Iodide [125I] (0.281-0.878) mCi CAPSULE

Iodide [131i] Sodium 100 mCi SOLUTION

Iodide [131i] Sodium 100 micCi CAPSULE







Iodine (131I) Tositumomab 5 mCi

Krypton [81mKr] Gas 4 mCi INHALER

Krypton [81mKr] Gas 8 mCi INHALER

Phosphate [32p] Sodium 5 mCi SOLUTION

Phosphorous [32P] Chromic Phosphate Colloid 5 mCi INJECTION

Rhenium (186Re) Sulfur Colloid (5-10) mCi

Rubidium (82Rb) Chloride Samarium (153 Sm) Lexidronam (70-300)mCiStrontium (89Sr) Chloride 1 mCi/ml

INJECTION, SOLUTION

INJECTION, SOLUTION


INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION


INJECTION, SOLUTION


INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION

Technesium [99mTc]Human Immunoglobulin G (15-25) mCi

Technesium [99mTc]Tyrosine Octreotate (15-25) mCi

Technesium [99mTc]Tyrosine Octreotide (15-25) mCi

Technetium (99mTc) EDDA-tricine-HYNIC-bombesin (15-20) mCiTechnetium (99mTc) Pentetate (25-30) mCi INHALER

Technetium [99mtc]antimony Sulfur Colloid (5 - 50) mCi INJECTION

Technetium [99mtc]bicisate (10 - 100) mCi

Technetium [99mtc]ethylenedicystein (10 - 100) mCi

Technetium [99mtc]etidronate (up to 150) mCi

Technetium [99mtc]exzametazine (10 - 30) mCi

Technetium [99mtc]glucoheptonate (up to 150) mCi

TECHNETIUM [99mTc]Human Immunoglobulin G (15-25) mCi

Technetium [99mtc]macrosalb (5 - 30) mCi

Technetium [99mtc]mebrofenin (up to 100) mCi

Technetium [99mtc]medronate (up to 300) mCi

Technetium [99mtc]mertiatide (10 - 100) mCi

Technetium [99mtc]pentate (up to 300) mCi

Technetium [99mtc]Pertechnetate 100 mCi INJECTION




Technetium [99mtc]phytate (up to 100) mCi

Technetium [99mtc]pyrophosphate (up to 80) mCi INJECTION

Technetium [99mtc]sestamibi (20-100) mCi

Technetium [99mtc]stannous Agent labelled Cells (10-100) mCi

Technetium [99mtc]succimer (up to 40) mCi

Technetium [99mtc]sulfur Colloid (10-100) mCi

Technetium [99mtc]tin Colloid (up to 100) mCi

Technetium[99mtc]pentavalent Succimer (20-80) mCi

Thallium [201Tl] Chloride 10 mCi INJECTION

Thallium [201Tl] Chloride 5 mCi INJECTION

Xenon (133Xe) (10-20) mCiYttrium (90Y) Citrate Colloid (5-6) mCiYttrium (90Y) Ibritumomab Tiuxetan (30-40) mCi

Yttrium (90Y)hydroxy apatite INJECTION


Technetium [99mTc]ciprofluxacin









INJECTION, POWDER, LYOPHILIZEDINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION



INJECTION, POWDER, LYOPHILIZEDINJECTION, POWDER, LYOPHILIZED



INJECTION, POWDER, LYOPHILIZED,INJECTION, POWDER, LYOPHILIZED,



INJECTION, POWDER, LYOPHILIZEDINJECTION, POWDER, LYOPHILIZED

INJECTION, SOLUTION

INJECTION, SOLUTION

INJECTION, SOLUTION



Germanium(68 Ge)/Gallium(68 Ga) Generator GENERATOR*

Gallium(68 Ga)-Octrotate

Lutetium(177Lu)ethylenediamine tetramethylene phosphonate INJECTION

Holmium(166Ho)chitosan INJECTION

Yttrium (90Y)DOTA-Tyr3-Otreotide INJECTION

Yttrium (90Y)Glass Beads INJECTION


داروها راديو فهرستRADIOPHARMACEUTICALS' LIST

مصرف راه دارو دسته توضيحات تاریخ

Route of Admin ATC Code DescriptionList Name Date

ORAL V09FX02 For Diagnostic Use 1389/10/25



ORAL V09FX02 For Therapeutic Use 1389/10/25





1389/10/25


INTRAVENOUS BOLUS V09HX01 -

INTRAVENOUS BOLUS V09HX01 -




PARENTERAL V09AX01 For Diagnostic Use 1389/10/25


PARENTERAL V10XA02 For Therapeutic Use 1389/10/25


TRANSDERMAL V09GB02 **Implant**

ORAL V09FX03 -

ORAL V09FX03 -

ORAL V09FX03 -

ORAL V09FX03 -

ORAL V09FX03 -

ORAL V09FX03 -

ORAL V09FX03 -

ORAL V09FX03 -

PARENTERAL V10XA53 For Diagnostic Use 1389/10/25

RESPIRATORY V09EX01 **Generator**

RESPIRATORY V09EX01 **Generator**

ORAL V10XX01 -

INTRACAVITARY V10AX01 -







دسترسی - سطح دارویی فهرست

INTRAVENOUS BOLUS V09HA01 -

INTRAVENOUS BOLUS V09HA01

INTRAVENOUS BOLUS V09 -


1389/10/25

RESPIRATORY V09EA For Diagnostic Use 1389/10/25

SUBCUTANEOUS V09DB -


INTRAVENOUS BOLUS V09CA -

INTRAVENOUS BOLUS V09BA -



PARENTERAL V09CA04

INTRAVENOUS BOLUS V09EB01 -

INTRAVENOUS BOLUS V09DA04 -




INTRAVENOUS BOLUS V09FX01 **Generator**











INTRAVENOUS BOLUS V09IA03 -

INTRAVENOUS BOLUS V09GX01 -

INTRAVENOUS BOLUS V09GX01 -

PARENTERAL V09EX03 For Diagnostic Use 1389/10/25

INTRA-CAVITY V10AA01 For Therapeutic Use 1389/10/25

PARENTERAL V10XX02 For Therapeutic Use 1389/10/25

PARENTERAL V10AA داروها راديو فهرست 1391/9/1

PARENTERAL V09H داروها راديو فهرست 1391/9/1

PARENTERAL V09H داروها راديو فهرست 1391/9/1

_

V09X داروها راديو فهرست 1391/9/1

PARENTERAL V09X داروها راديو فهرست 1391/9/1

PARENTERAL V10B داروها راديو فهرست 1391/9/1

PARENTERAL V10XX داروها راديو فهرست 1391/9/1



منبع عنوان به ژنراتور سامانه- گالیوم انواع 68تولید تولید برای

گالیوم* - حاوی داروهای رادیورود 68 می کار به

بالک داروهاي فهرستBULK LIST

دارو نام

No Drug Name Dosage Form Route of Admin ATC Code

1 Absorption Base BULK V03

2 Acetic Acid BULK V03

3 Acetone BULK V03

4 Aluminium Chloride BULK V03

5 Ammonium Alum BULK V03

6 Ammonium Chloride BULK V03

7 Ammonium Hydroxide BULK V03

8 Azelaic Acid BULK V03

9 Benzoic Acid BULK V03

10 Benzoin Tincture BULK V03

11 Benzyl Benzoate BULK V03

12 Betamethasone BULK V03

13 Borax BULK V03

14 Boric Acid BULK V03

15 Cade Oil BULK V03

16 Camphor BULK V03

17 Carbon [14C] Urea 5 micCi SOLUTION ORAL V04C

18 Chloroacetic Acid BULK V03

19 Citric Acid BULK V03

20 Clindamycin BULK V03

20 Clindamycin BULK V03

21 Coal Tar BULK V03

22 Collagen BULK V03

23 Collodion BULK V03

24 Copper Sulfate BULK V03

25 Cream Base BULK V03

26 Cresol BULK V03

27 Dexamethasone BULK V03

28 Dextrose BULK V03

29 Dichloroacetic Acid BULK V03

30 Distilled Water BULK V03

31 Dithranol BULK V03

32 Eosin BULK V03

33 Erythromycin BULK V03

34 Ethacridine Lactate BULK V03

35 Ethanol BULK V03

36 Ethanol * BULK V03

37 Formaldehyde BULK V03

38 Gentian Violet BULK V03

رديف

شکلدارويي

راهمصرف

دستهدارو

39 Glycerin BULK V03

40 Glycolic Acid BULK V03

41 Hyaluronic Acid BULK V03

42 Hydrochloric Acid BULK V03

43 BULK V03

44 Hydrophilic Petrolatum BULK V03

45 Hydroquinone BULK V03

46 Ichthyol BULK V03

47 Iodine BULK V03

48 Isopropyl Alcohol BULK V03

49 Ketoconazole BULK V03

50 Kojic Acid BULK V03

51 Lactic Acid BULK V03

52 Lactose BULK V03

53 Lanolin BULK V03

54 Menthol BULK V03

55 Mineral Oil BULK V03

56 Minoxidil BULK V03

57 Para-Aminobenzoic Acid BULK V03

58 Phenol BULK V03

59 BULK V03

60 BULK V03

61 BULK V03

62 Podophyllin BULK V03

63 Poly Ethylene Glycol BULK V03

64 Polysorbate 80 BULK V03

65 Potassium Citrate BULK V03

66 Potassium Iodide BULK V03

67 Potassium Permanganate BULK V03

68 Progesterone BULK V03

69 Propylene Glycol BULK V03

70 Resorcinol BULK V03

71 Salicylic Acid BULK V03

72 Silver Nitrate BULK V03

73 Sodium Bicarbonate BULK V03

74 Sodium Chloride BULK V03

75 Sodium Citrate BULK V03

76 Sodium Thiosulfate BULK V03

77 Starch BULK V03

78 Stearic Acid BULK V03

79 Sulfur BULK V03

80 Tartaric Acid BULK V03

Hydrogen Peroxide Concentrate

Phosphate, Potassium Monobasic Phosphate, Sodium Dibasic Phosphate, Sodium monobasic

81 Titanium Dioxide BULK V03

82 Tretinoin BULK V03

83 Urea BULK V03

84 Vaseline Officinal BULK V03

85 Vitamin C BULK V03

86 White Wax BULK V03

87 Xylene BULK V03

88 Zinc Oxide BULK V03

89 Zinc Sulfate BULK V03

90 Plastibase OINTMENT TOPICAL D

بالک داروهاي فهرستBULK LIST

توضيحات تاریخ

Description Date

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

** Anhydrous or Monohydrate **

**(As Phosphate)**

**(As Hydrochloride)**

-

-

-

-

-

-

-

-

-

-

-

-

**(Rivanol)**

**(Denaturated For medical use)**

-

-

(Pyroxylin 40g+Ether 750 ml+Alcohol 250 ml)/1000 ml

Denaturated for Medical Use **(Ethyl Alcohol)**

-

-

-

-

**(30% w/W H2O2 )**

-

**(Ichthammol)**

-

-

-

-

-

-

-

-

**(liquid Paraffin )**

-

**PABA**

-

**(KH2po4)**

**(Na2hpo4)**

**(Nah2po4)**

-

Macrogol 4000

-

-

-

-

-

-

**(Resorcin)**

-

-

-

-

-

**(Sodium Hyposulfite)**

-

-

**(Precipitated)**

-

(White Petrolatum86%+White Wax8%+Strearyl Alcohol3%+Cholestrol3%)

-

-

-

-

**(Ascorbic Acid)**

-

-

-

-

- 1390/1/29

طبيعي داروهاي فهرستNatural Products' LIST

دارو نام مصرف مورد

No Drug Name Uses ATC Code

1 Acneherb Topical Gel Antiacne D102 Acnil Topical Gel Antiacne D103 AFS Drop A03

4 Aghaghia Cream Skin protective D025 Agnugol FC Tab PMS & Menstrual disorders G036 Akbar1 Oint Burn Ointment D03

7 Akbar2 Oint Analgesic (Topical) M02

8 Alicom SC Tab Antihypertensive, Antihyperlipidemia C109 Allium-S FC Tab Antihypertensive, Antihyperlipidemia C1010 Alpha Oint Burn Ointment D0311 Althadin Lozenge Mouth and throat antiinflammatory R0212 Altib Powd Sedative, Hypnotic N0513 Anethum Granule Antihyperlipidemia C1014 Anethum Tab (Jar) Antihyperlipidemia C1015 Anethum Tab (bilister) Antihyperlipidemia C1016 Angi Pars Cap Diabetic foot ulcer D0317 Angi Pars Cream Diabetic foot ulcer D0318 Anti Diabetic Powd Antihyperglycemia A1019 Anti fissure Cream Relief of Hemoroid symptoms C0520 Antimigraine Drop Antimigraine, Sedative N0221 Aphrodit Drop Aphrodisiac G0322 Aphrodit SC Tab Aphrodisiac G0323 Arheumin Drop Motion sickness A0424 Arnisin Topical Gel Antiinfalmmatory M0225 Arthroherb FC Tab M0926 Avipect Drop Antitussive, Expectorant R0527 Avipect Syrup Antitussive, Expectorant R05

28 Babooneh Drop A07

29 Bebecold Oint Analgesic (Topical), Decongestant R0530 Belladin Tab Antispasmodic & Anticholinergic A0331 Belladomed Syrup Antispasmodic & Anticholinergic A0332 Bilineaster Drop Antihyperbilirubineamia A05

رديف

شکلدارويي

دستهدارو

Dosage Form

Carminative, Gastrointestinal antispasmodic

Degenerative disorders of musculo- skletal system

Gastrointestinal antiinflammatory & antispasmodic

33 Boldulax FC Tab Laxative A0634 Bran Powd Laxative A0635 Broncho barij Syrup Antitussive, Expectorant R0536 Broncho T.D. Syrup Antitussive, Expectorant R05

37 Bronchogol FC Tab R05

38 Broncosin Syrup Antitussive, Expectorant R0539 Calendit E Cream Antiinflammatory (Topical) D0240 Calendula Oint Antiinflammatory (Topical) D0241 Califig Syrup Laxative, Purgative A06

42 Camilasin Drop A07

43 Capex Cream Analgesic (Topical) M0244 Capoderm Ointment Muscular tention , Rheumatism M0245 Capsaicin 0.025%(30g) Cream Analgesic (Topical) M0246 Capsaicin 0.025%(60g) Cream Analgesic (Topical) M0247 Capsaicin 0.075%(30g) Cream Analgesic (Topical) M0248 Capsaicin 0.075%(60g) Cream Analgesic (Topical) M0249 Capsian Oint Analgesic (Topical) M0250 Capsicum Gel Analgesic (Topical) M02

51 Capsicum Porous Plaster Plaster Analgesic (Topical) M02

52 Capsidin Cream Analgesic (Topical) M0253 Capsipharm 0.075% Cream Analgesic (Topical) M0254 Caramine Powd A0355 Caraway mixture Oral Sol A0356 Cardioton Drop C0157 Cardioton FC Tab C01

58 Cariandom Powd Stomachic, Appetizer A13

59 Cariandom Syrup Stomachic, Appetizer A13

60 Cariandom Tab Stomachic, Appetizer A13

61 Carminatif Powd A0362 Carmint Drop A03

63 Carvil Powd Decreasing the body weight A08

64 Carvil Syrup Decreasing the body weight A08

65 Carvil Tab Decreasing the body weight A0866 Caster Oil Soft Gel Laxative, Purgative A0667 Castoroma Oil Laxative, Purgative A06

Acute bronchitis, various causes of bronchial spasms & for bronchial asthma



Infant carminative & gastrointestinal antispasmodicDecrease in cardiac output (Stage II NYHA)

Decrease in cardiac output (Stage II NYHA)



68 Cefakliman mono Cap PMS & Menstrual disorders G0369 Chamillogol Topical Sol Antiseptic and disinfectant D08

70 Chamisan Solution A07

71 Chicoridin Tab Tonic, Appetizer A1372 Cimifugol FC Tab PMS & Menstrual disorders G0373 Cinnamol Drop Mouth wash A0174 C-Lax Tab Laxative, Purgative A0675 CM Top Lotion M0276 Coldrub Cream Analgesic (Topical), Decongestant R0577 Colpermin Cap Irritable Bowel Syndrome (IBS) A0778 Cominon Powd Antirheumatic pain N02

79 Cominon Syrup Antirheumatic pain N02

80 Cominon Tab Antirheumatic pain N02

81 Crataegus Drop C0182 Cratagol SC Tab C0183 Cratasin Drop C0184 Cratavil FC Tab C0185 Cratonic-S FC Tab C0186 Curcumin Cap Dyspepsia A0387 Cylco3Fort Cap C0588 Cynabile Drop Cholagogue A0589 Cynar FC Tab Cholagogue A0590 Cynarchol Tab Cholagogue A0591 Cynarol Tab Cholagogue A0592 Deconjestan Inhaler Inh Stick Cold remedy R0593 Dentafort plus Gel Toothache A0194 Dentol Drop Toothache A0195 Deproherb Drop Antidepressant N0696 Dermatin Cream Cantact dermatits D0297 Derosil Drop Antitussive, Expectorant R0598 Diamed Sachet Antihyperglycemia A1099 Dillsun Drop A03100 Dineh inhaler Powd Cold remedy R05101 Diuretic Powd Diuretic C03102 Diurin Drop Diuretic C03103 D-Reglis Tab (Jar) Gastrointestinal antiinflammatory A07104 D-Reglis Tab (Blister) Gastrointestinal antiinflammatory A07


Topical antiinflammatory & analgesic in osteoarthritis



Decrease in cardiac output (Stage II NYHA)Decrease in cardiac output (Stage II NYHA)


Vascular disorders, Relief of Hemoroid symptoms


105 Ear-gol Ear Drop Ear wax softner S02106 Echiasin Tab Immunostimulant L03107 Echinamed Tab Immunostimulant L03108 Echinasoha FC Tab Immunostimulant L03109 Enoxolon Oint Antiinflammatory (Topical) D02110 Equidiuret Tab Diuretic C03111 Eucalyptus Inh Inh Cold remedy R05112 Eucalyptus Inh Inh Cold remedy R05113 Eucalyptus Inh Inh Cold remedy R05114 Eucalyptus Inh Inh Cold remedy R05115 Eucalyptus Inh Inh Cold remedy R05116 Eucalyptus Inh Inh Cold remedy R05117 Eucalyptus Inh Powd Cold remedy R05118 Fennelin Drop G03119 Fijan (120ml) Syrup Laxative, Purgative A06120 Fijan (60ml) Syrup Laxative, Purgative A06121 Formula For Men Tab G03122 Galega Tab Adjuant in Antihyperglycemia A10123 Galyx Lotion Antiacne D10124 Garcin SC Tab Antihypertensive, Antihyperlipidemia C10125 Garcin 500 SC Tab Antihypertensive, Antihyperlipidemia C10126 Garlet SC Tab (50) Antihypertensive, Antihyperlipidemia C10127 Garlet SC Tab (100) Antihypertensive, Antihyperlipidemia C10128 Garlic Drop Antihypertensive, Antihyperlipidemia C10129 Garlicap Cap Antihypertensive, Antihyperlipidemia C10130 Gasterin FC Tab Gastrointestinal antiinflammatory A07131 Gasterolan Drop A03132 Gastrodin Tab Gastrointestinal antiinflammatory A07133 Gastrolit Drop Irritable Bowel Syndrome (IBS) A07134 General tonic Powd Tonic, Appetizer A13135 Gentiana Powd Tonic A13

136 Gentiana Syrup Tonic A13

137 Gentiana Tab Tonic A13138 Gingiton Cap Motion sickness A04139 Ginkgo T.D. Tab N06140 Ginkgora FC Tab N06141 Ginkogol FC Tab N06

Treatment of dysmenorrhea symptoms

To assist the function and health of the prostate, urinary and male


Symptomatic relief of organic brain dysfunction

Symptomatic relief of organic brain dysfunctionSymptomatic relief of organic brain dysfunction

142 Ginseng Soft Cap Tonic A13143 Ginsin Cap Tonic A13144 Ginsin Syrup Tonic A13

145 Soft Cap Wemen Health V08

146 Golgripe Oral Sol A03147 Gripe mixture Oral Sol Infant carminative A03148 Gripe water Oral Sol A03149 Hemoroherb Ointment Relief of Hemoroid symptoms C05150 Herbilax Cap Laxative A06151 Hesa-A FC Tab Antineoplastic agnet L01152 Hirudoid Cream C05153 HIZEST (120ml) Mouthwash Anti bacterial ,Refresher A01154 HIZEST (240ml) Mouthwash Anti bacterial ,Refresher A01155 Honythym Syrup Antitussive, Expectorant R05156 Hypicum Cap N06157 Hypifor 425 Cap Antidepressant N06158 Hypifor250 FC Tab Antidepressant N06159 Hypiran Drop N06160 Hypiran FC Tab N06161 Immugen Syrup Immunostimulant L03162 Immunsuport Drop Immunostimulant L03163 Immustim Tab Immunostimulant L03164 Iralvex Drop Antiaphtosis D06165 Iralvex Gel Antiaphtosis D06166 Kamil Cream Antiinflammatory (Topical) D02167 Kamilan Drop Mouth wash A01168 Kamiloderm cream Antiinflammatory (Topical) D02

169 Kamisol Oral Sol A07

170 Kamoderma Oint Antiinflammatory (Topical) D02171 Lagex Cream Burn Ointment D03172 Laxaricin Emu Oil Purgative A06173 Leucorex Vaginal cream D01174 Licophar Lozenge R02175 Linoderm Cream Emolient and protective D02176 Lion Capsicum Plaster Analgesic (Topical) M02

177 Liporun Cap A05

178 Liquid menthol Drop Cold remedy R05

GMV Evening Primrose Oil 1000mg

Infant carminative & gastrointestinal antispasmodic


Precutaneous antithrombotic, Antiinflammatory

Antidepressant, Antimigraine,Sedative




Antifungal (Vaginal) ( Tricomona, Candidias & Gardenella)

Pharynge antiinflammatory, Antitussive

Supportive treatment in chronic toxic liver damage, Dyspeptic complaints

179 Livergol FC Tab A05

180 Livergol l40 FC Tab A05

181 Livomarin Cap A05

182 Lomex Drop A03183 Lubri T.D. Supp Laxative A06184 Marynthol Gel Analgesic (Topical) M02185 Masumint Chew Tab Carminative, Demulcent A03

186 Matrica Drop A07

187 Melagol Topical Gel Antiacne D10188 Melissan Top Gel (30g) Antiviral (Herpes simplex) (Topical) D06

189 Melissan Top Gel (5g) Antiviral (Herpes simplex) (Topical) D06190 Memoral FC Tab Antialzheimer N07191 Memorex Tab N06192 Menstrugol Cap Dysmenorrhea G03193 Mentha Chew Tab A03194 Mentha lotion Lotion Tension headache N06195 Menthazin Chew Tab Carminative, Demulcent A03196 MG Oint Relief of Hemoroid symptoms C05197 Migriheal Powd Antimigraine N02198 Mina sage FC Tab Hyperhydrosis D11199 Mina-detox FC Tab Cholagogue A05200 Mintagel Top Gel Antifungal (Topical) D01201 Moderic SC Tab Diuretic C03202 Musylium Sachet Laxative A06

203 Sachet Laxative A06



206 Mycocin Vaginal cream Antifungal (Vaginal) D01207 Mycoderm Lotion Topical Antifungal (Tinea versicolor) D01208 Myrtex Drop Antiaphtosis D06209 Myrtoplex Oint Antiviral (Herpes simplex) (Topical) D06

210 Soft Cap Wemen Health V07




Gastrointestinal antispasmodic, Antidiarrhea




Musylium with banana flavorMusylium with orange flavorMusylium with strawberry flavor

Natural Life Evening Primrose Oil 1000mg

211 Nervoxin Tab Antidepressant, Antimigraine,Sedative N06212 Neurogol SC Tab Sedative, Hypnotic N05213 Neurogol fort SC Tab Sedative, Hypnotic N05214 Noushdaru Powd Diuretic C03

215 Noushdaru Syrup Diuretic C03

216 Noushdaru Tab Diuretic C03

217 Nurse Harvy's Grip Mixture Oral Sol A03

218 Olea-Crat Powd Antihypertensive C02219 Origanum Powd Antiasthma & Antibronchitis R03

220 Origanum Syrup Antiasthma & Antibronchitis R03

221 Origanum Tab Antiasthma & Antibronchitis R03

222 Otrifel Powd Laxative A06

223 Otrifel Syrup Laxative A06

224 Otrifel Tab Laxative A06225 Padma 28 Tab Circulatory disorders C01226 Pasipay Drop Sedative, Hypnotic N05227 Pasival Drop Sedative, Hypnotic N05228 Passiflorin Oral sol Sedative, Hypnotic N05229 Pepercin Cream Analgesic (Topical) M02230 Perforan SC Tab Antidepressant, Antimigraine,Sedative N06231 Persica Drop Mouth wash A01232 Phenovil Powd Gastrointestinal antispasmodic A03

233 Phenovil Syrup Gastrointestinal antispasmodic A03

234 Phenovil Tab Gastrointestinal antispasmodic A03235 Phytoarthrit Cap symptoms of arthritis M01236 Phytocin Susp for Inh Cold remedy R05237 Phytocold SC Tab Supportive therapy for cold L03238 Phytoton Cap Tonic A13239 Phytoven FC Tab Symptoms of Varicose Veins C05240 Plantagel Granule Antidiarrhea A07241 Plantagel Sachet Antidiarrhea A07242 Prospan Eff Tab Antitussive, Expectorant R05

243 Prospan Syrup Antitussive, Expectorant R05

244 Prosta Pharma Syrup G04


Supportive treatment in prostatic hyperplasia

245 Prostatan Drop G04

246 Prostatan FC Tab G04

247 Prostatcin Drop G04248 Psyllium Powd Laxative A06249 Psyllium Sachet Laxative A06250 Psyllium Sachet Laxative A06251 Psyllium Granule Laxative A06252 Psyllium Sachet Laxative A06

253 Psyllium (bnana flavour) Sachet Laxative A06

254 Psyllium musciloid Powd Laxative A06

255 Psyllium orange flavored Sachet Laxative A06

256 Psyllium( orange flavour) Sachet Laxative A06

257 Pygium affricanum Soft Gel Antiprostatic hyperplasia G04258 Raha Oral sol Relief of withdrawal syndrom N02259 Rasin Chew Tab Carminative, Demulcent A03260 Recove Oint Burn Ointment D03261 Reglis moattar Granule A07262 Remicold Cap Immunostimulant L03263 Repelgol Lotion Insecticide and repellent P03264 Repelgol Topical Gel Insecticide and repellent P03265 Rosemary Oint Analgesic (Topical) M02266 Rouz-psyllium Husk Sachet Laxative A06267 Rouz-psyllium Seed Granule Laxative A06

268 Rowachol Soft Cap A05

269 Rowatinex Soft Gel Antiurolithiasis, Diuretic C03270 Salvigol SC Tab Hyperhydrosis D11271 Salvisan Top Gel R02272 Samilax Tab Laxative, Purgative A06273 Sankol Drop Antiurolithiasis, Diuretic C03274 Sedamin Cap Sedative, Hypnotic N05275 Senagole Syrup Infant Laxative, Purgative A06276 Senagraph Syrup Purgative A06277 Senalax Tab (Jar) Laxative, Purgative A06278 Senalax Tab (Blister) Laxative, Purgative A06279 Senaline Powd Laxative A06280 Senaline 7.5 SC Tab Laxative, Purgative A06




Gastrointestinal antiinflammatory,Carminative

Antiinfalmmatory in hepatitis, Anticholesistitis, Anticholelithiasis

Antiinflamatory of the mocous membranes of nose & throat

281 Shirafza Cap Lactation stimulator G03282 Shirafza Drop Lactation stimulator G03283 Shirinush Powd Gastrointestinal antiinflammatory A07

284 Silarin 70mg FC Tab A05

285 Silymarin Drop A05

286 Silymarin70 FC Tab A05

287 Slim quik FC Tab Anti appetite N07288 Sohalax FC Tab Laxative A06289 Songha Night SC Tab Sedative, Hypnotic N05

290 Spinal-Z Cap Gastrointestinal neoplastic agent L01

291 Supermint Drop A03292 Tanamigrain Cap Antimigraine N02293 Tavipec Syrup Antitussive, Expectorant R05294 Tebokan SC Tab N06

295 Teltonal 480mg FC Tab M09296 Thermorub Oint (19g) Analgesic (Topical), Decongestant R05297 Thermorub Oint (38g) Analgesic (Topical), Decongestant R05298 Thymex Drop Antitussive, Expectorant R05299 Thymex Syrup Antitussive, Expectorant R05300 Thymex Tab Antitussive, Expectorant R05301 Thymian Syrup Antitussive, Expectorant R05302 Thymicold Drop Antitussive, Expectorant R05303 Thymicold Syrup Antitussive, Expectorant R05304 Thymorant Syrup Antitussive, Expectorant R05305 Tichoke Cap Cholagogue A05306 Tragzacom Powd Hypnotic N05

307 Tragzacom Syrup Hypnotic N05

308 Tragzacom Tab Hypnotic N05309 Tranquival FC Tab Sedative, Hypnotic N05310 Tropin Powd Antiurolithiasis, Diuretic C03

311 Tropin Syrup Antiurolithiasis, Diuretic C03

312 Tropin Tab Antiurolithiasis, Diuretic C03313 Tussian Syrup Antitussive, Expectorant R05314 Tussigol Drop Antitussive, Expectorant R05315 Tussivin Drop Antitussive, Expectorant R05

Dyspeptic complaints ,Liver & gallblader complaints





Degenerative disorders of musculo- skletal system

316 Urtan Drop G04

317 Urtidine Drop G04318 Valerian Cap Sedative, Hypnotic N05319 Valeric Syrup Sedative, Hypnotic N05320 Valeric FC Tab Sedative, Hypnotic N05321 Vali Oint (20g) Burn Ointment D03322 Vali Oint (500g) Burn Ointment D03323 Vali Oint (250g) Burn Ointment D03324 Valiflor SC Tab Sedative, Hypnotic N05325 Valiris 545mg FC Tab Sedative, Hypnotic N05326 Vasogol FC Tab Mild Antihypertensive C02327 Veinovital FC Tab Symptoms of Varicose Veins C05328 Venogol Cream Symptoms of Varicose Veins C05329 Vitagnus Drop PMS & Menstrual disorders G03330 Vitagnus FC Tab PMS & Menstrual disorders G03

331 Wings Organic Heart Drops Drop C01

332 Ziabits Powd Antihyperglycemia A10

333 Ziabits Syrup Antihyperglycemia A10

334 Ziabits Tab Antihyperglycemia A10335 Zintoma Cap Motion sickness A04



Promote & support cardiovascular health

طبيعي داروهاي فهرستNatural Products' LIST

Barij Essence

Ahoura darou

Giah Essence

Gol Daru

Niak

Dineh Iran

Pars Daru

Dineh Iran

Gol Daru

Iran Darouk

Iran Darouk

Iran Darouk

Sobhan Daru

Sobhan Daru

Iran Darouk

Barij Essence

Gol Daru

Gol Daru

Gol Daru

Yas Daru

Pursina

Amin

Dineh Iran

Dineh Iran

Amin

Gol Daru

Dineh Iran

Iran Darouk

Sobhan Daru

توليد شرکتکننده

Company Name

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Pursina

Dineh Iran

Barij Essence

Tolid Daru

Gol Daru

Pursina

Gol Daru

Dineh Iran

Armansetad

Pursina

Barij Essence

Niak

Sina Darou

Sina Darou

Sina Darou

Sina Darou

Gol Daru

Darou pakhsh

Paydar Fard

Dineh Iran

Kish Medipharm

Gol Daru

Iran Darouk

Dineh Iran

Dineh Iran

Dineh Iran

Pursina

Geneian Darou

Kimiagar Toos

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Aram

Gol Daru

Golchai

Dineh Iran

Gol Daru

Gol Daru

Dineh Iran

Barij Essence

Gol Daru

Rossendarman

Iran Darouk

Gol Daru

Pursina

Razak

SOHA Helal

Tolid Daru

Cobel Darou

Barij Essence

Pursina

Dineh Iran

Niak

Tolid Daru

Ahoura darou

Khoraman

Barij Essence

Barij Essence

Giah Essence

Iran Darouk

Barij Essence

Dineh Iran

Iran Darouk

Iran Darouk

Iran Darouk

Iran Darouk

Hakim momen tabrizi

Hakim momen tabrizi

Hakim momen tabrizi

Gol Daru

Iran Darouk

Iran Darouk

SOHA Helal

Darou pakhsh

Pursina

Ahoura darou

Pursina

Dineh Iran

Golchai

Gol Daru

Iran Darouk

Iran Darouk

Barij Essence

Razak

Razak

Daru Teb Salamat

Dineh Iran

Barij Essence

Gol Daru

Gol Daru

Amin

Amin

Iran Darouk

Herbi Darou

Gol Daru

Gol Daru

Dineh Iran

Barij Essence

Dineh Iran

Herbi Darou

Tolid Daru

Ahoura darou

Gol Daru

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Tadbir Kala Jam

Gol Daru

Gol Daru

Gol Daru

Pars Minoo

Dineh Iran

Gol Daru

Herbi Darou

Osveh

Pursina

Pursina

Yas Daru

Darou pakhsh

SOHA Helal

SOHA Helal

Pursina

Pursina

Kimiagar Toos

Giah Essence

Gol Daru

Gol Daru

Gol Daru

Niak

Iran Darouk

pursina

Iran Darouk

Razak

Barij Essence

Dineh Iran

Barij Essence

Gol Daru

Barij Essence

Behnavar Iran

Ahoura darou

Pursina

Salamat Sazan Parsa

Haftruz Tejarat Tehran

Gol Daru

Gol Daru

Darou Pakhsh

Barij Essence

Tolid Daru

Razak

Ebne Masouyeh

Barij Essence

Gol Daru

Gol Daru

Gol Daru

Gol Daru

Iran Darouk

Gol Daru

Dineh Iran

Barij Essence

Ebne Masouyeh

Barij Essence

Mim Daru

Mina

Mina

Pharmashimi

Gol Daru

Iran Darouk

Iran Darouk

Iran Darouk

Iran Darouk

Gol Daru

Barij Essence

Barij Essence

Darou Pakhsh

Nedaye Mahya

Dineh Iran

Gol Daru

Gol Daru

Iran Darouk

Shafa Safe

Iran Darouk

Dineh Iran

Pursina

Abureihan

Gol Daru

Pursina

Gol Daru

Giah Essence

Gol Daru

Gol Daru

Amin

Dineh Iran

Dineh Iran

Behestan Behdasht

Behestan Behdasht

Pharmashimi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Darou Darman Sepehr

Hakim Momen Tabrizi

Hakim momen tabrizi

Hakim momen tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Gol Daru

Gol Daru

pursina

Iran Darouk

Iran Darouk

Herbi Darou

Dineh Iran

Dineh Iran

Pursina

Niak

Rouz Darou

Pursina

Zahravi

Gol Daru

Ebne Masouyeh

Pariz Marham

Iran Darouk

Ahoura darou

Gol Daru

Gol Daru

Gol Daru

Rouz Darou

Rouz Darou

Aram

Aram

Gol Daru

Gol Daru

Samisaz

Gol Daru

Gol Daru

Gol Daru

Iran Darouk

Iran Darouk

Iran Darouk

Gol Daru

Gol Daru

Gol Daru

Gol Daru

Gol Daru

SOHA Helal

Amin

Amin

Gol Daru

SOHA Helal

Daru Pakhsh

Barij Essence

Zahravi

Aria Tak Khavar

Niak

Behestan Behdasht

Tolid Daru

Tolid Daru

Iran Darouk

Iran Darouk

Iran Darouk

Mina

Amin

Amin

Razak

Gol Daru

Dineh Iran

Gol Daru

Gol Daru

Barij Essence

Elm Pharmed Ghostar

Hakim momen tabrizi

Hakim momen tabrizi

Hakim momen tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Pursina

Barij Essence

Herbi Darou

Mina

Mina

Pursina

Pursina

Pursina

Niak

SOHA Helal

Gol Daru

Dineh Iran

Gol Daru

Pursina

Pursina

Ghatreh Hayat

Gol Daru

Hakim Momen Tabrizi

Hakim Momen Tabrizi

Hakim Momen Tabrizi

apps.who.intapps.who.int/medicinedocs/documents/s21677en/s21677… · xls file · web...

Documents